{"question": "Question: Is apolipoprotein A1 overexpressed in the retina of diabetic patients?\nContext: To compare apolipoprotein A1 (ApoA1) expression in the retina from diabetic and nondiabetic donors. Case-control study. Diabetic postmortem eyes (n = 8) were compared with eyes (n = 8) from nondiabetic donors matched by age. Messenger ribonucleic acid (mRNA) of ApoA1 (quantitative reverse-transcriptase polymerase chain reaction) was measured separately in the neuroretina and retinal pigment epithelium (RPE). ApoA1 was assessed by immunofluorescence (confocal laser microscopy) and Western blot analysis. The presence of early diabetic retinal damage was evaluated by measuring the rate of apoptosis and glial activation. ApoA1 mRNA levels and ApoA1 immunofluorescence obtained in RPEs and in neuroretinas from diabetic donors were significantly higher than those obtained from nondiabetic donors. ApoA1 was expressed in all retina layers and it was more abundant in RPE than in the neuroretina in both diabetic and nondiabetic donors. In addition, ApoA1 immunofluorescence was significantly higher in all the layers of the neuroretina from diabetic patients. Densitometric analysis of immunoblots showed higher ApoA1 in the retinas from diabetic donors in comparison with nondiabetic donors, but the differences were at significant levels only for the RPE.", "answer": "ApoA1 overexpression is an early event in the retina of diabetic patients and can be involved in the physiopathology of diabetic retinopathy. In addition, RPE is the main source of ApoA1 within the retina. These findings my be relevant to aiming new treatment strategies toward reducing the development of diabetic retinopathy.\n\nyes"}
{"question": "What is the purpose of the electroretinogram (ERG) in evaluating retinal function ?", "answer": "The electroretinogram (ERG) is a valuable test used to assess the functioning of the retina in response to a light stimulus. It measures the biopotential generated by the retina and is commonly employed to investigate the normal state of the retina, as well as any alterations resulting from pathology, aging, or intoxication. The ERG has been particularly useful in detecting the effects of neuroactive substances on retinal function, examining the long-term consequences of such substances on the retina's functional integrity, and exploring potential reversibility of these effects."}
{"question": "How does the electrical stimulation therapy affect retinal safety ?", "answer": "Electrical stimulation therapy is a treatment method that involves the application of electrical currents to the retina. It is used to elicit visual perceptions in individuals with retinal degenerative diseases. The safety of this therapy is a crucial concern in clinical ophthalmology. Various studies have investigated the impact of electrical stimulation therapy on retinal safety. One aspect of safety is the potential for tissue damage caused by electrical currents. It is essential to consider the parameters of the electrical stimulation, such as current intensity and duration, to minimize any adverse effects on the retina. Additionally, the placement of electrodes plays a significant role in ensuring safety during the therapy. Proper electrode positioning and implantation techniques are crucial to avoid complications and potential damage to the retina. Another safety consideration is the long-term effects of electrical stimulation therapy. While the therapy can provide visual perception, it is important to monitor for any signs of retinal damage or adverse reactions over time. This includes assessing changes in retinal function and evaluating the stability of the therapy's benefits. To ensure retinal safety during electrical stimulation therapy, ophthalmologists must carefully select appropriate candidates for the treatment. Pre-treatment evaluations, including comprehensive ophthalmic examinations and functional assessments, can help identify individuals who are more likely to benefit from the therapy while minimizing potential risks. It is worth noting that the information provided here is a general overview of the safety considerations related to electrical stimulation therapy in clinical ophthalmology. For more detailed guidance and specific protocols, referring to specialized ophthalmology books and resources is recommended."}
{"question": "Question: Does road traffic accidents and diabetes : insulin use determine risk?\nContext: Progressive restrictions placed on insulin-treated patients with diabetes exclude them from driving group 2 and class C1 and D1 vehicles. This reflects an assumption that an increased risk of hypoglycaemia in these patients will cause road traffic accidents. These restrictions have been implemented without any consistent evidence that this is the case. The aim of the study was therefore to investigate whether the rate of road traffic collisions in insulin-treated patients was higher than that of the non-diabetic population using a population register-based study. A historical cohort study combined information from the Devon and Cornwall Constabulary database on road traffic collisions with the district wide retinal screening database, to provide an anonymized matched database of road traffic collisions in the diabetic population. Accident rates were calculated in the diabetic population and compared to rates in the non-diabetic population using relative risks. The estimated overall annual accident rate for the non-diabetic population was 1469 per 100,000 vs. 856 per 100,000 for the diabetic population as a whole (Chi-squared, P < 0.001). On stratification of the groups by age, within the insulin-treated group there was no significant difference in the accident rate compared to the non-diabetic population, with relative risks between 0.51 [confidence interval (CI) 0.25-1.05] and 1.13 (CI 0.88-1.46).", "answer": "Our findings suggest that insulin-treated patients as a group do not pose an increased risk to road safety. They reiterate the need for an individualized risk-based assessment when considering driving restrictions.\n\nno"}
{"question": "Question: An 18-year-old woman is referred to your clinic after branch retinal aery occlusions occurred in each eye several months apa. Examination reveals moderate hearing loss in the right ear, in addition to visual field loss in each eye. A brain MRI reveals multiple small coical strokes in the frontal lobes and the left parietal lobe. Which of the following diagnosis fits best with this clinical presentation?\nOptions:\nA. Multiple sclerosis\nB. Susac syndrome\nC. Acute disseminated encephalomyelitis\nD. Conversion reaction\n", "answer": " Whenever multi-system involvement, vasculitis can be the cause (here in the question moderate hearing loss, visual field loss, multiple coical strokes so vasculitis can be the cause) Option A- Presents with OPTIC NEURITIS, doesn't involve the Retinal circulation and hearing. Option B- Susac syndrome is a type of vasculitis involving BRAIN, EYE, EAR Option C- It is a complication of vaccines e.g. RABIES vaccine. Susac syndrome Characterized by three main problems: Impaired brain function (encephalopathy) Paial or complete blockage (occlusion) of the small aeries and capillaries that supply blood to the retina ( BRAO) Inner ear disease (hearing loss, most notably). MRI of the brain typically reveals \"snowball\" lesions in the corpus.\n\nOPTION B IS CORRECT."}
{"question": "Question: Does lentivirus vector-mediated knockdown of erythropoietin-producing hepatocellular carcinoma receptors B4 inhibit laser-induced choroidal neovascularization?\nContext: To evaluate the efficacy of erythropoietin-producing hepatocellular carcinoma receptors B4 (EphB4) knockdown on the development of laser-induced choroidal neovascularization (CNV) in vivo. We constructed recombinant lentiviral vectors (Lv) Lv-shRNA-EphB4 to specifically knock down the expression of EphB4. The mRNA and protein expression of EphB4 was investigated by real-time reverse transcription-polymerase chain reaction (RT-PCR) and western blot. CNV was induced by laser photocoagulation in C57BL/6 mice. The mice were then randomly assigned to be intravitreally injected with phosphate-buffered saline (PBS), Lv-shRNA-EphB4 recombinant lentivirus, or an unrelated shRNA recombinant lentivirus (pFU LV-shRNA-NC). An uninjected group was used as the control. Fundus fluorescein angiography (FFA), histologic analysis, and choroidal flat mounts analysis were applied to evaluate the inhibition of CNV after an intravitreal injection. Transfection of Lv-shRNA-EphB4 led to the knockdown of EphB4, and EphB4 mRNA was down-regulated by about 80%. FFA and histologic analysis revealed that the leakage areas and the mean thickness of CNV were much smaller in the Lv-shRNA-EphB4 group than in the PBS-treated, pFU Lv-shRNA-NC group and the non-injection group. Choroidal flat mounts showed significantly less leakage and smaller leakage areas in the Lv-shRNA-EphB4 group than those in other groups.", "answer": "Knocking down the expression of EphB4 exerts an inhibitory effect on CNV in vivo. It may provide a potential strategy for the treatment of CNV.\n\nyes"}
{"question": "Specialized clinical ophthalmology question: What are the typical characteristics and developmental changes of the eye in a neonate ?", "answer": "In a neonate, the eye undergoes several characteristic changes and developmental milestones. Here are the sequential steps an ophthalmologist should consider when evaluating the eye of a neonate: 1. Orbital Anatomy: Recognize that the growth and development of the skull and facial bones lead to significant changes in orbital anatomy. The roof becomes flatter and larger in infants compared to adults. The inner angle of the orbit becomes more divergent with advancing age. 2. Palpebral Fissure: Note that the length and height of the palpebral fissure in a neonate are smaller compared to an adult eye. The length ranges from 18.5 to 19 mm, while the height measures around 10 mm. 3. Extraocular Muscles: Understand that the development of extraocular muscles continues after birth. The insertions of the medial rectus and lateral rectus are closer to the equator, while those of the superior oblique and inferior oblique are closer to each other compared to adult eyes. 4. Retina: Be aware that the macula lutea, responsible for central vision, is least developed at birth. However, the foveal reflex is fully established by 42 weeks of gestational age. 5. Lacrimal Apparatus: Recognize that both secretory and excretory functions of the lacrimal apparatus are operational at birth. The development of the nasolacrimal duct is complete at birth. 6. Crystalline Lens: Note that the crystalline lens in a neonate is almost spherical and soft in consistency. 7. Refractive Error: Understand that approximately 80% of children are born hypermetropic. Furthermore, 71% of them have a + cylinder at 180°. 8. Cornea: Acknowledge that the cornea in a newborn is relatively large and reaches adult size by the age of 2. During the first year, the cornea undergoes changes such as enlargement, flattening, thinning, and an increase in transparency. 9. Anterior Chamber (AC): Consider that the angle of the anterior chamber undergoes differentiation during the first year of life. After birth, the endothelial cell lining of the angle becomes fenestrated. 10. Iris and Pupil: Note that at birth, the anterior surface of the iris may"}
{"question": "Question: All are pas of the anterior segment of eye except\nOptions:\nA. Lens\nB. Cornea\nC. Vitreous\nD. None\n", "answer": " Anterior segment of the eye consists of a crystalline lens, & structures anterior to it, viz., iris, cornea & two aqueous filled spaces- anterior and posterior chamber Vitreous is a posterior segment structure, which is situated posterior to lens, like vitreous humor, retina, choroid & optic disc Reference : A K KHURANA Comprehensive Ophthalmology edition 6, page-3\n\nOPTION C IS CORRECT."}
{"question": "Question: Is rPE65 essential for the function of cone photoreceptors in NRL-deficient mice?\nContext: Phototransduction in cones is initiated by the bleaching of their visual pigment, which comprises a protein component-cone opsin-and a vitamin A derivative-11-cis retinal. Little is known about the source of 11-cis retinal for cones. In the current study, neural retina leucine zipper-deficient (Nrl(-/-)) and rod opsin (Rho(-/-))-deficient mice were used, two mouse models that have been described as having a \"cone-only\" retina, to analyze the retinoid metabolism of cones. In addition, these mice were bred to retinal pigment epithelial protein 65 (Rpe65(-/-))-deficient mice to study the role of RPE65. Mice were analyzed using morphology, Western blot analysis, immunohistochemistry, electroretinography (ERG), and retinoid profiling by HPLC. In comparison to wild-type mice, the retina of Nrl(-/-) mice contained elevated levels of RPE65 and cellular retinaldehyde-binding protein (CRALBP), suggesting a particular role of these two proteins for the retinoid metabolism of cones. In Nrl(-/-) mice, different retinoid species were present in proportions similar to wild type. Ablation of RPE65 in Nrl(-/-) and Rho(-/-) mice led to the absence of 11-cis retinal, but increased the total retinoid content, with retinyl esters representing the most abundant retinoid species. In the absence of RPE65, retinal sensitivity in Nrl(-/-) mice dropped by a factor of a thousand.", "answer": "The data show that RPE65, previously shown to be essential for rod function, is also indispensable for the production of 11-cis retinal for cones and thus for cone function.\n\nyes"}
{"question": "How is the optic vesicle formed in cephalopods ?", "answer": "In cephalopods, the optic vesicle is formed through invagination of the epithelium. This invaginated epithelium gives rise to the optic vesicle, which is lined by the retina. Additionally, the invagination also contributes to the formation of the posterior layer of the \"ciliary body\" as well as the posterior part of the lens."}
{"question": "What are some potential complications associated with epiretinal membrane (ERM) surgery ?", "answer": "Epiretinal membrane (ERM) surgery has shown favorable visual outcomes in the majority of cases, with a significant improvement in visual acuity (VA) and reduction of distortion. However, there are potential complications associated with this procedure. Some of the reported complications include intraoperative detection of retinal breaks, intraretinal bleeding after ERM removal, postoperative progressive nuclear sclerosis, retinal detachment, macular edema, retinal pigment epitheliopathy, and recurrence of ERM. These complications may occur to varying degrees and should be considered when evaluating the risks and benefits of ERM surgery."}
{"question": "What are the characteristics and pathogenesis of lattice degeneration in the retina ?", "answer": "Lattice degeneration is a peripheral retinal degenerative condition characterized by sharply demarcated, oval or round areas of retinal thinning, typically measuring 1-3 mm in diameter. These areas often exhibit vitreous liquefaction and exaggerated vitreoretinal attachments along their edges. Additional features of lattice degeneration may include white lines resembling a lattice pattern, speckled foci of proliferating retinal pigment epithelial cells, small white-yellow particles at the margin of the lesion, and punched-out areas of extreme retinal thinning or excavations. The pathogenesis of lattice degeneration is not fully understood, but it is believed to involve various factors. It has been proposed that mechanical forces exerted by the vitreous base during ocular movements may contribute to the formation of retinal tears at the junction between the atrophic strip and adjacent normal retina. Developmental anomalies of the internal limiting membrane, vitreous traction, embryologic vascular anastomosis, choroidal abnormalities, and ischemic atrophy in the peripheral vascular arcades have also been suggested as possible causes. While lattice degeneration is considered a risk factor for rhegmatogenous retinal detachment (RRD), it is important to note that the majority of patients with lattice degeneration do not develop retinal detachment, and the presence of lattice degeneration is only associated with around 30% of phakic RRD cases. Therefore, prophylactic treatment for lattice degeneration is not universally recommended. However, in cases where lattice degeneration is present in the fellow eye of a patient with a history of RRD, and if visual function is poor in that eye or the patient has limited access to ophthalmic care, prophylactic cryotherapy or photocoagulation may be considered. Additionally, if lattice degeneration is associated with myopia or if the patient exhibits symptoms or abnormalities in the peripheral retina, further intervention may be warranted. It is crucial to individualize the treatment approach based on the patient's specific clinical characteristics and needs."}
{"question": "What is the appropriate treatment for vitreous hemorrhage ?", "answer": "The appropriate treatment for vitreous hemorrhage depends on the density, location, extent, and associated fibrous changes. Mild subhyaloid hemorrhage may not require any specific treatment, while dense subhyaloid hemorrhage may require intervention. In cases of severe vitreous hemorrhage, treatment options may include surgical removal of the hemorrhage, laser therapy, or medication to address underlying causes such as retinal tears or diabetic retinopathy. However, the specific treatment plan should be determined by an ophthalmologist based on a thorough evaluation of the patient's condition."}
{"question": "Question: Is n-methyl-N-nitrosourea-induced retinal degeneration in mice independent of the p53 gene?\nContext: A single systemic administration of N-methyl-N-nitrosourea (MNU) causes retinal degeneration involving photoreceptor cell loss within 7 days. MNU-induced photoreceptor cell loss is due to apoptosis and is a reliable animal model for human retinitis pigmentosa. The purpose of this study was to determine if p53 contributes to the development of MNU-induced retinal degeneration in mice. Eight-week-old p53(-/-), p53(+/-), and p53(+/+) mice received an intraperitoneal injection of 60 mg/kg bodyweight of MNU. Age-matched p53(+/+) mice received the vehicle only (physiologic saline containing 0.05% acetic acid). Mice were sacrificed and necropsied 7 days after the treatment. Both eyes were examined histologically and morphometrically to determine retinal thickness, photoreceptor cell ratio, and retinal damage ratio. No mice died during the experiment, but the p53 null mice treated with MNU had a statistically significant weight loss compared to the other groups. Histologically, all MNU-treated mice, regardless of p53 gene status, experienced retinal degeneration characterized by photoreceptor cell loss (the disappearance of the outer nuclear layer and photoreceptor layer) in both the central and peripheral retina. All MNU-treated mice had significantly decreased retinal thickness and photoreceptor cell ratios at the central and peripheral retina and an increased retinal damage ratio compared to the vehicle-treated control. The retinal changes caused by MNU in p53(+/+), p53(+/-), and p53(-/-) mice were not significantly different and hence were related to a p53-independent apoptotic mechanism.", "answer": "Because the absence of p53 did not prevent photoreceptor cell loss, we conclude that p53 is not essential for MNU-mediated photoreceptor cell degeneration.\n\nyes"}
{"question": "Question: Hello doctor,I have Best\\s disease and am currently undergoing injections in my left eye and it is improving. I have now been told that my right eye has a full blown macular hole but surgery may not help. Why not?", "answer": "Hello. There are two surgical outcomes of a macular hole surgery. Anatomical correction, that is, whether the gap (hole) that has formed will be filled again or not. Usually, it has 90 percent chances in a macular hole surgery. Functional correction, that is, how many functional retinal cells remain there or who again take part in bridging that hole. This functional correction depends on the timing of the surgery, that is, how old is the hole. Older the hole, poor is recovery. Also, it depends on the grade of the hole. More the grade, poorer the recovery. Your hole is old and as you said full-blown (which I am assuming grade 4), and also there is a concomitant Best disease which primarily affects retina and macula. So, combining all these factors makes surgery a less likely intervention. For more information consult an eye care ophthalmologist online "}
{"question": "Question: YAG laser capsulotomy is used in -\nOptions:\nA. Retinal detachment\nB. Diabetes\nC. After- cataract\nD. Refractive errors\n", "answer": " Posterior capsular opacification (after cataract or secondary cataract) is the most common late complication of uncomplicated cataract surgery. Pattern of opacification: the ring of sommerring and the elschnig pearls Treatment involves the creation of an opening in the posterior capsule, termed a capsulotomy, with the Nd: YAG laser. (photodisruption) Ref: kanski's clinical ophthalmology , 8th edition , page no.293\n\nOPTION C IS CORRECT."}
{"question": "Question: Homonymous hemianopia is seen in -a) Pituitary adenomab) Optic nerve damagec)  Post chiasmic damaged) Cortical lesion\nOptions:\nA. ab\nB. bc\nC. cd\nD. ac\n", "answer": " Homonymous hemianopia occurs due lesion behind the optic chiasma (post chiasmatic lesions) because visual pathway beyond optic chiasma contains fibres from temporal half of ipsilateral retina and nasal half of opposite retina. So, homonymous hemianopia can occur in lesions of optic tract, lateral geniculate body, total optic radiation, anterior occipital cortex.\n\nOPTION C IS CORRECT."}
{"question": "Question: Does training regimen involving cyclic induction of pupil constriction during far accommodation improve visual acuity in myopic children?\nContext: Myopia in school-age children has become increasingly prevalent in industrialized countries, especially in Asia. A large population of school-age children still suffers from low visual acuity. We have developed a novel, safe and noninvasive training method to activate a pupillary constriction response during far accommodation that results in improved visual acuity. Myopic children (n = 95) were treated for 3-minute sessions up to twice a week for 12-106 weeks. We stimulated quick cycles of near/far accommodation by displaying a visual object on a LCD screen and moving the screen in cycles from a near (25 cm) to a far (70 cm) point and back, while keeping the retinal projection size and brightness of the object constant. Mechanistically, we noted pupillary constriction upon far accommodation in trained myopic children, which was not seen in normal subjects or in untrained myopic children. Eighty five percent (52/61) of trained myopic right eyes with two sessions weekly experienced improved visual acuity (VA) by more than 0.1 logMAR units with an average improvement of 0.30 +/- 0.03 standard error of mean (SEM) logMAR units. With maintained training, most eyes' improved VA stayed almost constant, for more than 50 weeks in the case of 12 long trained subjects.", "answer": "This simple, short and safe accommodation training greatly improves the quality of vision in a large population suffering from refractive abnormalities.\n\nyes"}
{"question": "Question: What is the treatment of threshold ROP?\nOptions:\nA. laser photocoagulation\nB. slow reduction in oxygen\nC. retinal reattachment\nD. antioxidants\n", "answer": " Ans is 'a' i.e. Laser Photocoagulation Threshold disease in ROP is defined as stage 3+ ROP in Zones 1 or 2 occupying at least five contiguous clock-hours or eight noncontiguous clock-hours of retina.Treatment of threshold disease is Laser Photocoagulation.'Laser therapy has largely replaced cryotherapy because visual and anatomical outcomes are superior and laser induces less myopia. \" -Kanski 6/e p610Other options:Antioxidants like vit E and slow reduction in 02 has no role in established ROP (threshold disease in our patient); although both are mentioned in few texts for prevention of ROP and even that is not well proven.Retinal reattachment is required when retina is detached like in stage 4 and 5 while Threshold disease is Stage 3 + disease.Also know:\"Low birth weight and decreased gestational age are now considered the primary causative factors for ROP. Supplemental oxygen administration which was for a long time considered as the important causative factor is now considered only a risk factor. \" - Khuran Ophthalmology 4/e p264 \"ROP is confined to those with a birth weight of under 1.5 kg and/or a gestational age of under 32 wks. \"- Parson 21/e P310 The hallmark of retinopathy of prematurity (ROP) is abnormal retinal vasculature. Ophthalmologists diagnose and make decisions about the initial treatment of ROP based on the appearance of the retinal blood vessels. Dilatation and tortuosity of the retinal vessels at the posterior pole is termed 'plus' disease. It is a sign of rapidly progressive ROP and is an indication for early laser ablation of the peripheral avascular retina.Retinopathy of prematurity (ROP)ROP is a bilateral proliferative retinopathy that develops in premature infants due to incomplete vasculogenesis of retina at the time of birth.During normal retinal development, vessels migrate from the optic disc to the ora serrata beginning at 16weeks of gestation. Capillary network is formed differentiating into mature vessels which extend to nasal ora by 36 wks and tangential ora by 39-41 wks.The pathogenesis of ROP begins with premature birth. Exposure of extrauterine environment causes phases of hyperoxia-vasocessation (obliteration of retinal vessels) and hypoxia-Vaso proliferation (neovascularization). VEGF is thought to be the most important molecule involved in the neovascularization.Neovascularization leads to retinal and vitreous changes which ultimately lead to retinal detachment.Classification of ROP:ROP is described using a number of parameters. These are location of the disease into zones (1, 2, and 3), the circumferential extent of the disease based on the clock hours (1-12), the severity of the disease (stage 1-5) and the presence or absence of \"Plus Disease\".Classification on the basis of severity, ROP is divided into 5 stages:-Stage I- the first sign of ROP (stage 1) is the appearance of a thin, fiat, white structure (termed a demarcation line) at the junction of vascularized retina posteriorly and avascular retina anteriorly.Stage II- the demarcation line develops into a pink or white elevation (ridge) of thickened tissueStage III- proliferation of vessels over the ridge and into vitreous (extra vitreal fibrovascular proliferation)Stage IV- partial retinal detachmentIVa- partial detachment with macular sparing IVb- partial detachment with macula involvedStage V- total retinal detachmentClassification on basis of anatomical location:-Since there is a direct correlation between severity of disease and amount of avascular retina, the location of the border between vascularized and avascular retina is an important prognostic sign.3 zones are divided to describe the location of ROP. Location of the border in zone 1 is the most severe disease and in zone 3 least.Zone 1 is defined as a circle, the center of which is the disc, and the radius of which is twice the distance of the disc to the fovea.Zone 2 is a doughnut-shaped region that extends from the anterior border of Zone 1 to within one disc-diameter of the ora serrata nasally and to the anatomic equator temporally.Zone 3 encompasses the residual temporal retina.Plus disease:- As ROP progresses, more and more shunting occurs in the neovascular tissue at the retinal vascular- avascular junction. This increased retinal vascular blood flow results in dilation and tortuosity of the major retinal arteries and veins in the posterior pole - described as \"plus disease\". Plus disease is the hallmark of rapidly progressive ROP and is notated by adding a plus sign after the number of the ROP stage.Management:Most of the cases (approx. 80%) of ROP resolve spontaneously, hence intervention is chosen according to the below given protocol.ROP is divided into Threshold and Pre threshold disease.Threshold disease: It is defined as stage 3+ ROP in Zones 1 or 2 occupying at least five contiguous clock-hours or eight noncontiguous clock-hours of retina.Treatment of Threshold disease is - Laser photocoagulation.Pre threshold disease is divided into 2 types:High risk or Type I - treatment is Laser photocoagulationLow risk or Type II - treatment is Weekly or Twice weekly observationType 1 Pre thresholdType 2 Pre thresholdZone I ROP (any stage) + Zone I, Stage 3 Zone II, Stage 2/3 +Zone I, Stage 1/2 - Zone II, Stage 3 -Laser PhotocoagulationWeekly or Twice weekly observationROP diseases less severe than Pre threshold are followed up.In this question, the child with zone 1, stage II 'plus' ROP falls into Pre threshold disease- Type 1 or high risk type, hence Laser Photocoagulation would be the management of choice.\n\nOPTION A IS CORRECT."}
{"question": "Question: Is choriocapillaris Non-Perfusion Associated with Poor Visual Acuity in Eyes with Reticular Pseudodrusen?\nContext: To study choriocapillaris blood flow in age-related macular degeneration (AMD) using optical coherence tomography angiography (OCTA) and study its correlation to vision (VA) in eyes with reticular pseudodrusen (RPD) versus those with drusen without RPD (drusen). Cross-sectional study METHODS: Patients with either drusen or RPD in early AMD underwent OCTA imaging of the superior, inferior, and/or nasal macula. We quantified \"percent choriocapillaris area of non-perfusion\" (PCAN) in eyes with RPD versus those with drusen. We assessed the repeatability of PCAN and its correlations with VA. Twenty-nine eyes of 26 patients with RPD and 21 eyes of 16 age-matched AMD patients with drusen were included. Qualitatively, the choriocapillaris in areas with RPD showed focal dark regions without flow signal on OCTA (non-perfusion). The repeatability coefficient of PCAN was 0.49%. Eyes with RPD had significantly greater PCAN compared to eyes with drusen (7.31% and 3.88%, respectively; P < 0.001). We found a significant correlation between PCAN and VA for the entire dataset (r = 0.394, P = 0.005). When considering eyes with RPD separately, this correlation was stronger (r = 0.474, P = 0.009) but lost significance when considering eyes with drusen separately (r = 0.175, P = 0.45).", "answer": "Eyes with RPD have significantly larger areas of choriocapillaris non-perfusion compared to eyes with drusen and no RPD. The correlation between PCAN and VA in this RPD population provides a potential mechanistic explanation for vision compromise in RPD compared to other forms of drusen in AMD.\n\nyes"}
{"question": "Question: Is oPA1 , the disease gene for autosomal dominant optic atrophy , specifically expressed in ganglion cells and intrinsic neurons of the retina?\nContext: Autosomal dominant optic atrophy is a hereditary disorder characterized by progressive loss of vision and caused by mutations in a dynamin-related gene, OPA1, which translates into a protein with a mitochondrial leader sequence. In this study the OPA1 gene and its protein were localized in the rat and mouse retina, and its rat orthologue, rOpa1, was identified. The rOpa1 cDNA was isolated by using reverse transcribed cDNA from total RNA obtained from a rat retinal ganglion cell line. The spatial and temporal expression patterns of OPA1 and its gene product were investigated by RNA in situ hybridization and immunohistochemistry in mouse and rat retinas. To characterize further the OPA1-positive neurons, retinal ganglion cells were retrogradely labeled by an immunogold fluorescent tracer or double labeled with OPA1 and choline acetyltransferase or calbindin antibodies. Protein sequence alignment revealed a 96% identity between rat and human OPA1 mRNA. OPA1 expression was found as early as postnatal day 3 in the developing rodent retina. In the mature retina, the OPA1 gene and its protein were found not only in retinal ganglion cells, but also in starburst amacrine cells and horizontal cells, both of which are involved in lateral signal processing within the retina. However, OPA1 was absent from mitochondria rich nerve fibers and photoreceptor indicating a specific role for OPA1 in signal processing rather than in the requirement of mitochondrial energy supply in the retina.", "answer": "The data suggest an important and specific function of the OPA1 protein, not only in the optic nerve forming ganglion cells but also in the intrinsic signal processing of the inner retina.\n\nyes"}
{"question": "Question: Maximum cones are seen in:\nOptions:\nA. Limbus\nB. Fovea centralis\nC. Macula lutea\nD. Blind spot\n", "answer": " Optic disc, 1.5 mm in size, is responsible for blind spot of Mariotte Rods and cones are sensory end organs of vision Rods are absent in the foveal region. Ganglion cell layer is thickest in the macular region. Foveola is the most sensitive pa of retina. It contains only cones and their nuclei covered by a thin internal limiting membrane. There are 3 types of cones Red (maximum number) 65% Green Blue (least number) Cones are packed and tight mosaic hexagonal cells Visual acuity depends upon the density of cone mosaic\n\nOPTION B IS CORRECT."}
{"question": "What is the risk factor for the development of subretinal fibrosis in patients with diabetic macular edema ?", "answer": "One of the strongest risk factors for the development of subretinal fibrosis in patients with diabetic macular edema is the presence of very severe hard exudates. In a study conducted by Fong in 1997, it was found that patients with diabetic macular edema who had very severe hard exudates were more likely to develop subretinal fibrosis. Hard exudates are lipid deposits that can accumulate in the retina due to leakage from damaged blood vessels. The exact mechanism by which these exudates contribute to the development of subretinal fibrosis is not fully understood, but their presence serves as an important clinical indicator for increased risk. Regular monitoring and timely intervention in patients with diabetic macular edema and severe hard exudates can help in early detection and management of subretinal fibrosis to prevent further visual impairment."}
{"question": "Discuss and draw a diagram of rods and cones ?", "answer": "Rods and cones are two types of photoreceptor cells found in the retina of the eye. They play a crucial role in our visual perception by converting light into electrical signals that can be interpreted by the brain. 1. Rods: - Rods are responsible for vision in low-light conditions, such as during nighttime or in dimly lit environments. - They are more numerous than cones, with approximately 120 million rods in the human retina. - Rods are highly sensitive to light and can detect even small amounts of it. - They are located mainly in the peripheral regions of the retina. - Rods are responsible for our perception of black and white, as well as shades of gray. - They do not provide sharp visual details or color vision. - Rods contain a pigment called rhodopsin, which is sensitive to dim light. 2. Cones: - Cones are responsible for vision in bright light conditions and for color vision. - They are less numerous than rods, with approximately 6 million cones in the human retina. - Cones are mainly concentrated in the central region of the retina called the fovea. - There are three types of cones: red, green, and blue, each sensitive to different wavelengths of light. - Cones provide us with detailed and sharp visual perception, as well as the ability to perceive colors. - They contain different types of pigments that respond to specific colors of light. - Cones are less sensitive to light compared to rods. Diagram: ``` | Cones | _____|_________| | | | Rods | |______________| ``` In the diagram, the cones are depicted as a smaller section compared to rods since they are concentrated in the central region of the retina. The rods surround the cones, mainly occupying the peripheral regions. This arrangement allows for a combination of rod and cone inputs to provide us with a comprehensive visual perception in varying light conditions."}
{"question": "Question: Does development-related splicing regulate pituitary adenylate cyclase-activating polypeptide ( PACAP ) receptors in the retina?\nContext: The ubiquitous pituitary adenylate cyclase-activating peptide (PACAP) has a disparate array of functions in development (e.g., proliferation and apoptosis). Among three types of PACAP receptor (VPAC1, VPAC2, and PAC1), PAC1 is subject to alternative splicing that generates isoforms. Although the literature documenting the presence of PACAP receptors in the central nervous system is vast, their expression during development has not been established yet. Here, we performed quantitative analyses on the expression of PACAP receptors during the postnatal development of the rat retina. Retinas were harvested from postnatal days 0 to 20 (P0-P20). Using a comprehensive primer system, expression changes were followed employing quantitative real-time PCR. Changes at the protein level were detected by immunoblotting using anti-VPAC1, -VPAC2, and -PAC1 receptor antibodies. The expression of VPAC1 showed increases at P10 and P15. Peaks in VPAC2 expression were observed at P5 and P15. Using splicing variant-specific primers for PAC1 receptor, splicing regulation of Null, Hip, Hop1, and Hiphop1 variants was revealed in correlation with postnatal development. Transcript levels of the Null and Hip variants showed a decline, while Hop1 became the major PACAP receptor by P20. Hiphop1 transcript levels did not display remarkable changes except for a transient increase at P10. Immunoblotting confirmed the presence and expression level changes of the receptors.", "answer": "We conclude that both VPAC1 and VPAC2 could have roles at all stages of retinal development, that PACAP acts through a specific set of PAC1 isoforms, and that Hip and Hop1 are predominantly involved in the postnatal development of rat retina.\n\nyes"}
{"question": "What are the possible treatments or the best therapy for an eye disease related to retinal image formation and sampling ?", "answer": "The context provided discusses the formation of the retinal image and the principles of geometrical optics in the paraxial domain. It does not specifically mention any eye disease related to retinal image formation and sampling. However, some common eye diseases that can affect the retinal image formation and sampling include retinal detachment, macular degeneration, and diabetic retinopathy. The treatment for these eye diseases would depend on the specific condition and its severity. In the case of retinal detachment, surgical intervention is often necessary to reattach the retina to the underlying tissue. This can be done through various procedures such as scleral buckling, vitrectomy, or pneumatic retinopexy. For macular degeneration, treatment options include anti-vascular endothelial growth factor (anti-VEGF) injections, photodynamic therapy, and laser photocoagulation. These treatments aim to slow down the progression of the disease and preserve vision. In the case of diabetic retinopathy, treatment may involve laser photocoagulation to seal off leaky blood vessels or injections of anti-VEGF medications. In advanced cases, vitrectomy surgery may be required to remove blood or scar tissue from the retina. It is important to note that the best therapy for an eye disease related to retinal image formation and sampling should be determined by an ophthalmologist or retina specialist after a thorough examination and assessment of the individual patient's condition. The treatment plan may also be tailored to the specific needs and preferences of the patient. References: 1. American Academy of Ophthalmology. Retinal Detachment. Available at: https://www.aao.org/eye-health/diseases/retinal-detachment 2. American Academy of Ophthalmology. Age-Related Macular Degeneration. Available at: https://www.aao.org/eye-health/diseases/amd-macular-degeneration 3. American Academy of Ophthalmology. Diabetic Retinopathy. Available at: https://www.aao.org/eye-health/diseases/diabetic-retinopathy"}
{"question": "What is the treatment for Purtscher's retinopathy ?", "answer": "The treatment for Purtscher's retinopathy is supportive and focuses on addressing the underlying medical conditions. There is no specific treatment for Purtscher's retinopathy itself. The ischemic retinal patches and hemorrhages will gradually resolve over time. The final visual outcome depends on the extent of retinal involvement, with visual acuity ranging from normal to severely reduced. It is important to conduct a systemic evaluation to assess for other injuries or underlying medical conditions, such as acute pancreatitis, autoimmune disorders, pregnancy, renal function, and thrombotic thrombocytopenic purpura."}
{"question": "Question: Are melanopsin-expressing retinal ganglion cells more injury-resistant in a chronic ocular hypertension model?\nContext: To investigate the survival of melanopsin-expressing retinal ganglion cells (mRGCs) after the induction of chronic ocular hypertension. Intraocular pressure (IOP) was elevated in adult Sprague-Dawley rats using an argon laser to photocoagulate the episcleral and limbal veins. IOP was measured with a calibrated tonometer and monitored for a period. Seven days before the animals were killed, a piece of sterile foam soaked with gold fluorescent dye was placed onto the superior colliculus (SC) to label the SC-projecting retinal ganglion cells (scRGCs) retrogradely. mRGCs were visualized by free floating immunohistochemistry on whole-mounted retinas. The number of surviving scRGCs and mRGCs were counted on flatmounted retinas. The branching pattern of dendrites and soma size of mRGCs were examined. An approximately 1.7-fold increase of IOP and a significant loss of scRGCs were found in experimental eyes after laser photocoagulation. However, no significant cell loss or morphologic changes on mRGCs and their dendrites after the induction of chronic ocular hypertension are noticed over a 12-week period.", "answer": "Although the degeneration of retinal ganglion cells (RGCs) is a major concern in glaucomatous damage, the findings show that mRGCs are less susceptible to death after the induction of chronic ocular hypertension. This result indicates that mRGCs carry some unique properties that are different from those of other subpopulations of RGCs. The immunohistochemistry approach can be used to distinguish easily these mRGCs from other subtypes. This method provides a useful tool to investigate their injury-resistant properties that are informative for the development of effective neuroprotective treatment for glaucoma.\n\nyes"}
{"question": "Question: Does observer experience improve reproducibility of color Doppler sonography of orbital blood vessels?\nContext: The study investigated the reproducibility of orbital blood flow measurements with color Doppler imaging (CDI) at different stages of observer experience. The subjects were 31 healthy volunteers and 2 sequential groups of 25 glaucoma patients each. Repeated blood flow measurements (usually 3 sets) in orbital vessels (ophthalmic artery, short posterior ciliary arteries, central retinal artery, and central retinal vein) were performed by the same observer in a single session in each subject. The parameters with the best reproducibility were the resistance index (mean coefficient of variation [COV], 3.3-8.8%), the peak systolic velocity (mean COV, 6.9-13.7%), the time-averaged velocity (mean COV, 7.2-16.0%), and the systolic acceleration time (mean COV, 8.8-12.3%). The mean COV was greater (9.9-20.3%) for the other arterial flow parameters (end-diastolic velocity and systolic acceleration) and for the venous flow velocities (maximum and minimum). The COVs of the parameters were improved by 20-40% as the observer became more experienced in ophthalmic CDI.", "answer": "We confirm the general reliability of CDI measurements in orbital vessels and show that observer experience improves reproducibility. It appears, however, that observer performance in these measurements is vessel specific.\n\nyes"}
{"question": "Question: Light entering the eye first passes through _______ retinal layer?\nOptions:\nA. Inner nuclear layer\nB. Outer nuclear layer\nC. Outer plexiform Layer\nD. Retinal ganglion layer\n", "answer": " Light passes through the retinal ganglion layer, the most anterior layer of the retina. Light then passes through other layers of the retina until it reaches the photoreceptors in the posterior region of the retina. Retina is organised into 10 layers or zones where distinctive components are clustered together to form continuous strata. Light passes in the direction: Vitreous humor(anterior) - Choroid (most posterior) encountering the cell layers in that direction (ganglion cell layer - photoreceptor) Visual processing/Phototransduction occurs in the opposite direction (Photoreceptors - Ganglion cell layer) Ref: Guyton and Hall 13th edition Pgno: 674\n\nOPTION D IS CORRECT."}
{"question": "Question: A 35-year-old female presented to the medicine OPD with paresthesias and weakness of B/L lower limbs with a band like sensation of tightness around the torso along with painful loss of vision in both eyes along with diplopia and periorbital pain. There is a history of similar attacks in the past with period of normalcy in between O/E, Ataxia- present Papillitis (on fundus examination) Facial myokymia Bladder incontinence and constipation CSF studies revealed mononuclear cell pleocytosis along with increased IgG. Which of the following are the oral drugs approved for the above condition: - 1. Fingolimod 2. Natalizumab 3. Teriflunomide 4. Glatiramer acetate\nOptions:\nA. Only 1\nB. Both 1 and 3\nC. 1,2 and 3\nD. All of the above\n", "answer": " This is a case of relapsing-remitting multiple sclerosis. 1ST IMAGE: -Demonstrates multiple bright signal abnormalities in white matter, typical for MS. 2ND IMAGE: - Shows the classical Dawson finger sign. DRUGS APPROVED: - Interferon beta: inhibition of T-lymphocyte proliferation Glatiramer acetate: immunomodulation (GIVEN SUBCUTANEOUSLY) Teriflunomide: reduces both T-cell and B-cell activation and proliferation (GIVEN ORALLY) Dimethyl fumarate: immunomodulation Fingolimod: prevents lymphocyte migration out of lymph nodes and into CNS (GIVEN ORALLY) Natalizumab: inhibits binding of lymphocytes to endothelium (INTRAVENOUSLY GIVEN) Alemtuzumab: immunomodulation of T-cell and B-cell function Mitoxantrone: reduces T-cell and B-cell proliferation and reduces T-cell activation\n\nOPTION B IS CORRECT."}
{"question": "Question: The retina receives its blood supply from all, except –\nOptions:\nA. Posterior ciliary artery\nB. Central retinal artery\nC. Retinal arteries\nD. Plexus of Zinn and Haller arteries\n", "answer": " This question is very tricky. As all the given vessels supply nutrition to retina. First see the nutrition and blood\n\nsupply of retina.\nNutrition and blood supply of retina\n\nThe retina recieves nutrition from two discrete circulatory systems :- i) Retinal vascular system ii) Choroidal vascular system.\n\n\nOuter four layers are avascular and recieve nutrition by diffusion from choriocapillaries (choroid vascular system through anterior and posterior ciliary arteries).\nInner six layers are vascular and recieve blood supply and nutrition from central retinal artery through four retinal branches :- Superior nasal, inferior nasal, superior temporal, inferior temporal.\nArterial circle of zinn or heller (formed by anastomosis between retinal vessels and short ciliary system) supplies optic nerve head and surrounding retina.\n\nComing to the question\n\nHave any one of you noticed that the outer four layers derive their nutrition by diffusion from anterior and posterior ciliary artery, but not blood supply. These layers are avascular (you can compare these four layers as cornea, which is avascular but gets its nutrition from other sources).\n\n\n \n\nCentral retinal artery (through its four retinal branches) and arterial circle of zinn or Haller provide blood supply and nutrition to retina.\nNow read the question, examiner has specifically asked for blood supply of retina (not nutrition).\nThus, the best answer here is posterior ciliary artery.\nHowever, posterior ciliary artery also provide blood supply indirectly as its branches participate in formation of arterial circle of Zinn or Haller (but it does not supply directly, while other three options supply directly).\nSo, in brief :-\n\n\nNutrition ofRetina :- Anterior and posterior ciliary arteries, central retinal artery and its retinal branches, arterial circle of Zinn or Haller.\nBlood supply of Retina :- Central retinal artery and its retinal branches, arterial circle of Zinn or Haller.\n\nOPTION A IS CORRECT."}
{"question": "What is the underlying cause of spontaneous posterior vitreous detachment (PVD) and its association with retinal tears ?", "answer": "Spontaneous posterior vitreous detachment (PVD) is a common age-related phenomenon characterized by the separation of the vitreous from its posterior attachments to the surface of the retina and optic nerve. While the fundamental biomechanisms of PVD are still not fully understood, aging and age-related syneresis of the vitreous are considered the most common underlying causes. Age-related syneresis refers to the liquefaction process of the vitreous gel, which occurs as a person ages. It involves a decrease in the proportion of gel to liquid within the vitreous, resulting in changes in collagen fibers and soluble vitreous content. The prevalence of PVD increases with advancing age and the axial length of the eye. In fact, studies have shown that partial or complete PVD is common in individuals who have undergone prior intracapsular cataract extraction. It has been observed that the concentration of hyaluronic acid, a component of the vitreous, is greater in eyes without PVD compared to those with total PVD. However, the concentration of hyaluronic acid in the gel and liquefied portions of the vitreous is similar. The clinical significance of PVD lies in its association with retinal tears. As the vitreous separates from the retina during PVD, it can exert traction on the retina, potentially leading to the formation of retinal tears. Prompt identification and management of retinal tears associated with PVD are crucial to prevent further complications such as retinal detachment. It should be noted that while the underlying cause of age-related syneresis and PVD is uncertain, laboratory evidence suggests that the photodegradation of hyaluronic acid may contribute to the process. Factors such as light-induced free-radical formation could potentially damage vitreous collagen and hyaluronic acid over time. Further research is needed to fully understand the mechanisms underlying PVD and its association with retinal tears."}
{"question": "Question: Worth 4 dot test is done for:\nOptions:\nA. Color deficiency\nB. Strabismus\nC. Binocular vision\nD. Squint\n", "answer": " Ans. (c) Binocular visionRef: A.K. Khurana 6th ed. 1342* Worth four dot test (WFDT) is a test for binocular vision using red-green color dissociation.* It is a dissociation test which can be used with both distance and near fixation and differentiate between binocular single vision, abnormal retinal correspondence and suppression.* NOTE: result of WFDT can only be interpreted if the presence or absence of manifest squint is known at the time of testing.\n\nOPTION C IS CORRECT."}
{"question": "What are the clinical presentations of wet Age-Related Macular Degeneration (AMD) ?", "answer": "Wet AMD can present with varying degrees of visual loss. In the early stages, patients may have mild symptoms or be completely asymptomatic. As the disease progresses to the intermediate stage, patients may experience a loss of contrast sensitivity, blurred vision, and scotomas. Other visual abnormalities associated with wet AMD include metamophopsia (distortion of straight lines), disparity of image size, macropisa and micropsia, hyperopic refractive shift with associated anisometriopia, light glare, floaters, and photopsia. Unlike the dry subtype of AMD, wet AMD can have a sudden onset of presentation due to subretinal hemorrhages and exudates, which can lead to retinal detachment and acute visual loss. It is important to note that although wet AMD accounts for only 15% of total AMD cases, it is responsible for more than 80% of AMD-related severe visual loss and blindness."}
{"question": "Question: A 7 year old presents with left exotropia; right eye has 6/6 vision with normal fundus. Left eye has only close hand movements with subretinal yellow exudates and retinal detachment and telegiectatic vessels. Diagnosis is:\nOptions:\nA. Sympathetic ophthalmia\nB. Coats disease\nC. ROP\nD. Familial exudative vitreous retinopathy (FEVR)\n", "answer": " Ans. (b) Coats diseaseRef: Kanski 7/e, p. 582* Unilateral loss of vision with squint, exudates & RD points towards Coats diseaseFamilial exudative vitreoretinopathy (FEVR) Usually a positive family (AD, XLR) Bilateral but may be asymmetrical involved Unlike ROP not associated with LBW or prematurity Peripheral vascular telangiectasias Fibrovascular proliferation with tractional retinal detachment Massive subretinal exudates May present with leukocoria & squint\n\nOPTION B IS CORRECT."}
{"question": "What are the different types of pigmented cell dispersion syndromes and their clinical presentations ?", "answer": "Pigmented cell dispersion syndromes refer to conditions characterized by the dispersion of pigmented cells in various structures of the eye, particularly in the iris. While the provided excerpt does not explicitly mention the specific syndromes, it does allude to their existence. Pigmented cell dispersion syndromes can be broadly classified into several types based on their clinical presentations. These include: 1. PEX iridopathy: Pseudoexfoliation (PEX) syndrome can lead to the deposition of abnormal extracellular material on various ocular structures, including the iris. In the pupillary zone, PEX iridopathy presents as a characteristic diaphanoscopic pattern. 2. Radial in idiopathic melanin dispersion syndrome: This syndrome involves the radial dispersion of melanin in the iris. It can be associated with myopia (nearsightedness) and is typically observed in patients without any identifiable underlying cause. 3. Punctate dispersion in diabetic iridopathy: Diabetic iridopathy, resulting from poorly controlled diabetes, can lead to the punctate dispersion of pigmented cells throughout the iris. This manifestation is often seen in individuals with unregulated glucose metabolism. 4. Sectorial necrosis: Sectorial necrosis of the iris can occur due to various causes, including viral iritis or ischemic infarction following acute pupillary block angle closure glaucoma. This condition is characterized by localized areas of necrotic tissue within the iris. 5. Pigmentation due to blunt trauma: Blunt trauma to the eye can cause dispersion of pigmented cells throughout the iris. This can manifest as increased pigmentation in the affected areas. It is important for ophthalmologists to consider these various pigmented cell dispersion syndromes when evaluating patients with iris pigmentation anomalies. A comprehensive clinical examination, including detailed iris examination and imaging techniques, may be necessary to make an accurate diagnosis and determine the most appropriate management approach for each individual case."}
{"question": "What is the definition of age-related macular degeneration ?", "answer": "Age-related macular degeneration (AMD) refers to a progressive eye condition that affects the macula, the central part of the retina responsible for sharp central vision. It is most commonly seen in older adults and can cause a loss of central vision, making it difficult to read, drive, or recognize faces. AMD is characterized by the formation of drusen (yellow deposits) and the growth of abnormal blood vessels in the macula. There are two forms of AMD: dry AMD, which involves the accumulation of drusen, and wet AMD, which involves the growth of abnormal blood vessels. Prompt diagnosis and management are crucial in preventing severe vision loss associated with AMD."}
{"question": "How are threshold determinations carried out in ophthalmology ?", "answer": "In ophthalmology, threshold determinations are conducted to determine the minimum charge required to elicit a visual perception through electrical stimulation of the retina. This process involves two parts: determination and verification. During the determination phase, consecutive current pulse trains are applied to the retina, each lasting 0.5 seconds and consisting of 30 pulses. This synchronous triggering of 30 ganglion cell spikes helps in eliciting visual perceptions. Additionally, a sound is presented to the subject simultaneously with each electric pulse train to indicate the stimulation process. This method allows subjects to differentiate visual perceptions generated by true electric stimulation from those produced by other sources. The threshold is defined as the lowest charge applied to the retina that reliably evokes a visual perception for a given electrode. After determining the threshold, the verification phase commences. Stimulation currents slightly above the determined threshold are mixed with randomly inserted \"placebo\" stimulations, where no electric current is used, only a sound is presented. The verification is considered successful if no more than 2 errors out of 10 events occur (5 stimulations and 5 placebos). This procedure helps in accurately determining the threshold for visual perception in ophthalmology."}
{"question": "What is the appropriate timing to operate on a patient with retinitis pigmentosa ?", "answer": "The appropriate timing to consider surgery for patients with retinitis pigmentosa depends on various factors, including the stage of the disease, the patient's visual acuity, and the specific surgical intervention being considered. Retinitis pigmentosa is a progressive genetic disorder that affects the retina and can lead to significant visual impairment. The timing of surgery should be carefully evaluated in order to optimize visual outcomes and minimize potential complications. In the early stages of retinitis pigmentosa, when visual acuity is relatively preserved, surgical interventions may focus on addressing secondary complications such as cataracts or vitreous floaters. Cataract surgery can improve visual function by replacing the clouded lens with an artificial one, while vitrectomy can remove floaters and improve visual clarity. As the disease progresses and visual acuity deteriorates, more advanced surgical options may be considered. These may include implanting retinal prostheses or microelectrode arrays to stimulate the remaining functional photoreceptors and restore visual perception. However, it is important to note that these interventions are still considered experimental and their efficacy is still being studied. It is crucial for patients with retinitis pigmentosa to consult with a retinal specialist who can assess their individual case and provide personalized recommendations regarding the timing of surgery. Regular monitoring of the disease progression through various diagnostic tools such as electroretinography (ERG) and optical coherence tomography (OCT) can help guide treatment decisions. References: 1. Da Cruz L, Dorn JD, Humayun MS, et al. Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial. Ophthalmology. 2016 Jan;123(10):2248-54. 2. Ayton LN, Blamey PJ, Guymer RH, et al. First-in-Human Trial of a Novel Suprachoroidal Retinal Prosthesis. PLoS One. 2014 Dec 3;9(12):e115239. 3. Ho AC, Humayun MS, Dorn JD, et al. Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind. Ophthalmology. 2015 Dec;122(12):2344-52."}
{"question": "Question: Does minocycline protect photoreceptors from light and oxidative stress in primary bovine retinal cell culture?\nContext: To determine whether minocycline, a compound known to protect the retina against light-induced damage in rodent models, and its structurally related analogues would protect photoreceptor cells in primary bovine retinal cell culture against light and oxidative stress. Minocycline and its analogues were tested in primary retinal cell culture to see whether they would inhibit light or oxidative stress-induced cell death. Primary cell cultures composed of photoreceptors, bipolar cells, and glial cells were prepared from bovine retinas. The extent of cell death induced by light or oxidative stress was assessed by using Sytox Green (Invitrogen-Molecular Probes, Eugene, OR) a nucleic acid dye uptake assay. Differential protection of photoreceptor cells from stress were examined using immunocytochemistry. Minocycline and methacycline were cytoprotective against light- or oxidative stress-induced damage of bovine primary photoreceptors in culture with an EC(50) < 10 microM. In contrast, structurally related analogues such as demeclocycline, meclocycline, and doxycycline were phototoxic at >3 to >10 microM. Though demeclocycline was found to be phototoxic, it was cytoprotective (EC(50) = 5 microM) against oxidative stress in the absence of exposure to light.", "answer": "The protective action of minocycline against light-induced damage in the cell-based assays agrees with earlier reports in animal models and suggests that the in vitro assay using bovine primary retinal cell culture is a suitable model for evaluating compounds for retinal protection. Cellular protection or toxicity produced by structurally related compounds show that minor structural modifications can alter the function of minocycline and lead to potent retinal protective compounds.\n\nyes"}
{"question": "Question: Does microRNA-218 inhibit Oxygen-induced Retinal Neovascularization via Reducing the Expression of Roundabout 1?\nContext: The mechanisms of pathological retinal neovascularization (RNV) remain unknown. Several microRNAs were reported to be involved in the process of RNV. Oxygen-induced retinopathy (OIR) is a useful model to investigate RNV. Our present work explored the expression and the role of microRNA-128 (miR-218) in oxygen-induced RNV. OIR was used to establish RNV model. The expression level of miR-218 in the retina from OIR mice was assessed by quantitative real-time reverse transcriptase polymerase chain reaction. Fluorescein angiography was performed in retinae of OIR mice, and RNV was quantified by hematoxylin and eosin staining to evaluate the effect of pCDH-CMV-miR-218 intravitreal injection on RNV in OIR mice. Roundabout 1 (Robo1) expression was detected by Western blotting in mouse retinal vascular endothelial cells expressing a high or low level of miR-218 and retinal tissues from OIR mice. Cell migration was evaluated by scratch wound assay. In OIR mice, the expression level of miR-218 was significantly down-regulated (P = 0.006). Retinal Robo1 expression was significantly increased at both mRNA and protein levels (P = 0.001, 0.008; respectively). miR-218 intravitreal injection inhibited retinal angiogenesis in OIR mice, and the restoration of miR-218 in retina led to down-regulation of Robo1.", "answer": "Our experiments showed that restoration of miR-218 inhibited retinal angiogenesis via targeting Robo1. MiR-218 contributed to the inhibition of retinal angiogenesis and miR-218 might be a new therapeutic target for preventing RNV.\n\nyes"}
{"question": "Question: Does activation of matrix metalloproteinase-9 via neuronal nitric oxide synthase contribute to NMDA-induced retinal ganglion cell death?\nContext: Understanding the mechanism of neuronal cell death in retinal diseases like glaucoma is important for devising new treatments. One factor involves excitatory amino acid stimulation of N-methyl-D-aspartate (NMDA)-type glutamate receptors, excessive Ca2+ influx, and formation of nitric oxide (NO) via neuronal NO synthase (nNOS). Another factor is the abnormal activation of matrix metalloproteinases (MMPs), in particular MMP-9, which triggers an extracellular signaling cascade leading to apoptosis. This study was designed to investigate the mechanism of excitotoxic retinal ganglion cell (RGC) death in vivo and its relationship to MMP activation. NMDA and glycine were injected into the vitreous of the eye in rats and in nNOS-deficient mice (nNOS-/-) versus control. Gelatinolytic activity of MMP-9 and MMP-2 by zymography and cellular localization by immunohistochemistry were examined, and the effect of MMP inhibition on NMDA-induced RGC death was tested. NMDA was found to upregulate the proform of MMP-9 in the retina and to increase MMP-9 gelatinolytic activity. Retrograde labeling with aminostilbamidine to identify RGCs confirmed that MMP activity occurred only in these retinal neurons and not in glial or other retinal cell types after excitotoxic insult. Deconvolution fluorescence microscopy revealed that MMP activity colocalized with immunoreactive S-nitrosylated protein. NMDA-induced MMP activation was diminished in the retina of nNOS-/- mice, implying that S-nitrosylation of MMP had indeed occurred. In addition, the broad-spectrum MMP inhibitor GM6001 protected RGCs after intravitreal NMDA injection.", "answer": "These findings suggest that an extracellular proteolytic pathway in the retina contributes to RGC death via NO-activated MMP-9.\n\nyes"}
{"question": "Question: Do statins decrease the risk for wet age-related macular degeneration?\nContext: To investigate the effect of statins on the risk for age-related macular degeneration (AMD) treated with photodynamic therapy (PDT). All members in one district of a health maintenance organization in Israel, older than 50 years (n = 139,894), were included. PDT procedures for AMD (775 procedures; 283 patients) and filled statin prescriptions between 1999 and 2002 (471,232 prescriptions; 29,417 patients) were documented. For all age groups, PDT was more prevalent in statin users. Among statin users, the age adjusted proportion of patients undergoing PDT for wet AMD was 0.27% (95% confidence interval (CI): 0.20-0.34%), compared to 0.16% (95% CI: 0.14-0.18%) among non-users (p = 0.002, chi2 test, relative risk = 1.66 (95% CI: 1.29-2.19)). After correction for age, gender, socioeconomic status, place of birth, place of residence, hyperlipidemia, hypertension, ischemic heart disease, diabetes, and congestive heart failure, statins did not have any additional effect on the risk for undergoing PDT for wet AMD. In a case control analysis, statin use in PDT patients was similar to their use by matched controls (odds ratio = 1.0; 95% CI = 0.8-1.3).", "answer": "This study does not support a beneficial effect of statin use for reducing the risk for wet AMD requiring PDT.\n\nno"}
{"question": "Question: Do mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity?\nContext: The authors studied the therapeutic effect of rat mesenchymal stem cells (MSCs) on experimental autoimmune uveoretinitis (EAU) induced in rats by peptide 1169-1191 of the interphotoreceptor retinoid-binding protein (IRBP). The authors intravenously injected syngeneic (isolated from Lewis rats) or allogeneic (isolated from Wistar rats) MSCs into IRBP-induced EAU Lewis rats, either before disease onset (simultaneous with immunization, preventive protocol) or at different time points after disease onset (therapeutic protocol). T-cell response to IRBP 1169-1191 from MSC-treated rats was evaluated, Th1/Th2/Th17 cytokines produced by lymphocytes were measured, and CD4(+)CD25(+) regulatory T cells (Treg) were detected. MSC administration before disease onset not only strikingly reduced the severity of EAU, it also delayed the onset of the disease. MSC administration was also effective after disease onset and at the peak of disease, but not after disease stabilization. Clinical efficacy for all treatments was consistent with reduced cellular infiltrates and milder uveal and retinal impairment. T-cell response to IRBP 1169-1191 from MSC-treated rats was inhibited. MSCs significantly decreased the production of IFN-γ and IL-17 and increased the production of IL-10 of T lymphocytes from EAU rats either in vivo or in vitro. Allogeneic and syngeneic MSCs showed a similar immunosuppression potential with regard to clinical effect, T cell proliferation, and cytokine secretion, and MSC therapy upregulated Treg cells.", "answer": "These data suggest that the immunoregulatory properties of MSCs effectively interfere with the autoimmune attack in the course of EAU through the comprehensive modulation of systemic autoimmunity.\n\nyes"}
{"question": "Can you explain the relationship between surgical specialization in ophthalmology and the complexity of different eye conditions ?", "answer": "Surgical specialization in ophthalmology is closely linked to the complexity of various eye conditions. Different subspecialties within ophthalmology require distinct skill sets and knowledge to successfully manage specific eye disorders. In the provided context, the author humorously describes the varying levels of complexity in different surgical subspecialties. Cataract surgeons, for example, primarily focus on performing lens extractions and intraocular lens implantations. While this procedure requires technical precision, it is considered relatively straightforward compared to other subspecialties. Cataract surgery is often described as \"carpentry\" because it involves rearranging the furniture at the front of the eye, referring to the lens extraction. Glaucoma surgeons, on the other hand, deal with the management of intraocular pressure and fluid dynamics within the eye. Their primary strategies involve either lowering the eye's fluid production or improving its outflow. This subspecialty is often compared to plumbing due to the straightforwardness of these strategies compared to the complexity of other eye conditions. In contrast, strabismus specialists face more intricate challenges. Strabismus refers to misalignment of the eyes caused by imbalances in the ocular muscles. Strabismus surgeons must possess in-depth knowledge of neurophysiology and anatomy to devise appropriate strategies for each type of strabismus case. They often have to think critically to address the wide array of strabismus presentations. The author humorously suggests that strabismus specialists must embrace thinking, which they portray as a painful process, unlike cataract and glaucoma surgeons. Retina surgeons primarily focus on conditions affecting the retina, such as retinal detachment or macular holes. Historically, their main concern was successfully repositioning the retina, with post-operative functional vision left to be addressed by the referring doctor. However, advancements in retinal function testing have led to increased attention to post-operative visual outcomes. It is important to note that the author's comments are meant to be humorous and not reflective of the actual difficulty or importance of each subspecialty. Each area of ophthalmology requires significant expertise, and all ophthalmologists play crucial roles in providing comprehensive eye care."}
{"question": "Question: Is the iron carrier transferrin upregulated in retinas from patients with age-related macular degeneration?\nContext: Iron can cause oxidative stress, and elevated iron levels have been associated with several neurodegenerative diseases including age-related macular degeneration (AMD). Transferrin, an iron transport protein, is expressed at high levels in the retina. The purpose of this study was to assess transferrin involvement in AMD by determining the expression profile of transferrin in retinas with AMD compared with retinas without evidence of disease. Postmortem retinas were obtained from AMD and non-AMD eyes. Expression of transferrin was assessed in a microarray dataset from 33 retinas of unaffected donors and 12 retinas of patients with AMD (six with neovascular AMD and six with non-neovascular AMD). Quantitative real-time RT-PCR (QPCR) was used to confirm the microarray results. Transferrin protein expression was assessed by semiquantitative Western blot analysis and immunohistochemistry. In comparison to unaffected retinas, mean transferrin mRNA levels, as measured by microarray analysis were elevated 3.5- and 2.1-fold in non-neovascular and neovascular AMD retinas, respectively. Semiquantitative Western blot analysis demonstrated a 2.1-fold increase in transferrin protein in AMD eyes. Immunohistochemistry showed more intense and widespread transferrin label in AMD maculas, particularly in large drusen, Müller cells, and photoreceptors.", "answer": "These data demonstrate that transferrin expression is increased in the retinas of patients with AMD relative to those of healthy control patients of comparable age. Along with previous studies that have demonstrated elevated iron levels in AMD retinas, early onset drusen formation in a patient with retinal iron overload resulting from aceruloplasminemia, and retinal degeneration with some features of macular degeneration in the iron-overloaded retinas of ceruloplasmin/hephestin knockout mice, the present study suggests that altered iron homeostasis is associated with AMD.\n\nyes"}
{"question": "Question: Arcuate field defect akin to glaucoma is seen in?\nOptions:\nA. Pituitary tumor\nB. Occipital lobe infarct\nC. Optic nerve lesion\nD. None of the above\n", "answer": " Ans. is 'c' i.e., Optic nerve lesion An arcuate visual field defect usually results from damage to retinal nerve fibers or ganglion cells in the superior or inferior arcuate nerve fiber bundles. In such cases there is a central field defect that is not circular but instead is limited above or below by the horizontal meridian. This visual field defect may occur in patients with occlusion of blood supply of the superior or inferior poion of macula or in patients with glaucoma. In both settings, the scotoma is associated with normal visual acuity, since it does not completely affect the macula. Viually any lesion, whether ischemic, infiltrative or compressive, can cause arcute field defect, and may be located in either the retina or optic nerve. Impoant causes of arcuate scotoma are :- Glaucoma Optic neuritis Anterior ischemic optic neuropathy (AION) Branch retinal vascular occlusion (aery or vein) Optic nerve drusen\n\nOPTION C IS CORRECT."}
{"question": "What is the association between dietary omega-3 fatty acid intake and age-related macular degeneration (AMD) ?", "answer": "Several studies have investigated the relationship between dietary omega-3 fatty acid intake and age-related macular degeneration (AMD). Augood et al. (2008) found an association between higher consumption of oily fish, dietary docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) with a reduced risk of neovascular AMD. SanGiovanni et al. (2008) reported that higher dietary intake of omega-3 long-chain polyunsaturated fatty acids (LCPUFAs) was associated with a lower risk of incident AMD. Tan et al. (2009) found that higher intake of dietary fatty acids was associated with a decreased 10-year incidence of AMD. Wang et al. (2009) demonstrated that the combined effects of complement factor H genotypes, fish consumption, and inflammatory markers influenced the long-term risk for AMD. A systematic review and meta-analysis by Chong et al. (2008) also supported the protective role of dietary omega-3 fatty acids in preventing AMD. On the other hand, Hodge et al. (2006) conducted a systematic review and found inconclusive evidence regarding the efficacy of omega-3 fatty acids in preventing AMD. It is important to note that the dosage and duration of omega-3 fatty acid supplementation might play a role in its effectiveness. Elevated serum homocysteine levels have been associated with an increased risk of AMD in some studies. Axer-Siegel et al. (2004), Rochtchina et al. (2007), and Nowak et al. (2005) found a positive association between hyperhomocysteinemia and AMD. Additionally, Heuberger et al. (2002) reported a relationship between blood homocysteine levels and age-related maculopathy. In summary, the evidence suggests that higher intake of dietary omega-3 fatty acids, particularly DHA and EPA, may be associated with a reduced risk of AMD. However, more research is needed to determine the optimal dosage and duration of supplementation. Additionally, elevated levels of homocysteine may be a potential risk factor for AMD. It is important to consider a comprehensive approach to AMD prevention and management, including a well-balanced diet, regular eye examinations, and lifestyle modifications."}
{"question": "Question: Baby born prematurely at 29 wks, on examination at 42 weeks with ROP, both eyes shows stage 2 zone 1 `plus' disease, how will you manage the patient ?\nOptions:\nA. Examine the patient after 1 week\nB. Laser photocoagulation of both eyes\nC. Laser photocoagulation of worse eye, follow up of other eye\nD. Vitreoretinal surgery\n", "answer": " The hallmark of retinopathy of prematurity (ROP) is abnormal retinal vasculature. Ophthalmologists diagnose and make decisions about the initial treatment of ROP based on the appearance of the retinal blood vessels. Dilatation and tortuosity of the retinal vessels at the posterior pole is termed plus' disease. It is a sign of rapidly progressive ROP and is an indication for early laser ablation of the peripheral avascular retina.\n\nOPTION B IS CORRECT."}
{"question": "Question: Do intravitreal tPA and SF6 promote clearing of premacular subhyaloid hemorrhages in shaken and battered baby syndrome?\nContext: Child abuse is a serious problem in many cultures. The ocular signs of shaken baby include intraretinal, subretinal, and preretinal hemorrhages. The hemorrhages may be unilateral or bilateral and are seen in 50% to 80% of patients. Previous treatment was limited to observation or vitrectomy, but some observed eyes develop amblyopia, and pediatric vitrectomy has many complications. We report 4 eyes in 2 children with shaken baby syndrome in whom we administered intravitreal tissue plasminogen activator (tPA) in an attempt to resolve preretinal hemorrhages earlier than observation alone without the complications of vitrectomy. The tPA dose ranged from 12.5-25 microg per injection. Eyes were injected once weekly for 3 consecutive weeks. Each time 0.25 cc of sulfur hexafluoride gas was also injected. Within 1 week following the last tPA administration, complete resolution of the preretinal hemorrhage was seen. There were no associated ophthalmic complications.", "answer": "Intravitreal tPA with an expansive gas is an alternative method to observation or vitrectomy for resolution of preretinal hemorrhages in battered babies and may allow faster resolution of hemorrhages without the complications of vitrectomy.\n\nyes"}
{"question": "What are the different types of color blindness and how can they be identified and diagnosed ?", "answer": "Color blindness, also known as color vision deficiency, encompasses various types that result from specific abnormalities in the photopigments of the cone cells in the retina. The most common types of color blindness include red-green color blindness and blue-yellow color blindness. To diagnose color blindness, ophthalmologists employ a range of tests, such as the Ishihara color plates, Farnsworth D-15 test, and anomaloscope. These tests assess the individual's ability to perceive and differentiate between colors accurately. Timely and accurate identification of color blindness is crucial for understanding its impact on an individual's everyday life and determining appropriate strategies for managing and adapting to the condition."}
{"question": "Question: Axial length of eye ball is: March 2005\nOptions:\nA. 16 mm\nB. 20 mm\nC. 24 mm\nD. 28 mm\n", "answer": " Ans. C: 24 mm The eye of the newborn is hypermetropic and the average axial length is about 18mm.At the age of 3 years it is 23 mm and from age 3-14 years it increases by 1 mm. In the emmetropic eye, the axial length (from the posterior corneal surface to the retina) varies from 22 to 26 millimeters. In the emmetropic eye (which has no refractive error), the range of corneal refracting power is between 39 and 48 diopters, while the range of lenticular refracting power is between 15 and 24 diopters.\n\nOPTION C IS CORRECT."}
{"question": "What findings were observed during the ophthalmoscopic examination of the patient's right eye ?", "answer": "During the ophthalmoscopic examination of the patient's right eye, multiple dot and blot hemorrhages were observed in one field nasal to the optic nerve and temporal to the macula. Additionally, there were a few nerve fiber layer infarcts along the supero-temporal arcade. The central macula showed thickening of the distance between the surface of the retina and the retinal pigment epithelium, along with the presence of microaneurysms and lipid."}
{"question": "What is the significance of using a pattern stimulus consisting of an alternating black-white checkerboard in clinical VEP ?", "answer": "The pattern stimulus consisting of an alternating black-white checkerboard is commonly used in clinical VEP because it generates the most vigorous cortical response. The cells of the retina and the lateral geniculate body respond well to a change in luminance in their receptive field. However, the cortical neurons of the striate cortex respond more actively to light-dark edges and orientation. The use of a checkerboard pattern stimulus helps to elicit a strong cortical response, providing valuable information about the visual processing in the striate cortex."}
{"question": "Question: Does the response to visual form deprivation differ with age in marmosets?\nContext: To characterize the effects of visual form deprivation by diffuser in marmoset monkey eyes across a range of ages. Twenty-four common marmosets were grouped by onset of deprivation (group 1: 0-39 days, n = 6; group 2: 40-99 days, n = 10; and group 3: 100-200 days, n = 8). Monocular form deprivation was induced with a white translucent diffuser worn for 28 to 88 days (mean durations: group 1, 32 days; group 2, 56 days; and group 3, 51 days). Refractive state, corneal curvature, and vitreous chamber depth were measured after cycloplegia. Both experimental and control eyes were measured multiple times before, during, and after the visual deprivation period. Marmosets in all age groups tested were susceptible to visual form deprivation myopia; however, the response to form deprivation was variable and included a majority with axial myopia (n = 15), several nonresponders (n = 4), a single late responder (axial myopia after the end of deprivation period), and several axial hyperopes (n = 4). For all animals that responded with axial myopia, the increase in vitreous chamber depth and myopia was inversely proportional to the age of onset of deprivation (ANOVA, P < 0.05). After the end of the period of deprivation, recovery from myopia by reduction of the axial growth rate was observed in three animals from group 1 and three animals from group 2.", "answer": "Form deprivation by diffusers disrupted emmetropization in marmosets over a range of ages. The responses varied among individuals and with age, suggesting that the maturity of the eye may influence the response to visual signals responsible for form deprivation myopia and perhaps emmetropization. Recovery from diffuser-induced form deprivation myopia was apparent in some animals, in contrast to that reported for visual deprivation by lid-suturing, and appears more prevalent in the younger animals.\n\nyes"}
{"question": "Question: Does retinal pigment epithelium fold as a diagnostic finding of Vogt-Koyanagi-Harada disease?\nContext: To examine using the folds of the retinal pigment epithelium (RPE) to diagnose Vogt-Koyanagi-Harada (VKH) disease. Retrospective clinical review of 57 Japanese patients between July 2005 and April 2009. Optical coherence tomography (OCT), fundus photographs and fluorescein angiography (FA) were studied to investigate Kendall's coefficients of concordance in seven findings by four ophthalmologists. The sensitivity and specificity of each finding were examined to confirm its efficacy. Each result was defined as positive when more than three of the ophthalmologists judged that the finding existed. The folds of the RPE on OCT were observed in 30/42 (71.4 %) eyes having VKH disease, but none in the other 72 eyes. Kendall's coefficient of concordance in the detection of the folds of the RPE was 0.90 and was the highest among all other findings. Sensitivity was higher in the detection of the RPE folds on OCT and in optic nerve staining on FA than other findings and the specificity was 100 % for the RPE folds and 26.7 % for the optic nerve staining.", "answer": "The detection of the folds of the RPE on OCT is a simple and effective method to help diagnose VKH disease at its acute stage which does not require pupil dilation.\n\nyes"}
{"question": "Question: Infection within the right cavernous sinus results in the following signs except:\nOptions:\nA. Constricted pupils in response to light\nB. Engorgement of retinal veins\nC. Ptosis of right eyelid\nD. Right ophthalmoplegia\n", "answer": " (a) Constricted pupils in response to light (Ref. Cummings, 6th ed., 174)In cavernous sinus thrombosis pupils are dilated and fixed due to the involvement of 3rd nerve and stimulation of sympathetic plexus.\n\nOPTION A IS CORRECT."}
{"question": "Question: Is retinal vascular caliber associated with renal function in apparently healthy subjects?\nContext: To assess the relation between retinal vascular caliber and renal function. Eighty apparently healthy subjects screened for cardiovascular risk factors (mean age 47 years, 51% female, 36% hypertensive, without diabetes or renal dysfunction) were recruited. Retinal vascular calibers were measured from fundus photographs and expressed as central retinal artery and venular equivalent. Renal function was assessed by measurement of glomerular filtration rate (urinary clearance of 99mTc-DTPA) and urinary albumin/creatinine ratio. Mean glomerular filtration rate was 117 ml/min/1.73m(2). Overall, central retinal artery and venular equivalent were positively correlated with glomerular filtration rate (r = +0.31, p = 0.005 and r = +0.30, p = 0.006, respectively). In addition, central retinal artery equivalent was negatively correlated with urinary albumin/creatinine ratio (r = -0.34, p = 0.002). No significant relationship was found between central retinal venular equivalent and urinary albumin/creatinine ratio (r = +0.12, p = 0.32). The observed relations between retinal vascular calibers and renal function parameters remained significant after adjusting for potential confounding factors.", "answer": "In apparently healthy subjects with normal renal function, retinal arteriolar and venular calibers were negatively correlated with kidney function, suggesting common determinants of these preclinical target organ damages.\n\nyes"}
{"question": "Question: A 75-year-old man presents to the physician with progressive difficulty reading over the past year. Currently, he avoids driving as he has trouble reading road signs. He has no history of a serious illness and takes no medications. The fundoscopic examination shows localized retinal elevation and drusen. A description of the patient’s visual on the Amsler grid is shown. Fluorescein angiography shows early hyperfluorescence. Which of the following is the most likely diagnosis in this patient?\nOptions:\nA. Choroidal melanoma\nB. Macular degeneration\nC. Open-angle glaucoma\nD. Retinal detachment\n", "answer": "OPTION B IS CORRECT."}
{"question": "Discuss the ocular structure and development ?", "answer": "The ocular structure refers to the anatomy and components of the eye. The eye is a complex organ responsible for vision and consists of several structures working together. The main components of the ocular structure include: 1. Cornea: The transparent, dome-shaped front surface of the eye that helps to focus incoming light. 2. Iris: The colored part of the eye that controls the size of the pupil, regulating the amount of light entering the eye. 3. Pupil: The small, adjustable opening in the center of the iris through which light enters the eye. 4. Lens: A clear, flexible structure located behind the iris that focuses light onto the retina. 5. Retina: The inner layer of the eye that contains light-sensitive cells called photoreceptors. It converts light into electrical signals that are sent to the brain for processing. 6. Optic nerve: A bundle of nerve fibers that carries the electrical signals from the retina to the brain, allowing us to interpret visual information. 7. Sclera: The tough, white outer layer of the eye that helps to maintain the shape of the eye. The development of the ocular structure begins early in embryonic development. The eye starts as a small outgrowth from the brain called the optic vesicle. Over time, this vesicle invaginates and forms a cup-shaped structure called the optic cup. The outer layer of the optic cup becomes the pigmented layer of the retina, while the inner layer gives rise to the neural retina. During development, various cell types differentiate within the ocular structure. Photoreceptor cells, such as rods and cones, develop in the retina and are responsible for detecting light. Other cell types, including ganglion cells, bipolar cells, and interneurons, form complex neural networks within the retina to process visual information. Proper development of the ocular structure is crucial for normal vision. Any disruptions or abnormalities during development can lead to vision problems or eye conditions like cataracts,"}
{"question": "Discuss the anatomy of the cornea and the factors responsible for maintaining corneal transparency ?", "answer": "The cornea is the transparent, dome-shaped outermost layer of the eye. It plays a crucial role in focusing incoming light onto the retina. Understanding its anatomy and the factors responsible for maintaining its transparency is essential. Anatomy of the Cornea: 1. Epithelium: The outermost layer consists of a thin, non-keratinized epithelium. It helps maintain the cornea's smooth surface and protects against foreign substances and infection. 2. Bowman's Layer: This second layer lies beneath the epithelium and is composed of densely packed collagen fibers. It provides structural support. 3. Stroma: The largest and thickest layer, it constitutes around 90% of the cornea's thickness. The stroma consists of parallel collagen fibers that contribute to the cornea's transparency. 4. Descemet's Membrane: This tough, elastic layer is located beneath the stroma. It acts as a barrier against injury and helps maintain the cornea's shape. 5. Endothelium: The innermost layer is a single layer of endothelial cells. These cells are responsible for regulating the fluid content of the cornea, preventing excessive swelling and maintaining transparency. Factors Maintaining Corneal Transparency: 1. Organization of Collagen Fibers: The highly organized arrangement of collagen fibers in the stroma plays a vital role in corneal transparency. These fibers are uniformly spaced and parallel, allowing for the passage of light without scattering or distortion. 2. Regular arrangement of Cells: The corneal cells, including the epithelium, stromal cells, and endothelium, have a regular arrangement. This cellular organization minimizes light scatter and maintains transparency. 3. Dehydration: The cornea naturally dehydrates to maintain transparency. The endothelial cells actively pump out excess fluid from the cornea, preventing swelling and maintaining optimal thickness. 4. Avascularity: The cornea is avascular, meaning it lacks blood vessels. This absence"}
{"question": "What are the indicators and potential role of wide-field multifocal ERG in the clinical setting for central retinal vein occlusion (CRVO) ?", "answer": "The preliminary study suggests that the P1 amplitudes and latencies of the first-order multifocal ERG response correlate significantly with the full-field 30-Hz cone flicker amplitudes and latencies in CRVO. This indicates that wide-field multifocal ERG can be a sensitive indicator of disease in CRVO. Furthermore, it may have a potential role in the clinical setting for evaluating and managing patients with CRVO. However, further research and validation are required to fully establish its clinical utility."}
{"question": "How should vision be considered normal in a child under one year of age ?", "answer": "In a child under one year of age, vision should be considered normal if the media (such as the cornea and lens) are clear, there is no refractive error, the pupils are centrally circular and respond promptly to direct and indirect light, there is no squint or nystagmus (involuntary eye movement), and the fundus (back of the eye) appears normal with appropriate developmental milestones. It is important to note that the presence of pupillary reaction to light does not indicate visual ability; it simply suggests that the afferent and efferent pathways of the light reflex are intact. Additional investigations, such as electroencephalogram, electroretinogram, visually provoked response, and imaging of ocular structures and the brain (CT and MRI), may be necessary for children suspected to be blind or those with specific risk factors."}
{"question": "Question: Does glucosamine modulate TNF-α-induced ICAM-1 expression and function through O-linked and N-linked glycosylation in human retinal pigment epithelial cells?\nContext: The purpose of this article was to investigate the effects of glucosamine (GlcN) on the TNF-α-induced expression of intercellular adhesion molecule 1 (ICAM-1) and the function of ICAM-1 in ARPE-19 cells in vitro. We quantified protein levels of TNF-α-induced ICAM-1 in ARPE-19 cells with Western blotting. The effects of GlcN on O-linked glycosylation, and therefore on ICAM-1 expression, were compared after the addition of alloxan, an inhibitor of O-linked N-acetylglucosamine transferase (OGT), or O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc), an inhibitor of N-acetylglucosaminidase (O-GlcNAcase [OGA]), or after OGT gene overexpression. The effect of GlcN on the N-linked glycosylation of ICAM-1 was evaluated by the change in its molecular mass on Western blotting. The effect of O-linked glycosylation on the nuclear factor κB (NF-κB) signaling pathway was examined using an NF-κB reporter gene assay. The effect of GlcN on ICAM-1 adhesion activity was examined using an ICAM-1 adhesion assay. GlcN, PUGNAc, and OGT overexpression inhibited TNF-α-induced ICAM-1 expression and NF-κB activity in ARPE-19 cells. Alloxan increased ICAM-1 expression and NF-κB activity in TNF-α-induced ARPE-19 cells. GlcN and tunicamycin reduced the molecular mass of TNF-α-induced ICAM-1 in ARPE-19 cells. The proteasome inhibitor MG-132 suppressed the GlcN-induced reduction in the molecular mass of TNF-α-induced ICAM-1. GlcN also attenuated the adhesion activity of TNF-α-induced ICAM-1.", "answer": "GlcN inhibits ICAM-1 expression and functions by modulating the O-linked glycosylation of factors involved in NF-κB signaling and by reducing the N-linked glycosylation of TNF-α-induced ICAM-1 in ARPE-19 cells. These effects may contribute to the GlcN-mediated anti-inflammatory effects in the eye.\n\nyes"}
{"question": "What are the clinical manifestations of idiopathic polypoidal choroidal vasculopathy ?", "answer": "Idiopathic polypoidal choroidal vasculopathy (IPCV) presents with several clinical manifestations. These include orange-red subretinal lesions, recurrent choroidal neovascularization, and an expanding clinical spectrum. The disease is characterized by polypoidal lesions in the choroidal vasculature, which can lead to subretinal fluid and hemorrhage. Optical coherence tomography (OCT) can be useful in visualizing these lesions. IPCV is associated with exudative age-related macular degeneration and can lead to visual impairment if left untreated."}
{"question": "Describe the anatomy of the cornea and its congenital anomalies ?", "answer": "The cornea is the transparent, dome-shaped structure that covers the front of the eye. It is responsible for focusing and refracting light onto the retina at the back of the eye. The cornea consists of several layers, each with its own specific function. The outermost layer of the cornea is the epithelium, which is a thin layer of cells that provides protection against injury and infection. Beneath the epithelium is the Bowman's layer, which provides additional strength and support. The next layer is the stroma, which makes up about 90% of the cornea's thickness. The stroma is composed of collagen fibers arranged in a highly organized pattern. This layer contributes to the cornea's clarity and provides structural integrity. The deepest layer of the cornea is the endothelium, which is a single layer of cells that maintains the proper hydration of the cornea by pumping out excess fluid. This layer is crucial for maintaining the cornea's transparency. Congenital anomalies of the cornea can occur during fetal development and can result in various abnormalities. Some examples of congenital corneal anomalies include: 1. Corneal opacity: This refers to an area of the cornea that is cloudy or opaque, impairing vision. It can be caused by genetic conditions, infections during pregnancy, or other developmental disorders. 2. Corneal dystrophy: These are inherited conditions that affect the clarity and transparency of the cornea. They can cause progressive vision loss and may require corneal transplant surgery in severe cases. 3. Corneal coloboma: This is a rare condition where there is a missing piece of the cornea, resulting in a gap or notch. It can occur as a part of a larger syndrome or as an isolated defect. 4. Keratoconus: This is a progressive condition in which the cornea thins and bulges outward, resulting in a cone-shaped cornea. It can cause blurred vision, near"}
{"question": "Question: Does vitreous treatment of cultured human RPE cells result in differential expression of 10 new genes?\nContext: To analyze the differential gene expression in cultured human retinal pigment epithelial (RPE) cells after treatment with vitreous. Cultured human RPE cells were incubated for 48 hours with 25% human vitreous from donor eyes. Total RNA from treated and untreated cells was extracted. The gene expression was analyzed by differential expression analysis (DEmRNA-PCR). The differentially expressed genes were identified by gene bank searches. Differential expression was verified by a quantitative real-time RT-PCR fluorescent nucleic acid staining system. The in vivo mRNA expression of these genes in RPE cells was shown by gene-specific RT-PCR. Vitreous treatment of human RPE cells resulted in the reduced expression of NFIB2, KE03 (NY-REN-25ag), PIG-B, DKFZp564BC462, LKHA, G3BP, PAM, UEV-1, and MAP1B calibrated to the expression of GAPDH when compared with their expression in untreated cells. The reduced expression after vitreous treatment was quantified by gene-specific quantitative real-time RT-PCR and varied from 0.69 to 0.17 compared with untreated cells. The mRNA expression of UDP-GalNac mRNA remained constant. The mRNA expression of eight of these genes was demonstrated in this study for the first time in human RPE cells.", "answer": "Vitreous treatment of cultured RPE cells induces the differential expression of a variety of genes with functions in transcription, mediation of signal transduction and inflammation, glycosylation, ubiquitination and protein-protein interaction. Further examination of these genes may locate additional targets for treatment of diseases caused by contact of RPE cells with vitreous, typical in proliferative vitreoretinopathy.\n\nyes"}
{"question": "Question: Does transplantation of photoreceptor and total neural retina preserve cone function in P23H rhodopsin transgenic rat?\nContext: Transplantation as a therapeutic strategy for inherited retinal degeneration has been historically viewed to restore vision as a method by replacing the lost retinal cells and attempting to reconstruct the neural circuitry with stem cells, progenitor cells and mature neural retinal cells. We present evidence for an alternative strategy aimed at preventing the secondary loss of cones, the most crucial photoreceptors for vision, by transplanting normal photoreceptors cells into the eye of the P23H rat, a model of dominant retinitis pigmentosa. We carried out transplantation of photoreceptors or total neural retina in 3-month-old P23H rats and evaluated the function and cell counts 6 months after surgery. In both groups, cone loss was significantly reduced (10%) in the transplanted eyes where the cone outer segments were found to be considerably longer. This morphological effect correlated with maintenance of the visual function of cones as scored by photopic ERG recording, but more precisely with an increase in the photopic b-wave amplitudes by 100% and 78% for photoreceptor transplantation and whole retinal transplantation respectively.", "answer": "We demonstrate here that the transplanted tissue prevents the loss of cone function, which is further translated into cone survival.\n\nyes"}
{"question": "Question: What is the meaning of Retinal flecking?", "answer": "Presence of multiple yellowish-white lesions of various size and configuration on the retina not related to vascular lesions. [PMID:7952338]"}
{"question": "What are the sequential steps an ophthalmologist should take in diagnosing and managing a patient with cataracts ?", "answer": "First, the ophthalmologist should take a detailed patient history, including any symptoms such as blurry vision, glare, or difficulty with night vision. A comprehensive eye examination should be performed, including visual acuity testing, refraction, and a slit-lamp examination to assess the lens for opacity. If cataracts are suspected, further tests such as a dilated fundus examination and measurement of intraocular pressure may be necessary to rule out other ocular conditions. Once the diagnosis of cataracts is confirmed, the ophthalmologist should evaluate the impact of the cataracts on the patient's daily activities and visual function. If the cataracts are significantly affecting the patient's quality of life, surgical intervention should be considered. The next step involves discussing the surgical options with the patient, including the different types of intraocular lenses (IOLs) available. The ophthalmologist should explain the risks, benefits, and expected outcomes of cataract surgery. It is important to address any concerns or questions the patient may have and ensure they have realistic expectations. If the patient decides to proceed with surgery, preoperative testing, including biometry and keratometry, should be performed to determine the appropriate IOL power. The ophthalmologist should also assess the patient's overall health and discuss any necessary precautions or modifications to their medication regimen. On the day of surgery, the ophthalmologist will perform phacoemulsification, a technique that involves emulsifying and removing the cloudy lens through a small incision. The natural lens is replaced with an IOL, which can be monofocal, multifocal, or accommodating, depending on the patient's needs and preferences. Postoperative care is crucial to ensure optimal healing and visual outcomes. The ophthalmologist should provide detailed instructions on the use of prescribed eye drops, the importance of avoiding strenuous activities, and the need for regular follow-up visits. These visits allow for monitoring of the patient's visual acuity, intraocular pressure, and overall healing process. In summary, the sequential steps in diagnosing and managing a patient with cataracts involve taking a detailed patient history, performing a comprehensive eye examination, confirming the diagnosis, evaluating the impact on the patient's visual function, discussing surgical options, performing preoperative testing, conducting cataract surgery, and providing postoperative care and follow-up"}
{"question": "Question: Visual defect is contralateral homonymous hemianopia with macular sparing. What is the cause for it\nOptions:\nA. Block in optic tract\nB. Block in optic nerve\nC. Block in optic chiasma\nD. Block in posterior cerebral aery supplying visual coex\n", "answer": " Block in posterior cerebral aery supplying occipital lobe - Contralateral homonymous hemianopia with macular sparing Block in optic tract -Contralateral homonymous hemianopia CHOICE EXPLANATION & ELIMINATION REASON 1 Not correct 2 Not correct 3 Not Correct statement 4 Correct statement Visual pathways. Transection of the pathways at the locations indicated by the letters causes the visual field defects shown in the diagrams on the right. The fibers form the nasal half of each retina decussate in the optic chiasm, so that the fibers in the optic tracts are those from the temporal half of one retina and the nasal half of the other. A lesion that interrupts one optic nerve causes blindness in the eye (A) A lesion in one optic tract causes blindness in half of the visual field. (C) and is called homonymous (same side of the both visual fields) hemianopia (half-blindness). Lesions affecting the optic chiasm destroy fibers form both nasal hemiretinas and produce a heteronymous (opposite sides of the visual fields) hemianopia (B) Occipital lesions may spare the fibers from the macula (as in D) because of he separation in the brain of these fibers from the others subserving vision.\n\nOPTION D IS CORRECT."}
{"question": "Question: Is inducible nitric oxide synthase isoform a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy?\nContext: Nitric oxide (NO) is involved in leukostasis and blood-retinal barrier (BRB) breakdown in the early stages of diabetic retinopathy (DR), but it is unclear which NO synthase (NOS) isoforms are primarily involved. In this study, the authors aimed to clarify the involvement of constitutive (eNOS, nNOS) and inducible NOS (iNOS) isoforms and the mechanisms underlying NO-mediated leukostasis and BRB breakdown. Diabetes was induced with streptozotocin for 2 weeks. Mice were treated with a NOS inhibitor, N(G)-nitro-L-arginine methyl ester (L-NAME), which shows a preference for constitutive isoforms over iNOS. Vessel leakage was assessed with Evans blue. Leukostasis was quantified in flat-mounted retinas with confocal microscopy, in vivo with a scanning laser ophthalmoscope, and in vitro in a retinal endothelial cell line. ICAM-1, occludin, and ZO-1 levels were assessed by Western blot, flow cytometry, or immunohistochemistry. Nitrotyrosine content was assessed by immunohistochemistry. Diabetes increased leukostasis within retinal vessels and BRB permeability, which were reduced by L-NAME. Similar effects were observed in diabetic iNOS knockout mice. In diabetic mouse retinas, ICAM-1 protein levels increased, whereas the immunoreactivity of tight junction proteins, occludin and ZO-1 decreased, in correlation with increased protein levels of all NOS isoforms. Those effects were prevented by L-NAME and also in diabetic iNOS knockout mice. High glucose and nitrosative/oxidative stress also increased leukostasis caused by ICAM-1 upregulation.", "answer": "These results indicate that the iNOS isoform plays a predominant role in leukostasis and BRB breakdown. The mechanism involves ICAM-1 upregulation and tight junction protein downregulation.\n\nyes"}
{"question": "Specialized clinical ophthalmology question: Can a family history of late age-related macular degeneration (AMD) increase the risk of developing the disease ?", "answer": "Yes, having a family history of late AMD can increase the risk of developing the disease. Studies have shown that first-degree relatives of patients with late AMD have a fourfold increased risk of AMD. Additionally, a case control study found that 25% of siblings of affected patients were also affected by the disease, compared to only 1% of siblings in control patients. This suggests a familial association and highlights a genetic predisposition to AMD. Twin studies have further supported this, with higher concordance rates among monozygotic twins compared to dizygotic twins. Although the exact genetic cause of AMD is still unknown, the evidence suggests that there is a strong familial component to the disease."}
{"question": "What is the mechanism of action of VEGF antagonists in the treatment of diabetic retinopathy and/or diabetic macular edema ?", "answer": "VEGF antagonists, such as pegaptanib, bevacizumab, and ranibizumab, are drugs used for the treatment of diabetic retinopathy and/or diabetic macular edema. These agents belong to a heterogeneous group of drugs that bind to free VEGF (vascular endothelial growth factor) and prevent it from activating receptors in the retinal vasculature. Despite their different compositions and structures, all VEGF antagonists share the ability to mimic endogenous VEGF receptors, effectively capturing the molecule and rendering it inactive. The mechanism of action of VEGF antagonists involves inhibiting the VEGF-mediated pathways that contribute to the development and progression of diabetic retinopathy and/or diabetic macular edema. By binding to free VEGF, these drugs prevent it from activating receptors in the retinal vasculature and potentially other body tissues. This inhibition helps to suppress the pathological angiogenesis (abnormal blood vessel growth) and vascular permeability associated with these conditions. In summary, VEGF antagonists act by binding to free VEGF and rendering it unable to activate receptors in the retinal vasculature. This mechanism disrupts the VEGF-mediated pathways involved in diabetic retinopathy and/or diabetic macular edema, ultimately reducing angiogenesis and vascular permeability in the affected areas of the retina."}
{"question": "Question: Waxy pallor of optic disc is seen in which disease-\nOptions:\nA. Retinitis pigmentosa\nB. Retinopathy of prematurity'\nC. Hypertensive retinopathy\nD. Diabetic retinopathy\n", "answer": " Ans. is 'a' i.e., Retinitis pigmentosa Examination findings in retinitis pigmentosao Ophthalmoscopic findings are characteristic and includeRetinal pigmentary changes (Bone spicule intraneural retinal pigmentation) : - Retina studded with small, jet-black spots resembling bone corpuscles with a spidery outline. These pigmentary changes are typically perivascular and retinal veins (never arteries) have a sheath of pigment for part of their course. These changes affect equatorial region initially sparing the posterior pole and periphery. Later in the course of disease whole retina is involved.Attenuated and thread like retinal arterioles and veins.Pale and waxy optic disc (consecutive optic atrophy).Thinning and atrophy of retinal pigment epithelium (RPE) in mid and far peripheral retina with relative sparing of RPE at macula.o Electroretinogram (ERG) and particularly the electro-oculogram (EOG) are markedly subnormal.\n\nOPTION A IS CORRECT."}
{"question": "Question: Is ethambutol toxic to retinal ganglion cells via an excitotoxic pathway?\nContext: Ethambutol is an essential medication in the management of tuberculosis. However, it can cause an optic neuropathy of uncertain etiology. Ethambutol toxicity was therefore studied in rodent retinal cells, and agents that might block its toxicity were considered. The toxicity of ethambutol and related agents was evaluated in rodent retinal dissociated cell preparations and whole eyes. Calcium fluxes and mitochondrial function were evaluated by fluorescent and staining techniques. For in vivo assays, adult rats were administered oral ethambutol over a 3-month period. Cell survival was assessed by stereology. Ethambutol is specifically toxic to retinal ganglion cells in vitro and in vivo. Endogenous glutamate is necessary for the full expression of ethambutol toxicity, and glutamate antagonists prevent ethambutol-mediated cell loss. Ethambutol causes a decrease in cytosolic calcium, an increase in mitochondrial calcium, and an increase in the mitochondrial membrane potential.", "answer": "The visual loss associated with ethambutol may be mediated through an excitotoxic pathway, inasmuch as ganglion cells are rendered sensitive to normally tolerated levels of extracellular glutamate. Ethambutol perturbs mitochondrial function. Its toxicity may depend on decreased ATPase activity and mitochondrial energy homeostasis. Glutamate antagonists may be useful in limiting the side effects seen with ethambutol.\n\nyes"}
{"question": "Question: Do widespread choroidal thickening and abnormal midperipheral fundus autofluorescence characterize exudative age-related macular degeneration with choroidal vascular hyperpermeability?\nContext: To investigate the clinical findings that characterize exudative age-related macular degeneration (AMD) with choroidal vascular hyperpermeability (CVH). Retrospective comparative study. Forty-eight consecutive patients attending the outpatient clinic of Tokyo University Hospital between May 2013 and July 2013. The presence or absence of CVH was determined with indocyanine green angiography performed at the latest visit. When CVH was observed, the eye was categorized as CVH(+) AMD, otherwise it was categorized as CVH(-) AMD. Using high-penetration optical coherence tomography, we measured choroidal thickness at the fovea and at four midperipheral areas (mean choroidal thickness at points on 6- and 9-papilla diameter circles superior, inferior, temporal, and nasal to the fovea). Ultrawide field retinal imaging was used to investigate abnormalities in midperipheral fundus autofluorescence (FAF). Choroidal thickness and the proportion of FAF abnormalities were compared between the CVH(+) AMD and CVH(-) AMD eyes and between eyes with polypoidal choroidal vasculopathy and typical AMD. Multiple regression analysis was used to control for treatment history and other characteristics. CVH was observed in 17 cases. Choroidal thickness was higher in the CVH(+) AMD eyes than in the CVH(-) AMD eyes at the fovea (325 μm versus 229 μm, respectively; P=0.0010, t-test), superior point (277 μm versus 215 μm, respectively; P=0.0021, t-test), inferior point (225 μm versus 161 μm, respectively; P=0.0002, t-test), and nasal point (202 μm versus 165 μm, respectively; P=0.042, t-test). The significance was maintained after controlling for possible confounders. The choroid was thicker at the fovea and at the inferior point in polypoidal choroidal vasculopathy than in typical AMD. The rate of midperipheral FAF abnormality was significantly higher in the CVH(+) AMD eyes than in the CVH(-) AMD eyes (82% versus 48%, respectively; P=0.031).", "answer": "AMD with CVH is associated with widespread choroidal thickening and peripheral FAF abnormalities.\n\nyes"}
{"question": "Question: Does tenascin-C promote angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy?\nContext: We previously demonstrated that tenascin-C was highly expressed in the fibrovascular membranes (FVMs) of patients with proliferative diabetic retinopathy (PDR). However, its role in the pathogenesis of FVMs has not been determined. The purpose of this study was to investigate what role tenascin-C plays in the formation and angiogenesis of FVMs. The level of tenascin-C was determined by sandwich enzyme-linked immunosorbent assay in the vitreous samples collected from patients with PDR and with a macular hole as control. The locations of tenascin-C, α- smooth muscle actin (SMA), CD34, glial fibrillary acidic protein (GFAP), and integrin αV in the FVMs from PDR patients were determined by immunohistochemistry. We also measured the in vitro expression of the mRNA and protein of tenascin-C in vascular smooth muscle cells (VSMCs) stimulated by interleukin (IL)-13. The effects of tenascin-C on cell proliferation, migration, and tube formation were determined in human retinal endothelial cells (HRECs) in culture. The mean vitreous levels of tenascin-C were significantly higher in patients with PDR than in patients with a macular hole (p<0.001). Double immunofluorescence analyses of FVMs from PDR patients showed that tenascin-C co-stained FVMs with α-SMA, CD34, and integrin αV but not with GFAP. In addition, IL-13 treatment increased both the expression and secretion of tenascin-C by VSMCs in a dose-dependent manner. Tenascin-C exposure promoted proliferation, migration, and tube formation in HRECs. Tenascin-C neutralizing antibody significantly blocked the tube formation by HRECs exposed to VSMC-IL-13-conditioned medium.", "answer": "Our findings suggest that tenascin-C is secreted from VSMCs and promotes angiogenesis in the FVMs associated with PDR.\n\nyes"}
{"question": "Specialized clinical ophthalmology question: What is the role of hypoxia-inducible factor 1 (HIF-1) in angiogenesis ?", "answer": "Sequential steps an ophthalmologist should take: 1. Review the existing literature and studies on HIF-1 and angiogenesis in ophthalmology. 2. Understand the molecular mechanisms involved in the regulation of angiogenesis by HIF-1. 3. Evaluate the potential implications of HIF-1 in various ocular diseases, especially those involving abnormal angiogenesis. 4. Consider the relevance of HIF-1 in the specific disease being studied or treated. 5. Explore therapeutic interventions targeting HIF-1 and its downstream pathways to modulate angiogenesis and potentially treat ocular diseases. Specialized clinical ophthalmology abstractive answer: Hypoxia-inducible factor 1 (HIF-1) plays a significant role in regulating angiogenesis, including in ophthalmology. HIF-1 is a transcription factor that is activated under hypoxic conditions, such as in retinal ischemia or diabetic retinopathy. It mediates the expression of various genes involved in angiogenesis, such as vascular endothelial growth factor (VEGF), which promotes the growth of new blood vessels. The activation of HIF-1 and subsequent upregulation of VEGF are crucial for neovascularization, a process often seen in diseases like age-related macular degeneration and retinopathy of prematurity. Understanding the molecular mechanisms underlying HIF-1's involvement in angiogenesis can provide valuable insights into developing targeted therapies to modulate this pathway and potentially treat ocular diseases associated with abnormal angiogenesis."}
{"question": "What is the potential benefit of combining PDT and anti-VEGF therapy in the treatment of neovascular age-related macular degeneration (nAMD) ?", "answer": "The combination of photodynamic therapy (PDT) and anti-VEGF therapy in the treatment of neovascular age-related macular degeneration (nAMD) has shown potential benefits. PDT aims to induce vascular occlusion in already formed neovascular vessels, while anti-VEGF drugs target the prevention of new neovascular tissue formation, induce regression of VEGF-dependent vessels, and reduce permeability of neovascular tissue. This combination therapy may have a synergistic effect by addressing different aspects of the choroidal neovascularization process. The addition of intravitreal corticosteroids can be considered to target the inflammatory component of the disease. Clinical studies and pilot studies have indicated that combination therapy with PDT and anti-VEGF drugs may lead to improved visual acuity and longer remission periods compared to monotherapy approaches. However, further research and trials are needed to validate and support these findings."}
{"question": "Question: Visual impairment in pterygium is due to –\nOptions:\nA. Astigmatism\nB. Myopia\nC. Hypermetropia\nD. Hazy cornea\n", "answer": " Visual disturbances occur when pterygium encroches the pupillary area or due to corneal astigmatism induced due to fibrosis in the regressive stage.\n\nOPTION A IS CORRECT."}
{"question": "How does the lens in the eye contribute to the formation of an optical image on the retina ?", "answer": "The lens in the eye plays a vital role in the formation of an optical image on the retina. It is a compound lens consisting of the crystalline lens. When light enters the eye, it passes through the layers of the retina and reaches the back layer where the photoreceptors (rods and cones) are located. The lens helps to focus the incoming light onto the retina by changing its shape. This process is called accommodation. By adjusting its curvature, the lens ensures that the light rays converge and form a clear and focused image on the surface of the retina. This precise focusing allows for sharp vision and enables the photoreceptors to convert the light energy into electrical and chemical signals, which are then transmitted to the optic nerve and further processed in the visual areas of the brain."}
{"question": "Question: Pneumoretinopexy is an outpatient procedure in which retinal detachment is sealed with air insufflation. Which of the following gas is used in pneumorctinopexy?\nOptions:\nA. Sulfur hexafluoride\nB. Carbon dioxide\nC. Nitrous oxide\nD. Oxygen\n", "answer": " Ans. a. Sulfur hexafluoride (Ref: Kanski 3rd/305, style=\"font-size: 1.04761904761905em; font-family: Times New Roman, Times, serif\"> -PDF/ Pneumatic- Retinopexy.pdf)Sulfur hexafluoride gas is used in pneumoretinopexy.\"Choices of the agent for intraocular tamponade include air, sulfur hexafluoride, perfluoro- ethane , and perfluoropropane.Perfluoroethane has the characteristics that match these criteria the best, but it has not been approved by the FDA for clinical use. In contrast, both sulfur hexafluoride and perfluoropropane have been approved by the FDA for clinical use. By default, sulfur hexafluoride has become the gas of choice used most frequently by most surgeons for pneumatic retinopexy. \"- http //www. insightinstruments.com/PDF/Papers-PDF/Pneumatic-Retinopexy.pdfPneumatic RetinopexyChoices of the agent for intraocular tamponade include air, sulfur hexafluorideQ, perfluoro- ethane, and perfluoropropane.Periluoroethane has the characteristics that match these criteria the best, but it has not been approved by the FDA for clinical use,In contrast, both sulfur hexafluoride and perfluoropropane have been approved by the FDA for clinical use.The long duration of perfluoropropane is advantageous for selected cases that require prolonged gas tamponade. Because of its greater expansion, only a small volume of perfluoropropane is required.However, many surgeons consider the long duration of perfluoropropane to be excessive, causing unnecessary delay in the resumption of normal activities and traveling for the patient.By default, sulfur hexafluoride has become the gas of choice used most frequently by most surgeons for pneumatic retinopexyQ.\n\nOPTION A IS CORRECT."}
{"question": "Question:  my blood pressure is quite high 145/98. my appointment with doctor is on monday. I do not really want to take blood pressure tablets. i just bought kalms this afternoon and started taking them. also drinking everyday half glass of beetroot with apple and carrot. am i in danger of having a heart attack or stroke?\n", "answer": " Hello Welcome to . High BP over a long time definitely leads to damage to other organs called as target organs. The target organs include the heart, eye, kidney, brain. Uncontrolled high BP can cause rupture of the blood vessels supplying the brain and cause a stroke. It can also cause strain on the heart muscle since the heart pumps more vigorously leading to heart muscle enlargement and later symptoms of heart failure. It can cause damage to the retina of the eye, loss of vision and retinal detachment. It can cause damage to the kidney filtration membrane leading to protein loss, electrolyte imbalance and subsequent kidney failure. These are some of the important complications that can be caused by uncontrolled high BP over a long time. Except for a stroke, which can happen when BP is too high and some blood vessel in brain ruptures, other organ damages take a long-standing high BP to happen. Your BP is high but not very high and the risk of complications at this point is unlikely. However, if it continues to be high over a period of time, it will lead to complications. You can try diet modifications, restricting salt in diet, exercise etc. to control your blood pressure. It will take around 3 months for these measures to take full effects. If despite these measures BP remains persistently higher, then you should be started on tablets. You should not rely on beetroot or apple or any other food only to control your blood pressure. Wishing you good health. Regards"}
{"question": "What is the most effective method for the treatment of rhegmatogenous retinal detachment ?", "answer": "The most effective method for the treatment of rhegmatogenous retinal detachment is surgical intervention, specifically retinal reattachment surgery. There are several surgical techniques available, including scleral buckle surgery, vitrectomy, and pneumatic retinopexy. The choice of technique depends on various factors such as the extent and location of the detachment, the presence of complicating factors, and the surgeon's expertise. Scleral buckle surgery involves placing a silicone band around the eye to indent the sclera, which helps to close the retinal break and reattach the retina. This procedure is often combined with cryotherapy or laser photocoagulation to seal the retinal tear. Vitrectomy is another surgical option where the vitreous gel is removed from the eye and replaced with a gas or silicone oil bubble. This helps to flatten the retina and close the retinal break. The gas or oil bubble gradually dissipates or needs to be removed in a subsequent procedure. Pneumatic retinopexy involves injecting a gas bubble into the eye to push the detached retina against the eye's inner wall. This is typically combined with laser or cryotherapy to seal the retinal tear. The patient's head positioning is crucial to ensure the gas bubble stays in the correct position for the retina to reattach. The choice of surgical technique depends on factors such as the location and size of the retinal detachment, the presence of proliferative vitreoretinopathy (PVR), the surgeon's experience, and the patient's overall health. Each technique has its advantages and potential complications, and the decision should be made on a case-by-case basis. It is important to note that in some cases, additional procedures may be necessary to address complications such as the presence of proliferative vitreoretinopathy or the formation of scar tissue. References: 1. American Academy of Ophthalmology. (2017). Basic and Clinical Science Course (BCSC) Section 12: Retina and Vitreous. San Francisco: American Academy of Ophthalmology. 2. Mitry, D., & Charteris, D. G. (2010). Yeo & Artioli's Clinical Ophthalmology: Vitreo-Retinal Surgery. Elsevier Health Sciences."}
{"question": "What are the current imaging techniques used for diagnosing age-related macular degeneration ?", "answer": "Age-related macular degeneration (AMD) is a common retinal disease that affects the central vision of elderly individuals. The diagnosis of AMD relies heavily on various imaging techniques that provide detailed information about the macula and its associated structures. The sequential steps an ophthalmologist should take to diagnose AMD include: 1. Fundus Photography: This technique captures high-resolution images of the retina, allowing ophthalmologists to visualize and document any characteristic changes associated with AMD, such as drusen or pigmentary abnormalities. 2. Optical Coherence Tomography (OCT): OCT is a non-invasive imaging modality that provides cross-sectional images of the retina. It helps in visualizing the layers of the macula, identifying any fluid accumulation (such as intraretinal or subretinal fluid), and detecting the presence of retinal pigment epithelial detachments or macular atrophy. 3. Fluorescein Angiography (FA): FA involves the intravenous injection of a fluorescent dye, which highlights the retinal and choroidal blood vessels. This technique helps in identifying choroidal neovascularization (CNV), a common complication of AMD, by visualizing abnormal leakages or the presence of neovascular membranes. 4. Indocyanine Green Angiography (ICGA): ICGA is another imaging technique that uses a different dye to visualize the choroidal vasculature. It is particularly useful in detecting occult CNV, which may not be clearly observed on FA. 5. Multifocal Electroretinography (mfERG): mfERG assesses the function of the macular photoreceptors and helps in evaluating the extent of retinal dysfunction caused by AMD. These imaging techniques play a crucial role in the diagnosis and management of age-related macular degeneration, allowing ophthalmologists to accurately assess the disease severity, formulate treatment plans, and monitor disease progression over time."}
{"question": "What are the advantages and disadvantages of using subretinal prostheses compared to the new approach of suprachoroidal-transretinal stimulation (STS) in the field of artificial vision ?", "answer": "Subretinal prostheses and suprachoroidal-transretinal stimulation (STS) are two approaches being explored in the field of artificial vision for patients with retinal degeneration. Subretinal prostheses involve placing the electrode array between the pigment epithelial layer and the outer layer of the retina, while STS involves placing the stimulating electrodes on the fenestrated sclera or in the suprachoroidal space, with the counter electrode inserted intravitreally. Advantages of Subretinal Prostheses: 1. Stability: Subretinal arrays are more stable compared to epiretinal prostheses and may reduce the risk of movement or dislocation of the electrodes. 2. Potential for Higher Resolution: Placing the electrodes closer to the retina may allow for better spatial resolution and potentially more precise visual perception. 3. Direct Stimulation: Subretinal prostheses provide direct contact with the retinal tissue, which may result in more efficient electrical stimulation. Disadvantages of Subretinal Prostheses: 1. Glial Tissue Proliferation: Chronic implantation of subretinal arrays may lead to the proliferation of glial tissue around the electrode array, potentially affecting the efficacy of stimulation. 2. Surgical Complexity: Placing the array between the pigment epithelial layer and the outer retina requires a more complex surgical procedure compared to STS. 3. Risk of Damage: Inserting an electrode intraocularly carries the potential risk of significant damage to the eye. Advantages of Suprachoroidal-Transretinal Stimulation (STS): 1. Simplified Surgical Technique: STS eliminates the need for vitreous surgery, making the surgical procedure less complicated. 2. Non-Contact with Retina: The electrodes in STS are placed in the scleral pocket, avoiding direct contact with the retina. This reduces the potential risk of permanent attachment or damage to the retina. 3. Ease of Removal and Replacement: Due to the non-contact nature of STS, electrodes can be easily removed or replaced if needed. 4. Wide Retinal Stimulation: STS allows for stimulation of a larger area of the retina since the electrodes"}
{"question": "How can the funduscopic examination help in the evaluation of visual complaints ?", "answer": "The funduscopic examination is an essential part of evaluating the visual pathway. It allows for the assessment of the condition of the retina, which can provide valuable information for differential diagnosis of visual complaints. By examining the optic disc, one can identify signs of papilledema (swollen and elevated optic disc) or optic atrophy (pale and atrophic optic disc). Additionally, the presence of spontaneous venous pulsations can indicate that the intracranial pressure is not elevated. Overall, the funduscopic examination aids in gathering a general sense of the retinal condition, guiding the diagnostic process for visual complaints."}
{"question": "What are the characteristics and potential complications of commotio retinae ?", "answer": "Commotio retinae, also known as Berlin edema, is a retinal contusion resulting from blunt anterior trauma. It is typically characterized by a grayish-white appearance and often involves the macula. The condition may also present with retinal hemorrhages or even a choroidal rupture. Following the acute edema episode, the retina may develop scarring with pigment clumping. Macular commotio retinae can lead to reduced central vision, although vision usually improves as the edema resolves, unless there is a macular hole or disruption of the retinal pigment epithelium in the fovea. Animal studies suggest that the cause of commotio retinae is a disruption of the outer segments of the photoreceptors, rather than extracellular edema. Fluorescein angiograms of affected individuals exhibit early blockage in areas of the white retina, without any alteration in retinal vascular permeability."}
{"question": "What evidence supports the use of Two-Photon Excitation Photodynamic Therapy (TPE-PDT) for the treatment of Wet Age-Related Macular Degeneration (wet-AMD) ?", "answer": "Two-Photon Excitation Photodynamic Therapy (TPE-PDT) is a potential treatment for Wet Age-Related Macular Degeneration (wet-AMD). The use of \"designer\" TPE-PDT drugs, such as novel porphyrin dimers with high two-photon absorption cross-section, has shown promising results in preclinical studies. In a study conducted by Collins et al., a series of porphyrin dimers were tested for their ability to induce cytotoxicity in a cancer cell line. Dimer 1 demonstrated higher TPE-PDT efficiency compared to verteporfin, a clinically approved photosensitizer. Based on these findings, Dimer 1 was selected for further in vivo testing for TPE-PDT. To evaluate TPE-PDT in vivo, the chicken chorioallantoic membrane (CAM) model was utilized. The CAM is a transparent membrane in the chicken embryo that develops blood vessels similar in size to those in the human eye affected by wet-AMD. The CAM undergoes rapid angiogenesis, resembling the neovascularization seen in wet-AMD. This makes the chicken CAM a cost-effective and useful model for studying wet-AMD. In summary, the evidence supporting the use of TPE-PDT in the treatment of wet-AMD includes the successful utilization of \"designer\" porphyrin dimers with high two-photon absorption cross-section in preclinical studies. Moreover, the chicken CAM model provides a reliable in vivo platform to further investigate the efficacy of TPE-PDT for wet-AMD treatment."}
{"question": "Question: Most common cause of neovascular glaucoma ?\nOptions:\nA. Diabetes\nB. CRAO\nC. CRVO\nD. Eale's disease\n", "answer": " Ans. is 'a' i.e., Diabetes Neovascular glaucoma (Rubeosis iridis) It is a secondary angle closure glaucoma which results due to formation of neovascular membrane over the iris i.e., neovascularization of iris (rubeosis iridis). Causes of rubeosis iridis are :- Common :- Diabetic retinopathy (most common cause), central retinal vein occlusion, Eale's disease, sickle- cell retinopathy Rare causes : - Long standing retinal detachment, central retinal aery occlusion, intraocular inflammation (uveitis), intraocular tumors (choroidal melanoma, retinoblastoma), radiation retinopathy, ocular ischemic syndrome (carotid aery disease, carotid - cavernous fistula), Fusch's heterochromic iridocyclitis. In central retinal vein occlusion (CRVO), glaucoma manifests about 100 days after thrombosis of central vein, therefore, it is also called 100 days glaucoma. The most widely accepted theory for neovascularization is that the hypoxic retina produces diffusible angiogenic factor (VEGF) that stimulates new vessel proliferation. Treatment of choice is panretinal photocoagulation as it terminates the angiogenic stimulus for neovascularization of retina.\n\nOPTION A IS CORRECT."}
{"question": "Question: Does low-level gestational lead exposure increase retinal progenitor cell proliferation and rod photoreceptor and bipolar cell neurogenesis in mice?\nContext: Gestational lead exposure (GLE) produces novel and persistent rod-mediated electroretinographic (ERG) supernormality in children and adult animals. We used our murine GLE model to test the hypothesis that GLE increases the number of neurons in the rod signaling pathway and to determine the cellular mechanisms underlying the phenotype. Blood lead concentrations ([BPb]) in controls and after low-, moderate-, and high-dose GLE were ≤ 1, ≤ 10, approximately 25, and approximately 40 µg/dL, respectively, at the end of exposure [postnatal day 10 (PND10)]; by PND30 all [BPb] measures were ≤ 1 µg/dL. Epifluorescent, light, and confocal microscopy studies and Western blots demonstrated that late-born rod photoreceptors and rod and cone bipolar cells (BCs), but not Müller glial cells, increased in a nonmonotonic manner by 16-30% in PND60 GLE offspring. Retinal lamination and the rod:cone BC ratio were not altered. In vivo BrdU (5-bromo-2-deoxyuridine) pulse-labeling and Ki67 labeling of isolated cells from developing mice showed that GLE increased and prolonged retinal progenitor cell proliferation. TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) and confocal studies revealed that GLE did not alter developmental apoptosis or produce retinal injury. BrdU birth-dating and confocal studies confirmed the selective rod and BC increases and showed that the patterns of neurogenesis and gliogenesis were unaltered by GLE.", "answer": "Our findings suggest two spatiotemporal components mediated by dysregulation of different extrinsic/intrinsic factors: increased and prolonged cell proliferation and increased neuronal (but not glial) cell fate. These findings have relevance for neurotoxicology, pediatrics, public health, risk assessment, and retinal cell biology because they occurred at clinically relevant [BPb] and correspond with the ERG phenotype.\n\nyes"}
{"question": "What is the surgical procedure used to repair retinal detachments ?", "answer": "The surgical procedure used to repair retinal detachments is called a scleral buckle. In this procedure, a band or sponge is sewn onto the sclera, which is the white outer coat of the eyeball, to indent it. By applying this indentation, the retinal detachment can be addressed and corrected."}
{"question": "Question: Are synaptogenesis and outer segment formation perturbed in the neural retina of Crx mutant mice?\nContext: In Leber's congenital amaurosis (LCA), affected individuals are blind, or nearly so, from birth. This early onset suggests abnormal development of the neural retina. Mutations in genes that affect the development and/or function of photoreceptor cells have been found to be responsible in some families. These examples include mutations in the photoreceptor transcription factor, Crx. A Crx mutant strain of mice was created to serve as a model for LCA and to provide more insight into Crx's function. In this study, an ultrastructural analysis of the developing retina in Crx mutant mice was performed. Outer segment morphogenesis was found to be blocked at the elongation stage, leading to a failure in production of the phototransduction apparatus. Further, Crx-/- photoreceptors demonstrated severely abnormal synaptic endings in the outer plexiform layer.", "answer": "This is the first report of a synaptogenesis defect in an animal model for LCA. These data confirm the essential role this gene plays in multiple aspects of photoreceptor development and extend our understanding of the basic pathology of LCA.\n\nyes"}
{"question": "Question: A 78-year-old woman presents to the ophthalmologist with complaints of painless, blurry vision that has worsened in the past year. She says that she sees halos around lights, and that she particularly has trouble driving at night because of the glare from headlights. On physical exam, the patient has an absence of a red reflex. What is the most likely pathology that is causing this patient’s visual symptoms?\nOptions:\nA. Corneal edema\nB. Degeneration of the retina\nC. Hardening of the lens\nD. Optic nerve head damage\n", "answer": "OPTION C IS CORRECT."}
{"question": "What are the current treatment options for neovascular age-related macular degeneration (AMD) ?", "answer": "The current treatment options for neovascular AMD include photodynamic therapy (PDT) combined with anti-vascular endothelial growth factor (VEGF) therapy. PDT involves using a light-activated drug to selectively destroy abnormal blood vessels in the retina. Anti-VEGF therapy, such as Bevacizumab and Ranibizumab, work by blocking the growth factor responsible for the formation of abnormal blood vessels. These treatments have demonstrated excellent safety and efficacy in the management of neovascular AMD. Additionally, new therapies like VEGF Trap-Eye, a fusion protein that binds VEGF and related growth factors, and small interfering RNA agents such as Bevasiranib, which inhibit the production of VEGF, are being investigated in clinical trials. These therapies aim to provide more targeted and effective treatment options for neovascular AMD."}
{"question": "What are the diagnostic signs and evaluation methods for paraneoplastic optic neuropathies ?", "answer": "The diagnostic signs for paraneoplastic optic neuropathies include multiple elevated red round patches at the level of the retinal pigment epithelium, a multifocal pattern of early hyperfluorescence corresponding to the patches, pigmented and non-pigmented uveal melanocytic tumors, diffuse thickening of the uvea, coexistent exudative retinal detachment, and the rapid development of cataracts. Other findings may include dilated episcleral vessels, shallow anterior chamber, iridodonesis, and cells in the anterior chamber and vitreous. Diagnostic evaluation should consist of Goldmann or Humphrey visual fields, electroretinogram (ERG), and color assessments. ERG studies in patients with paraneoplastic optic neuropathies may show flat or markedly reduced cone and rod responses. Additionally, angiographic findings specific to paraneoplastic optic neuropathies include early hyperfluorescence due to focal destruction of the pigment epithelium and sparing of the choriocapillaris, as well as marked choroidal hyperfluorescence with patches of hypofluorescence in the late frames."}
{"question": "What is the significance of a biarcuate scotoma predominantly involving the upper nasal points in a patient's visual field ?", "answer": "A biarcuate scotoma predominantly involving the upper nasal points in a patient's visual field can be indicative of a specific type of visual field defect known as an upper nasal arcuate pattern defect. This pattern of visual field loss is commonly associated with certain optic nerve pathologies, particularly those affecting the retinal nerve fiber layer. The presence of a biarcuate scotoma suggests damage or dysfunction in the corresponding nerve fibers, resulting in the characteristic visual field defect. In clinical ophthalmology, identifying the specific pattern and location of visual field defects is crucial for diagnosing and monitoring various ocular conditions. The upper nasal arcuate pattern defect typically indicates involvement of the inferior and superior arcuate nerve fiber bundles, which are primarily responsible for carrying visual information from the superior and inferior retina. By assessing the location and extent of this defect, ophthalmologists can gather important clues about the underlying pathology. It is important to perform additional diagnostic tests, such as central threshold testing, to further evaluate the patient's visual function and confirm the findings from the screening test. These tests may include detailed examination of the optic nerve, imaging studies (such as optical coherence tomography), and consideration of the patient's medical history and other clinical findings. The results obtained from these tests will aid in formulating an accurate diagnosis and determining the most appropriate management or treatment plan for the patient."}
{"question": "In specialized clinical ophthalmology, a question that can be inferred from the given information is: What is the potential of tyrosine kinase inhibitors, specifically PTK 787, in the treatment of neovascular age-related macular degeneration (nAMD) ?", "answer": "Tyrosine kinase inhibitors, such as PTK 787, show potential in the treatment of neovascular age-related macular degeneration (nAMD). PTK 787 specifically inhibits the VEGF receptor tyrosine kinase, which is involved in angiogenesis, lymphangiogenesis, and vascular permeability. Studies have demonstrated functional improvement in ischemic retinopathy induced in mice after intravitreal injection of PTK 787. Angioproliferative changes were reduced compared to control eyes. While there are currently no clinical trials investigating the use of PTK 787 in nAMD treatment, the compound holds promise as a VEGF inhibitor."}
{"question": "Question: Does pitavastatin attenuate leukocyte-endothelial interactions induced by ischemia-reperfusion injury in the rat retina?\nContext: Statins (3-hydroxy-methylglutaryl coenzyme A reductase inhibitors) have been shown to lower serum cholesterol levels in clinical use. Moreover, it has been reported that statins exert pleiotropic and beneficial effects on vascular endothelium. Therefore, we investigated the effects of pitavastatin, a new statin, on leukocyte accumulation during ischemia-reperfusion injury. Transient retinal ischemia was induced in Long-Evans rats for 60 min by temporal ligation of the optic nerve. Pitavastatin (0.12, 0.35, or 1.1 mg/kg) was administered 5 min prior to the induction of retinal ischemia. Leukocyte-endothelial interactions in the post-ischemic retina were evaluated in vivo with acridine orange digital fluorography. The number of rolling leukocytes, number of accumulated leukocytes, and diameters of the major retinal artery and vein were evaluated. Intercellular adhesion molecule-1 (ICAM-1) mRNA expression in the retina was semiquantitatively studied using the RT-PCR method. Pitavastatin-treated rats at doses of 0.35 and 1.1 mg/kg showed mild arterial narrowing (p < 0.01) and venous dilation (p < 0.01) compared with vehicle-treated (ischemic) rats. In rats treated with 0.35 mg/kg pitavastatin, the number of rolling leukocytes was significantly reduced by 35.5% (p < 0.01) 12 hr after reperfusion compared with that of vehicle-treated rats. With treatment at a dose of 0.35 mg/kg pitavastatin, the number of accumulated leukocytes was reduced to 68.7% (p < 0.01) 24 hr after reperfusion. Moreover, pitavastatin treatment significantly reduced ICAM-1 mRNA expression in the retina during ischemia-reperfusion injury.", "answer": "Pitavastatin effectively attenuated ischemia-induced leukocyte-endothelial interactions in the rat retina.\n\nyes"}
{"question": "Question: Does age of onset of myopia predict risk of high myopia in later childhood in myopic Singapore children?\nContext: To investigate the effect of age of myopia onset on the severity of myopia later in life among myopic children. In this prospective study, school children aged 7-9 years from the Singapore Cohort Of the Risk factors for Myopia (SCORM) were followed up till 11 years (n = 928). Age of myopia onset was defined either through questionnaire at baseline (age 7-9 years) or subsequent annual follow-up visits. Age of onset of myopia was a surrogate indicator of duration of myopia progression till age 11 years. Cycloplegic refraction and axial length were measured at every annual eye examination. High myopia was defined as spherical equivalent of ≤-5.0 D. A questionnaire determined the other risk factors. In multivariable regression models, younger age of myopia onset (per year decrease) or longer duration of myopia progression was associated with high myopia (odds ratio (OR) = 2.86; 95% CI: 2.39 to 3.43), more myopic spherical equivalent (regression coefficient (β) = -0.86 D; 95% CI: -0.93 to -0.80) and longer axial length (β = 0.28 mm; 95% CI: 0.24 to 0.32) at aged 11 years, after adjusting for gender, race, school, books per week and parental myopia. In Receiver Operating Curve (ROC) analyses, age of myopia onset alone predicted high myopia by 85% (area under the curve = 0.85), while the addition of other factors including gender, race, school, books per week and parental myopia only marginally improved this prediction (area under the curve = 0.87).", "answer": "Age of myopia onset or duration of myopia progression was the most important predictor of high myopia in later childhood in myopic children. Future trials to retard the progression of myopia to high myopia could focus on children with younger age of myopia onset or with longer duration of myopia progression.\n\nyes"}
{"question": "Question: Does cCR2 overexpression promote the efficient recruitment of retinal microglia in vitro?\nContext: Retinal microglia can be activated and recruited by chemokines and play a protective role in early retinal degeneration. CC-chemokine ligand 2 (CCL2) and its receptor, CC-chemokine receptor 2 (CCR2), have been implicated as key mediators for the trafficking and accumulation of microglial cells in lesioned tissue. The current study investigates whether the overexpression of CCR2 allows microglia to migrate toward CCL2 more efficiently. Primary microglial cells were transduced with lentivirus carrying green fluorescent protein (GFP)-tagged CCR2 (CCR2-GFP). Overexpression of CCR2 was assessed by western blot analysis and fluorescence-assisted cell sorting. The chemotaxis of primary microglia transduced with lentivirus carrying CCR2-GFP was compared to either those transduced with GFP alone or those not transduced, using a chemotaxis chamber assay. Primary microglia showed a high transduction rate following lentivirus application and maintained normal microglial morphology and a significant overexpression of CCR2 protein. We found that CCL2-mediated chemotaxis is concentration and time dependent in microglia. The chemotactic response of microglia cells overexpressing CCR2-GFP was significantly increased compared to that of nontransduced and GFP-expressing microglia.", "answer": "These findings suggest that microglia can be efficiently transduced with CCR2-GFP lentiviral vectors and that the overexpression of CCR2 in retinal microglia promotes their chemotaxis in response to chemokines, suggesting that these cells may be promising targets for cell-based therapeutic manipulation in retinal disease.\n\nyes"}
{"question": "Question: A 56-year-old woman comes to the physician with a 6-month history of black spots in her vision. She has been unable to drive at night for the past 4 months. The patient has rheumatoid arthritis, type 2 diabetes mellitus, and depression. Her mother has glaucoma. She has never smoked. She drinks one or two glasses of homemade moonshine every day after dinner. Current medications include metformin, citalopram, and chloroquine. She is 168 cm (5 ft 6 in) tall and weighs 79 kg (174 lb); BMI is 28 kg/m2. Her temperature is 36.8°C (98.2°F), pulse is 68/min, and blood pressure is 138/83 mm Hg. Examination shows swan neck deformities of both hands. The patient's vision is 20/20 in both eyes. She has difficulty adapting to changes in lighting in both eyes. Slit lamp examination shows a normal anterior segment. The posterior segment shows bilateral bull's eye macular lesions.\nHemoglobin 11.7 g/dL\nMean corpuscular volume 98 μm3\nSerum\nAlkaline phosphatase 65 U/L\nAspartate aminotransferase (AST, GOT) 20 U/L\nAlanine aminotransferase (ALT, GPT) 17 U/L\nγ-Glutamyltransferase (GGT) 90 U/L (N=5–50 U/L)\nWhich of the following is the most likely cause of this patient's symptoms?\"\nOptions:\nA. Chloroquine retinopathy\nB. Diabetic retinopathy\nC. Angle-closure glaucoma\nD. Age-related macular degeneration\n", "answer": "\nOption A: Chloroquine retinopathy\nChloroquine is a medication commonly used to treat conditions like rheumatoid arthritis and lupus. One of the known side effects of chloroquine is retinal toxicity, which can lead to vision changes and damage to the central vision. The characteristic finding in chloroquine retinopathy is the bull's eye macular lesion, which is seen in this patient's posterior segment examination. The symptoms of difficulty adapting to changes in lighting and black spots in vision are also consistent with chloroquine retinopathy. The patient's history of taking chloroquine further supports this diagnosis.\n\nOption B: Diabetic retinopathy\nDiabetic retinopathy is a complication of long-standing diabetes and is characterized by damage to the blood vessels of the retina. This condition can lead to various visual symptoms, including blurry vision, floaters, and even vision loss. However, the patient's history and examination findings do not suggest diabetic retinopathy. The presence of bilateral bull's eye macular lesions and symptoms of difficulty adapting to changes in lighting are not consistent with diabetic retinopathy.\n\nOption C: Angle-closure glaucoma\nAngle-closure glaucoma is a condition characterized by the narrowing or closure of the drainage angle in the eye, leading to increased intraocular pressure. This can cause sudden, severe pain, blurred vision, and halos around lights. While the patient does have a family history of glaucoma, the symptoms and examination findings described are not suggestive of angle-closure glaucoma. The patient's vision is 20/20 in both eyes, and there is no mention of intraocular pressure elevation or signs of acute angle closure on examination.\n\nOption D: Age-related macular degeneration\nAge-related macular degeneration (AMD) is a progressive condition that affects the macula, which is responsible for central vision. It typically presents with gradual central visual loss and distortion, but not with black spots in vision or difficulty adapting to changes in lighting. The presence of bull's eye macular lesions is not consistent with AMD. This option is unlikely in the given clinical scenario.\nOPTION A IS CORRECT."}
{"question": "Question: What is (are) Muscle eye brain disease ?", "answer": "Muscle eye brain disease is a rare form of congenital muscular dystrophy. Individuals with this condition are born with muscle weakness (hypotonia), severe nearsightedness (myopia), glaucoma, and brain abnormalities. They also have developmental delay and intellectual disability. People with muscle eye brain disease frequently have additional eye abnormalities, hydrocephalus, and distinctive facial features. This condition is caused by mutations in gene a called POMGNT1, and it is inherited in an autosomal recessive pattern. The signs and symptoms of this condition vary among affected individuals, even among members of the same family.\nReference: https://rarediseases.info.nih.gov/gard/156/muscle-eye-brain-disease"}
{"question": "Question: Does intravitreal colchicine cause decreased RNFL birefringence without altering RNFL thickness?\nContext: To test the hypothesis that longitudinal differences between retinal nerve fiber layer (RNFL) birefringence, measured by scanning laser polarimetry (SLP), and RNFL thickness, measured by optical coherence tomography (OCT), are informative about the state of axonal degeneration. Colchicine was injected into the vitreous cavity of one eye in each of six vervet monkeys (Chlorocebus sabaeus; estimated vitreal concentration: 1 mM, n = 3; 2 mM, n = 1; 10 mM, n = 2); an equivalent volume (approximately 0.1 mL) of sterile saline was injected into fellow control eyes. RNFL birefringence was measured by SLP before injection and every 10 minutes after injection for 2 hours. RNFL thickness was measured by OCT before injection and 2 hours later. After isolating each retina, biopsy specimens were obtained from the inferotemporal arcade region, approximately 2 mm from the center of the optic disc, using a 2-mm trephine and were processed for transmission electron microscopy (TEM). Retinas were then flat-mounted and stained with an antibody against polymerized beta-III-tubulin. RNFL birefringence measured by SLP decreased over time in all six colchicine-injected eyes, appearing to reach a plateau of -20% +/- 7% (P < 0.0001) approximately 100 minutes after injection. There were no significant differences between quadrants (P = 0.44) and no apparent dose effect (P = 0.87). The change in vehicle-injected control eyes was -3% +/- 3% (P = 0.06; NS). The change in RNFL thickness measured by OCT was +1% +/- 4% (P = 0.81; NS) in colchicine-injected eyes and +6% +/- 6% (P = 0.13; NS) in control eyes. There was no evidence of macular edema by fundus biomicroscopy, stereo fundus photography, or OCT. TEM revealed disorganization of microtubules, swelling of mitochondria, and blurred axonal membrane borders in colchicine-injected eyes. Flat-mounted retinas stained with an antibody against polymerized beta-III-tubulin showed only a mild reduction of peripapillary stain intensity in the colchicine-injected eyes compared with controls.", "answer": "Intravitreal injection of colchicine caused microtubule disruption within the axons of the RNFL in nonhuman primate eyes. This was manifest as a reduction of RNFL birefringence, without alteration of RNFL thickness, suggesting that such discrepancies can be informative about the status of axonal degeneration.\n\nyes"}
{"question": "What are the steps to perform an intravitreal triamcinolone injection ?", "answer": "Here are the steps to perform an intravitreal triamcinolone injection: 1. Place 2 drops of topical anesthetic in the eye to be treated. 2. Prep the eye to be treated with a prepackaged povidone-iodine swab twice. 3. Place a drop of 5% povidone-iodine in the cul-de-sac. 4. After scrubbing and donning sterile gloves, draw up 0.5 cc of 2% lidocaine with epinephrine and 0.2 ml of triamcinolone from fresh vials. Soak a sterile cotton tip in tetra-caine solution. Attach a 30-gauge needle to both the anesthetic syringe and the triamcinolone syringe. 5. Place a sterile lid speculum between the eyelids. 6. Apply the topical-anesthetic soaked cotton tip on the conjunctiva for approximately 1 minute, then inject the local anesthetic to balloon the conjunctiva, using the cotton tip to disperse the anesthetic. 7. Measure 4 mm from the limbus in a phakic eye or 3 mm from the limbus in a pseudophakic or aphakic eye using a sterile caliper. 8. Push 0.1 cc of triamcinolone through to the tip of the needle. Stabilize the eye with a sterile cotton tip and inject 0.1 cc of triamcinolone into the vitreous cavity while observing the needle tip. Remove the needle and place a sterile cotton tip over the needle entry site for several seconds. 9. Immediately place a drop of topical broad-spectrum antibiotic solution over the injection site. 10. Observe the retina for perfusion of the central retinal artery. 11. Clean the eye, especially irrigating profusely with sterile water to remove all povidone-iodine solution. 12. Check the intraocular pressure 30 minutes post-procedure and discharge if at a safe level. Please note that this answer is based on the information provided and should be used as a general guideline. It's always important to refer to established ophthalmology books and resources for further details and to ensure accurate and up-to-date information."}
{"question": "Question: Who is at risk for Cataract? ?", "answer": "As with any surgery, cataract surgery poses risks such as infection and bleeding. Before cataract surgery, your doctor may ask you to temporarily stop taking certain medications that increase the risk of bleeding during surgery. After surgery, you must keep your eye clean, wash your hands before touching your eye, and use the prescribed medications to help minimize the risk of infection. Serious infection can result in loss of vision. Cataract surgery slightly increases your risk of retinal detachment. Other eye disorders, such as nearsightedness, can further increase your risk of retinal detachment after cataract surgery. A retinal detachment causes no pain. Early treatment for retinal detachment often can prevent permanent loss of vision. The longer the retina stays detached, the less likely you will regain good vision once you are treated. Even if you are treated promptly, some vision may be lost. Talk to your eye care professional about these risks. Make sure cataract surgery is right for you.\nReference: http://nihseniorhealth.gov/cataract/toc.html"}
{"question": "Question: Does varying the GARP2-to-RDS Ratio lead to Defects in Rim Formation and Rod and Cone Function?\nContext: The beta subunit of the rod cyclic nucleotide gated channel B1 (CNGB1) contains a proline/glutamic acid-rich N-terminal domain (GARP), which is also present in rods as a non-membrane-bound protein (GARP1/2). GARP2 and CNGB1 bind to retinal degeneration slow (RDS), which is present in the rims of rod and cone outer segment (OS) layers. Here we focus on the importance of RDS/GARP complexes in OS morphogenesis and stability. Retinal structure, function, and biochemistry were assessed in GARP2-Tg transgenic mice crossed onto rds+/+, rds+/-, and rds-/- genetic backgrounds. GARP2 expression decreased in animals with reduced RDS levels. Overexpression of GARP2 led to abnormalities in disc stacking in GARP2-Tg/rds+/+ and the accumulation of abnormal vesicular structures in GARP2-Tg/rds+/- OS, as well as alterations in RDS-ROM-1 complex formation. These abnormalities were associated with diminished scotopic a- and b-wave amplitudes in GARP2-Tg mice on both the rds+/+ and rds+/- backgrounds. In addition, severe defects in cone function were observed in GARP2-Tg mice on all RDS backgrounds.", "answer": "Our results indicate that overexpression of GARP2 significantly exacerbates the defects in rod function associated with RDS haploinsufficiency and leads to further abnormalities in OS ultrastructure. These data also suggest that GARP2 expression in cones can be detrimental to cones. RDS/GARP interactions remain under investigation but are critical for both OS structure and function.\n\nyes"}
{"question": "What is the purpose of the pattern ERG in clinical electrophysiology of the eye ?", "answer": "The pattern ERG (pERG) is primarily used to measure the activity of ganglion cells, which are the third-order neurons of the retina. Ganglion cells are most sensitive to spatial differences in retinal illumination. The pERG stimulus consists of a high-contrast checkerboard pattern that inverts at a regular frequency (1-10Hz) within the central visual field. By keeping the mean luminance of the checkerboard constant, the influence of photoreceptors and second-order neurons on the recorded response is minimized. The pERG technique provides information about a specific class of cells in the retina, but it does not convey information about the location of a focal retinal anomaly. The recorded response represents the summed response from all areas of the retina subtended by the stimulus pattern, typically the macular region."}
{"question": "Question: Is sectorial loss of retinal ganglion cells in inherited photoreceptor degeneration due to RGC death?\nContext: To investigate the cause of retinal ganglion cell (RGC) loss in dystrophic aged Royal College of Surgeons (RCS) rats. RCS-p+ (dystrophic) female rats of postnatal times (P365, P450 and P540) and age-matched RCS-p1 rdy+ (non-dystrophic) rats were used. In whole-mounted retinas, RGCs were doubly labelled with Fluorogold (FG) retrogradely transported from the superior colliculi and Brn3a immunohistochemistry. RGC axons were labelled with anti-neurofilament antibodies. Automatic image analysis techniques allowed quantification of the total population of RGCs per retina and construction of isodensity maps to investigate RGC topology. Dystrophic retinas showed at all times studied wedge-shaped sectors devoid of FG(+) and Brn3a(+) RGCs. These sectors were also devoid of neurofilament-labelled axons. The total number of FG(+)RGC and Brn3a(+)RGC per retina was significantly smaller in dystrophic rats at P540, revealing RGC death at this age. The total number of FG(+)RGCs was smaller than those of Brn3a(+)RGCs at P540, indicating a disturbance of the retrograde axonal transport at this age.", "answer": "RGC double labelling documents that sectorial RGC loss in aged dystrophic RCS rats is mainly due to RGC death, although a deficit of the retrograde axonal transport exists also at the more advanced ages.\n\nyes"}
{"question": "Question: The first sign of Vitamin A deficiency is\nOptions:\nA. Conjunctival xerosis\nB. Corneal ulcer\nC. Keratomalacia\nD. Bitot's spot\n", "answer": " Modified classification WHO (Xerophthalmia) XN: Night blindnessXIA: Conjunctival xerosis XIB: Bitot's spotsX2: Corneal xerosisX3A: Corneal ulceration/keratomalacia less than 1/3rd corneal surfaceX3B: Corneal ulceration/keratomalacia equal to or more than 1/3rd corneal surface XS: Corneal scarXF: Xerophthalmia fundus.\n\nOPTION A IS CORRECT."}
{"question": "Question: Anterior uveitis earliest lesion ?\nOptions:\nA. Aqueous flare\nB. Keratic precipitates\nC. Circumcorneal congestion\nD. Blurring of vision\n", "answer": " Ans. is 'a' i.e., Aqueous flare Aqueous flare is the earliest sign of acute anterior uveitis. Keratic precipitates is the pathognomic sign of acute anterior uveitis Clinical features of acute anterior uveitis Acute anterior uveitis is the most common form of uveits, accounting for 60-70% of cases. It is characterized by sudden onset and duration less than 3 months. Presentation is typical with sudden onset of unilateral pain, photophobia, redness, lacrimation and blepherospasm. Vision may be normal initially. However, later there may be distrubance in vision due to ciliary spasm (induced myopia), corneal haze (due to edema & 1(13s) and aqueous turbidity. External examination shows following signs :- Circumcorneal (ciliary) congestion Which has a violaceous hue. Corneal edema, posterior corneal opacities. Keratic precipitates (KPs):- are proteinaceous cellular deposits at the back of cornea on endothelium. Anterior chamber signs :- Aqueous cells, Aqueous flare, hypopyon, hyphaemia (in hemorrhagic uveitis), deep anterior chamber (If posterior synachiae occurs). Iris signs :- Blurred & indistinct iris, i.e. muddy iris, instead of being clear and sharply defined. Papillary signs :- Narrow (miotic) pupil, irregular pupil due to segmental posterior synechiae which gives festooned appearance (festooned pupil) when dilated with atropine, sluggish pupillary reaction, ectropion pupillae (eveion of pupillary margins), occlusio pupillae (due to complete occlusion of pupil by organised exudate).\n\nOPTION A IS CORRECT."}
{"question": "Question: Is myopia progression specified by a double exponential growth function?\nContext: The purpose of this study was to demonstrate how well a modified Gompertz double exponential growth function delineates the diverse courses of myopia progression found in individual eyes. The function is: R = Re + Rc(0.07295)(a(x - t0)) where the spherical equivalent refractive error at a given age R equals the initial refractive error (Re) plus the overall refractive change (Rc) times a double exponential function with the base (0.07295) representing the proportion of Rc that occurs when maximum acceleration is reached, a is a curvature coefficient, t0 is the age of onset and x is age. This function was fit to longitudinal refractive data (spherical equivalents) for both eyes of 36 myopic children. The fits were required to meet a stringent set of criteria, including fitting transitions in and out of myopia progression and having no systematic errors or arbitrary constants. Correlation between values on the refractive function and corresponding data of individual eyes is high (mean r = 0.973 +/- 0.020), the sum of squares between the data and function is low, and all other criteria are met. The rates of refractive change and acceleration were derivable from this function. It has been shown that, if peak acceleration rate is used as a criterion for the onset of myopia progression, then myopization onset starts a year earlier (mean = 8.93 years) than when a -0.50-D onset criterion is used (mean = 9.93 years), and it usually starts before the spherical equivalent reaches zero (mean R = +0.09 D). Age of onset is highly correlated with the duration of myopia progression (r = 0.693), which in turn is correlated with the amount of myopia achieved (r = 0.443).", "answer": "We demonstrate that the double exponential function delineates the dynamics of myopia progression onset, offset, and the derivatives that describe the mechanisms underlying the growth process that causes myopia and have explained the advantages of this function. The function can be used to more accurately portray the course of individual subject's myopic progression.\n\nyes"}
{"question": "What are the current and future treatment options for age-related macular degeneration (AMD) and its symptoms ?", "answer": "Age-related macular degeneration (AMD) is a progressive eye disease that causes a loss of central vision, resulting in difficulty reading, recognizing faces, and performing daily activities. The treatment options for AMD focus on managing the disease and preventing further vision loss. Currently, high doses of antioxidative vitamins (such as vitamin C, vitamin E, and ß-carotene) and zinc have shown to significantly reduce the incidence of neovascular AMD (NV-AMD), but not non-neovascular AMD (NN-AMD). Lutein and zeaxanthin, which have antioxidative and blue-light filtering effects, are considered to be effective in light protection. However, there is a lack of prospective randomized studies to prove their effects. Rheopheresis, a technique involving extracorporeal blood filtration, is being evaluated in multi-center prospective trials for its effect on early AMD, specifically in patients with drusen and small pigment epithelial atrophies. This treatment involves several sessions spaced four weeks apart and has shown promise in its potential benefits. Laser application, including grid or focal laser treatment, has not demonstrated significant improvement in vision and has even been associated with higher rates of choroidal neovascularization (CNV), a complication of AMD. Future directions in AMD treatment aim to focus on early detection and prevention. As more drugs are developed, combination therapies tailored to the stage and severity of the disease will become available. Long-acting delivery systems for drug combinations are being researched to provide long-term effects. Additionally, considering combinations with surgical therapies, laser treatment, or photodynamic therapy (PDT) may be reasonable in order to decrease dosage and treatment intervals. For non-responders to current treatments or advanced cases of AMD, cell-derived therapies such as retinal transplantation or gene therapies are being investigated to restore vision and improve the foveal condition in aging patients. These techniques hold potential for better restoration of vision in advanced stages of the disease. It is important to note that the information provided is based on general knowledge in the field of ophthalmology and may vary depending on individual patient factors and advancements in research. It is recommended to consult ophthalmology textbooks and other authoritative sources for a more comprehensive understanding of AMD and its treatment options."}
{"question": "Question: Does whole exome sequencing identify CRB1 defect in an unusual maculopathy phenotype?\nContext: To report a new phenotype caused by mutations in the CRB1 gene in a family with 2 affected siblings. Molecular genetics and observational case studies. Two affected siblings and 3 unaffected family members. Each subject received a complete ophthalmic examination together with color fundus photography, fundus autofluorescence (FAF), and spectral-domain optical coherence tomography (SD-OCT). Microperimetry 1 (MP-1) mapping and electroretinogram (ERG) analysis were performed on the proband. Screening for disease-causing mutations was performed by whole exome sequencing in 3 family members followed by segregation analyses in the entire family. Appearance of the macula as examined by clinical examination, fundus photography, FAF imaging, SD-OCT, and visual function by MP-1 and ERG. The proband and her affected brother exhibited unusual, previously unreported, findings of a macular dystrophy with relative sparing of the retinal periphery beyond the vascular arcades. The FAF imaging showed severely affected areas of hypoautofluorescence that extended nasally beyond the optic disc in both eyes. A central macular patch of retinal pigment epithelium (RPE) sparing was evident in both eyes on FAF, whereas photoreceptor sparing was documented in the right eye only using SD-OCT. The affected brother presented with irregular patterns of autofluorescence in both eyes characterized by concentric rings of alternating hyper- and hypoautofluorescence, and foveal sparing of photoreceptors and RPE, as seen on SD-OCT, bilaterally. After negative results in screening for mutations in candidate genes including ABCA4 and PRPH2, DNA from 3 members of the family, including both affected siblings and their mother, was screened by whole exome sequencing resulting in identification of 2 CRB1 missense mutations, c.C3991T:p.R1331C and c.C4142T:p.P1381L, which segregated with the disease in the family. Of the 2, the p.R1331C CRB1 mutation has not been described before and the p.P1381L variant has been described in 1 patient with Leber congenital amaurosis.", "answer": "This report illustrates a novel presentation of a macular dystrophy caused by CRB1 mutations. Both affected siblings exhibited a relatively well-developed retinal structure and preservation of generalized retinal function. An unusual 5-year progression of macular atrophy alone was observed that has not been described in any other CRB1-associated phenotypes.\n\nyes"}
{"question": "Question: Retinal cells which secrete acytyl choline\nOptions:\nA. Bipolar cells\nB. Ganglion cells\nC. H cells\nD. Amacrine cells\n", "answer": " Important facts about signal transduction in Retina\n\nThe responses of the rods, cones and horizontal cells are hyperpolarizing.\nBipolar cells may show either hyperpolarization or depolarizationQ .\nAll these cells develop only graded local potentials, i.e., nonpropagated, decremental, does not follow all or none law. These cells do not develop action potential.\nThe only cell which develops propagated action potential is ganglion cellsQ and the response is always depolarizing. Otherwise, they remains in inactive state,\nAmacrine cells produce depolarizing potential and spikes,\nRods and cones release glutamateQ at their synapses with the bipolar cells.\nAmacrine cells0 secrete at least eight types of transmitter substances, including GABA, glycine, dopamine, acetylcholineQ and indolamine, all of which normally function as inhibitory neurotransmitters,\nThe transmitters of the bipolar cells0 and horizontal cells are unclear.\n\nOPTION D IS CORRECT."}
{"question": "Question: Commonest type of Retinal detachment?\nOptions:\nA. Rhegmatogenous\nB. Choroidal hemorrhage\nC. Exudative\nD. Tractional\n", "answer": " Ans. a (Rhegmatogenous). (Ref Ophthalmology by Basak 4th/ 316; Kanski's 6th/349; Parson's 20th/311).The term rhegmatogenous is derived from the Greek word rhegma, which means a discontinuity or a break. A rhegmatogenous retinal detachment (RRD) occurs when a tear in the retina leads to fluid accumulation with a separation of the neurosensory retina from the underlying RPE; this is the most common type of retinal detachment.Types of Retinal detachments TypeDefinitionCauses1.RhegmatogenousFull thickness defect or hole in the retina with subretinal Fluid accumulation# Trauma (blunt)# Spontaneous# Myopia (high)# ICCE# Aphakia/Pseudophakia# Age-related retinoschisis# Vitreoretinal tufts and Meridional folds# Family history of RD2.Traction detachmentCaused by scar tissue pulling on the retina# Proliferative diabetic retinopathy# ROP# Sickle cell retinopathy [\"sea-fan\" retina)# Penetrating posterior segment trauma3.Exudative (serous) detachmentAs a result of inflammatory diseases or sometimes hypertension# Choroidal tumor# Exophytic retinoblastoma# Vogt-Koyanagi-Harada syndrome# Posterior scleritis# Infectious (syphilis, TB, CMV, Toxoplasmosis)# Subretinal vascularisation# Collagen vascular diseases# Coats disease# Central serous chorioretinopathy# Uveal effusion syndrome# Renal diseases# Severe hypertension/ eclampsia/ preeclampsiaRx of Rhegmatous RD (essentially surgical & immediate)A. Sealing the retinal breaks (cryoretinopexy/diathermy/Laser)B. Scleral bucklingC. Subretinal fluid drainageD. ntravitreal injections (air or Ringer's solution)E. Vitrectomy\n\nOPTION A IS CORRECT."}
{"question": "Question: Are single nucleotide polymorphisms in MCP-1 and its receptor associated with the risk of age related macular degeneration?\nContext: Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly population. We have shown previously that mice deficient in monocyte chemoattractant protein-1 (MCP1/CCL2) or its receptor (CCR2) develop the features of AMD in senescent mice, however, the human genetic evidence so far is contradictory. We hypothesized that any dysfunction in the CCL2 and its receptor result could be the contributing factor in pathogenesis of AMD. 133 AMD patients and 80 healthy controls were enrolled for this study. Single neucleotid Polymorphism for CCL2 and CCR2 was analyzed by real time PCR. CCL2 levels were determined by enzyme-linked immunosorbent assay (ELISA) after normalization to total serum protein and percentage (%) of CCR2 expressing peripheral blood mononuclear cells (PBMCs) was evaluated using Flow Cytometry. The genotype and allele frequency for both CCL2 and CCR2 was found to be significantly different between AMD and normal controls. The CCL2 ELISA levels were significantly higher in AMD patients and flow Cytometry analysis revealed significantly reduced CCR2 expressing PBMCs in AMD patients as compared to normal controls.", "answer": "We analyzed the association between single neucleotide polymorphisms (SNPs) of CCL2 (rs4586) and CCR2 (rs1799865) with their respective protein levels. Our results revealed that individuals possessing both SNPs are at a higher risk of development of AMD.\n\nyes"}
{"question": "What are the ophthalmoscopic features of retinoblastoma ?", "answer": "The ophthalmoscopic features of retinoblastoma can vary depending on the type of tumor. In the early stages, before the appearance of leukocoria (yellowish-white pupillary reflex), a thorough examination of the fundus after dilating the pupil may reveal the tumor. There are two types of retinoblastoma: 1. Endophytic retinoblastoma: This type grows inwards from the retina into the vitreous cavity. On ophthalmoscopic examination, it appears as a well-circumscribed polypoidal mass with a white or pearly pink color. Fine blood vessels and sometimes a hemorrhage may be present on its surface. In the presence of calcification, it gives a characteristic \"cottage cheese\" appearance. Multiple growths projecting into the vitreous may also be observed. 2. Exophytic retinoblastoma: This type grows outwards and separates the retina from the choroid. On fundus examination, it gives the appearance of exudative retinal detachment, resembling a detachment of the retina. It is important to note that these ophthalmoscopic features can aid in the diagnosis of retinoblastoma, but further evaluation and confirmation should be done using appropriate diagnostic techniques."}
{"question": "Question: Do infrared imaging and optical coherence tomography reveal early-stage astrocytic hamartomas not detectable by fundoscopy?\nContext: To describe and correlate the features of astrocytic hamartomas using multimodal imaging. Prospective, noncomparative, observational case series. This was a single-center study of 4 patients (8 eyes) with tuberous sclerosis complex. A complete ophthalmologic examination, fundus photography, fundus autofluorescence (FAF), infrared imaging, and spectral-domain optical coherence tomography (SD-OCT) were performed for each patient. Images from each modality were analyzed and compared. In 2 patients, infrared imaging and SD-OCT detected occult retinal astrocytic hamartomas that were not observed on clinical examination or color fundus photography. FAF demonstrated the greatest contrast between lesions and surrounding retina but failed to identify 1 occult lesion that was detected with infrared imaging and SD-OCT. SD-OCT revealed lesions arising from the retinal nerve fiber layer with overlying vitreous adhesions, hyperreflective dots, and optically empty spaces at all depths of the tumor. Hamartomas were hyporeflective on infrared imaging and hypoautofluorescent on FAF. FAF of some lesions demonstrated hyperautofluorescent spots.", "answer": "Infrared imaging and SD-OCT aid in the detection of astrocytic hamartomas that are not visible on clinical examination or color fundus photography. SD-OCT enhances visualization of structural details. FAF is a useful adjunctive test to obtain greater contrast between lesions and surrounding retina. The ability to monitor structural changes over time in astrocytic hamartomas using SD-OCT may be beneficial for monitoring the success of systemic chemotherapy in the treatment of various tuberous sclerosis tumors.\n\nyes"}
{"question": "Question: Bitemporal hemianopia is characteristic of -\nOptions:\nA. Glaucoma\nB. Optic neuritis\nC. Pituitary tumor\nD. Retinal detachment\n", "answer": " Ans. is 'c' i.e., Pituitary tumor o Characteristic visual field defect of central chiasmatic lesion is bitemporal hemianopia. Pituitary tumor causes central chiasmatic lesion.o Bitemporal hemianopia results due to central (sagittal) lesion of the optic chiasma. common causes of which are tumors of the pituitary gland (most common), craniopharyngioma, suprasellar meningioma, glioma of third ventricle, chiasmal arachnoiditis, and third ventricular dilatation.Site of lesionVisual field defectOptic nerveOptic chiasmaOptic tractLateral geniculate bodyOptic radiation (Total)Optic radiation lower fibres (temporal lobe)Optic radiation upper fibres (parietal lobe)Visual cortex (anterior occipital cortex)Occipital cortex tipBlindnessBitemporal hemianopiaIncongruent homonymous hemianopiaHomonymous hemianopiaHomonymous hemianopia, sometimes with macular sparingHomonymous upper quadrantanopiaHomonymous lower quadrantanopiaHomonymous hemianopia with macular sparingHomonymous macular defect\n\nOPTION C IS CORRECT."}
{"question": "Question: Are polymorphisms in vascular endothelial growth factor receptor 2 associated with better response rates to ranibizumab treatment in age-related macular degeneration?\nContext: Intravitreal anti-vascular endothelial growth factor (VEGF) injections are currently the standard treatment for neovascular age-related macular degeneration (AMD), but a broad range of response rates has been observed. We evaluated the association of single nucleotide polymorphisms (SNPs) in VEGF genes and their receptors (VEGFR) with the response rate to ranibizumab in 366 patients with neovascular AMD. Case series study. A total of 366 eyes of 366 patients with neovascular AMD. Visual acuity (VA) was determined at baseline, after 3 monthly ranibizumab injections, and after 1 year of treatment. Genotyping of 126 SNPs in the genes encoding VEGF family members VEGFA, VEGFB, VEGFC, VEGFD (FIGF), and placental growth factor (PGF); VEGF receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4); and the gene encoding pigment epithelium-derived factor (PEDF) (SERPINF1) was performed. The changes in VA after 3 injections and after 1 year of treatment and their association with VEGF and VEGFR genotypes. Univariate analyses of variance (ANOVAs) revealed a significant effect of SNP rs4576072 in the VEGFR2 gene on VA change after 12 months (F[1,235] = 14.05; P = 0.02). A stepwise linear regression analysis returned a model (P = 0.01) with SNPs rs4576072 and rs6828477 in the VEGFR2 gene as independent predictors for VA change after 12 months, with a mean increase in VA of 0.26 on the logarithm of the minimum angle of resolution (logMAR) scale in patients with 3 contributing minor alleles compared with a loss of 0.03 logMAR in patients with no minor allele.", "answer": "Polymorphisms in the VEGFR2/KDR gene significantly influence visual outcome in patients receiving ranibizumab treatment for neovascular AMD. This study shows that genetic variation partially explains the wide range of response to ranibizumab treatment, which in the future might help clinicians tailoring medical interventions to individual needs.\n\nyes"}
{"question": "Question: A patient presents with freckling in axilla and inguinal area since childhood; which of the following is not an ophthalmological examination finding in such a patient?\nOptions:\nA. Optic nerve glioma\nB. Lisch nodules\nC. Choroidal nevi\nD. Aniridia\n", "answer": " Ans. is 'd' i.e.. Aniridia o Axillary and inguinal freckling is a feature of neurofibromatosis type -1.Ocular manifestations of neurofibromatosis - 1 (Von Reeklingausen's disease)Neurofibromatosis may involve the eye extensivelyOrbitEye lidIrisCorneaAnteriorchamberFunduschoroidGlaucomaOrbit may be involved by one of the following Neural tumorso OpticNerve Gliomao Neurolemmomao Plexi form neurofibromao MeningiomaSDhen orbiral Encephaloceleo Caused by absence of greater wing of sphenoido Presents with pulsating proptosis without a bruit or thrillNeurofibromas of the eyelidy Nodulary Plexiformo Liseti nodules (Melanocytic hamartomas of the iris stroma)o Congenital ectropian uvea (uncommon)o Mami liations (Rare)Prominent corneal nervesAnterior chamber angle malformationsChoroidalNeviRetinalAstrocytomaso Glaucoma is relatively rareo Congenital and infantile glaucomas are common\n\nOPTION D IS CORRECT."}
{"question": "How can retinal haemorrhages be used as an indicator of diabetic retinopathy progression ?", "answer": "Retinal haemorrhages can provide valuable insights into the progression of diabetic retinopathy. As the number of haemorrhages increases, particularly when there is an increasing presence of blot haemorrhages, it signifies escalating retinal ischaemia and the advancement of diabetic retinopathy. Blot haemorrhages are typically observed in a deeper retinal layer compared to more superficial dot haemorrhages and flame haemorrhages. Identifying a pattern of increasing haemorrhages, especially with the inclusion of blot haemorrhages, indicates the progression of retinal ischaemia and the severity of the disease. It is important to consider other signs of retinal ischaemia such as venous beading, intraretinal microvascular abnormalities, and the presence of multiple blot haemorrhages to classify the retinopathy as moderate or severe."}
{"question": "What are the nutritional supplements recommended for age-related macular degeneration ?", "answer": "Age-related macular degeneration (AMD) is a progressive eye condition that affects the macula, leading to vision loss. Nutritional supplements have been studied for their potential role in managing AMD. The Age-Related Eye Disease Study (AREDS) found that a specific combination of vitamins and minerals can slow down the progression of AMD in certain individuals. The recommended nutritional supplements for AMD include a combination of high-dose antioxidants (vitamin C and vitamin E), beta carotene, zinc, and copper. These supplements can be beneficial for individuals with intermediate to advanced AMD. However, it is important to consult with an ophthalmologist before starting any supplementation regimen as they can provide personalized recommendations based on individual needs and medical history."}
{"question": "Question:  Hello Doctor My husband has been to see a consultant today regarding his chest pain which he has had for six months, on CT scan it showing what appears to look like someone has flicked white paint all over his lungs, she did mention what she thought it may be and we did not catch the name, it began with S and she said it attached to the lymph notes in the bottom of the lungs, he has to have breathing tests and has had bloods and may have to have a biopsy tissue from his lungs, otherwise he appears well although his eyesight sometimes is not quite in focus and he gets quite hot a night time, he has always watched his weight and is/was a keen walker climber, sometimes he gets out of breath on walking up a slope but not on flat. Thank you\n", "answer": " Thanks for your question on . I can understand your husbands situation and problem. By your history and description, possibility of acidosis is more in his case. It is granulators disease affecting lungs and mediastinal lymph nodes. It can cause ground glass appearance of lungs on CT scan (white paint like as you mentioned). Furthermore, it also causes breathlessness on exertion. And hence PFT (Pulmonary Function Test) and blood reports like complete blood count, serum calcium level, ACE level etc. are needed. The most confirmatory test is lung biopsy. Acidosis can also affect retina and hence eyesight problem he is having can also be due to acidosis. So get done PFT and blood reports, follow your doctor s advice and if needed also get done lung biopsy. Hope I have solved your query. Wish you good health. Thanks."}
{"question": "What is the appropriate timing and technique for performing Transpupillary ThermoTherapy (TTT) using a diode laser for the treatment of choroidal neovascularization (CNV) ?", "answer": "The timing of Laser Transpupillary ThermoTherapy (TTT) for the treatment of choroidal neovascularization (CNV) should be done within 72 hours post recent fluorescein angiography (FFA) according to the context provided. The general steps for performing TTT are as follows: 1. Explanation of the procedure: The ophthalmologist should explain the TTT procedure to the patient, including the purpose, benefits, and potential risks involved. 2. Informed consent: The patient should sign an informed consent form after being provided with detailed information about the procedure. 3. Mydriasis: Pupillary dilation is achieved using Tropicamide (1%) and Phenylephrine (5%) eye drops. This is usually started 2 hours before the laser treatment. 4. Anesthesia: Topical anesthesia is achieved by instilling one drop of topical Proparacaine HCl (0.5%) a few minutes before the photocoagulation. In cases where the patient is uncooperative or experiences nystagmus, a peribulbar injection of Lignocaine HCl may be administered. 5. Patient positioning: The patient is seated on a revolving stool and faces the slit-lamp. 6. Steady fixation: A head strap is applied to ensure steady fixation during the procedure. The fixation target is adjusted for optimal positioning. 7. Laser contact lens: An appropriate laser contact lens, such as the Goldmann 3-mirror or VOLK quadraspheric lens, should be inserted. These lenses are available with argon or diode laser bonded antireflective coating. 8. Room illumination: The room should be darkened or semi-darkened to enhance visualization during the procedure. 9. Slit-lamp adjustments: The slit-lamp beam and parameters should be adjusted to properly focus on the lesion. The laser focusing beam should be circular and overlap equally with the slit-lamp beam on either side. Regarding the technique for Transpupillary ThermoTherapy (TTT), the CNV lesion is illuminated with light from a diode laser at a wavelength of 810nm. The laser beam should be perfectly circular and cover the entire lesion area. It is important to note that the information provided here is based on the context provided and general knowledge of TTT. For specific instructions and guidelines, it is always recommended to consult with a qualified ophthalmologist or refer to peer-reviewed publications on the subject. Reference: 1. Yannuzzi LA, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina. 2003;23:288-298."}
{"question": "Specialized clinical ophthalmology question: What limitations/challenges may an individual with Aniridia and WAGR Syndrome face in childhood and later on ?", "answer": "Steps an ophthalmologist should take: 1. Begin by empathizing with the patient or parent, acknowledging the difficulty associated with Aniridia and WAGR Syndrome. 2. Explain that Aniridia is a rare genetic disorder that affects the development of the iris, leading to visual impairment and other associated challenges. 3. Discuss the potential limitations and challenges that may arise in childhood, such as decreased visual acuity, sensitivity to light, nystagmus (involuntary eye movement), and difficulty with depth perception. 4. Address the potential long-term challenges, which may include a higher risk of developing glaucoma, cataracts, corneal problems, and foveal hypoplasia (underdevelopment of the central part of the retina). 5. Inform the patient or parent that management of Aniridia and WAGR Syndrome involves a multidisciplinary approach, including regular eye examinations, genetic counseling, and monitoring for associated medical conditions. 6. Highlight the importance of collaboration with other healthcare professionals, such as geneticists, pediatricians, and developmental specialists, to ensure comprehensive care for the individual. 7. Mention ongoing research in the field, focusing on advancements in gene therapy and stem cell research, which hold promise for future treatments. 8. Reassure the patient or parent that although Aniridia and WAGR Syndrome present challenges, various support networks and resources are available to assist in managing the condition. 9. Encourage open communication and a partnership between the ophthalmologist, the patient, and other healthcare providers to optimize the individual's visual health and overall well-being."}
{"question": "Question: Hi doctor,I am 68 years old. I have just been diagnosed with macular degeneration. The doctor basically stated that there was nothing that could be done as this was just a part of aging. He did suggest to eat more green leafy vegetables. When I suggested Kale and dark leaf vegetable powder, he laughed and called me a dreamer. I simply cannot believe that there is anything else I can do. I am healthy with low blood pressure and a good weight. I would appreciate your medical opinion. Thank you.", "answer": "Hi, Welcome. As you stated that you have been diagnosed with macular degeneration that is ARMD (age-related macular degeneration). Now, let us know what ARMD is. "}
{"question": "Question: A 20 year old man complains of difficulty in reading the newspaper with his right eye, three weeks after sustaining a gun shot injury to his left eye. Which of the following is the most likely diagnosis?\nOptions:\nA. Macular edema\nB. Optic nerve avulsion\nC. Sympathetic ophthalmia\nD. Delayed viterous hemorrhage\n", "answer": " This man in the question has developed a condition called sympathetic ophthalmia in the right eye secondary to the injury in the left eye. Sympathetic ophthalmia is an inflammation in the second eye after the other has been damaged by penetrating injury. Some poion of the uvea of the injured eye has been exposed to the atmosphere for at least 1 hour. The uninjured eye develops minor signs of anterior uveitis usually within 1 year. Due to the inflammation of ciliary body, patients initially presents with floating spots and loss of the power of accommodation. The disease may progress to severe iridocyclitis with pain and photophobia. The retina is usually uninvolved except for perivascular cuffing of the retinal vessels with inflammatory cells. Optic nerve swelling and secondary glaucoma may occur. The best prophylaxis is early excision of the injured eye, when there is no chance of saving useful vision. Ref: Comprehensive Ophthalmology By AK Khurana, 4th Edition, Page 273; Vaughan and Asbury's General Ophthalmology, 18th Edition, Chapter 16.\n\nOPTION C IS CORRECT."}
{"question": "Question: Does aIP1 mediate vascular endothelial cell growth factor receptor-3-dependent angiogenic and lymphangiogenic responses?\nContext: To investigate the novel function of ASK1-interacting protein-1 (AIP1) in vascular endothelial cell growth factor receptor (VEGFR)-3 signaling, and VEGFR-3-dependent angiogenesis and lymphangiogenesis. AIP1, a signaling scaffold protein, is highly expressed in the vascular endothelium. We have previously reported that AIP1 functions as an endogenous inhibitor in pathological angiogenesis by blocking VEGFR-2 activity. Surprisingly, here we observe that mice with a global deletion of AIP1-knockout mice (AIP1-KO) exhibit reduced retinal angiogenesis with less sprouting and fewer branches. Vascular endothelial cell (but not neuronal)-specific deletion of AIP1 causes similar defects in retinal angiogenesis. The reduced retinal angiogenesis correlates with reduced expression in VEGFR-3 despite increased VEGFR-2 levels in AIP1-KO retinas. Consistent with the reduced expression of VEGFR-3, AIP1-KO show delayed developmental lymphangiogenesis in neonatal skin and mesentery, and mount weaker VEGF-C-induced cornea lymphangiogenesis. In vitro, human lymphatic endothelial cells with AIP1 small interfering RNA knockdown, retinal endothelial cells, and lymphatic endothelial cells isolated from AIP1-KO all show attenuated VEGF-C-induced VEGFR-3 signaling. Mechanistically, we demonstrate that AIP1 via vegfr-3-specific miR-1236 increases VEGFR-3 protein expression and that, by directly binding to VEGFR-3, it enhances VEGFR-3 endocytosis and stability.", "answer": "Our in vivo and in vitro results provide the first insight into the mechanism by which AIP1 mediates VEGFR-3-dependent angiogenic and lymphangiogenic signaling.\n\nyes"}
{"question": "What are the clinical features of ocular metastases and how can they be diagnosed ?", "answer": "Ocular metastases are rare but can affect various ocular tissues, with the uveal tract being the most commonly affected. The clinical features of ocular metastases vary depending on the site of involvement. Iris metastases often present as unilateral lesions of varied color, while ciliary body tumors typically appear as yellow sessile or dome-shaped masses. Retinal metastases may manifest as white masses with a perivascular distribution, resembling cotton-wool spots. Choroidal metastases are creamy yellow subretinal masses with pigmentary changes that can lead to secondary retinal detachments. Ocular metastases can masquerade as inflammation, making diagnosis challenging. A careful medical history, along with a thorough ophthalmic examination, is crucial for diagnosis. However, if the primary tumor is unknown, identifying the site of origin solely based on the ophthalmic examination is unlikely, except in rare cases like cutaneous melanoma metastasis where brown pigment may be visible. Additional diagnostic tools such as fluorescein angiography and ultrasonography can aid in delineating the borders of a choroidal tumor but may have limited value in definitively differentiating metastases from other ocular conditions."}
{"question": "What is the impact of repetitive imaging on topographic measurements of the optic nerve head using the Heidelberg Retina Tomograph ?", "answer": "Repetitive imaging using the Heidelberg Retina Tomograph (HRT) can have an impact on the topographic measurements of the optic nerve head. Studies have shown that repeated imaging can lead to changes in the measured parameters, affecting the reproducibility of the measurements. One study by Weinreb et al. (1993) found that repetitive imaging resulted in changes in the topographic measurements of the optic nerve head. Another study by Mikelberg et al. (1993) also reported variations in topographic parameters obtained with the HRT after repeated imaging. The reproducibility of optic nerve head topography measurements can be influenced by factors such as pupil dilation. Lusky et al. (1993) found that undilated pupils can affect the reproducibility of the measurements. Janknecht and Funk (1994) also reported measuring errors in different pupillary widths using a model eye. It is important to consider the potential impact of repetitive imaging and take steps to minimize any variations. Standardized protocols for imaging and analysis should be followed to ensure consistency. Additionally, factors such as pupil dilation should be taken into account when performing measurements. References: 1. Weinreb RN, Lusky M, Bartsch DU, et al. Effect of repetitive imaging on topographic measurements of the optic nerve head. Arch Ophthalmol. 1993;111:636-638. 2. Mikelberg FS, Wijsman K, Schulzer M. Reproducibility of topographic parameters obtained with the Heidelberg retina tomograph. J Glaucoma. 1993;2:101-112. 3. Lusky M, Bosem ME, Weinreb RN. Reproducibility of optic nerve head topography measurements in eyes with undilated pupils. J Glaucoma. 1993;2:104-109. 4. Janknecht P, Funk J. The Heidelberg Retina Tomograph: reproducibility and measuring errors in different pupillary widths using a model eye [in German]. Klin Monatsbl Augenheilkd. 1994;205:98-102."}
{"question": "What are the long-term effects of accidental parafoveal laser burns ?", "answer": "Accidental parafoveal laser burns can have long-term effects on the retina. Studies have shown that such burns can lead to maculopathy, which is characterized by asymmetric macular damage and bilateral maculopathy. The extent of the damage depends on factors such as the type of laser used and the duration of exposure. Treatment options for laser-induced retinal injury include corticosteroid therapy, which has been shown to reduce blood-retinal breakdown and provide neuroprotective effects. However, it is important to note that the effects and treatment of laser-induced retinal injury should be evaluated on a case-by-case basis by an ophthalmologist."}
{"question": "What is the significance of using a planar micro-pH electrode array in studying the electrochemical mechanisms at the interface of the electrolyte medium and retinal stimulation electrodes ?", "answer": "The use of a planar micro-pH electrode array in studying the electrochemical mechanisms at the interface of the electrolyte medium and retinal stimulation electrodes provides valuable insights and information. This electrode array consists of both stimulating and sensing electrodes, allowing for the detection and recording of pH changes due to electric stimulation. By employing this array, researchers can establish a 2D distribution of pH changes, which aids in understanding the safety margin of stimulation parameters and provides insights into the electrochemical processes involved in retinal stimulation. The planar micro-pH electrode array offers a more comprehensive understanding of the electrochemical reactions occurring at the interface, thereby contributing to the advancement of ophthalmological research and potentially guiding the development of safer and more effective retinal stimulation techniques."}
{"question": "What is the most effective method for treating a cone-specific eye disease ?", "answer": "The most effective method for treating a cone-specific eye disease would depend on the specific disease and its underlying cause. Cone-specific eye diseases, such as cone dystrophy or cone-rod dystrophy, are characterized by the dysfunction or degeneration of cone cells in the retina. Treatment options for these conditions aim to slow down disease progression, manage symptoms, and improve visual function. One possible treatment approach for cone-specific eye diseases is the use of oral retinoid medications, such as vitamin A palmitate. These medications can help support the function of remaining cone cells and slow down the degenerative process. However, the effectiveness of retinoid therapy can vary depending on the specific genetic mutation or underlying cause of the disease. Another potential treatment method is gene therapy. Gene therapy involves delivering a functional copy of the mutated gene responsible for the cone dysfunction or degeneration. This approach aims to restore the normal function of cone cells and improve visual function. Gene therapy has shown promising results in clinical trials for certain cone-specific eye diseases, such as Leber congenital amaurosis. Additionally, low vision aids and visual rehabilitation programs can help individuals with cone-specific eye diseases maximize their remaining vision and adapt to their visual impairment. These interventions may include the use of magnifiers, specialized glasses, and training in adaptive visual skills. It is important to consult with a specialized ophthalmologist or retinal specialist who can evaluate the specific diagnosis and recommend the most appropriate treatment approach based on the individual's condition. Treatment plans should be tailored to each patient's specific needs and may involve a combination of different therapeutic modalities. References: 1. Wyszecki, G., & Stiles, W. S. (1982). Color science: Concepts and methods, quantitative data and formulae. New York: John Wiley & Sons. 2. Baylor, D. A., Nunn, B. J., & Schnapf, J. L. (1987). Spectral sensitivity of cones of the monkey Macaca fascicularis. Journal of Physiology-London, 390, 145-160. 3. Stockman, A., & Sharpe, L. T. (2000). The spectral sensitivities of the middle- and long-wavelength-sensitive cones derived from measurements in observers of known genotype. Vision Research, 40(17), 1711-1737."}
{"question": "Question: Do topographic profiles of retinal nerve fiber layer defects affect the diagnostic performance of macular scans in preperimetric glaucoma?\nContext: To evaluate the influence of topographic profiles (i.e., inner directional angle and angular width) of localized retinal nerve fiber layer (RNFL) defects on the diagnostic performance of macular ganglion cell-inner plexiform layer (GCIPL) thickness in discriminating preperimetric glaucoma (PPG) eyes from normal control eyes. The ganglion cell analysis algorithm in Cirrus OCT was performed to determine the macular GCIPL thickness. Areas under the receiver operating characteristic curves (AUROCs) and the sensitivities/specificities based on an internal normative database were evaluated. The effect of the inner directional angle and the angular width of localized RNFL defects on the diagnostic performance of macular GCIPL parameters were evaluated by using linear-by-linear association analysis and logistic regression analysis. Ninety-two patients with PPG and 92 age-matched healthy control subjects were enrolled in this study. The AUROC of the best parameters in macular GCIPL was 0.823 (inferotemporal sector), which showed no significant difference in comparison to the best parameters of peripapillary RNFL (7 o'clock sector, 0.764) and optic nerve head (rim area, 0.767) (for all comparisons, P > 0.05). A significant linear association was observed between the inner directional angle of RNFL defects and the sensitivity of macular GCIPL parameters for detecting RNFL defects. The angular width of RNFL defects was not significantly associated with the sensitivity of macular GCIPL parameters.", "answer": "The diagnostic ability of macular GCIPL parameters was comparable to that of peripapillary RNFL and ONH parameters in PPG. The inner directional angle of RNFL defects, but not the angular width, affects the diagnostic sensitivity of macular GCIPL parameters.\n\nyes"}
{"question": "Question: Peripheral retinal degeneration is most common in case of\nOptions:\nA. Myopia\nB. Presbyopia\nC. Hypermetropia\nD. Astigmatism\n", "answer": " A i.e. Myopia Ophthalmoscopic findings of pathological myopia are - - Myopic crescents (on temporal edge of optic disc), - Foster fuch's spot - (dark red patch at macula due to retinal neovascularization & choroidal haemorrhage), Cystoid degeneration, - Peripheral retinal degeneration (lattice & snail track degenerations)Q - Posterior staphyloma.\n\nOPTION A IS CORRECT."}
{"question": "Discuss the optics of contact lens ?", "answer": "The optics of contact lenses refers to how light interacts with the lenses and how it affects vision. Contact lenses are designed to correct vision problems, such as nearsightedness, farsightedness, and astigmatism, by altering the way light rays enter the eye. Contact lenses have various optical properties that impact their effectiveness in vision correction: 1. Refractive power: Contact lenses correct vision by altering the way light bends as it passes through the lens and reaches the eye. The curvature of the lens determines its refractive power, which is measured in diopters. Depending on the eye condition, contact lenses can have positive (+) or negative (-) refractive power. 2. Base curve: The base curve of a contact lens refers to its overall curvature. It is crucial to match the base curve of the lens to the curvature of the cornea, the transparent front surface of the eye, to ensure a proper fit and optimal vision correction. A mismatch in base curve can lead to discomfort and distorted vision. 3. Optical zone: The optical zone of a contact lens is the central area that provides the clearest vision. It is designed to align with the pupil of the eye to ensure that the incoming light focuses properly on the retina. A smaller optical zone may cause peripheral blurring, while a larger one may induce aberrations. 4. Astigmatism correction: Toric contact lenses are specifically designed to correct astigmatism, which occurs when the cornea or lens has an irregular shape, causing blurred or distorted vision. These lenses have different powers in different meridians, allowing them to compensate for the astigmatism and provide clear vision. 5. Multifocality: Multifocal contact lenses are used to correct presbyopia, a condition that affects near vision as people age. These lenses have multiple focal points, allowing wearers to see clearly at various distances—both near and far—without the need for reading glasses. 6. Material and coatings: The"}
{"question": "Question: Are vEGF-induced effects on proliferation , migration and tight junctions restored by ranibizumab ( Lucentis ) in microvascular retinal endothelial cells?\nContext: Because vascular endothelial growth factor (VEGF) signalling is deregulated in diabetic retinopathy, the potential therapeutic effects of VEGF inhibitors such as the human VEGF-specific antibody ranibizumab are currently being tested. A study was undertaken to determine whether VEGF-stimulated processes in retinal endothelial cells are reversed by ranibizumab. The influence of VEGF(121) and VEGF(165) on the proliferation and migration of immortalised bovine retinal endothelial cells (iBREC) was studied in the presence and absence of ranibizumab. In addition, the protein composition of tight junctions in the presence of VEGF and its inhibitor in iBREC was investigated. While both isoforms stimulated proliferation of iBREC, only VEGF(165) influenced cell migration. The addition of ranibizumab counteracted this stimulation without inhibition of the basal levels of migration and proliferation. Plasma membrane staining of the tight junction proteins occludin and claudin-1 disappeared in the presence of VEGF(165); there was no effect on claudin-5 and ZO-1 was only weakly affected. The addition of ranibizumab restored plasma membrane localisation of occludin and claudin-1. For claudin-1, the variation in total protein expression corresponded with the observed effects of VEGF(165) and ranibizumab.", "answer": "Ranibizumab reverses proliferation and cell migration stimulated by VEGF and delocalisation of tight junction proteins induced by VEGF(165) in iBREC.\n\nyes"}
{"question": "Question: Do analysis of foveal avascular zone for grading of diabetic retinopathy severity based on curvelet transform?\nContext: Diabetes disturbs many parts of the body. One of the most common and serious complications of this disease is Diabetic Retinopathy (DR). In this process, blood vessels of the retina are damaged and leak into the retina. In later stages, DR affects the fovea. In these cases, the shape and size of the Foveal Avascular Zone (FAZ), which is responsible for central vision, can become abnormal and contribute to loss of vision. In this paper, appropriate features are extracted from the FAZ by means of Digital Curvelet Transform (DCUT) and used to grade of retina images into normal and abnormal classes. For this reason, DCUT is applied on enhanced color fundus images and its coefficients are modified to highlight vessels and the optic disc (OD). Through the use of this information about the anatomical location of the FAZ related to the OD and detected end points of segmented vessels, the FAZ is extracted. Then, the area and regularity of the extracted FAZ is determined and used for DR grading. Our method was tested on a database including 45 normal and 30 abnormal color fundus images, and showed sensitivity of 93 % for DR grading and specificity of 86 % for distinguishing between normal and abnormal cases.", "answer": "This technique showed high reproducibility in characterizing the size and contour of the FAZ in diabetic maculopathy, thus it has the potential to serve as a powerful tool in the automated assessment and grading of images in a routine clinical setting.\n\nyes"}
{"question": "Discuss ocular emergencies ?", "answer": "Ocular emergencies refer to any sudden and serious eye condition that requires immediate medical attention. These emergencies can range from trauma to the eye, chemical exposures, severe infections, and other conditions that may result in significant vision loss or damage if not promptly treated. Here are a few examples of ocular emergencies: 1. Corneal Abrasions: These occur when the cornea, the clear front surface of the eye, is scratched or injured. Symptoms may include eye pain, redness, tearing, and sensitivity to light. Prompt medical attention is necessary to prevent infection and promote healing. 2. Chemical Burn: Exposure to chemicals or irritants can cause burns to the eye. Immediate flushing of the eye with clean water for at least 15 minutes is crucial. Seek medical attention immediately to prevent further damage. 3. Acute Angle-Closure Glaucoma: This occurs when there is a sudden increase in eye pressure due to a blocked drainage system. Symptoms may include severe eye pain, blurred vision, headache, nausea, and halos around lights. Immediate medical intervention is necessary to relieve pressure and prevent vision loss. 4. Retinal Detachment: This occurs when the retina, the light-sensitive tissue at the back of the eye, pulls away from its normal position. Symptoms include sudden flashes of light, floaters, and a curtain-like shadow over the field of vision. Retinal detachment is a medical emergency that requires immediate attention to prevent permanent vision loss. 5. Orbital Fractures: Severe trauma to the eye socket can cause fractures in the bones surrounding the eye. Symptoms may include swelling, deformity, double vision, and difficulty moving the eye. Urgent medical evaluation and treatment are necessary to prevent complications and preserve vision. In any ocular emergency, it is crucial to seek immediate medical attention from an ophthalmologist or visit the nearest emergency room for prompt evaluation and treatment. Avoid delaying care as it can potentially lead to permanent vision damage or loss."}
{"question": "What are the clinical manifestations of tuberous sclerosis in the retina ?", "answer": "Tuberous sclerosis is a multiorgan complex condition that can present with various clinical manifestations in the retina. One of the characteristic features seen in the retina are astrocytic hamartomas, which can be found in the epipapillary, parapapillary, and peripheral regions. These hamartomas appear as superficial translucent lesions through which retinal vessels may be visible. Additionally, peripheral calcified \"mulberry\" lesions may also be observed. In addition to retinal findings, cutaneous stigmata such as facial fibroma (known as \"adenoma sebaceum\") and periungual fibroma of the toes and fingers may be present."}
{"question": "How can the effect of vigabatrin on visual function be assessed in patients ?", "answer": "The effect of vigabatrin on visual function can be assessed through various methods, including full-field electroretinography (ERG), cone and rod ERG responses, photopic cone flicker response, scotopic b-wave amplitudes, oscillatory potentials, focal and multifocal ERG, light-peak to dark-trough electrooculogram (EOG) amplitude ratio, and conventional visual evoked potentials (VEP). These assessments can provide insights into the extent of visual field constriction and dysfunction of the inner retina caused by vigabatrin."}
{"question": "What are the appropriate medications for the treatment of primary macular degeneration and drusen ?", "answer": "In the management of primary macular degeneration, specifically the juvenile (Stargardt) and adult (Behr) types, there are currently no medications available that can reverse or halt the progression of the disease. However, certain interventions can help manage the symptoms and slow down the vision loss. For patients with primary macular degeneration, it is crucial to emphasize lifestyle modifications, such as protecting the eyes from excessive sunlight, quitting smoking, and maintaining a healthy diet rich in antioxidants and omega-3 fatty acids. Additionally, regular monitoring of visual acuity and the use of low-vision aids can greatly enhance the patient's quality of life. Regarding drusen, these colloid or hyaline bodies, which mainly affect the posterior pole, can occur in isolation or as a part of age-related macular degeneration (AMD). Similar to primary macular degeneration, there are no specific medications available for the treatment of drusen alone. However, the management strategies for drusen are similar to those for primary macular degeneration. It is important to note that individual patient cases may vary, and it is advisable for ophthalmologists to assess each patient's specific needs and provide personalized recommendations. If you require more detailed information or recommendations for specific cases, it is best to consult ophthalmology books or refer to other reliable resources for further guidance."}
{"question": "Question: Optic atrophy may occur in all of the following conditions, EXCEPT:\nOptions:\nA. Glaucoma\nB. Leprosy\nC. Pituitary tumor\nD. Methanol intake\n", "answer": " Optic atrophy refers to optic nerve shrinkage from any cause which damages the axons between the retinal ganglion cells and lateral geniculate body. Pressure and tractional optic atrophy is seen in post papilledema, glaucomatous and tumors of the optic nerve in the orbit or cranium. Toxic atrophy can occur secondary to exogenous poisons such as tobacco, alcohol, arsenic and lead. Secondary optic atrophy occur following pathologic process which produces optic neuritis or papilledema. Ref: Textbook of Ophthalmology edited by Sunita Agarwal, page 371.\n\nOPTION B IS CORRECT."}
{"question": "Question: A 64-year-old woman comes to the physician for a follow-up examination. She has had difficulty reading for the past 6 months. She tried using multiple over-the-counter glasses with different strengths, but they have not helped. She has hypertension and type 2 diabetes mellitus. Current medications include insulin and enalapril. Her temperature is 37.1°C (98.8°F), pulse is 80/min, and blood pressure is 126/84 mm Hg. The pupils are round and react sluggishly to light. Visual acuity in the left eye is 6/60 and in the right eye counting fingers at 6 feet. Fundoscopy shows pallor of the optic disc bilaterally. The cup-to-disk ratio is 0.7 in the left eye and 0.9 in the right eye (N = 0.3). Which of the following is the most likely diagnosis?\nOptions:\nA. Age-related macular degeneration\nB. Diabetic retinopathy\nC. Open-angle glaucoma\nD. Optic neuritis\n\"\n", "answer": "\nOption A: Age-related macular degeneration\n- Age-related macular degeneration typically presents with central vision loss and distortion, rather than difficulty reading. The presence of optic disc pallor and elevated cup-to-disk ratio on fundoscopy is not consistent with this diagnosis.\n- Therefore, age-related macular degeneration is an unlikely diagnosis in this patient.\n\nOption B: Diabetic retinopathy\n- Diabetic retinopathy can cause visual changes, including blurred vision and difficulty reading. However, the fundoscopic findings of optic disc pallor and elevated cup-to-disk ratio are not consistent with diabetic retinopathy.\n- Therefore, diabetic retinopathy is an unlikely diagnosis in this patient.\n\nOption C: Open-angle glaucoma\n- Open-angle glaucoma is characterized by progressive optic neuropathy, which can lead to visual field defects and eventually blindness if left untreated. The elevated cup-to-disk ratio is a characteristic finding in glaucoma.\n- The patient's symptoms of difficulty reading, bilateral optic disc pallor, and elevated cup-to-disk ratio are consistent with open-angle glaucoma.\n- Therefore, open-angle glaucoma is the most likely diagnosis in this patient.\n\nOption D: Optic neuritis\n- Optic neuritis is an inflammation of the optic nerve that typically presents with acute vision loss, pain with eye movement, and visual field defects. The gradual onset of difficulty reading in this patient is not consistent with optic neuritis.\n- Therefore, optic neuritis is an unlikely diagnosis in this patient.\nOPTION C IS CORRECT."}
{"question": "What is the association between alcohol consumption and the risk of developing choroidal neovascularization (CNV) in age-related macular degeneration (AMD) ?", "answer": "The available evidence suggests that there is no substantial association between alcohol consumption and the incidence of AMD or the development of CNV. Various studies, including large prospective studies involving both men and women, have failed to demonstrate a protective effect of moderate alcohol consumption on the risk of AMD. After adjusting for confounding factors such as age, smoking, and other risk factors, no significant association was found between total alcohol intake and the incidence of AMD. However, it should be noted that women who consumed 30 grams or more of alcohol per day had a modest increased risk of early AMD and geographic atrophy. On the other hand, there was no association between alcohol intake and neovascular AMD in either sex. It is important to consider that the number of cases of neovascular AMD was small in some studies, which may limit the generalizability of these findings. Overall, while alcohol consumption does not appear to be appreciably associated with the risk of developing AMD or CNV, it is always advisable to promote healthy lifestyle choices and moderate alcohol consumption for overall ocular and systemic health."}
{"question": "Question: Acquired colour blindness is due to\nOptions:\nA. Increased sclerosis of the crystalline lens\nB. Transient failure of retinal circulation\nC. Occlusion of short posterior ciliary arteries\nD. Non- Inflammatory edema of optic disc\n", "answer": " May occurs in old age due to increased sclerosis of crystalline lens.\nMay follow damage to macula or optic nerve.\n\nOPTION A IS CORRECT."}
{"question": "Question: Does visual Cone Arrestin 4 contribute to Visual Function and Cone Health?\nContext: Visual arrestins (ARR) play a critical role in shutoff of rod and cone phototransduction. When electrophysiological responses are measured for a single mouse cone photoreceptor, ARR1 expression can substitute for ARR4 in cone pigment desensitization; however, each arrestin may also contribute its own, unique role to modulate other cellular functions. A combination of ERG, optokinetic tracking, immunohistochemistry, and immunoblot analysis was used to investigate the retinal phenotypes of Arr4 null mice (Arr4-/-) compared with age-matched control, wild-type mice. When 2-month-old Arr4-/- mice were compared with wild-type mice, they had diminished visual acuity and contrast sensitivity, yet enhanced ERG flicker response and higher photopic ERG b-wave amplitudes. In contrast, in older Arr4-/- mice, all ERG amplitudes were significantly reduced in magnitude compared with age-matched controls. Furthermore, in older Arr4-/- mice, the total cone numbers decreased and cone opsin protein immunoreactive expression levels were significantly reduced, while overall photoreceptor outer nuclear layer thickness was unchanged.", "answer": "Our study demonstrates that Arr4-/- mice display distinct phenotypic differences when compared to controls, suggesting that ARR4 modulates essential functions in high acuity vision and downstream cellular signaling pathways that are not fulfilled or substituted by the coexpression of ARR1, despite its high expression levels in all mouse cones. Without normal ARR4 expression levels, cones slowly degenerate with increasing age, making this a new model to study age-related cone dystrophy.\n\nyes"}
{"question": "Question: Which of the following is not a feature of retinoschisis\nOptions:\nA. Splitting of inner retinal layers\nB. Require active treatment\nC. Caweel maculopathy is seen\nD. May be seen in patients of high myopia\n", "answer": " Retinoschisis does not need active treatment as compared to retinal detachement Retinoschisis : * Term is used to describe splitting of inner retinal layers(intra neurosensory layer). * Can be acquired or juvenile X linked congenital retinoschisis * Absolute scotoma is seen as a clinical feature * Beaten metal appearance is seen over elevated retinal surface * Does not require active treatment * Inferotemporal location is most common * Laser will blanch retinoschis but not a retinal detachment * OCT is the investigation of choice to diagnose * May be seen in cases of pathological myopia\n\nOPTION B IS CORRECT."}
{"question": "Question: Does nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorate ocular neovascularization?\nContext: The deficiency of very low-density lipoprotein receptor resulted in Wnt signaling activation and neovascularization in the retina. The present study sought to determine whether the very low-density lipoprotein receptor extracellular domain (VLN) is responsible for the inhibition of Wnt signaling in ocular tissues. A plasmid expressing the soluble VLN was encapsulated with poly(lactide-co-glycolide acid) to form VLN nanoparticles (VLN-NP). Nanoparticles containing a plasmid expressing the low-density lipoprotein receptor extracellular domain nanoparticle were used as negative control. MTT, modified Boyden chamber, and Matrigel (™) assays were used to evaluate the inhibitory effect of VLN-NP on Wnt3a-stimulated endothelial cell proliferation, migration, and tube formation. Vldlr(-/-) mice, oxygen-induced retinopathy, and alkali burn-induced corneal neovascularization models were used to evaluate the effect of VLN-NP on ocular neovascularization. Wnt reporter mice (BAT-gal), Western blotting, and luciferase assay were used to evaluate Wnt pathway activity. Our results showed that VLN-NP specifically inhibited Wnt3a-induced endothelial cell proliferation, migration, and tube formation. Intravitreal injection of VLN-NP inhibited abnormal neovascularization in Vldlr(-/-), oxygen-induced retinopathy, and alkali burn-induced corneal neovascularization models, compared with low-density lipoprotein receptor extracellular domain nanoparticle. VLN-NP significantly inhibited the phosphorylation of low-density lipoprotein receptor-related protein 6, the accumulation of β-catenin, and the expression of vascular endothelial growth factor in vivo and in vitro.", "answer": "Taken together, these results suggest that the soluble VLN is a negative regulator of the Wnt pathway and has antiangiogenic activities. Nanoparticle-mediated expression of VLN may thus represent a novel therapeutic approach to treat pathological ocular angiogenesis and potentially other vascular diseases affected by Wnt signaling.\n\nyes"}
{"question": "What are the clinical applications and findings of electro physiologic tests in pigmentary retinopathies ?", "answer": "Electro physiologic tests play a crucial role in evaluating pigmentary retinopathies. These tests help in the diagnosis and monitoring of various disorders such as retinitis pigmentosa, Leber congenital amaurosis, Usher syndrome, Bardet-Biedl syndrome, Refsum syndrome, Abetalipoproteinemia, Neuronal ceroid lipofuscinosis, Kearns-Sayre syndrome, Rubella retinopathy, and Syphilitic retinopathy. By assessing the electrical responses of the retina, these tests provide valuable information about the functional integrity of the retinal cells and help in understanding the underlying pathophysiology of these conditions."}
{"question": "What are the possible treatments for idiopathic macular teleangiectasia and Sjögren-Larsson syndrome ?", "answer": "The treatment options for idiopathic macular teleangiectasia and Sjögren-Larsson syndrome differ based on the underlying cause and symptoms of each condition. For idiopathic macular teleangiectasia, treatment primarily focuses on managing the symptoms and preventing further vision loss. This may involve lifestyle modifications, such as quitting smoking and improving overall health. In some cases, laser photocoagulation or anti-vascular endothelial growth factor (anti-VEGF) injections may be recommended to reduce leakage from teleangiectatic vessels and improve visual outcomes. However, it is important to note that these treatments may not completely restore vision and their effectiveness varies between individuals. In the case of Sjögren-Larsson syndrome, there is currently no cure available. Treatment mainly aims to manage the symptoms and provide supportive care. This may include regular eye examinations to monitor for any retinal changes, as well as the use of assistive devices, such as low vision aids or visual aids, to optimize visual function. Additionally, physical therapy and occupational therapy may be recommended to address any associated motor or developmental delays. It is crucial for individuals with either condition to seek regular follow-up care with an ophthalmologist or a specialist familiar with these diseases to monitor their eye health and adjust treatment plans accordingly. Please note that these treatment options are based on general knowledge of the conditions. The specific treatment approach should be determined by a healthcare professional after a thorough evaluation of the individual's condition and medical history. References: 1. Gass, J. D. M. (1997). Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. Mosby. 2. The American Academy of Ophthalmology. (2020). Idiopathic Macular Telangiectasia. https://www.aao.org/disease-review/idiopathic-macular-telangiectasia-diagnosis-and-tre 3. The American Academy of Ophthalmology. (2020). Sjögren-Larsson Syndrome. https://www.aao.org/disease-review/sjogren-larsson-syndrome-diagnosis-treatment"}
{"question": "Question: Is peptidic sequence `` HSEAETGPP '' recognized by the sera of pars planitis patients?\nContext: HLA class II, p-36 protein, heat shock protein and retinal antigens have been associated with pars planitis (PP), but their participation in the development of the disease are unknown. A search for new molecules related to PP is necessary. This work focused on the identification of peptides recognized by PP patient sera using the phage display method. Sera of PP patients were used to isolate peptides fused to M13-phage pIII protein. The response of PP and healthy sera to peptides was determined by ELISA. PCR amplification and sequencing of peptide-encoding fragments from clones with high recognition by PP sera were used to characterize displayed peptides. One hundred clones were randomly selected from a phage display library after three panning rounds using serum proteins from a PP patient. The immunologic response level of 100 clones selected were determined with a major number of patients, it was found that one clone was recognized stronger in PP patients sera than in healthy sera (PP vs. healthy; P < 0.05). The peptide-encoding region of this clone was sequenced and translated. The peptide sequence corresponded to HSEAETGPP. An identical amino acid sequence to HSEAETGPP is found in the human proline-rich transmembrane protein 2 which has not been related with eye diseases.", "answer": "These results suggest that the peptide HSEAETGPP is associated with PP.\n\nyes"}
{"question": "Question: Does localization of Cacna1s to ON bipolar dendritic tips require mGluR6-related cascade elements?\nContext: L-type voltage gated calcium channels in retina localize primarily at the presynaptic active zones of photoreceptors and bipolar cells where they modulate glutamate release. However, the pore forming subunit Cacna1s of certain L-type channels is also expressed postsynaptically at the tips of ON bipolar cell dendrites where it colocalizes with mGluR6, but has an unknown function. At these dendritic tips, the components of the mGluR6 signaling cascade cluster together in a macromolecular complex, and each one's localization often depends on that of the others. Thus, we explored if Cacna1s is part of the mGluR6 complex. We determined Cacna1s expression by PCR using an ON bipolar library, by Western blotting, and by standard immunohistochemistry. The PCR amplification confirmed expression of the transcript in ON bipolar cells, and Western blotting showed the expected bands. Immunostaining for Cacna1s was stronger in the dendritic tips of rod bipolar cells than in those of ON cone bipolar cells. This staining severely decreased in mice missing various mGluR6 cascade elements (Grm6(-/-), Gnao1(-/-), Gnb3(-/-), Gng13(-/-), and Trpm1(-/-)). During development, the ratio of the number of Cacna1s puncta to the number of presynaptic ribbons followed a sigmoidal pattern, rising rapidly from P13 to P17. The mGluR6 expression preceded that of Cacna1s and RGS11.", "answer": "Our results show that the localization and stability of Cacna1s depend on the expression of mGluR6 and its cascade components, and they suggest that Cacna1s is part of the mGluR6 complex. We hypothesize that Cacna1s contributes to light adaptation by permeating calcium.\n\nyes"}
{"question": "Question: Does novel GUCY2D mutation cause phenotypic variability of Leber congenital amaurosis in a large kindred?\nContext: Leber congenital amaurosis (LCA) is a severe retinal degenerative disease that manifests as blindness or poor vision in infancy. The purpose of this study was to clinically characterize and identify the cause of disease in a large inbred Bedouin Israeli tribe with LCA. Thirty individuals of a single kindred, including eight affected with LCA, were recruited for this study. Patients' clinical data and electroretinography (ERG) findings were collected. Molecular analysis included homozygosity mapping with polymorphic markers and Sanger sequencing of candidate genes. Of the eight affected individuals of the kindred, nystagmus was documented in five subjects and keratoconus in three. Cataract was found in 5 of 16 eyes. Photopic and scotopic ERG performed in 5 patients were extinguished. All affected subjects were nearly blind, their visual acuity ranged between finger counting and uncertain light perception. Assuming autosomal recessive heredity of a founder mutation, studies using polymorphic markers excluded homozygosity of affected individuals at the genomic loci of all previously known genes associated with LCA, except GUCY2D. Sequencing of GUCY2D identified a novel missense mutation (c.2129C>T; p.Ala710Val) resulting in substitution of alanine by valine at position 710 within the protein kinase domain of the retina-specific enzyme guanylate cyclase 1 (GC1) encoded by GUCY2D. Molecular modeling implied that the mutation changes the conformation of the regulatory segment within the kinase styk-domain of GC1 and causes loss of its helical structure, likely inhibiting phosphorylation of threonine residue within this segment, which is needed to activate the catalytic domain of the protein.", "answer": "This is the first documentation of the p.Ala710Val mutation in GC1 and the second ever described mutation in its protein kinase domain. Our findings enlarge the scope of genetic variability of LCA, highlight the phenotypic heterogeneity found amongst individuals harboring an identical LCA mutation, and possibly provide hope for gene therapy in patients with this congenital blinding disease. As the Bedouin kindred studied originates from Saudi Arabia, the mutation found might be an ancient founder mutation in that large community.\n\nyes"}
{"question": "Discuss the visual cycle ?", "answer": "The visual cycle is a series of biochemical reactions that occur in the retina of the eye, allowing us to see. It is a complex process that involves the conversion of light into electrical signals that can be transmitted to the brain for interpretation. The visual cycle begins when light enters the eye and passes through the cornea and lens, ultimately reaching the retina at the back of the eye. The retina contains specialized cells called photoreceptors, which are responsible for detecting light and initiating the visual process. The two types of photoreceptors in the retina are called rods and cones. Rods are responsible for vision in low light conditions and cones are responsible for color vision and visual acuity in brighter light conditions. When light reaches the photoreceptors, it activates a protein called opsin, which is embedded in the membrane of the photoreceptor cells. Opsin undergoes a conformational change when exposed to light, triggering a cascade of biochemical reactions within the cell. One key molecule involved in the visual cycle is called retinal, which is derived from vitamin A. When light interacts with retinal, it undergoes a change in shape, which leads to the activation of other proteins involved in the visual cycle. Once activated, these proteins generate electrical signals that are transmitted to other cells in the retina, ultimately reaching the optic nerve. The optic nerve then carries these signals to the brain, where they are processed and interpreted as vision. After the initial response to light, the photoreceptor cells need to regenerate their light-sensitive molecules in order to continue detecting light. This regeneration process involves the recycling and recombining of the retinal molecule with opsin. Overall, the visual cycle is a highly coordinated and intricate process that allows us to perceive and make sense of the visual world around us. It is essential for our ability to see and is constantly occurring as long as light is present."}
{"question": "Question: Does mechanical force enhance MMP-2 activation via p38 signaling pathway in human retinal pigment epithelial cells?\nContext: Rhegmatogenous retinal detachment and proliferative vitreoretinopathy (PVR) are eye diseases that are characterized by mechanical stress involving stretching of the retinal pigment epithelial (RPE) cells by the vitreous or the hyperplastic membranes. Here, we assessed whether mechanical force could change the expression of matrix metalloproteinases (MMPs) in RPE cells via the mitogen-activated protein kinase (MAPK) pathway. Collagen-coated magnetite beads and magnetic fields were used to apply tensile forces to cultured RPE cells at focal adhesions. Activation of the MAPK, including extracellular signal-regulated protein kinase (ERK), c-jun N-terminal kinase (JNK), and p38 were determined over a time course from 5 to 30 min by Western-blot analysis. Activation of p38 was also tested using immunofluorescence staining. The mRNA levels of MMP-2, MMP-9, tissue inhibitor of MMP (TIMP)-2 and fibronectin (FN) were analyzed by RT-PCR. Active MMP-2 and MMP-9 were demonstrated by zymography. MMP-2 secretion was evaluated by enzyme immunoassay. Stimulation of RPE cells with mechanical stress did not change the total protein expression of the MAPK proteins ERK, JNK, and p38. However, of the three kinases, only active p38 showed an increased protein expression which was also shown by a 2.8-fold increase in immunofluorescence staining at 5 min following mechanical stress stimulation. This increase in active p38 expression was blocked by treating the cells with the p38 inhibitor SB203580. FN mRNA increased 2.4-fold at 15 min and MMP-2 mRNA increased 2.1-fold at 4 h. MMP-2 secretion increased 1.5-fold at 4 h and 1.9-fold at 12 h. The expression of MMP-2 and FN, and the activation and secretion of MMP-2, were inhibited in the presence of SB203580. The mRNA expression of MMP-9 and TIMP-2 did not change throughout.", "answer": "This study shows that mechanical stress upregulates MMP-2 and FN expression through activation of the p38 pathway. The increase in MMP-2 levels evoked by mechanical force may contribute to the remodeling of the extracellular matrix around RPE cells, weakening the interlinkage and membrane attachment between RPE cells, and facilitate cellular migration.\n\nyes"}
{"question": "Question: Does intravitreal transplantation of human umbilical cord blood stem cells protect rats from traumatic optic neuropathy?\nContext: To treat traumatic optic neuropathy (TON) with transplantation of human umbilical cord blood stem cells (hUCBSC) and explore how transplanted stem cells participate in the neuron repairing process. A total of 195 Sprague-Dawley rats were randomly assigned to three groups: sham-surgery, optic nerve injury, and stem cell transplant group. Optic nerve injury was established in rats by directly clamping the optic nerve for 30 seconds. hUCBSC was microinjected into the vitreous cavity of injured rats. Optic nerve function was evaluated by flash visual evoked potentials (F-VEP). Apoptosis in retina tissues was detected by TUNEL staining. GRP78 and CHOP gene expression was measured by RT-PCR. After injury, transplantation of hUCBSC significantly blunted a reduction in optic nerve function indicated by smaller decreases in amplitude and smaller increases in peak latency of F-VEP waveform compared to the injury alone group. Also, significant more in retinal ganglion cell (RGC) count and less in RGC apoptosis were detected after transplantation compared to injured rats. The protective effect correlated with upregulated GRP78 and downregulated CHOP mRNA expression.", "answer": "Intravitreal transplantation of hUCBSCs significantly blunted a reduction in optic nerve function through increasing RGC survival and decreasing retinal cell apoptosis. The protective role of transplantation was associated with upregulation of GRP78 expression and downregulation of CHOP expression in retinal cells.\n\nyes"}
{"question": "Question: Does mean retinal ganglion cell axon diameter vary with location in the human retina?\nContext: We examined retinal ganglion cell (RGC) axon diameters within the human retinal nerve fibre layer in order to provide information about the possible effects of axonal stimulation when a retinal prosthesis includes the nonfoveal regions. Five pairs of eyes were obtained from donors aged from 48 to 84 years. Fixation delay ranged from 5 to 22 h. Tissue was processed for electron microscopy. Inferior and/or nasal RGC axons were on average larger than superior and/or temporal axons. The inferior retina contained some very large axons. Foveal axons were on average smaller than nonfoveal axons and had a size distribution that suggested different size groupings not seen in other samples. Peripheral versus central axons within the superior and inferior nasal retinal samples were compared; peripheral axons were significantly larger, unlike the inferior temporal samples or the samples nasal to the optic disc.", "answer": "Stimulus-current thresholds will change as a retinal prosthesis increases in size and encroaches on the nonfoveal axons. These changes can be anticipated based on mean axon diameter. Knowing in advance the possible outcome of electrical stimulation of the axonal population may help refine prosthetic procedures and patient training.\n\nyes"}
{"question": "Question: A 70 year-old man comes to the emergency department for sudden loss of vision in the right eye over the last 24 hours. He has noticed progressive bilateral loss of central vision over the last year. He has had difficulty reading his newspaper and watching his television. He has smoked 1 pack daily for 50 years. Ophthalmologic examination shows visual acuity of 20/60 in the left eye and 20/200 in the right eye. The pupils are equal and reactive to light. Tonometry reveals an intraocular pressure of 18 mm Hg in the right eye and 20 mm Hg in the left eye. Anterior segment exam is unremarkable. Slit-lamp examination shows subretinal fluid and small hemorrhage with grayish-green discoloration in the macular area in the right eye, and multiple drusen in the left eye with retinal pigment epithelial changes. Which of the following is the most appropriate initial treatment for the patient's illness?\nOptions:\nA. Etanercept\nB. Thermal laser photocoagulation\nC. Ranibizumab\nD. Macular translocation surgery\n", "answer": "OPTION C IS CORRECT."}
{"question": "Question: Chvostek's sign is elicited by:\nOptions:\nA. Facial nerve stimulation by tapping over the parotid\nB. BP cuff in arm for 5 minutes\nC. Tapping over extensor policies brevis\nD. Tapping over flexor retinaculum\n", "answer": " Chvostek sign This can be elicited by tapping over the facial nerve when it is entering into the parotid gland. This will cause twitching of facial musculature. The sign is referred to as Chvostek sign. It is seen in patients with hypocalcemia due to irritability of nerves But it can be seen in ~10% of normal individuals also\n\nOPTION A IS CORRECT."}
{"question": "What are the possible treatments or the best therapy for an eye disease related to potassium channels and potassium buffering currents in Müller cells ?", "answer": "The context provided discusses the role of potassium channels and potassium buffering currents in Müller cells in the retina. While the specific eye disease related to these channels is not mentioned, we can explore potential treatments based on the understanding of these channels. One possible treatment option for eye diseases involving potassium channels and currents in Müller cells is the modulation of potassium conductance. Since the potassium conductance in different regions of the Müller cell membrane varies among species, targeting specific potassium channels may be beneficial in managing the disease. Modulating the activity of inward rectifying potassium channels (KIR) or outward potassium channels (KO) could be a potential therapeutic approach. This modulation can be achieved using specific drugs or compounds that target these channels and modify their activity levels. Another treatment strategy could involve the regulation of potassium buffering currents. These currents play a role in maintaining potassium homeostasis in the retina. In diseases where potassium deposition in the vitreous or distal retina is a concern, targeting the membrane distribution of KIR channels could help regulate potassium buffering currents. This regulation may prevent excessive potassium accumulation in specific regions and promote its proper clearance. It is important to note that specific eye diseases related to potassium channels and currents in Müller cells may require individualized treatment approaches. These treatments can be determined based on the underlying pathology and the specific manifestation of the disease. To explore the best therapy for a particular eye disease, it is essential to consult with an ophthalmologist or retina specialist who can assess the patient's condition and recommend the most appropriate treatment options. They may consider factors such as the patient's medical history, disease severity, and response to previous treatments. Additionally, further research and clinical trials in the field of ophthalmology may provide more targeted treatments for eye diseases involving potassium channels and currents in Müller cells. References: 1. Bringmann, A., & Reichenbach, A. (2001). Role of Müller cells in retinal degenerations. Frontiers in bioscience: a journal and virtual library, 6, E72-E92. 2. Newman, E. A. (2003). New roles for astrocytes: regulation of synaptic transmission. Trends in neurosciences, 26(10), 536-542. 3. Reichenbach, A., & Bringmann, A. (2013). Müller cells in the healthy and diseased retina. In Retinal Degenerative Diseases (pp. 77-86). Springer, Berlin, Heidelberg."}
{"question": "Question: Does protein kinase D regulate several aspects of development in Drosophila melanogaster?\nContext: Protein Kinase D (PKD) is an effector of diacylglycerol-regulated signaling pathways. Three isoforms are known in mammals that have been linked to diverse cellular functions including regulation of cell proliferation, differentiation, motility and secretory transport from the trans-Golgi network to the plasma membrane. In Drosophila, there is a single PKD orthologue, whose broad expression implicates a more general role in development. We have employed tissue specific overexpression of various PKD variants as well as tissue specific RNAi, in order to investigate the function of the PKD gene in Drosophila. Apart from a wild type (WT), a kinase dead (kd) and constitutively active (SE) Drosophila PKD variant, we also analyzed two human isoforms hPKD2 and hPKD3 for their capacity to substitute PKD activity in the fly. Overexpression of either WT or kd-PKD variants affected primarily wing vein development. However, overexpression of SE-PKD and PKD RNAi was deleterious. We observed tissue loss, wing defects and degeneration of the retina. The latter phenotype conforms to a role of PKD in the regulation of cytoskeletal dynamics. Strongest phenotypes were larval to pupal lethality. RNAi induced phenotypes could be rescued by a concurrent overexpression of Drosophila wild type PKD or either human isoform hPKD2 and hPKD3.", "answer": "Our data confirm the hypothesis that Drosophila PKD is a multifunctional kinase involved in diverse processes such as regulation of the cytoskeleton, cell proliferation and death as well as differentiation of various fly tissues.\n\nyes"}
{"question": "Question: A 45-year-old female with a long history of progressive myopia develops sudden patchy loss of vision in her right eye. She is very alarmed and rushes to her family doctor. Funduscopic examination reveals a large retinal detachment in the right eye. The retina in the left eye is normal. When the pupillary light reflex is tested by shining a light in the right eye, the physician would likely note?\nOptions:\nA. Constriction of the right pupil and constriction of the left\nB. Constriction of the right pupil and dilatation of the left\nC. Dilatation of the right pupil and constriction of the left\nD. Dilatation of the right pupil and dilatation of the left\n", "answer": " This patient is exhibiting the Marcus-Gunn phenomenon. When light strikes the retina, the pupillary light reflex is automatically triggered, leading to simultaneous constriction of both pupils. In the absence of adequate light entering the eye, for example following retinal detachment or optic neuritis, paradoxical dilatation of the pupils occurs. The retina receives far less light than it normally would, and the pupils dilate in order to absorb as much light as possible.\n\nOPTION D IS CORRECT."}
{"question": "What are some complications of uveitis ?", "answer": "Complications of uveitis can include secondary glaucoma, cataracts, macular edema, retinal detachment, and optic nerve damage. These complications can lead to vision loss if not managed appropriately. It is important to closely monitor and treat uveitis to prevent these complications from occurring or worsening."}
{"question": "Can receptor-mediated endocytosis play a role in the development of ocular immune responses ?", "answer": "Receptor-mediated endocytosis has been shown to play a crucial role in the uptake and processing of antigens by dendritic cells (DCs), which are key regulators of immune responses. While the given context does not specifically mention ocular immune responses, it provides insights into the mechanisms by which DCs selectively take up antigens for presentation to immune cells. In the field of specialized clinical ophthalmology, we can explore how receptor-mediated endocytosis might contribute to the development of immune responses in the eye. In the eye, DCs are present in various ocular tissues, including the conjunctiva, cornea, and retina, where they serve as sentinels of the immune system. DCs in these ocular tissues have the ability to recognize and take up antigens through receptor-mediated endocytosis. The selective uptake of antigens allows the DCs to determine which antigens are presented to immune cells and subsequently influence the type of immune response induced. In the context of ophthalmic diseases, such as ocular infections or autoimmune disorders, receptor-mediated endocytosis by DCs in the eye can have significant implications. For example, certain pathogens may exploit specific receptors on DCs to evade immune surveillance and impair the intracellular targeting of antigens to lysosomal compartments. This evasion mechanism can result in a persistent infection or inflammation within the ocular tissues. Moreover, the improper intracellular targeting of antigens, as seen in the impaired lysosomal targeting of the tumor antigen MUC-1 mentioned in the context, can lead to poor antigen presentation and inferior T-cell responses. This suggests that the quality of antigen uptake by DCs, influenced by receptor-mediated endocytosis, can impact the initiation and regulation of ocular immune responses. Understanding the role of receptor-mediated endocytosis in ocular immune responses is crucial for the development of targeted therapeutic interventions. By modulating the receptors involved in antigen uptake, it may be possible to influence the balance between tolerance and immunity in ocular diseases. Further research in this area can provide valuable insights into the pathogenesis and potential treatment strategies for various ophthalmic conditions."}
{"question": "Inferential specialized clinical ophthalmology procedural question: What are the possible causes of acute visual disturbance in a non-inflamed eye ?", "answer": "Acute visual disturbance in a non-inflamed eye can have various causes. Some common causes include vitreous detachment, retinal detachment, vitreous hemorrhage, and optic neuritis. Other conditions such as migraines, vascular occlusions, and disciform macular degeneration can also lead to acute visual disturbances. It is important to consider the patient's age, medical history (such as diabetes, hypertension, and cerebrovascular disease), and associated symptoms in order to narrow down the potential underlying cause. Additionally, the visual acuity of the patient can provide important clues regarding the severity and nature of the insult to the retina or optic nerve."}
{"question": "Question: Does depression of retinal glutamate transporter function lead to elevated intravitreal glutamate levels and ganglion cell death?\nContext: Elevated levels of extracellular glutamate have been implicated in the pathophysiology of neuronal loss in both central nervous system and ophthalmic disorders, including glaucoma. This increase in glutamate may result from a failure of glutamate transporters (molecules that ordinarily regulate extracellular glutamate; E:xcitatory A:mino A:cid T:ransporter; EAAT). Elevated glutamate levels can also lead to alterations in glutamate receptor expression. It was hypothesized that selective blockade of glutamate transporters would be toxic to retinal ganglion cells. Glutamate transporters were blocked either pharmacologically or with subtype-specific antisense oligonucleotides against EAAT1. Glutamate levels, transporter levels and ganglion cell survival were assayed. Pharmacological inhibition of glutamate transporters with either an EAAT2 specific inhibitor or a nonspecific inhibitor of all the subtypes of transporters was toxic to ganglion cells. Treatment with oligonucleotides against the glutamate transporter EAAT1 decreased the levels of expression of the transporter, increased vitreal glutamate, and was toxic to ganglion cells.", "answer": "These results demonstrate that normal function of EAAT1 and EAAT2 is necessary for retinal ganglion cell survival and plays an important role in retinal excitotoxicity. Manipulation of retinal glutamate transporter expression may become a useful tool in understanding retinal neuronal loss.\n\nyes"}
{"question": "Question: Does inhibition of vascular endothelial growth factor prevent retinal ischemia-associated iris neovascularization in a nonhuman primate?\nContext: To determine if the angiogenic peptide vascular endothelial growth factor (VEGF) is required for retinal ischemia-associated iris neovascularization in a nonhuman primate. Laser retinal vein occlusion was used to produce retinal ischemia in 16 eyes of eight animals (Macaca fascicularis). Eyes were randomized to treatment every other day with intravitreal injections of either a neutralizing anti-VEGF monoclonal antibody or a control monoclonal antibody of the same isotype. Serial iris fluorescein angiograms were assessed using a standardized grading system and masked readers. Retinal VEGF and placental growth factor expression were assessed by Northern blotting. The specificity of the antibodies was determined in capillary endothelial cell proliferation assays prior to intravitreal injection. Zero of eight eyes receiving the neutralizing anti-VEGF antibodies developed iris neovascularization. Five of eight control antibody-treated eyes developed iris neovascularization. The difference was statistically significant (P = .03). Intravitreal antibody injection did not impair the ability of the ischemic retina to increase VEGF messenger RNA expression. The anti-VEGF antibodies specifically inhibited VEGF-driven capillary endothelial cell proliferation in vitro.", "answer": "These data demonstrate that VEGF is required for iris neovascularization in an adult nonhuman primate eye. The inhibition of VEGF is a new potential therapeutic strategy for the treatment of ocular neovascularization.\n\nyes"}
{"question": "Question: Does retinoic acid induce VEGF gene expression in human retinal pigment epithelial cells ( ARPE-19 )?\nContext: The aim of this study was to evaluate the expression of vascular endothelial growth factor (VEGF) in response to retinoic acid (RA) in human retinal pigment epithelial cells. Expression of VEGF in human ARPE-19 cells was determined by a semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). mRNA stability was assessed after the administration of actinomycin D. The induction of the VEGF gene by various RAs was also determined by semiquantitative RT-PCR. All-trans retinoic acid (atRA) time-dependently increased VEGF mRNA levels. The effect of atRA was dose-dependent in a range between 10(-7) M and 10(-6) M. Treatment with actinomycin D revealed that atRA induces the VEGF gene at the transcriptional level. Of the various RAs tested, atRA was the most potent inducer of the VEGF gene.", "answer": "We demonstrated that atRA stimulates the induction of the VEGF gene in ARPE-19 cells, suggesting a novel pathway for the development of age-related macular degeneration.\n\nyes"}
{"question": "What is the crossing pattern of nasal fibers in the optic chiasm ?", "answer": "In the optic chiasm, the nasal fibers cross or decussate. The ratio of crossed to uncrossed fibers in the chiasm is approximately 53 to 47. The inferior nasal retinal fibers are inferior in the anterior chiasm and cross to the other side. Many of these fibers loop into the terminal part of the opposite optic nerve before turning to run back through the chiasm into the contralateral optic tract. The superior nasal fibers enter the superior chiasm, cross, and then leave the chiasm in the contralateral optic tract. Some of these fibers loop posteriorly into the optic tract on the same side before crossing."}
{"question": "Question: Does prenatal human ocular degeneration occur in Leber 's congenital amaurosis ( LCA2 )?\nContext: Leber's congenital amaurosis (LCA) encompasses the most precocious and severe forms of inherited retinal dystrophy, displaying very significant visual handicap at or soon after birth. Among the currently identified mutations, alterations in the gene coding for retinal pigment epithelium 65-kDa protein (RPE65) lead to LCA2. Existing animal models for LCA2 (RPE65(-/-) null mice and naturally occurring RPE65(-/-) Briard dogs) exhibit near normal retinal histology at birth, although no recordable photofunction can be detected. Structural degeneration in both cases occurs with delayed onset, cone death generally preceding that of rods. We obtained retinal tissue from a voluntarily aborted embryo of an LCA2 carrier in order to compare histopathology and immunohistochemistry with age-matched normal foetal retina. Compared to normal retinas, affected retina displayed cell loss and thinning of the outer nuclear (photoreceptor) layer, decreased immunoreactivity for key phototransduction proteins, and aberrant synaptic and inner retinal organisation. The gene mutation abolished detectable expression of RPE65 within the retinal pigment epithelium (RPE) of affected eyes, and ultrastructural examination revealed the presence of lipid and vesicular inclusions not seen in normal RPE. In addition, mutant eyes demonstrated thickening, detachment and collagen fibril disorganisation in the underlying Bruch's membrane, and the choroid was distended and abnormally vascularised, in comparison with controls.", "answer": "Such data contrast with the late-onset ocular changes observed in animal models, indicating caution should be exercised when inferring human retinal pathophysiology from information based on other species.\n\nyes"}
{"question": "Question: Hi doctor,I wear glasses with a minimal prescription of - .25 with slight astigmatism and + 2 reading. Recently, I got a new pair of progressive lenses. I am finding that my right eye cannot focus properly and it is always blurry. First, I thought that the prescription was wrong. But after making many attempts with my new lens, I was able to notice that my old progressive lens had an incorrect pupillary distance by 2 mm on my right eye. I wore that glasses for three years, and I was unaware.I am worried whether wearing glasses with PD by 2 mm so long have caused any adjustments in my right eye? Why is my eye blurry? I was wondering why my new lenses were not focussing correctly as they were present with a correct PD. Is it possible to retrain my eye to focus accurately? Can I start wearing a single vision lens which can help me for a while?", "answer": "Hi. By going through your query, I can understand that you are suffering from intolerance to progressive lenses. It can be due to an increase in near vision with age. It is not due to incorrect PD (pupillary distance). If you work on a computer, intermediate vision glasses can provide you more comfort rather than progressive. Intermediate vision glasses gives the support of vision when they are used for indoor work and reading. For distant vision, you may choose to remove your glasses. In case, if both of your eyes are not working together (binocular vision defects), a change in IPD (interpupillary distance) may develop. In that case, few tests for binocular vision can help. Also, some types of cataract or glaucoma in early stage produces glass intolerance, and it leads to a frequent change of glasses in an older age group. A slit lamp examination and dilated fundus examination are advised to rule out the causes of glass intolerance.  Take care."}
{"question": "How can diplopia testing be performed in cases of strabismus ?", "answer": "Diplopia testing in cases of strabismus can be performed using red and green glasses. When these glasses are placed before the right and left eye respectively, they dissociate the two images and cause them to be seen double in cases of strabismus. Esodeviations (inward deviation of the eye) cause uncrossed diplopia (homonymous diplopia), where the image falls on the nasal half of the retina and is projected on the same side of the eye. Exodeviations (outward deviation of the eye) cause crossed diplopia (heteronymous diplopia), where the image falls on the temporal retina and is seen on the opposite side of the eye. To chart the deviations, it is preferable to use an illuminated slit target, both for near and distance testing. The slit can be used vertically to chart horizontal deviations and horizontally to chart vertical deviations. A slit target helps in appreciating any tilt of the image. For distance testing, the Maddox tangent scale or cross can be utilized to quantify the deviation, while prisms are used for deviation measurement at near."}
{"question": "Question: Does aAV2-mediated subretinal gene transfer of mIL-27p28 attenuate experimental autoimmune uveoretinitis in mice?\nContext: Advances in gene transfer techniques have provided long-term, safe and stable transduction of retinal cells following subretinal injection with adeno-associated viral (AAV) vectors. In this study we investigated whether subretinal injection of AAV2-murine IL-27p28 vector was effective in inhibiting experimental autoimmune uveoretinitis (EAU) induced in B10RIII mice. An AAV2 vector encoding the murine IL-27p28 gene (rAAV2-CMV-mIL-27p28) was prepared and subretinally injected into B10RIII mice (4.35×10(8) vector genome (v.g.)). AAV2 vector mediating green fluorescent protein (rAAV2-CMV-GFP) served as a control (5×10(8) v.g.). The concentration of mIL-27p28 in homogenized eyes and serum was assayed by enzyme linked immunosorbent assay (ELISA) after subretinal injection. Human IRBP(161-180) peptide and Complete Freund's Adjuvant were injected into mice receiving either the rAAV2-CMV-mIL-27p28 or rAAV2-CMV-GFP vector. EAU was evaluated clinically and pathologically. The level of IL-17 and IL-10 in homogenized eyes was measured on day 12 and day 21 following immunization. Delayed type hypersensitivity (DTH) and IRBP(161-180)-specific proliferation of lymphocytes from the spleen and lymph nodes were assayed to examine the influence of the subretinal delivery of rAAV2-CMV-mIL-27p28 on the systemic immune response. IL-27p28 was detectable by ELISA within the eyes from two weeks following subretinal injection of the rAAV2-CMV-mIL-27p28 vector and showed a sustained high expression from day 14 to 9 months with a highest expression at 5 months. Subretinal injection of the vector significantly attenuated the severity of EAU disease clinically and pathologically in association with a significantly decreased IL-17 expression and an increased IL-10 expression. The IL-27p28 vector did not affect the systemic immune response, as determined by DTH and IRBP(161-180)-specific lymphocyte proliferation.", "answer": "A high and stable expression of IL-27p28 was observed for at least 9 months following subretinal delivery of rAAV2-CMV-mIL-27p28. The amelioration of EAU disease severity was associated with a decreased IL-17 expression and an increased IL-10 expression.\n\nyes"}
{"question": "Question: The fibers from the contralateral nasal hemiretina project to the following layers of the lateral geniculate nucleus\nOptions:\nA. Layers 2,3 & 5.\nB. Layers 1,2 & 6.\nC. Layers 1,4 & 6.\nD. Layers 4,5 &6.\n", "answer": " Look at figure 12-17 trace the nasal field of one eye it goes to layers 1,4,6 on contralateral side. Ref: Ganong&;s review of medical physiology;23rd edition; pg:194\n\nOPTION C IS CORRECT."}
{"question": "Question: Does diabetes change expression of genes related to glutamate neurotransmission and transport in the Long-Evans rat retina?\nContext: This study investigated changes in the transcript levels of genes related to glutamate neurotransmission and transport as diabetes progresses in the Long-Evans rat retina. Transcript levels of vascular endothelial growth factor (VEGF), erythropoietin, and insulin-like growth factor binding protein 3 (IGFBP3) were also measured due to their protective effects on the retinal vasculature and neurons. Diabetes was induced in Long-Evans rats with a single intraperitoneal (IP) injection of streptozotocin (STZ; 65 mg/kg) in sodium citrate buffer. Rats with blood glucose >300 mg/dl were deemed diabetic. Age-matched controls received a single IP injection of sodium citrate buffer only. The retinas were dissected at 4 and 12 weeks after induction of diabetes, and mRNA and protein were extracted from the left and right retinas of each rat, respectively. Gene expression was analyzed using quantitative real-time reverse-transcription PCR. Enzyme-linked immunosorbent assay was used to quantify the concentration of VEGF protein in each retina. Statistical significance was determined using 2×2 analysis of variance followed by post-hoc analysis using Fisher's protected least squares difference. Transcript levels of two ionotropic glutamate receptor subunits and one glutamate transporter increased after 4 weeks of diabetes. In contrast, 12 weeks of diabetes decreased the transcript levels of several genes, including two glutamate transporters, four out of five N-methyl-D-aspartate (NMDA) receptor subunits, and all five kainate receptor subunits. Diabetes had a greater effect on gene expression of NMDA and kainate receptor subunits than on the α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor subunits, for which only GRIA4 significantly decreased after 12 weeks. VEGF protein levels were significantly increased in 4-week diabetic rats compared to age-matched control rats whereas the increase was not significant after 12 weeks. Transcript levels of VEGF and VEGF receptors were unchanged with diabetes. Erythropoietin and IGFBP3 mRNA levels significantly increased at both time points, and IGFBP2 mRNA levels increased after 12 weeks.", "answer": "Diabetes caused significant changes in the transcriptional expression of genes related to ionotropic glutamate neurotransmission, especially after 12 weeks. Most genes with decreased transcript levels after 12 weeks were expressed by retinal ganglion cells, which include glutamate transporters and ionotropic glutamate receptors. Two genes expressed by retinal ganglion cells but unrelated to glutamate neurotransmission, γ-synuclein (SNCG) and adenosine A1 receptor (ADORA1), also had decreased mRNA expression after 12 weeks. These findings may indicate ganglion cells were lost as diabetes progressed in the retina. Decreased expression of the glutamate transporter SLC1A3 would lead to decreased removal of glutamate from the extracellular space, suggesting that diabetes impairs this function of Müller cells. These findings suggest that ganglion cells were lost due to glutamate excitotoxicity. The changes at 12 weeks occurred without significant changes in retinal VEGF protein or mRNA, although higher VEGF protein levels at 4 weeks may be an early protective response. Increased transcript levels of erythropoietin and IGFBP3 may also be a protective response.\n\nyes"}
{"question": "What is the conoid of Sturm in ophthalmology ?", "answer": "The conoid of Sturm is a term used in ophthalmology to describe the three-dimensional shape of the wavefront in a patient's eye. It refers to the alignment of the focal points of light rays passing through the eye's optical system. Specifically, it represents the point at which the wavefront, or the front surface of the light, converges to a single point on the retina. In the context of mixed astigmatism, when the conoid of Sturm is in the retinal plane, it means that the center of the wavefront map has the same color as the surrounding green frame, indicating a balanced and optimal focusing of light on the retina."}
{"question": "Definition question: What is neovascular AMD ?", "answer": "Neovascular AMD, also known as wet age-related macular degeneration, is a progressive eye condition characterized by abnormal blood vessel growth beneath the retina. These new blood vessels are fragile and prone to leaking fluid and blood, which can cause damage to the macula - the central part of the retina responsible for sharp, central vision. Neovascular AMD can lead to severe vision loss if left untreated. Common symptoms include blurred or distorted central vision, difficulty recognizing faces or reading, and the appearance of dark spots or straight lines appearing wavy."}
{"question": "Question: Is bax the heterodimerization partner necessary for sustained anti-photoreceptor-cell-death activity of Bcl-2?\nContext: Ectopic expression of Bcl-2 in photoreceptors of certain mouse models of retinitis pigmentosa (RP) temporarily slows disease progression. The temporary effect produced by Bcl-2 may result from insufficient levels of functional complexes between Bcl-2 and additional proteins necessary for maintaining the anti-apoptotic activity of Bcl-2. Although the overexpression of Bax generally induces apoptosis, Bax exerts anti-apoptotic properties when complexed with Bcl-2 in certain cell culture systems. These studies were designed to determine whether coexpression of Bcl-2 and Bax would improve the neuroprotective effect provided by Bcl-2 alone in photoreceptors of mice with autosomal dominant RP (adRP). Transgenic mice were produced that overexpressed Bax and Bcl-2 specifically in photoreceptor cells, using the murine opsin promoter to drive transgene expression. These mice were crossed with an adRP mouse model to assess the effect of coexpression of Bax and Bcl-2 on retinal degeneration. Morphologic analysis was performed on retinas isolated at various developmental times to monitor disease progression. Ectopic expression of Bax in photoreceptors resulted in extensive rod cell death dependent on the level of Bax transgene expression. Although Bcl-2 was able to inhibit Bax-induced photoreceptor cell death, the coexpression of Bcl-2 and Bax in photoreceptors of mice with adRP did not enhance the protective effect against photoreceptor cell death exerted by Bcl-2 alone.", "answer": "Coexpression of Bax and Bcl-2, at the levels produced in the transgenic lines, does not extend the temporary neuroprotective effect produced by Bcl-2 in photoreceptors of mice with adRP.\n\nno"}
{"question": "What is the significance of the b-wave in the electroretinogram (ERG) and how is it generated ?", "answer": "The b-wave in the electroretinogram (ERG) is a positive waveform that plays a crucial role in assessing retinal function. It is generated by the on-bipolar cells in the retina, which receive signals from the rod system. The b-wave amplitude, measured from the baseline to the peak of the response, provides valuable information about the integrity of rod and on-bipolar cell function. During dark adaptation, a dim flash of light is used to elicit the rod response in the dark-adapted eye for recording the ERG. The stimulus intensity should be 2.5 log units below the standard flash (SF), and a period of at least 20 minutes of dark adaptation is recommended. Serial averaging of responses can be performed, but the inter-stimulus duration should not be less than 2 seconds to avoid light adaptation of the retina. The b-wave represents the synaptic activity between the photoreceptors (rods) and on-bipolar cells, where signals are transmitted from the rods to the bipolar cells. A normal waveform with an intact rod and on-bipolar cell function typically shows a well-defined b-wave. The measurement of the b-wave amplitude, along with the time to peak, is crucial in evaluating retinal function. Changes in the amplitude or latency of the b-wave can indicate abnormalities in the rod system or on-bipolar cell function. Therefore, the analysis of the b-wave in the ERG provides valuable insights into the functional status of the retina. It's important to note that if there are any uncertainties or if more detailed information is required, referring to ophthalmology books and resources or consulting with a specialist would be beneficial."}
{"question": "What are the appropriate medicines for the treatment of geographic atrophy secondary to age-related macular degeneration ?", "answer": "For the treatment of geographic atrophy secondary to age-related macular degeneration, the appropriate medicines include novel therapeutics that target the disease. The FDA is now considering the loss of retinal tissue as a primary endpoint for trials studying geographic atrophy. While the determination of the proper imaging modality to evaluate the extent of retinal tissue loss is still ongoing, potential treatments are being evaluated through clinical trials. These novel therapeutics aim to prevent the deterioration of retinal tissue, as the loss of retinal tissue is considered a bad outcome regardless of the immediate effect on vision."}
{"question": "Question: Papilloedema is characterised by all of the following EXCEPT-\nOptions:\nA. Loss of retinal venous pulsations\nB. Transient obscurations of vision\nC. Sudden painless loss of vision\nD. Disc oedema\n", "answer": " Vision loss occurs in long standing papilloedema (not in acute pappiloedema), and that occurs in less than 25% of patients.\nPost neuritic atrophy also occurs in long standing papilloedema and not acute papilloedema.\n\nOPTION C IS CORRECT."}
{"question": "What are the ocular manifestations and diagnostic steps for a patient suspected of having mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome ?", "answer": "Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a multisystem disorder with various ocular manifestations. When a patient is suspected of having MELAS syndrome, ophthalmologists should consider the following sequential steps: 1. Evaluate for visual symptoms: Patients with MELAS syndrome may present with visual disturbances such as hemianopsia, scotoma, or cortical blindness. It is essential to assess the patient's visual complaints and obtain a detailed medical history. 2. Perform a comprehensive ophthalmic examination: A thorough examination should be conducted, including visual acuity assessment, pupillary examination, ocular motility evaluation, and slit-lamp examination of the anterior segment. Dilated fundus examination is crucial to evaluate for characteristic findings associated with MELAS syndrome. 3. Look for retinal abnormalities: In MELAS syndrome, retinal manifestations can include pigmentary retinopathy, optic disc swelling (papilledema), arterial attenuation, and vascular tortuosity. These findings may not be present in all cases, but their presence can aid in the diagnosis. 4. Consider electrophysiological testing: Multifocal electroretinography (mfERG) and visual evoked potentials (VEPs) can be helpful in assessing retinal and cortical visual function, respectively. These tests may reveal abnormalities even in the absence of obvious clinical signs. 5. Collaborate with other specialists: MELAS syndrome is a multisystem disorder, and the involvement of other organs should not be overlooked. Close collaboration with neurologists, geneticists, and other relevant specialists is crucial for confirmation of the diagnosis and comprehensive patient management. It is important to note that the above steps are general guidelines, and each patient's evaluation should be tailored to their specific clinical presentation. Additionally, given the complexity of MELAS syndrome, suspected cases should be referred to specialized centers with expertise in mitochondrial disorders for further evaluation and management."}
{"question": "What is the diagnostic approach for Stargardt macular dystrophy and how can electrophysiologic tests aid in the diagnosis ?", "answer": "The diagnosis of Stargardt macular dystrophy is primarily based on clinical findings, such as the presence of choroidal blockage on fluorescein angiography. Genetic findings can also provide support when available. Electrophysiologic tests can be helpful in detecting retinal dysfunction and assessing disease progression. Full-field ERG responses are typically within the normal range in most patients with Stargardt macular dystrophy. However, these responses can vary among patients and may show impaired cone responses as well as impaired rod and cone responses, especially in individuals with more extensive retinal atrophy and fleck-like lesions. Prolonged rod dark adaptation, lasting at least 45 minutes, has been observed in Stargardt patients and can also be considered as part of the diagnostic evaluation."}
{"question": "What is the technique for performing cryotherapy in patients with peripheral retinal neovascularization and a history of vitreous hemorrhage ?", "answer": "Cryotherapy is generally administered directly over areas of neovascularization utilizing a freeze, thaw and refreeze technique. Under direct visualization, the area covered with the new vessels and the gelatinous exudates is frozen for 10–15 seconds, or until ice formation is evident for 1–2 seconds. On average, 10–20 freezes are performed per eye, just posterior to the ora serrata."}
{"question": "Inferential specialized clinical ophthalmology procedural question: What are the effects of combining coma with astigmatism on retinal image quality ?", "answer": "Combining coma with astigmatism can actually improve retinal image quality compared to astigmatism alone. A study by de Gracia et al. (2010) found that the simultaneous presence of coma and astigmatism had a positive impact on retinal image quality. This suggests that the presence of coma, which is a higher-order aberration, may compensate for some of the negative effects of astigmatism on visual acuity. However, it is important to note that further research is needed to fully understand the specific mechanisms behind this improvement and to explore its clinical implications."}
{"question": "Question: \" Polychromatic luster\" is a feature of\nOptions:\nA. Nuclear cataract\nB. Cortical cataract\nC. Zonular cataract\nD. Complicated cataract\n", "answer": " Ans. d (Complicated cataract) (Ref. Basak's ophthalmology 2nd ed., 181)COMPLICATED CATARACTS# It is a complication of any protracted intraocular inflammation, especially heterochromia, chronic iridocyclitis, retinal vasculitis, and retinitis pigmentosa.# Complicated cataract results from a disturbance of the lens metabolism due to inflammatory or degenerative diseases.# The result is a \"pumice-like posterior subcapsular cataract\" that progresses axially toward the nucleus.# Vision is much impaired even in early stage, due to position of the opacity near nodal point of eye.# The opacity usually commences in posterior cortex in the axial plane (posterior cortical cataract).# The opacity appears grayish with \"bread-crumb\" appearance in oblique illumination.# This form of cataract produces extreme light scattering.# On slit lamp, the opacity shows a characteristic rainbow display of colors, the polychromatic luster.# Rx: Operative and visual prognosis in complicated cataract is usually poor.Note: Riders (\"spoke wheel\") are seen in lamellar cataract, which is the most common type of congenital cataract.\n\nOPTION D IS CORRECT."}
{"question": "What are the classifications of diabetic macular edema (DME) according to Bresnick, ETDRS, and the International classification systems ?", "answer": "Diabetic macular edema (DME) can be classified according to different systems. The Bresnick classification includes focal DME, which involves localized retinal thickening often surrounded by exudates, diffuse DME, which is characterized by generalized thickening of the central macula, and ischemic maculopathy, which refers to extended macular capillary occlusion. The ETDRS classification defines macular edema as retinal thickening and/or exudates within one disc diameter of the center of the macula. Clinically significant DME is characterized by thickening of the retina at or within 500 µm of the center of the macula, hard exudates at or within 500 µm of the center of the macula, or a zone or zones of retinal thickening one disc area or larger, any part of which is within one disc diameter of the center of the macula. The International classification system considers macular edema as any apparent retinal thickening or exudates in the posterior pole. It further categorizes DME as mild, moderate, or severe based on the extent of retinal thickening or exudates involving the center of the macula."}
{"question": "What is the purpose of performing Hruby Lens Biomicroscopy in ophthalmology ?", "answer": "Hruby Lens Biomicroscopy is performed in ophthalmology to evaluate the fundus in a non-contact manner. It allows for a detailed examination of the posterior segment of the eye, including the retina, optic nerve, and macula. This technique is useful in diagnosing and monitoring various retinal conditions, such as macular degeneration, diabetic retinopathy, and retinal detachments. By providing a magnified view of the fundus, Hruby Lens Biomicroscopy aids in the identification of abnormalities and assists ophthalmologists in making accurate diagnoses and treatment plans for their patients."}
{"question": "Question: Does imaging of the macula indicate early completion of structural deficit in autosomal-dominant optic atrophy?\nContext: Optical coherence tomography (OCT) enables 3-dimensional imaging of the retina, including the layer of ganglion cells that supplies the optic nerve with its axons. We tested OCT as means of diagnosing and phenotyping autosomal-dominant optic atrophy (ADOA). Cross-sectional study. The study included 49 patients with OPA1 exon 28 (2826delT) ADOA (age, 8.6-71.5 years; best-corrected visual acuity [BCVA], 20/700-20/20) and 51 mutation-free first-degree relatives as healthy controls (BCVA 20/25-20/10). Participants underwent routine examination, including automated perimetry, and OCT with segmentation of the perifoveal retinal ganglion cell-inner plexiform layer (GC-IPL) and the peripapillary retinal nerve fiber layer (RNFL). Perifoveal GC-IPL thickness. All subjects with ADOA had a thinner GC-IPL in the inferonasal macula than the thinnest healthy control. The GC-IPL thickness was also subnormal in the superotemporal macula (P<0.0001), where it varied with visual acuity (P ≤ 0.03). Attenuation of the peripapillary nerve fiber layer was prominent on the temporal side of the optic disc in ADOA (P <0.0001), but there was considerable overlap with healthy controls. In ADOA, there was no detectable variation with age in BCVA, autoperimetry mean deviation, GC-IPL thickness, or RNFL thickness, except that the thickness of the superior RNFL quadrant decreased with age.", "answer": "Optical coherence tomography enabled a highly sensitive diagnosis of ADOA and identification of a structural correlate with the variation in visual acuity. The defect associated with the OPA1 exon 28 (2826delT) seems to be fully developed from early childhood or the perinatal period.\n\nyes"}
{"question": "What are the age-related changes in ICG-angiographic findings in normal subjects ?", "answer": "Age-related changes in ICG-angiographic findings in normal subjects include the appearance of small areas of hypofluorescence at the posterior pole, decreased intensity of arteriolar fluorescence, thinning and increased tortuosity of choroidal arterioles, and a decrease in the number of collateral vessels. Additionally, the vertical watershed zone, which passes through the optic nerve, becomes harder to detect with age. These changes may be indicative of reduced blood flow through the macular choroid and delayed arterial filling. Studies using laser Doppler flowmetry have confirmed age-related decreases in choroidal blood volume. Various methods can be used to study ocular blood flow, including fluorescein angiography, scanning laser ophthalmoscopy, scanning laser Doppler flowmetry, Heidelberg retinal flowmetry, magnetic resonance imaging, transcranial Doppler, and color Doppler ultrasound. Color Doppler ultrasound, in particular, provides precise information on hemodynamic parameters in real time."}
{"question": "Question: Is choroidal involution a key component of oxygen-induced retinopathy?\nContext: Retinopathy of prematurity (ROP) is a major cause of visual handicap in the pediatric population. To date, this disorder is thought to stem from deficient retinal vascularization. Intriguingly, functional electrophysiological studies in patients with mild or moderate ROP and in the oxygen-induced retinopathy (OIR) model in rats reveal central photoreceptor disruption that overlies modest retinal vessel loss; a paucity of retinal vasculature occurs predominantly at the periphery. Given that choroidal circulation is the major source of oxygen and nutrients to the photoreceptors, the authors set out to investigate whether the choroidal vasculature system may be affected in OIR. Rat models of OIR treating newborn animals with 80% or 50/10% alternated oxygen level for the first two postnatal weeks were used to mimic ROP in humans. Immunohistology staining and vascular corrosion casts were used to investigate the vessel layout of the eye. To investigate the effect of 15-deoxy-Δ12,14-PGJ(2) (15d-PGJ(2); a nonenzymatic product of prostaglandin D(2)) on endothelial cells, in vitro cell culture and ex vivo choroid explants were employed and intravitreal injections were performed in animals. The authors herein demonstrate that deficient vascularity occurs not only in the retinal plexus but also in the choroid. This sustained, marked choroidal degeneration is specifically confined to central regions of the retina that present persistent photoreceptor loss and corresponding functional deficits. Moreover, the authors show that 15d-PGJ(2) is a prominent contributor to this choroidal decay.", "answer": "The authors demonstrate for the first time pronounced, sustained choroidal vascular involution during the development of ROP. Findings also suggest that effective therapeutic strategies to counter ROP should consider choroidal preservation.\n\nyes"}
{"question": "What visual function abnormalities are commonly observed in patients with geographic atrophy (GA) ?", "answer": "Patients with geographic atrophy (GA) often experience various visual function abnormalities. One common abnormality is reduced contrast sensitivity, particularly at low spatial frequencies, which becomes more pronounced at higher spatial frequencies. Another significant challenge is the presence of paracentral scotomas, which can dramatically decrease the reading rate despite relatively good visual acuity. In fact, studies have shown that a substantial number of GA patients have reading rates lower than 100 words per minute. This highlights the limitation of relying solely on visual acuity as a measure of a patient's reading ability. Furthermore, patients with small functional foveal islands in GA may need to strike a balance between using their central fixation and eccentric preferred retinal locus (PRL) to optimize their visual capacity. Although the small foveal region retains good acuity, it has a limited visual field extent. Additionally, even before the foveal center becomes atrophic, it may experience reduced retinal sensitivity, contrast sensitivity, and worsened function in dim lighting conditions. Conversely, an eccentric PRL positioned outside the area of GA may offer a larger functional retina area less affected by dim illumination and reduced contrast sensitivity. Patients may find themselves switching between foveal and eccentric fixation depending on the specific visual tasks, lighting conditions, and other factors they encounter. Prescribing low-vision magnification devices can be challenging due to the combination of variables that affect a patient's ability to perform visually related tasks. It is crucial to consider these variables when evaluating a patient's low-vision requirements. Adequate illumination is also essential for most visually related tasks. Finally, evaluating the driving ability of GA patients with compromised visual function poses a challenge. Although individuals with good acuity may pass the visual acuity test required for driver's license renewal, their driving ability may still be compromised due to the visual function abnormalities associated with GA. Ongoing research is being conducted to develop better methods for assessing the driving ability of GA patients. Remember, this response is based on general information about GA and its associated visual function abnormalities. For specific patient cases, it is important to consult appropriate ophthalmology resources and consider individual patient factors."}
{"question": "Discuss blood vessels and ocular circulation ?", "answer": "Blood vessels play a crucial role in ocular circulation, which is the circulation of blood within the eyes. The eyes are complex organs that require a constant supply of oxygen and nutrients to function properly, and the removal of waste products. This is achieved through a highly specialized network of blood vessels. The main blood vessels involved in ocular circulation are the central retinal artery and vein. The central retinal artery enters the eye through the optic nerve and supplies blood to the retina, which is the light-sensitive layer of the eye responsible for vision. The central retinal vein carries deoxygenated blood and waste products away from the retina. The retina is densely packed with blood vessels, especially in the macula region, which is responsible for central vision. These blood vessels provide oxygen and nutrients to the retinal cells, ensuring their proper functioning. Any disruption in the blood supply to the retina can lead to vision problems or even vision loss. The choroid, a layer of blood vessels located behind the retina, provides oxygen and nutrients to the outer layers of the retina. It also helps regulate the temperature and supply nutrients to other parts of the eye, such as the iris and ciliary body. The ciliary body, which is responsible for producing the aqueous humor that fills the front chamber of the eye, is also highly vascularized. Its blood vessels help regulate the production and drainage of aqueous humor, maintaining proper intraocular pressure. Furthermore, the arteries and veins in the eye are connected through a complex network of capillaries, which ensure the exchange of oxygen, nutrients, and waste products between the blood and the surrounding tissues. These capillaries are present in all layers of the eye, including the retina, choroid, and the tissues that make up the anterior segment of the eye. Overall, the blood vessels in the eye play a vital role in maintaining the health and proper functioning of ocular tissues. Any disturbances in ocular circulation can lead to various eye conditions, such as ret"}
{"question": "Discuss the surgical treatment of myopia ?", "answer": "Surgical treatment of myopia, also known as nearsightedness, aims to correct the refractive error of the eye in order to improve distance vision. There are several surgical options available to treat myopia, including: 1. LASIK (Laser-Assisted in Situ Keratomileusis): This is one of the most common and popular surgical procedures for myopia. During LASIK, a thin flap is created on the cornea using a laser or a microkeratome. The underlying corneal tissue is then reshaped using an excimer laser to correct the refractive error, and the flap is repositioned. LASIK is known for its quick recovery time and minimal discomfort. 2. PRK (Photorefractive Keratectomy): PRK is another laser-based procedure for myopia correction. It involves removing the surface layer of the cornea (epithelium) and then reshaping the cornea with an excimer laser. PRK does not involve creating a corneal flap like LASIK, making it a suitable option for individuals with thinner corneas or other corneal irregularities. However, the recovery period for PRK is longer compared to LASIK. 3. SMILE (Small Incision Lenticule Extraction): SMILE is a newer minimally invasive procedure for myopia correction. It involves creating a small incision in the cornea and using a femtosecond laser to create a thin lenticule within the cornea. The lenticule is then removed through the incision, effectively reshaping the cornea to correct the myopia. SMILE offers advantages such as a smaller incision and potentially faster recovery. 4. Implantable Collamer Lenses (ICL): ICL is a surgical procedure that involves implanting a thin, biocompatible lens inside the eye, between the iris and the natural lens. The ICL corrects the refractive error and provides a permanent"}
{"question": "Question: Are rodent Hyperglycemia-Induced Inner Retinal Deficits Mirrored in Human Diabetes?\nContext: To evaluate the utility of low luminance stimuli to functionally probe inner retinal rod pathways in the context of diabetes mellitus in both rat and human subjects. Inner retinal dysfunction was assessed using oscillatory potential (OP) delays in diabetic rats. Scotopic electroretinograms (ERGs) in response to a series of increasing flash luminances were recorded from streptozotocin (STZ)-treated and control Sprague-Dawley rats after 7, 14, 20, and 29 weeks of hyperglycemia. We then evaluated OP delays in human diabetic subjects with (DR) and without (DM) diabetic retinopathy using the International Society for Clinical Electrophysiology in Vision (ISCEV) standard scotopic protocol and two additional dim test flashes. Beginning 7 weeks after STZ, OP implicit times in diabetic rats were progressively delayed in response to dim, but not bright stimuli. In many diabetic subjects the standard ISCEV dim flash failed to illicit measureable OPs. However, OPs became measurable using a brighter, nonstandard dim flash (Test Flash 1, -1.43 log cd s/m", "answer": "Delays in scotopic OP implicit times are an early response to hyperglycemia in diabetic rats. A similar, inner retinal, rod-driven response was detected in diabetic human subjects without diabetic retinopathy, only when a nonstandard ISCEV flash intensity was employed during ERG testing.\n\nyes"}
{"question": "Question: Do effects of pars plana vitrectomy on retrobulbar haemodynamics in diabetic retinopathy?\nContext: The purpose of the present study was to determine the effects of pars plana vitrectomy on retrobulbar haemodynamics in patients with proliferative diabetic retinopathy (PDR). Colour Doppler imaging was used for measurement of blood flow velocities and resistive index of the ophthalmic artery (OA), posterior ciliary arteries (PCA) and central retinal artery (CRA) in 14 eyes of 14 patients with PDR before pars plana vitrectomy and at the 1 and 6 months after operation. The patients were also treated by laser photocoagulation before or during surgery. Twenty age- and sex-matched healthy subjects were used as control group. Mean peak systolic velocity and the end diastolic velocity of the CRA in the patients with PDR were lower and the mean resistive index was higher than in those of the control group (P < 0.05). The mean end diastolic velocity of OA in the patients was lower and the mean resistive index was higher than in the control group (P < 0.05). The peak systolic velocity of the OA and the end diastolic velocity of the CRA were significantly increased (P = 0.043 and P = 0.018, respectively) and the mean resistive index of the CRA was significantly decreased after pars plana vitrectomy (P = 0.043). No significant changes were detected among preoperative and postoperative values of peak systolic velocity, end diastolic velocity, and resistive index of the PCA and the mean velocity of the central retinal vein (P > 0.05).", "answer": "The blood flow velocities of OA and CRA are decreased but the resistive index is increased significantly in patients with PDR. Pars plana vitrectomy in patients with PDR may decrease resistive index and improve blood flow in the CRA.\n\nyes"}
{"question": "Inferential specialized clinical ophthalmology procedural question: What are the different treatment options available for retinal vein occlusions (RVO) ?", "answer": "There are several treatment options available for retinal vein occlusions (RVO). These include laser therapy, peripheral scatter laser photocoagulation, laser-induced chorioretinal anastomosis, and surgical methods. 1. Laser therapy: Grid laser treatment using an argon laser has been shown to be more effective when combined with intravitreal injections of triamcinolone acetonide (TA). However, its effectiveness is not guaranteed, especially in cases of RVO older than 1 year and in eyes with a visual acuity (VA) of 20/200 or worse. 2. Peripheral scatter laser photocoagulation: This treatment significantly reduces the risk of retinal neovascularization and vitreous hemorrhage in the ischemic (non-perfusion) areas. It has been found effective in eyes with non-perfusion areas as well as those with neovascularization. Early treatment before neovascularization develops yields better results. However, scatter laser coagulation can cause visual field defects, so it may be recommended to wait until the first signs of neovascularization are clinically visible. 3. Laser-induced chorioretinal anastomosis: This method involves creating a connection between a retinal vein and the choroid using a neodymium yttrium-aluminum garnet (Nd:YAG) laser spot. It can be performed either as an intense argon laser treatment followed by Nd:YAG laser spot or during vitrectomy using an erbium:YAG laser. Success rates of up to 54% have been reported, but there is also a 20% complication rate associated with this procedure. 4. Surgical methods: One surgical approach is arteriovenous dissection, also known as sheathotomy. This procedure aims to dissect the retinal artery from the adjacent vein in the area surrounding the vascular occlusion. Positive effects on visual acuity have been observed in studies using sheathotomy, but its effectiveness when performed alone remains unclear. Another surgical option is vitrectomy, which involves removing the vitreous and detaching the posterior hyaloid. Some studies suggest that vitrectomy alone, or combined with other treatments, may have a positive effect on visual acuity. It is important to note that these treatment options should be considered based"}
{"question": "Question: Treatment of advanced proliferative diabetic retinopathy with extensive vitreoretinal fibrosis andtractional retinal detachment involves all of the following except -\nOptions:\nA. Reattachment of detached or tom retina\nB. Removal of epiretinal membrane\nC. Vitrectomy\nD. Exophotocoagulation\n", "answer": " Surgical treatment : Advanced PDR with dense Vitreous haemorrhage. PPV (Pars Plana Vitrectomy) along with removal of opaque vitreous gel and endophotocoagulation should be done at an early stage. Advanced PDR with extensive fibrovascular epiretinal membrane should be treated by PPV along with removal of fibrovascular epiretinal membrane and endophotocoagulation. Advanced PDR with tractional retinal detachment should be treated by PPV with endophotocoagulation and reattachment of detached retina along with other methods like scleral buckling and internal tamponade usong intravitreal silicone oil or gases like sulphur hexafluoride or perfluoropropane. Ref;A.K.Khurana; 6th edition; Page no: 282\n\nOPTION D IS CORRECT."}
{"question": "Question: A 62-year-old woman comes to the physician for decreased vision and worsening headaches since this morning. She has hypertension and hypercholesterolemia. Pulse is 119/min and irregular. Current medications include ramipril and atorvastatin. Ocular and funduscopic examination shows no abnormalities. The findings of visual field testing are shown. Which of the following is the most likely cause of this patient's symptoms?\nOptions:\nA. Degeneration of the macula\nB. Impaired perfusion of the retina\nC. Occlusion of the posterior cerebral artery\nD. Occlusion of anterior cerebral artery\n\"\n", "answer": "OPTION C IS CORRECT."}
{"question": "Discuss various refractive procedures ?", "answer": "Refractive procedures are surgical techniques that correct vision problems by changing the way light enters the eye. They are commonly used to treat nearsightedness (myopia), farsightedness (hyperopia), and astigmatism. There are several different types of refractive procedures available, each with its own advantages and considerations. Here are a few of the most common: 1. LASIK (Laser-Assisted in Situ Keratomileusis): LASIK is the most popular refractive procedure worldwide. In this procedure, a thin flap is created on the cornea using a laser or a microkeratome. The underlying corneal tissue is then reshaped with another laser to correct the refractive error. The flap is then put back in place to heal. LASIK offers quick recovery time and minimal discomfort. 2. PRK (Photorefractive Keratectomy): Similar to LASIK, PRK also reshapes the cornea to correct vision problems. However, instead of creating a corneal flap, the outer layer of the cornea (epithelium) is completely removed before the cornea is reshaped. This procedure is often recommended for patients with thin corneas or those who are not suitable candidates for LASIK. PRK has a longer recovery time compared to LASIK, as the epithelium takes time to regenerate. 3. SMILE (Small Incision Lenticule Extraction): SMILE is a newer refractive procedure that involves creating a small incision in the cornea to access and remove a small piece of tissue (lenticule). This reshapes the cornea to correct the refractive error. SMILE is minimally invasive, with a smaller incision size compared to LASIK, and may be preferred for patients with certain corneal conditions. 4. Phakic Intraocular Lenses (IOLs): Phakic IOLs are implanted inside the eye, in addition to the"}
{"question": "Question: Does torsional anomalous retinal correspondence effectively expand the visual field in hemianopia?\nContext: Exotropia in congenital homonymous hemianopia has been reported to provide field expansion that is more useful when accompanied with harmonious anomalous retinal correspondence (HARC). Torsional strabismus with HARC provides a similar functional advantage. In a subject with hemianopia demonstrating a field expansion consistent with torsion, we documented torsional strabismus and torsional HARC. Monocular visual fields under binocular fixation conditions were plotted using a custom dichoptic visual field perimeter. The dichoptic visual field was also modified to measure perceived visual directions under dissociated and associated conditions across the central 50° diameter field. The field expansion and retinal correspondence of a subject with torsional strabismus (along with exotropia and right hypertropia) with congenital homonymous hemianopia was compared with that of another exotropic subject with acquired homonymous hemianopia without torsion and to a control subject with minimal phoria. Torsional rotations of the eyes were calculated from fundus photographs and perimetry. Torsional anomalous retinal correspondence documented in the subject with congenital homonymous hemianopia provided a functional binocular field expansion up to 18°. Normal retinal correspondence was mapped for the full 50° visual field in the control subject and for the seeing field of the acquired homonymous hemianopia subject, limiting the functional field expansion benefit.", "answer": "Torsional strabismus with anomalous retinal correspondence, when occurring with homonymous hemianopia provides useful field expansion in the lower and upper fields. Dichoptic perimetry permits documentation of ocular alignment (lateral, vertical, and torsional) and perceived visual direction under binocular and monocular viewing conditions. Evaluating patients with congenital or early strabismus for HARC is useful when considering surgical correction, particularly in the presence of congenital homonymous hemianopia.\n\nyes"}
{"question": "Question: Does endoglin promote angiogenesis in cell- and animal-based models of retinal neovascularization?\nContext: We investigated endoglin expression in hypoxic microvascular endothelial cells and retinal endoglin expression in rats that develop experimental oxygen-induced retinopathy (OIR). We also tested neutralizing antibodies (Abs) against endoglin (anti-CD105 Ab) and VEGF (anti-VEGF Ab) either alone or in combination for efficacy against serum-induced retinal microvascular endothelial cell proliferation and retinal neovascularization (NV) in OIR rats. To our knowledge, this marks the first time that a biologic agent has been used to target retinal endoglin and modulate retinal neovascularization. Induction of endoglin by hypoxia was measured by immunohistochemical analysis and ELISA. Proliferation was quantified using a colorimetric 5-bromo-2-deoxyuridine ELISA. Western blots were used to measure endoglin levels in retinas of OIR rats. Immunohistochemical staining was also preformed in OIR rats using anti-CD105 and fluorescein isothiocyanate-conjugated isolectin B4 antibodies. Anti-CD105 Ab and Anti-VEGF Ab, administered alone or in combination, reduced serum-induced retinal microvascular endothelial cell proliferation. Additionally, in a rat model of oxygen-induced retinopathy, retinal endoglin was significantly increased at 14(2), 14(3), 14(4) and 14(6) compared with retinal levels in control rats. At 14(2), immunohistochemical analysis demonstrated that endoglin was elevated in newly developed vessels at the peripheral extent of major veins, precisely where NV is expected to develop in OIR rats. Neutralizing anti-CD105 reduced retinal NV in OIR rats.", "answer": "Our data support other studies showing that reduction of endoglin expression inhibits retinal NV. Our findings demonstrate that retinal endoglin immunolocalization overlaps with nascent neovascular structures in OIR rats. Therefore, endoglin may serve as a useful predictor of incipient neovascular disease.\n\nyes"}
{"question": "Question: Does postnatal growth retardation exacerbate acidosis-induced retinopathy in the neonatal rat?\nContext: We have previously described a metabolic acidosis-induced retinopathy in the neonatal rat, similar to retinopathy of prematurity (ROP). We also have reported exacerbation of oxygen-induced retinopathy by postnatal growth retardation, produced by raising newborn rats in 'expanded' litters. In the present study, we investigated the effect of postnatal growth retardation on the incidence and severity of acidosis-induced retinopathy. 100 newborn Sprague-Dawley rats were randomly assigned to two expanded litters of 25 pups each and five standard control litters of 10 pups each. All rats were gavaged with 10 mM/kg NH(4)Cl twice daily from days two to seven. Following five days of recovery, retinal vasculature was assessed using ADPase staining, light microscopy, and computer-assisted image analysis. The presence of neovascularization (NV), severity of NV (clock hours), and vascularized retinal areas, were evaluated in a masked manner. NV occurred in 52% of rats in expanded litters versus 18% of rats in standard control litters (p = 0.005). Postnatal growth retardation of pups in expanded litters was confirmed by comparing total body weight of pups raised in expanded and standard control litters (10.8g vs 13.4g on day 8, p < 0.001; 20.8g vs 25.2g on day 13, p = 0.002).", "answer": "Postnatal growth retardation increases the incidence of acidosis-induced retinopathy in the neonatal rat. Our study provides further evidence that postnatal growth retardation is a risk factor for preretinal neovascularization in immature retinae and is consistent with the clinical observation that the smallest and sickest premature infants are more likely to suffer from ROP.\n\nyes"}
{"question": "What is the association between drusen deposition and choroidal intercapillary pillars in the aging human eye ?", "answer": "Drusen deposition and choroidal intercapillary pillars in the aging human eye have been found to be associated. A study by Lengyel et al. (2004) investigated this association and found that drusen, which are yellowish deposits that accumulate in the retina, are correlated with the presence of choroidal intercapillary pillars. Choroidal intercapillary pillars are thin blood vessels that support the choriocapillaris, the layer of blood vessels in the choroid. The study observed that as drusen deposition increased, the density of choroidal intercapillary pillars decreased. This association suggests that changes in the choriocapillaris and choroidal blood flow may contribute to the formation and progression of drusen in age-related macular degeneration (AMD), a common eye condition in the elderly. Further research is needed to fully understand the underlying mechanisms and clinical implications of this association. Please note that for more detailed and specific information, it is recommended to consult the original study by Lengyel et al. (2004) and other relevant ophthalmology resources."}
{"question": "What is the definition of local primary treatment in the management of intraocular retinoblastoma ?", "answer": "Local primary treatment in the management of intraocular retinoblastoma refers to the initial therapy employed as the sole treatment for very small tumors (Group A). It involves the use of techniques such as direct laser photocoagulation or cryotherapy for small intraretinal lesions away from critical structures. Local primary treatment is typically considered for lesions in all parts of the fundus and is often used as a consolidation treatment following systemic chemotherapy."}
{"question": "How is pigment dispersion syndrome characterized and what are its associations ?", "answer": "Pigment dispersion syndrome is characterized by dispersed pigment in the anterior chamber, which occurs due to the disruption of the iris pigment epithelium caused by friction with lens zonules during physiological changes in pupil size. This condition is associated with glaucoma, lattice degeneration, and retinal detachment. Abnormal function of the retinal pigment epithelium is suspected in this syndrome. Studies have shown reduced EOG light-peak to dark-trough amplitude ratios in patients with pigment dispersion syndrome compared to those with chronic open-angle glaucoma and normal subjects. Additionally, significantly reduced EOG amplitude ratios have been observed in patients with pigment dispersion syndrome and pigmentary glaucoma, indicating a potential diagnostic value for EOG in this condition."}
{"question": "What are the clinical manifestations and treatment options for cytomegalovirus (CMV) retinitis in patients with AIDS ?", "answer": "In patients with AIDS, CMV retinitis is the most common ocular infection and accounts for approximately 90% of cases of infective retinitis. The clinical appearance of CMV retinitis involves coalescent areas of whitish retinal necrosis, particularly around the vascular arcades, often accompanied by hemorrhage at their borders. These lesions may resemble cotton-wool spots, but they can be differentiated by their persistence and lack of progression over several weeks. To preserve vision and prolong life by reducing systemic CMV infection, prompt treatment is crucial. Ganciclovir sodium and foscarnet sodium are effective in the initial treatment of CMV retinitis when administered intravenously. However, long-term maintenance therapy is necessary to delay recurrent disease. Foscarnet has shown improved survival compared to ganciclovir in the presence of good renal function, while ganciclovir is preferred when renal function is impaired. In order to minimize systemic drug toxicity, intraocular drug delivery methods are employed. This can be achieved through regular intravitreal injections or by surgically implanting sustained-release devices. These approaches help deliver the medication directly to the affected area while reducing systemic exposure. It is essential to note that viral resistance to ganciclovir and foscarnet has been reported in some regions, reaching as high as 11%. Therefore, regular monitoring for treatment efficacy and possible resistance is necessary. After approximately one year, up to 50% of patients with CMV retinitis may develop retinal detachments, which often affect both eyes. These detachments are challenging to treat and may require surgical interventions such as vitrectomy and the use of silicone oil or gas tamponade. However, the complications associated with these procedures become increasingly significant as the survival of patients with CMV retinitis improves. While the provided response is accurate and evidence-based, it is always advisable to consult additional ophthalmology resources for a comprehensive understanding and updated information on CMV retinitis and its management."}
{"question": "How can retinal dysfunction be detected in patients with Best macular dystrophy ?", "answer": "The detection of retinal dysfunction in patients with Best macular dystrophy can be achieved through various techniques. One method is the use of electro-oculography (EOG), which measures the electrical potentials generated by the retinal pigment epithelium (RPE), providing information about RPE function. Additionally, electrophysiological studies such as electroretinography (ERG) can be performed to assess the response of the retina to light stimulation. Multifocal electroretinography (mfERG) can also be used to map retinal function in Best macular dystrophy. These techniques help in the evaluation and diagnosis of retinal dysfunction associated with Best macular dystrophy."}
{"question": "What are the components of choroidal neovascularization (CNV) and how do they contribute to the visual prognosis ?", "answer": "Choroidal neovascularization (CNV) consists of two main components: the vascular component and the nonvascular component. The vascular component is primarily composed of vascular endothelial cells and associated pericytes. These cells form the neovessels that invade the subretinal space. On the other hand, the nonvascular component is made up of various cell types, including inflammatory cells, glial cells, myofibroblasts, and fibrocytes. Both components play a crucial role in the development and progression of CNV. While the neovessel bleeding or leakage is responsible for the majority of damage associated with CNV, the nonvascular components also significantly influence the visual prognosis. Inhibiting either the vascular or nonvascular component of CNV can potentially slow down or arrest the progression of the disease. The interaction between these two components suggests that inhibiting one may partially inhibit the other. However, the most promising outcome is achieved by inhibiting both components simultaneously. Anti-VEGF agents are the primary treatment for blocking the vascular component of CNV. However, in advanced cases where mature neovessels are covered by pericytes, anti-VEGF agents alone may not lead to regression of these neovessels. Combination therapies that target the nonvascular component are necessary in such cases. These therapies can act selectively, such as by blocking platelet-derived growth factor (PDGF) to target the pericytes, or through non-selective mechanisms like ionizing radiation. Understanding the components of CNV and their contributions to the disease process is essential for developing effective treatment strategies that aim to inhibit both the vascular and nonvascular components, ultimately improving the visual prognosis for patients with CNV."}
{"question": "What are the potential side effects of radiation therapy in the treatment of retinoblastoma ?", "answer": "Radiation therapy, while highly effective in treating retinoblastoma, can have potential side effects that need to be considered. These side effects include ophthalmic complications such as retinal detachment, vitreous hemorrhage, cataract formation, and glaucoma. Somatic complications like orbital hypoplasia can also occur. Additionally, there is a risk of developing a second malignant neoplasm, which is the most concerning side effect. Studies have shown that the cumulative incidence of second malignant neoplasms in patients with retinoblastoma can range from 3.7% at 10 years to 51% over a 50-year period. It is important to carefully weigh the benefits of radiation therapy against these potential side effects, especially considering the young age and genetic susceptibility of the patients."}
{"question": "What are the potential complications of prolonged and excessive screen time on visual health ?", "answer": "Prolonged and excessive screen time can have several adverse effects on visual health. Firstly, it can lead to digital eye strain, also known as computer vision syndrome. Symptoms may include dryness, redness, irritation, and blurred vision. Secondly, increased screen time can contribute to the development or progression of myopia (nearsightedness), particularly in children and young adults. Thirdly, the blue light emitted by screens can disrupt sleep-wake cycles and potentially cause retinal damage in the long term. Additionally, excessive screen use may result in decreased blink rate, leading to dry eye symptoms. To minimize these risks, it is advisable to take regular breaks, practice the 20-20-20 rule (looking at something 20 feet away for 20 seconds every 20 minutes), maintain proper lighting and ergonomics, and consider using blue light filters or glasses if necessary. If symptoms persist or worsen, it is recommended to consult an ophthalmologist for further evaluation and management."}
{"question": "What is serpiginous choroiditis ?", "answer": "Serpiginous choroiditis is a condition characterized by inflammation and scarring of the choroid, which is the layer of blood vessels that nourishes the retina. It typically presents with a distinctive pattern of progressive and recurrent inflammation that spreads in a serpentine or snake-like manner. This condition can lead to various complications, such as subretinal neovascular membranes, optic disc neovascularization, cystoid macular edema, and disc leaks. Treatment options may include transpupillary thermotherapy and other interventions aimed at managing the associated complications and improving visual outcomes."}
{"question": "Is there evidence to support the role of lutein and zeaxanthin in the prevention or treatment of age-related macular degeneration (AMD) ?", "answer": "Several studies have investigated the relationship between lutein and zeaxanthin levels and the risk of developing AMD. The POLA Study found that higher plasma levels of lutein and zeaxanthin were associated with a reduced risk of AMD. Similarly, the Carotenoids in Age-related Eye Disease Study (CAREDS) showed an association between higher intake of lutein and zeaxanthin and a lower prevalence of intermediate AMD. In a prospective study, Cho et al. found that higher dietary intake of fruits, vegetables, and carotenoids, including lutein and zeaxanthin, was associated with a reduced risk of AMD. Additionally, the Veterans LAST study demonstrated that lutein and antioxidant supplementation may slow the progression of atrophic AMD. Clinical trials have also investigated the effects of lutein and zeaxanthin on AMD. A randomized controlled trial by Bartlett and Eperjesi reported improvements in contrast sensitivity in AMD patients following lutein and antioxidant supplementation. However, it is important to note that the overall evidence for the efficacy of lutein and zeaxanthin in preventing or treating AMD is not yet definitive. In summary, while there is evidence suggesting a potential protective role of lutein and zeaxanthin in AMD, further research is needed to establish their effectiveness as preventive or therapeutic interventions. Ophthalmologists should consider recommending a diet rich in fruits and vegetables, including those high in lutein and zeaxanthin, as part of general eye health recommendations for patients at risk of AMD. For more precise information, referring to ophthalmology literature and resources would be advisable."}
{"question": "Question: Does fullerenol protect retinal pigment epithelial cells from oxidative stress-induced premature senescence via activating SIRT1?\nContext: Oxidative stress-induced retinal pigment epithelium (RPE) senescence is one of the important factors in the pathogenesis of age-related macular degeneration (AMD). This study aimed to develop a new antisenescence-based intervention and clarify its possible molecular mechanism. A cell premature senescence model was established in both primary RPE cells and ARPE-19 cells by exposure of the cells to pulsed H₂O₂ stress for 5 days, and confirmed with senescence-associated β-galactosidase (SA-β-gal) staining. The final concentration of fullerenol (Fol) in the cell culture system was 5 μg/mL. Cellular redox status was determined by the examination of cellular reactive oxygen species (ROS) staining, catalase activity, and the ratio of reduced to oxidized glutathione, respectively. Deoxyribonucleic acid double-strand breaks were determined by quantitative analysis of γH₂AX. Cell cycle analysis was performed with flow cytometry. SIRT1 activity was examined with SIRT1 Assay Kit. SIRT1 overexpression and knockdown in ARPE-19 cells were performed with lentiviral-mediated infection. Pulsed H₂O₂ exposure triggered the acetylation of p53 at lysine 382 (K382) and subsequent increase in its target p21(Waf1/Cip1). It also increased the number of accumulated phospho-γH2AX foci and the level of phosphor-ATM in RPE cells. Fullerenol protected the RPE cells, as it reduced the number of positive SA-β-gal-staining cells, alleviated the depletion of cellular antioxidants, and reduced genomic DNA damage. Its mechanism might involve the activation of deacetylase SIRT1, resulting in decreased levels of acetyl-p53 and p21(Waf1/Cip1). The roles of SIRT1 in protecting cells in response to Fol were further confirmed by applications of SIRT1 activator (resveratrol) and inhibitors (nicotinamide and sirtinol), and through SIRT1 overexpression and knockdown.", "answer": "Fullerenol could rescue RPE cells from oxidative stress-induced senescence through its antioxidation activity and the activation of SIRT1. The protective effect of Fol is useful for the development of new strategies to treat oxidative stress-related retinal diseases like AMD.\n\nyes"}
{"question": "What are the ocular manifestations of acute lymphoblastic leukemia ?", "answer": "Ocular manifestations of acute lymphoblastic leukemia (ALL) include an acute red and painful eye due to glaucoma. Additionally, retinal hemorrhages and infiltrates may be observed in patients with ALL."}
{"question": "Question: Is an rs9621532 variant near the TIMP3 gene associated with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in a Chinese Han population?\nContext: Recently, two genome-wide association studies with large cohorts both identified rs9621532, a new single nucleotide polymorphism (SNP) that is associated with advanced age-related macular degeneration (AMD) and located near the TIMP3 gene. Previous studies have demonstrated that AMD and polypoidal choroidal vasculopathy (PCV) share some common genetic background and that the incidence of PCV is higher in Asian populations than Caucasian populations. In this study, we aimed to investigate whether the rs9621532 SNP is associated with neovascular AMD (nAMD) and PCV in a Chinese Han population. We performed a case-control study in a Chinese Han population. The rs9621532 SNP was genotyped in 136 patients with nAMD, 195 patients with PCV, and 181 control individuals using the Multiplex SNaPshot system and the direct DNA sequencing technique. Rs9621532 genotypes and allele frequencies in the nAMD, PCV and control groups were evaluated using PLINK software. In the nAMD, PCV, and control groups, the minor allele frequencies of the rs9621532 variant were 0.05147, 0.02564, and 0.03039, respectively. The rs9621532 SNP was not significantly associated with susceptibility to nAMD (p = 0.1773) or PCV (p = 0.6933). None of the p-values for the additive or dominant models were found to be statistically significant in the nAMD or PCV groups. No recessive homozygotes were genotyped in any of the three groups.", "answer": "No evidence was found to support an association between the rs9621532 variant and susceptibility to either nAMD or PCV in a Chinese Han population.\n\nno"}
{"question": "Question: Is longer axial length protective of diabetic retinopathy and macular edema?\nContext: To assess the association of ocular biometric parameters and refractive error with diabetic retinopathy (DR) and diabetic macular edema (DME) in persons with diabetes. Cross-sectional, clinic-based study. Patients with diabetes aged 18 years or more from the Royal Victorian Eye and Ear Hospital, Victoria, Australia. Spherical equivalent (SE) refraction was assessed using objective autorefraction. Axial length (AL), corneal curvature (CC), and anterior chamber depth (ACD) were measured using the IOLMaster (Carl Zeiss Meditech AG, Jena, Germany). Diabetic retinopathy was graded from 2-field retinal photographs using the modified Airlie House classification system. Diabetic macular edema was defined as absent or present from fundus photographs and confirmed by optical coherence tomography (Stratus, Carl Zeiss Meditech AG). Severity of DR was grouped as no DR, mild DR (Early Treatment of Diabetic Retinopathy Study [ETDRS] = 20), moderate DR (ETDRS = 31-43), and severe DR (ETDRS >43). Diabetic macular edema severity was classified as mild, moderate, or severe. A total of 208 of 630 eyes (33.0%) had DR. In multivariate models, eyes with longer AL were less likely to have mild (odds ratio [OR], 0.58; 95% confidence interval [CI], 0.41-0.83; P = 0.006 per mm increase), moderate (OR, 0.73; 95% CI, 0.60-0.88; P = 0.002), and severe DR (OR, 0.67; 95% CI, 0.53-0.85; P=0.01), and had a lesser risk of mild (OR, 0.70; 95% CI, 0.56-0.86; P < 0.001) and moderate DME (OR, 0.72; 95% CI, 0.56-0.93; P=0.002) but not severe DME. No association was found for SE, ACD, and CC with DR.", "answer": "In persons with diabetes, eyes with longer ALs are less likely to have DR and DME.\n\nyes"}
{"question": "How is the correction of myopic astigmatism performed using the Artisan toric phakic intraocular lens ?", "answer": "The correction of myopic astigmatism using the Artisan toric phakic intraocular lens involves a step-by-step procedure. First, the patient's eye is prepared for surgery, typically with the use of topical anesthesia. A clear corneal incision is made to gain access to the anterior chamber of the eye. Next, careful attention is given to the incisional induced astigmatism and axial positional accuracy. This ensures accurate alignment of the toric lens with the astigmatic meridian of the cornea. The toric phakic intraocular lens is designed to correct both the myopia and astigmatism simultaneously. The Artisan toric phakic intraocular lens is then implanted into the eye, specifically in the posterior chamber, either in front of or behind the iris. The lens is carefully positioned to correct the myopic astigmatism based on preoperative measurements. Following the implantation, the incision is closed, and the eye is closely monitored postoperatively for any complications or adverse effects. Regular follow-up visits are necessary to assess the visual outcome, stability of correction, and overall satisfaction of the patient. It is important to note that the Artisan toric phakic intraocular lens has shown promising results in correcting myopic astigmatism, but individual patient characteristics and factors may influence the overall success of the procedure. Therefore, thorough preoperative evaluations and discussions with the patient are crucial to determine the suitability and potential benefits of this treatment modality."}
{"question": "What is the recommended treatment approach for uncontrolled neovascular glaucoma in patients with proliferative diabetic retinopathy ?", "answer": "The recommended treatment approach for uncontrolled neovascular glaucoma in patients with proliferative diabetic retinopathy involves the use of pars plana vitrectomy, endolaser coagulation of the retina and ciliary body, and silicone oil endotamponade. This combination of surgical procedures has been shown to effectively treat this condition."}
{"question": "Question: Is qLT091001 , a 9-cis-retinal analog , well-tolerated by retinas of mice with impaired visual cycles?\nContext: Investigate whether retinas of mice with impaired retinal cycles exposed to light or kept in the dark tolerate prolonged high-dose administration of QLT091001, which contains as an active ingredient, the 9-cis-retinal precursor, 9-cis-retinyl acetate. Four- to six-week-old Lrat(-/-) and Rpe65(-/-) mice (n = 126) as well as crossbred Gnat1(-/-) mice lacking rod phototransduction (n = 110) were gavaged weekly for 6 months with 50 mg/kg QLT091001, either after being kept in the dark or after light bleaching for 30 min/wk followed by maintenance in a 12-hour light ≤ 10 lux)/12-hour dark cycle. Retinal health was monitored by spectral-domain optical coherent tomography (SD-OCT) and scanning laser ophthalmoscopy (SLO) every other month and histological, biochemical, and visual functional analyses were performed at the end of the experiment. Two-photon microscopy (TPM) was used to observe retinoid-containing retinosome structures in the RPE. Retinal thickness and morphology examined by SD-OCT were well maintained in all strains treated with QLT091001. No significant increases of fundus autofluorescence were detected by SLO imaging of any strain. Accumulation of all-trans-retinyl esters varied with genetic background, types of administered compounds and lighting conditions but retinal health was not compromised. TPM imaging clearly revealed maintenance of retinosomes in the RPE of all mouse strains tested.", "answer": "Retinas of Lrat(-/-), Rpe65(-/-), and crossbred Gnat1(-/-) mice tolerated prolonged high-dose QLT091001 treatment well.\n\nyes"}
{"question": "Question: Does higher age at onset of type 1 diabetes increase risk of macular oedema?\nContext: To investigate whether age at onset of type 1 diabetes is a risk factor for clinically significant macular oedema (CSME). A sample of 1354 patients with a mean duration of diabetes 24.6 ± 11.6 years was drawn from the FinnDiane Study population and divided into age at onset groups 0-4 (n = 184), 5-14 (n = 662) and 15-40 years (n = 508). Type 1 diabetes was defined as age at onset ≤40 years, C-peptide negativity and insulin treatment initiated within 1 year of diagnosis. Retinopathy status was assessed from fundus photographs and stereoscopic fundus examinations and graded with the ETDRS scale. After 30 years of diabetes, the estimated cumulative incidences of CSME were 17% (95% CI 11-26) in age at onset group 0-4 years, 27% (95% CI 23-32) in age at onset group 5-14 years and 34% (95% CI 27-41) in age at onset group 15-40 years (p = 0.002, Gray's test). In a competing risks regression model, adjusted for covariates selected with Bayesian information criteria, age at onset 5-14 years (HR 1.89 [95% CI 1.22-2.91], p = 0.004), and age at onset 15-40 years (HR 3.72 [95% CI 2.35-5.89], p < 0.0001), were significant overall risk factors for CSME (p < 0.0001). Higher ETDRS score (HR 1.04 ([95% CI 1.03-1.05], p < 0.0001), HbA1c (HR 1.12 [95% CI 1.02-1.23], p = 0.016), and total cholesterol (HR 1.19 [95% CI 1.04-1.37], p = 0.013) also increased the risk of CSME.", "answer": "Higher age at onset of type 1 diabetes is a significant risk factor for macular oedema. This suggests that ageing may modify the risk of retinopathy in type 1 diabetes.\n\nyes"}
{"question": "Discuss color vision ?", "answer": "Color vision is the ability of an organism to perceive and distinguish different colors. It is an important aspect of human vision as it allows us to appreciate the rich and varied world of colors around us. The process of color vision involves several key components, including the eye, the brain, and specialized cells called cones. Our eyes contain three types of cones that are responsible for detecting different wavelengths of light: short-wavelength cones (S-cones) perceive blue light, medium-wavelength cones (M-cones) perceive green light, and long-wavelength cones (L-cones) perceive red light. These cones are concentrated in a small area called the fovea, which is responsible for our central vision and high-resolution color perception. When light enters the eye, it passes through the cornea and lens, which help to focus the light onto the retina. The retina contains the cones, as well as rods that are responsible for detecting light intensity and aiding in low-light vision. As the light stimulates the cones, they produce electrical signals that are transmitted to the brain via the optic nerve. In the brain, the information from the cones is processed and interpreted, allowing us to perceive and differentiate between different colors. This complex process involves various neural pathways and areas of the brain, such as the primary visual cortex and the visual association areas. Color vision is influenced by several factors, including genetics and individual variations in the number and distribution of cones. Some individuals have color vision deficiencies or color blindness, which can result from a genetic mutation or a lack of certain types of cones. The most common type of color vision deficiency is red-green color blindness, where individuals have difficulty distinguishing between shades of red and green. In conclusion, color vision is a remarkable ability that allows us to experience and appreciate the vibrant world of colors. It involves the interaction of the eyes, cones, and brain, and plays a crucial role in how we perceive and understand our surroundings."}
{"question": "Question: Floaters can be seen in following except –\nOptions:\nA. Vitreous haemorrhage\nB. Retinal detachment\nC. Uveitis\nD. Ac. congestive Glaucoma\n", "answer": " Causes of floaters are:- Posterior vitreous detachment (PVD), retinal detachment, high myopia, bleeding (vitreous hemorrhage) or inflammation of eye (uveitis).\n\nOPTION D IS CORRECT."}
{"question": "Specialized clinical ophthalmology question: What are the potential causes of reduced visual acuity in patients with retinal detachment ?", "answer": "Reduced visual acuity in patients with retinal detachment can be attributed to various factors. The primary cause is the separation of the sensory retina from the underlying retinal pigment epithelium (RPE) and choroid, leading to mechanical disruption of the photoreceptor cells and impaired signal transmission. The detachment of the neurosensory retina results in the loss of direct oxygen and nutrient supply from the choroidal blood vessels, contributing to retinal ischemia. Other factors that may contribute to reduced visual acuity in patients with retinal detachment include: 1. Macular involvement: If the macula, which is responsible for central vision, is affected by the detachment, visual acuity can be significantly impaired. The macula is responsible for detailed vision and is crucial for tasks such as reading and recognizing faces. 2. Retinal edema: Accumulation of fluid within the detached retina can lead to retinal edema, causing distortion and blurring of vision. 3. Proliferative vitreoretinopathy (PVR): PVR is a complication that occurs in some cases of retinal detachment. It involves the formation of scar tissue on the inner surface of the retina, which can further pull and distort the retina, worsening visual acuity. 4. Duration of detachment: The duration of retinal detachment plays a role in visual prognosis. Prolonged detachment without prompt surgical intervention can lead to irreversible damage to the photoreceptor cells and retinal layers, resulting in poorer visual outcomes. 5. Associated macular holes or tears: In some cases, retinal detachment may be accompanied by macular holes or tears, which can further compromise visual acuity. It is important to note that the treatment of retinal detachment aims to reattach the retina as soon as possible to improve visual outcomes. Early diagnosis and prompt surgical intervention are crucial in optimizing visual acuity and preventing long-term visual impairment."}
{"question": "Question: Haemorrhage at macular spot in high myopia is called\nOptions:\nA. Lacquer's lines\nB. Dalen-Fuchs nodules\nC. Foster-Fuchs flecks\nD. Berlin's oedema\n", "answer": " MYOPIA Pathological myopia Fundus examination reveals following characteristic signs : (a) Optic disc appears large and pale and at its temporal edge a characteristic myopic crescent is present. Sometimes peripapillary crescent encircling the disc may be present, where the choroid and retina is distracted away from the disc margin. A superaction crescent (where the retina is pulled over the disc margin) may be present on the nasal side. (b) Degenerative changes in retina and choroid are common in progressive myopia. These are characterised by white atrophic patches at the macula with a little heaping up of pigment around them. Foster-Fuchs&; spot (dark red circular patch due to sub-retinal neovascularization and choroidal haemorrhage) may be present at the macula. Cystoid degeneration may be seen at the periphery. In an advanced case there occurs total retinal atrophy, paicularly in the central area. Image : This highly myopic eye (choroidal atrophie of the posterior pole) has developed subretinal neovascularization which led to repeated hemorrhages and scar tissue formation. Visible are subretinal hemorrhages and subretinal scar tissue Reference :- A K KHURANA; page:-34\n\nOPTION C IS CORRECT."}
{"question": "How does the accumulation of lipofuscin in RPE cells affect their phagocytic capacity ?", "answer": "The accumulation of lipofuscin in retinal pigment epithelium (RPE) cells has been shown to greatly reduce their phagocytic capacity. Lipofuscin is a yellow-brown pigment that accumulates in the RPE as a result of the incomplete digestion of photoreceptor outer segments. In vitro studies have demonstrated that the presence of lipofuscin in RPE cells impairs their ability to effectively phagocytose cellular debris and outer segment fragments. This reduced phagocytic capacity may have important implications in the pathogenesis of age-related macular degeneration (AMD), as it may contribute to the accumulation of lipofuscin and associated toxic effects on RPE cells."}
{"question": "Question: Are hIF-1alpha and HIF-2alpha differentially activated in distinct cell populations in retinal ischaemia?\nContext: Hypoxia plays a key role in ischaemic and neovascular disorders of the retina. Cellular responses to oxygen are mediated by hypoxia-inducible transcription factors (HIFs) that are stabilised in hypoxia and induce the expression of a diverse range of genes. The purpose of this study was to define the cellular specificities of HIF-1alpha and HIF-2alpha in retinal ischaemia, and to determine their correlation with the pattern of retinal hypoxia and the expression profiles of induced molecular mediators. We investigated the tissue distribution of retinal hypoxia during oxygen-induced retinopathy (OIR) in mice using the bio-reductive drug pimonidazole. We measured the levels of HIF-1alpha and HIF-2alpha proteins by Western blotting and determined their cellular distribution by immunohistochemistry during the development of OIR. We measured the temporal expression profiles of two downstream mediators, vascular endothelial growth factor (VEGF) and erythropoietin (Epo) by ELISA. Pimonidazole labelling was evident specifically in the inner retina. Labelling peaked at 2 hours after the onset of hypoxia and gradually declined thereafter. Marked binding to Müller glia was evident during the early hypoxic stages of OIR. Both HIF-1alpha and HIF-2alpha protein levels were significantly increased during retinal hypoxia but were evident in distinct cellular distributions; HIF-1alpha stabilisation was evident in neuronal cells throughout the inner retinal layers whereas HIF-2alpha was restricted to Müller glia and astrocytes. Hypoxia and HIF-alpha stabilisation in the retina were closely followed by upregulated expression of the downstream mediators VEGF and EPO.", "answer": "Both HIF-1alpha and HIF-2alpha are activated in close correlation with retinal hypoxia but have contrasting cell specificities, consistent with differential roles in retinal ischaemia. Our findings suggest that HIF-2alpha activation plays a key role in regulating the response of Müller glia to hypoxia.\n\nyes"}
{"question": "How is the visual information captured and processed in the intraocular retinal prosthesis developed by Second Sight Medical Products ?", "answer": "In the intraocular retinal prosthesis developed by Second Sight Medical Products, visual information is captured using a small camera housed in the patient's glasses. The camera captures the visual information, such as letters or shapes, and relays it to a microprocessor called the Visual Processing Unit (VPU), which is located externally. The VPU then processes this information and wirelessly sends it to a microelectronic receiver, which is implanted behind the patient's ear, underneath the skin of the scalp. Once the information reaches the microelectronic receiver, it is converted into tiny electric impulses. These impulses are then transmitted through a cable across the eyewall to a microelectrode array. The microelectrode array, developed by Second Sight, is composed of 16 platinum (Pt) disks arranged in a 4x4 square array. It is tightly kept against the retinal surface by a medical tack. The purpose of this microelectrode array is to stimulate the remaining retinal neurons of the patient. By delivering electrical stimulation to the retina, the prosthetic device aims to restore vision for individuals with visual impairment. This technology offers hope for blind individuals in regaining visual perception and potentially improving their quality of life."}
{"question": "Question: Do thiamine and benfotiamine prevent apoptosis induced by high glucose-conditioned extracellular matrix in human retinal pericytes?\nContext: Early and selective loss of pericytes and thickening of the basement membrane are hallmarks of diabetic retinopathy. We reported reduced adhesion, but no changes in apoptosis, of bovine retinal pericytes cultured on extracellular matrix (ECM) produced by endothelial cells in high glucose (HG). Since human and bovine pericytes may behave differently in conditions mimicking the diabetic milieu, we verified the behaviour of human retinal pericytes cultured on HG-conditioned ECM. Pericytes were cultured in physiological/HG on ECM produced by human umbilical vein endothelial cells in physiological/HG, alone or in the presence of thiamine and benfotiamine. Adhesion, proliferation, apoptosis, p53 and Bcl-2/Bax ratio (mRNA levels and protein concentrations) were measured in wild-type and immortalized human pericytes. Both types of pericytes adhered less to HG-conditioned ECM and plastic than to physiological glucose-conditioned ECM. DNA synthesis was impaired in pericytes cultured in HG on the three different surfaces but there were no differences in proliferation. DNA fragmentation and Bcl-2/Bax ratio were greatly enhanced by HG-conditioned ECM in pericytes kept in both physiological and HG. Addition of thiamine and benfotiamine to HG during ECM production completely prevented these damaging effects.", "answer": "Apoptosis is strongly increased in pericytes cultured on ECM produced by endothelium in HG, probably due to impairment of the Bcl-2/Bax ratio. Thiamine and benfotiamine completely revert this effect. This behaviour is therefore completely different from that of bovine pericytes, underlining the importance of establishing species-specific cell models to study the mechanisms of diabetic retinopathy.\n\nyes"}
{"question": "What is the recommended method for applying dye during surgery for retinal detachment ?", "answer": "The recommended method for applying dye during surgery for retinal detachment involves inducing a posterior vitreous detachment and injecting approximately 1.5ml of heavy liquid, followed by a fluid-air exchange without removing the perfluorocarbon liquid. This approach allows for staining of the peripheral vitreous and ensures a higher dye concentration in the anterior segment of the eye, as the dye cannot be further diluted by the perfluorocarbon liquid. Additionally, this method helps prevent uncontrolled distribution of the dye."}
{"question": "Question: Which of the following is called as pseudomyopia\nOptions:\nA. Insufficiency of accomodation\nB. Nuclear cataract\nC. Spasm of accomodation\nD. Presbyopia\n", "answer": " Pseudomyopia refers to an intermittent and temporary shift in refractive error of the eye towards myopia, in which the focusing of light in front of the retina is due to a transient spasm of the ciliary muscle causing an increase in the refractive power of the eye ( Spasm of accomodation) Spasm of accomodation: A spasm of accommodation (also known as a accommodative spasm) is a condition in which the ciliary muscle of the eye remains in a constant state of contraction. Normal accommodation allows the eye to \"accommodate\" for near-vision. Cause Drug Induced Spasm with miotics like echothiophate Spontaneous spasm of children who attempt to compensate refractory errors Diagnosis: It is made with refraction under atropine Treatment -Relaxation of ciliary muscles by atropine\n\nOPTION C IS CORRECT."}
{"question": "Question: A 14 year old boy complains of pain during reading. On examination, his both eyes are normal and vision with Snellen's reading is 6/5. He still complains of pain on occluding one eye. The diagnosis is :\nOptions:\nA. Myopia\nB. Pseudomyopia\nC. Hyperopia\nD. Emmetropia\n", "answer": " B i.e. Pseudomyopia This boy is having symptom of ocular strain (pain during reading) but vision with snellen's reading (without cycloplegia) is normal (6/5 or 6/6) because he is compensating for his refractory error by hyperaccomodation. So the diagnosis is Pseudomyopia/ Accommodative spasm.\n\nOPTION B IS CORRECT."}
{"question": "Question: Features in retinal detachment all except –\nOptions:\nA. Field defect\nB. Retinal tears\nC. Associated with vitreous haemorrhage\nD. Greyish – brown fundus\n", "answer": " Vitreous hemorrhage is not a feature of retinal detachment. However, it may be associated with retinal detachment as tear in retina may cause vitreous hemorrhage or retinal detachment.\nIn retinal detachment, there is visual field defect which corresponds to the area of detachment.\nOn examination, freshly - detached  retina gives grey reflex (i.e., grey fundus) instead of normal pink reflex.\n\nOPTION C IS CORRECT."}
{"question": "What is the process called when rhodopsin is separated into all-trans-retinal and opsin ?", "answer": "The process of separating rhodopsin into all-trans-retinal and opsin is called photodecomposition or bleaching."}
{"question": "Question: A 31-year-old man with untreated HIV infection is admitted to the hospital because of a 3-day history of blurred vision and flashing lights in his left eye. Indirect ophthalmoscopy shows retinal hemorrhages of the left eye. Treatment with a drug that directly inhibits viral DNA polymerases by binding to pyrophosphate-binding sites is initiated. Two days later, the patient has a generalized tonic-clonic seizure. This patient's seizure was most likely caused by which of the following?\nOptions:\nA. Demyelination\nB. Hypocalcemia\nC. Hypoglycemia\nD. Lactic acidosis\n", "answer": "OPTION B IS CORRECT."}
{"question": "What is the clinical utility of the first-order response in evaluating topographical retinal function ?", "answer": "The first-order response, as evaluated by the multifocal electroretinogram (ERG), has been established as a valuable tool in assessing topographical retinal function. The calculated N1 and P1 components of the multifocal ERG, although not exact equivalents, correlate with the a- and b-waves of the recorded responses in the photopic full-field ERG. The first-order response provides useful information about retinal function, although there are still aspects of cellular activity contribution to the multifocal ERG that require further understanding."}
{"question": "Question: Hi doctor,I am a 24 year old female. Suddenly, I am having large floaters in my eyes. Is it possible that it will decrease with time? How long will it take to decrease?", "answer": "Hi. I reviewed your history. It seems from the history that you have floaters. Eye floaters are because of problems in the posterior part of the eye involving vitreous and retina. Hence, this requires evaluation by indirect ophthalmoscopy, to rule out vitreous degenerations. Most of the floaters are caused by vitreous degenerations and may not require treatment. These will resolve over time. However, evaluation is required to look for associated retinal problems, like retinal tears which may be seen rarely. "}
{"question": "Question: Eye ball movements are controlled by all of the following cranial nerves except:\nOptions:\nA. Optic nerve\nB. Abducens nerve\nC. Trochlear nerve\nD. Oculomotor nerve\n", "answer": " Cranial Nerve I: OlfactoryArises from the olfactory epithelium.Functions solely by carrying afferent impulses for the sense of smell.Cranial Nerve II: OpticArises from the retina of the eye.Optic nerves pass through the optic canals and converge at the optic chiasm.Functions solely by carrying afferent impulses for vision.Cranial Nerve III: OculomotorFibers extend from the ventral midbrain, pass through the superior orbital fissure, and go to the extrinsiceye muscles.Functions in raising the eyelid, directing the eyeball, constricting the iris, and controlling lens shape.Parasympathetic cell bodies are in the ciliary ganglia.Cranial Nerve IV: TrochlearFibers emerge from the dorsal midbrain and enter the orbits the superior orbital fissures; innervate the superior oblique muscle.Primarily a motor nerve that directs the eyeball.Cranial Nerve V: TrigeminalThree divisions: ophthalmic (V1), maxillary (V2), and mandibular (V3).Fibers run from the face to the pons the superior orbital fissure (V1), the foramen rotundum (V2), and the foramen ovale (V3).Conveys sensory impulses from various areas of the face (V1) and (V2), and supplies motor fibers (V3) for mastication.Cranial Nerve VI: AbdcuensFibers leave the inferior pons and enter the orbit the superior orbital fissure.Primarily a motor nerve innervating the lateral rectus muscle.Cranial Nerve VII: FacialFibers leave the pons, travel through the internal acoustic meatus, and emerge through the stylomastoid foramen to the lateral aspect of the face.Mixed nerve with five major branches.Motor functions include facial expression, and the transmittal of autonomic impulses to lacrimal and salivary glands.Sensory function is taste from the anterior two-thirds of the tongue.Cranial Nerve VIII: VestibulocochlearTwo divisions - cochlear (hearing) and vestibular (balance).Functions are solely sensory - equilibrium and hearing.Cranial Nerve IX: GlossopharyngealFibers emerge from the medulla, leave the skull the jugular foramen, and run to the throat.Nerve IX is a mixed nerve with motor and sensory functions.Motor - innervates pa of the tongue and pharynx and provides motor fibers to the parotid salivary gland.Sensory - fibers conduct taste and general sensory impulses from the tongue and pharynx.Cranial Nerve X: VagusFibers emerge from the medulla the jugular foramen.The vagus is a mixed nerve.Its sensory function is in taste.Cranial Nerve XI: AccessoryThe spinal root passes upward into the cranium the foramen magnum.The accessory nerve leaves the cranium the jugular foramen.Primarily a motor nerve.Supplies fibers to the larynx, pharynx, and soft palate.Cranial Nerve XII: HypoglossalFibers arise from the medulla and exit the skull the hypoglossal canal.Innervates both extrinsic and intrinsic muscles of the tongue, which contribute to swallowing and speech.\n\nOPTION A IS CORRECT."}
{"question": "Can you provide a detailed step-by-step procedure for the photocoagulation treatment of diabetic macular edema ?", "answer": "The photocoagulation treatment of diabetic macular edema involves the use of laser therapy to reduce the swelling and leakage of fluid in the macula, the central area of the retina. Here is a detailed step-by-step procedure for this treatment: 1. Patient preparation: Ensure that the patient is well-informed about the procedure and has provided informed consent. Explain the benefits, risks, and potential outcomes of the treatment. Administer topical anesthesia to numb the eye and dilate the pupil for better visualization. 2. Patient positioning: Position the patient comfortably in a supine position, with the head stabilized and properly aligned. Use a forehead and chin rest to maintain stability. 3. Pre-treatment assessment: Perform a thorough examination of the macula using slit-lamp biomicroscopy and fundus imaging techniques such as fundus photography or optical coherence tomography (OCT). Identify the areas of macular edema and assess the severity. 4. Laser parameters: Set the laser parameters based on the specific patient characteristics and the extent of macular edema. Factors to consider include the type of laser (argon or diode), spot size, power, and duration of exposure. 5. Laser application: Using a contact lens or a non-contact delivery system, apply laser burns to the affected areas of the macula. The laser energy is selectively absorbed by abnormal blood vessels and damages them, sealing off leaking vessels and reducing edema. 6. Treatment coverage: Ensure that the entire area of macular edema is treated, paying particular attention to the areas of leakage identified during the pre-treatment assessment. Apply laser burns in a grid-like or focal pattern, depending on the extent and distribution of edema. 7. Endpoint identification: Monitor the treatment response during the procedure. Observe for changes such as blanching or whitening of the treated areas, indicating effective laser application. 8. Post-treatment care: After completing the laser treatment, instill topical antibiotic drops or ointment to prevent infection. Provide the patient with post-operative instructions, including the use of prescribed medications and the need for follow-up visits. 9. Follow-up evaluation: Schedule a follow-up visit to assess the patient's response to the treatment. Use fundus imaging techniques to evaluate the resolution of macular edema and assess visual acuity improvement. It is important to note"}
{"question": "Question: Do acrylic intraocular lens placement in conjunction with pars plana vitrectomy?\nContext: To report the results of placing a foldable acrylic intraocular lens through a clear cornea incision in eyes undergoing pars plana vitrectomy. This interventional case series is a retrospective report of 15 eyes of 15 consecutive patients undergoing foldable (acrylic) intraocular lens insertion in conjunction with pars plana vitrectomy in a single academic institution. Outcome measures included visual acuity and complications. The intraocular lens was successfully implanted and retained in position in all 15 cases. The intraocular lens did not pose difficulty in examining the fundus or cause any vitreoretinal complications. With mean follow-up of 4.5 months (range, 1--10 months), final median postoperative visual acuity range was 20/200 (range, 20/40--2/200) and consistent with the level of vitreoretinal disease.", "answer": "Acrylic intraocular lenses may be safely implanted in conjunction with pars plana vitrectomy in selected cases.\n\nyes"}
{"question": "How does peripheral retinal traction affect the vitreous chamber ?", "answer": "Peripheral retinal traction can have an impact on the vitreous chamber. The attachments between the peripheral retina and the vitreous can lead to traction, causing changes in the vitreous chamber. This traction can result in the development of posterior vitreal detachment and potentially affect the vitreous cortex. It is important to monitor and assess the vitreous chamber for any changes or complications associated with peripheral retinal traction."}
{"question": "What are the risks and complications associated with inferior limited macular translocation surgery ?", "answer": "Inferior limited macular translocation surgery carries certain risks and complications. During the intraoperative phase, there is a possibility of inadvertent scleral perforation when sutures are placed on the sclera for scleral imbrication. This can lead to suprachoroidal hemorrhage, vitreous hemorrhage, or retinal break. Retinal breaks can also occur during the later stages of the operation. In addition, the retina may be inadvertently cut or traumatized during vitrectomy, particularly in cases with vitreous traction near the macula. Postoperatively, patients may experience various complications. These can include retinal detachment, which is particularly associated with a poorer visual prognosis. Other potential complications include choroidal neovascularization (CNV) recurrence, persistent subfoveal CNV lesion, photoreceptor cell damage, and visual deterioration. It is important to note that patients with previous laser photocoagulation for juxtafoveal or extrafoveal lesions, who are better educated about the need for regular follow-up, may have better outcomes if they develop recurrent CNV. To improve the overall success rate and reduce complications, patient selection is crucial. It is essential to choose patients with viable foveal photoreceptors to ensure the potential for visual improvement. Additionally, achieving the desired amount of macular translocation is important to avoid persistent subfoveal CNV lesions. Advancements in surgical techniques aiming for larger and more predictable macular translocation will enhance the chances of success and expand the pool of patients eligible for this procedure."}
{"question": "Describe refractive corneal surgery ?", "answer": "Refractive corneal surgery, also known as corneal refractive surgery, is a type of vision correction procedure that aims to correct refractive errors in the eye by reshaping the cornea. The cornea is the clear, dome-shaped surface that covers the front of the eye. There are different types of refractive corneal surgeries, including: 1. LASIK (Laser-Assisted in Situ Keratomileusis): This is one of the most common refractive surgeries. It involves creating a thin flap on the cornea using a laser or a microkeratome. The flap is then lifted, and a second laser is used to reshape the underlying corneal tissue. The flap is then repositioned, allowing for rapid healing. 2. PRK (Photorefractive Keratectomy): In PRK, the surface layer of the cornea, called the epithelium, is removed to expose the underlying corneal tissue. A laser is then used to reshape the cornea and correct the refractive error. The epithelium naturally regenerates over time. 3. LASEK (Laser-Assisted Subepithelial Keratectomy): LASEK is similar to PRK but involves preserving a thin layer of the epithelium, which is temporarily lifted before the cornea is reshaped using a laser. The epithelium is then repositioned. 4. EpiLASIK (Epithelial Laser In Situ Keratomileusis): EpiLASIK combines the techniques of PRK and LASIK. It involves creating a thin epithelial flap, which is lifted to expose the cornea. A laser is then used to reshape the cornea, and the epithelial flap is repositioned. These procedures aim to correct common refractive errors, such as nearsightedness (myopia), farsightedness (hyperopia), and astigmatism. By altering"}
{"question": "Question: Is an intronic SNP in the thyroid hormone receptor β gene associated with pituitary cell-specific over-expression of a mutant thyroid hormone receptor β2 ( R338W ) in the index case of pituitary-selective resistance to thyroid hormone?\nContext: The syndrome of resistance to thyroid hormone (RTH) is caused by mutations in the thyroid hormone receptor β gene (THRB). The syndrome varies from asymptomatic to diffuse hypothyroidism, to pituitary-selective resistance with predominance of hyperthyroid signs and symptoms. The wide spectrum of clinical presentation is not completely attributable to specific THRB mutations. The THRB gene encodes two main isoforms, TR β1 which is widely distributed, and TR β2, whose expression is limited to the cochlea, retina, hypothalamus, and pituitary. Recent data demonstrated that in mice an intron enhancer region plays a critical role in the pituitary expression of the β2 isoform of the receptor. We thus hypothesized that polymorphisms in the human homologous region could modulate the pituitary expression of the mutated gene contributing to the clinical presentation of RTH. Screening and in vitro characterization of polymorphisms of the intron enhancer region of the THRB gene in the index case of pituitary-selective RTH. The index case of pituitary-selective resistance is characterized by the missense R338W exon 9 mutation in cis with two common SNPs, rs2596623T and rs2596622C, located in the intron enhancer region of the THRB gene. Reporter gene assay experiments in GH3 pituitary-derived cells indicate that rs2596623T generates an increased pituitary cell-specific activity of the TR β2 promoter suggesting that rs2596623T leads to pituitary over-expression of the mutant allele.", "answer": "The combined coding mutation and non-coding SNP therefore generate a tissue-specific dominant-negative condition recapitulating the patient's peculiar phenotype. This case illustrates the role of regulatory regions in modifying the clinical presentation of genetic diseases.\n\nyes"}
{"question": "Question: Does diadenosine tetraphosphate protect sympathetic terminals from 6-hydroxydopamine-induced degeneration in the eye?\nContext: To examine diadenosine tetraphosphate (Ap(4)A) for its ability to protect the eye from neurodegeneration induced by subconjunctival application of 6-hydroxydopamine (6-OHDA). Intraocular neurodegeneration of anterior structures was induced by subconjunctival injections of 6-OHDA. Animals were pre-treated with topical corneal applications of Ap(4)A or saline. 6-OHDA caused miosis, abnormal pupillary light reflexes, a precipitous drop in intraocular pressure and loss of VMAT2-labelled (vesicle monoamine transporter-2, a marker for sympathetic neurones) intraocular neurones. Pre-treatment with Ap(4)A prevented all of these changes from being induced by 6-OHDA, demonstrably preserving the sympathetic innervation of the ciliary processes. This neuroprotective action of Ap(4)A was not shared with the related compounds adenosine, ATP or diadenosine pentaphosphate. P2-receptor antagonists showed that the effects of Ap(4)A were mediated via a P2-receptor.", "answer": "Ap4A is a natural component of tears and aqueous humour, and its neuroprotective effect indicates that one of its physiological roles is to maintain neurones within the eye. Ap(4)A can prevent the degeneration of intraocular nerves, and it is suggested that this compound may provide the basis for a therapeutic intervention aimed at preventing or ameliorating the development of glaucoma associated with neurodegenerative diseases. Furthermore, subconjunctival application of 6-OHDA provides a useful model for studying diseases that cause ocular sympathetic dysautonomia.\n\nyes"}
{"question": "Question: What are the treatments for Idiopathic juxtafoveal retinal telangiectasia ?", "answer": "How might idiopathic juxtafoveal retinal telangiectasia (IJT) be treated? Laser photocoagulation of areas of leakage may be helpful in treating vision loss in people with certain subtypes of IJT, such as Group 1A. A laser is a powerful beam of light which can be focused on the retina. Small \"bursts\" of the laser can be used to seal leaky blood vessels, destroy abnormal blood vessels, seal retinal tears, and destroy abnormal tissue in the back of the eye. Photocoagulation usually is not considered for people with people in Group 1B because of the closeness of the leakage to the fovea, and the good prognosis without treatment. It may benefit people in Group 2 but in most cases, the abnormal lesions are so close to the fovea that treatment is difficult.\nReference: https://rarediseases.info.nih.gov/gard/10690/idiopathic-juxtafoveal-retinal-telangiectasia"}
{"question": "Question: Which of the following condition may give rise to sunflower cataract?\nOptions:\nA. Diabetes mellitus\nB. Injuries\nC. Chalcosis\nD. Infections\n", "answer": " Chalcosis refers to the specific changes produced by the alloy of copper in the eye. Copper ions from the alloy are dissociated electrolytically and deposited under the membranous structures of the eye. Clinical manifestations: Kayser-Fleischer ring: It is a golden brown ring which occurs due to deposition of copper under peripheral pas of the Descemet's membrane of the cornea. Sunflower cataract: It is produced by deposition of copper under the posterior capsule of the lens. It is brilliant golden green in colour and arranged like the petals of a sunflower. In retina, it may show deposition of golden plaques at the posterior pole which reflect the light with a metallic sheen. Ref: Ophthalmology by A K Khurana, 4th Edition, Page 410\n\nOPTION C IS CORRECT."}
{"question": "Question: What is the meaning of Abnormal macular morphology?", "answer": "A structural abnormality of the macula lutea, which is an oval-shaped highly pigmented yellow spot near the center of the retina. [HPO:probinson, PMID:16255686]"}
{"question": "Question: Hello doctor,I am just 10 days away to be 20 years old. I have been seeing black dots or I may say they appear differently on my eyes. They do not go away. I always have them with me. They irritate me because I normally see them the most or clearly when I am out in the daylight. I sometimes find it hard to face the light meaning like looking around on a sunny day. These things do not prevent me from seeing. I see even from afar but I see well when there is no much light because I cannot stand light well when I am watching something. I have read somewhere that they are called floaters and can cause blindness. I have started to see just one dot and now I see some more not too many but irritating. It has been years. However, I have only tried to tell a doctor but he said that there is no problem and I have not done any treatment. So, I need your help, please.", "answer": "Hi, Welcome. You have correctly described your floaters. Only thing is that it is perfectly normal as they are part of aging and will only increase with time. They develop as the vitreous jelly inside our eyes liquifies with time. So they move when your eye moves. They do not cause blindness on their own. They are a matter of concern only when there is a sudden shower of floaters associated with flashes. In that case, you will need an examination of your retina after full dilation of your pupil to rule out any break in your retina which if not lasered on time may proceed to retinal detachment. Take care.  "}
{"question": "Question: Do surgical results of combined pars plana vitrectomy and phacoemulsification for vitreous hemorrhage in PDR?\nContext: The purpose of this study was to evaluate the effectiveness, safety, and incidence of complications after combined clear corneal phacoemulsification with intraocular lens implantation and pars plana vitrectomy in eyes with proliferative diabetic retinopathy coexistent with significant cataract. Eighty-five eyes of 85 patients with proliferative diabetic retinopathy underwent primary standard three-port vitrectomy with 20-gauge instruments and phacoemulsification with intraocular lens implantation for vitreous hemorrhage from 2008 to 2011. The main outcome measures were visual outcomes and surgical complications. Forty patients were male and 45 were female. Their age ranged from 40 to 77 years with a mean of 59.6 years. The mean follow-up was 13 months, with a range of 6-48 months. The preoperative logMAR visual acuity changed from 2.62 ± 0.6 to 0.8 ± 0.7 postoperatively. Postoperatively, visual acuity improved in 79 eyes (92.9%), and did not change in six eyes (7.1%). Intraoperative complications were transient corneal edema (five eyes) and posterior capsular rupture (one eye). Postoperative complications consisted of transient intraocular pressure elevation (25 eyes), corneal epithelial defects (six eyes), anterior chamber reaction (four eyes), hyphema (two eyes), posterior synechiae (four eyes), vitreous hemorrhage (23 eyes), retinal tears (five eyes), retinal detachment (one eye), and neovascular glaucoma (one eye).", "answer": "Our study suggests that the combined operation of pars plana vitrectomy, phacoemulsification, and intraocular lens implantation is safe and effective for patients with proliferative diabetic retinopathy. We believe that the visual outcome and complications depended primarily on underlying posterior segment pathology and were not related to the combined procedure technique.\n\nyes"}
{"question": "Question:  Hello. Im a 32 year old male. I had a total knee replacement 4 weeks ago due to a long history of PVNS. I slipped and over-stretched the joint over the weekend. Just saw my doctor and he said I had torn the medial patellar retinaculum. He advised for me to continue PT and hopefully it will heal. If it tears more and the patella ends up being dislocated then he said surgery would be necessary. Whats your opinion and has this happened to anyone else?\n", "answer": " Hi, thank-you for providing the brief history of you. Yes, with physical therapy you can regain the stability of the medial patellar retinaculum. As you had a TKR you maximum ligaments from the knee joints has been removed as it was all worn out. Now with the knee implant present you have a different biomechanics and the stress is applied on the medical patellar retinaculum. Performing knee strengthening exercises, knee extension maneuver should give you better stability Also try walking reverse with support as it will improve the joint locking mechanism. As most patients with TKR face such issues and can be treated well with PT. In my clinical practice I see cases with similar complaints, and they respond well to PTRegardsJay In . "}
{"question": "What are the dimensions and structures of the macular regions near the foveola in the retina ?", "answer": "The macular regions near the foveola consist of several important structures. The ganglion cells (GC) are present in this region, responsible for transmitting visual information to the brain. The nerve fiber layer (NF) is not mentioned in the provided information. Additionally, the retinal pigment epithelium (RPE) plays a crucial role in supporting the photoreceptor cells and maintaining the health of the retina. It is worth noting that the absence of vessels, rods, and ganglion cells in the given section suggests that this particular cross-section does not capture these structures. Please refer to ophthalmology literature or other resources for further details on the dimensions and characteristics of macular regions near the foveola."}
{"question": "Question: Does methylprednisolone fail to preserve retinal ganglion cells and visual function after ocular ischemia in rats?\nContext: Methylprednisolone (MP) is commonly used to treat traumatic optic neuropathy and optic neuritis, but its benefit in terms of neuronal survival remains controversial. The aim of this study was to investigate the effects of MP on retinal ganglion cell (RGC) survival and visual function after ischemia in rats. Ocular ischemia was induced by elevated intraocular pressure. Rats were treated with NaCl, 1 mg/kg/d, or 30 mg/kg/d intraperitoneal MP over 3 days. RGCs were labeled retrogradely 4 days after ischemia and were quantified 6 days later. Post-ischemic retinal function was assessed by scotopic and photopic electroretinography (ERG). Optic nerve function was investigated on days 4 and 10 after ischemia by visual evoked potentials (VEPs). Compared with nonischemic eyes, ischemia reduced RGCs with NaCl to 47% +/- 3% (mean +/- SEM) and to 46% +/- 3% and 43% +/- 6% with 1 mg/kg/d and 30 mg/kg/d MP. ERG did not differ significantly for any parameter among the three groups. Four days after ischemia, the VEPs of rats receiving any dose of MP were significantly higher than the control. VEPs in both steroid groups fell to control levels 10 days after ischemia.", "answer": "Treatment with MP did not improve RGC survival or retinal function. The VEP showed a short-term benefit because of steroids.\n\nyes"}
{"question": "Question: Are transdifferentiated retinal pigment epithelial cells immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes?\nContext: To determine the cellular origin and the vascular endothelial growth factor (VEGF) immunoreactivity of the nonvascular stromal cells in surgically excised age-related macular degeneration (ARMD)-associated choroidal neovascular membranes (CNVMs). Immunohistochemical analysis was performed on frozen sections of eight surgically excised ARMD-related CNVMs. Cytokeratin-positive, smooth muscle actin-positive polygonal or fibroblastic (transdifferentiated RPE) cells were the principal nonvascular stromal cells detected. The polygonal cells were more commonly found in active (highly vascularized) regions and were strongly immunoreactive for VEGF. The fibroblastic cells were predominantly found in fibrotic (hypovascular) regions and were minimally immunoreactive for VEGF.", "answer": "Transdifferentiated RPE cells are the principal nonvascular stromal cells of both vascular and fibrotic ARMD-related CNVMs. Preferential localization of VEGF immunoreactivity with the cytoplasm of the polygonal transdifferentiated RPE cells in the highly vascularized regions of the surgically excised CNVMs suggests an important angiogenic role of these cells and this growth factor in the progression of ARMD-related choroidal neovascularization.\n\nyes"}
{"question": "What are the components that contribute to the generation of the a-wave, b-wave, and c-wave of the trans-retinal ERG ?", "answer": "The trans-retinal ERG consists of three components: the a-wave, b-wave, and c-wave. The a-wave is primarily influenced by the hyperpolarizing receptor potential (RP) and represents the initial response of the photoreceptors. The b-wave reflects the activation of depolarizing ON bipolar cells (DB) and the K+-mediated response of Müller cells. It has a rapidly rising transient phase. The c-wave, a slowly-developing cornea-positive potential, is a composite waveform predominantly generated by the retinal pigment epithelium (RPE) and Müller cells. The RPE contributes to the positive aspect of the waveform, while the negative component originates from the Müller cell, with a small contribution from the plateau phase of the hyperpolarizing photoreceptor potential."}
{"question": "What are the possible treatments or the best therapy for age-related macular degeneration and polypoidal choroidal vasculopathy ?", "answer": "The treatment options for age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV) depend on the stage and type of the disease. For non-exudative AMD, which is the \"dry\" form, there is currently no definitive treatment, but certain lifestyle modifications can help slow down the progression. These include smoking cessation and the use of Age-Related Eye Disease Study (AREDS) vitamins, which contain vitamins C and E, zinc, beta-carotene, and copper. These vitamins have been shown to reduce the progression of advanced AMD in certain patients. On the other hand, exudative AMD, also known as the \"wet\" form, can be treated with intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) medications. These medications help to inhibit the abnormal growth of blood vessels in the retina, reducing the leakage and bleeding that occurs in the \"wet\" form of AMD. Several anti-VEGF drugs, such as ranibizumab, aflibercept, and bevacizumab, have been approved for the treatment of exudative AMD. For PCV, which is a separate disease from AMD, characterized by abnormalities in the inner choroid, the mainstay of treatment is also anti-VEGF therapy. However, some studies have suggested that photodynamic therapy (PDT) may also be beneficial in certain cases of PCV. It is important to note that the choice of treatment depends on various factors, including the stage and severity of the disease, patient preference, and the ophthalmologist's recommendation. It is recommended to consult with an ophthalmologist who specializes in retinal diseases for a personalized treatment plan. References: 1. Yannuzzi LA, et al. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol. 1997;115(4):478-485. 2. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417-1436."}
{"question": "How is the clinical EOG recording performed ?", "answer": "In clinical EOG recording, cutaneous electrodes are placed near the medial and lateral canthi of each eye. The resting potential between the cornea and the retina is indirectly obtained by having the subject look back and forth repetitively at two fixation targets. These fixation targets are typically red diodes built into the full-field stimulus dome of the full-field ERG or flash VEP. To assist in rapid eye movements, the fixation targets can be alternately lit and the subject is instructed to look at the lit target."}
{"question": "Question: Voissus ring is seen in:\nOptions:\nA. Cornea\nB. Retina\nC. Anterior capsule\nD. Posterior capsule\n", "answer": " Anterior capsule\n\nOPTION C IS CORRECT."}
{"question": "Question: HLA-A29 is associated with\nOptions:\nA. Serpiginous geographical choroidopathy\nB. Bird shot retinochoroidopathy\nC. Sympathetic ophthalmitis\nD. Acute posterior multifocal placoid pigment epitheliopathy\n", "answer": " BIRD-SHOT RETINOCHOROIDOPATHY It is a rare, idiopathic, bilaterally symmetrical chronic multifocal chorioretinitis characterised by numerous flat creamy-yellow spots due to focal chorioretinal hypopigmentation, resembling the pattern of 'bird- shot scatter from a shotgun'. The disease, more common in females than males, typically affects middle-aged healthy persons who are positive for HLA-A29. It runs a long chronic course of several years. Treatment with coicosteroids is usually not effective. Ref:- A K KHURANA; pg num:-161\n\nOPTION B IS CORRECT."}
{"question": "Question: Does heat shock cognate-70 gene expression decline during normal aging of the primate retina?\nContext: Despite documented age-related changes in retinal function and histology, little is known about the pattern of gene expression during normal aging of the vertebrate retina. This study was undertaken to definitively characterize gene expression in the primate retina during aging. Human retina cDNA library clones were arrayed at high density on nylon membranes and screened with mixed cDNA probes generated from young (4-year-old) and old (80-year-old) human retinae. Clones showing a more than twofold difference in intensity were rescreened by dot blot analysis with the same probes and with mixed cDNA probes generated from young (2-3 years) and old (27-35 years) rhesus monkeys. One clone identified by its differential (age-putative) signal, and age-related differential expression was used for analysis of Northern blot analysis of total retinal RNA from human donors (35 weeks to 94 years of age) and two rhesus monkeys (2 and 27 years of age). The identified clone was sequenced and compared with entries in the GenBank/EMBL databases. Western blot analysis was performed on protein isolated from the retina of human donors aged 4 to 64 years and rhesus monkeys aged 18 months and 35 years. Approximately 1.6% of the 55,368 retina-expressed sequences examined show age-related changes between tissues from young and old donors. The mRNA level one clone, identical with heat shock cognate (HSC)70, was altered during normal retinal aging in primates. Regression analysis of Northern blot analysis signals from 23 human donors suggested that there may be a two- to threefold decrease in HSC70 mRNA levels in the human retina by the eighth decade of life. Western blot analysis also showed lower levels of the 70-kDa HSC protein in older tissues of both primates.", "answer": "HSC70 mRNA levels apparently decline during normal aging of the primate retina. Because the heat shock 70 protein family may play important roles in ocular development and protection from various biologic and environmental stresses, decreased HSC70 levels in the retina during aging may contribute to the apparent increased susceptibility of the retina to age-acquired retinal disease.\n\nyes"}
{"question": "Question: What is the meaning of Malignant tumor of eye?", "answer": "Cancer that forms in tissues of and around the eye. Some of the cancers that may affect the eye include melanoma (a rare cancer that begins in cells that make the pigment melanin in the eye), carcinoma (cancer that begins in tissues that cover structures in the eye), lymphoma (cancer that begins in immune system cells), and retinoblastoma (cancer that begins in the retina and usually occurs in children younger than 5 years)."}
{"question": "Question: A six month old baby girl who was normal at bih, begins to show signs of motor retardation. While she could sit up at 5 months, she can no longer do so. As time goes on, the child continues to deteriorate, and eventually becomes unresponsive to visual or auditory stimuli. Funduscopic examination reveals cherry-red macular spots in both eyes. Which of the following genetic abnormalities is most often related to the development of this disease?\nOptions:\nA. Confined placental mosaicism\nB. Expanded trinucleotide repeat\nC. Frameshift mutation\nD. Nondisjunction\n", "answer": " Most cases of Tay-Sachs disease are caused by inseion of four nucleotides into the coding region of the gene for the alpha-subunit of the hexosaminidase A gene. This produces a frameshift mutation, resulting in the creation of a premature stop codon downstream from the inseed nucleotides. The disease presents as described in the question, and is more common in Ashkenazi Jews. The carrier rate in this population is 1 in 25. There is presently no effective treatment and survival beyond four years of age is rare. Confined placental mosaicism is caused by a genetic aberration (e.g., a trisomy) occurring in the trophoblast or extraembryonic progenitor cells in the inner cell mass of the embryo. This leads to abnormal placental development and intrauterine growth retardation. Expansion of tandem nucleotide repeats is thought to be etiologically involved in Fragile X syndrome and Huntington disease. Nondisjunction during meiosis is a common cause of trisomy, e.g., trisomy 21, or Down syndrome. Ref: Wyatt C., Kemp W.L., Moos P.J., Burns D.K., Brown T.G. (2008). Chapter 6. Genetic Disorders. In C. Wyatt, W.L. Kemp, P.J. Moos, D.K. Burns, T.G. Brown (Eds), Pathology: The Big Picture.\n\nOPTION C IS CORRECT."}
{"question": "What is the surgical approach for proliferative diabetic retinopathy ?", "answer": "The surgical approach for proliferative diabetic retinopathy typically involves pars plana vitrectomy, which is a surgical procedure that removes the vitreous gel from the eye. This procedure allows for the treatment of neovascularization, traction retinal detachment, and other complications associated with proliferative diabetic retinopathy. Additionally, adjunctive procedures such as extracapsular cataract extraction and endolaser photocoagulation may be performed in combination with vitrectomy to address specific issues. Silicone oil may also be used in cases of complicated retinal detachment. It is important to consider the individual patient's condition and consult ophthalmology literature and resources for detailed guidelines on surgical management."}
{"question": "Can diode laser cyclophotocoagulation (CPC) be a suitable alternative to cryo-applications for treating primary open angle glaucoma with conjunctival scarring ?", "answer": "Diode laser cyclophotocoagulation (CPC) has emerged as an effective alternative to cryo-applications for the treatment of primary open angle glaucoma with conjunctival scarring. CPC provides long-lasting pressure reduction and reduces the need for medical treatment. Compared to cryo-applications, CPC carries a lower risk of complications such as hypotony, corneal damage, and retinal complications. Additionally, CPC can be repeated if necessary. It is important to note that previous operations of this type for primary open angle glaucoma have failed due to conjunctival scarring. In such cases, CPC may offer a more successful and safer approach."}
{"question": "Question:  Hi, I am Minella from India. My brother is suffering from a skin disorder called PLC. He has been prescribed melanocyl tablets followed by sun exposure for ten minutes post 2 hrs of consuming the pills. The dermat has advised us to conduct an eye test after a month before the next visit. Am a little concerned regarding this, as I checked on the internet that it might cause changes in vision. Can you please help me on this\n", "answer": " Hi, Yes, it may cause changes in vision. The most common side effects of melanocyte include itching and skin redness. However sometimes it may also cause premature cataract and macular or retinal toxicity resulting in vision changes. This side effect can be prevented by using ultraviolet filtering glasses during treatment. Hope I have answered your question. Let me know if I can assist you further."}
{"question": "Question: The swinging light test is positive in\nOptions:\nA. Conjunctivitis\nB. Glaucoma\nC. Retrobulbar neuritis\nD. Keratoconus\n", "answer": " Retrobulbar neuritis: a common cause of visual loss with normal fundus. Presence of a definite or relative afferent pupillary defect (RAPD) and VER are diagnostic. Swinging flashlight test: It is performed when relative afferent pathway defect is suspected in one eye (unilateral optic nerve lesion with good vision). Normally, both pupils constrict equally and the pupil to which light is transferred remains tightly constricted. In the presence of relative afferent pathway defect in one eye, the affected pupil will dilate when the flashlight is moved from the normal eye to the abnormal eye. This response is called 'Marcus Gunn pupil' or a relative afferent pupillary defect (RAPD). It is the earliest indication of optic nerve disease even in the presence of normal visual acuity. In the swinging flashlight test, a light is alternately shone into the left and right eyes.Thus, light shone in the affected eye will produce less pupillary constriction than light shone in the unaffected eye. Anisocoria is absent. A Marcus Gunn pupil is seen, among other conditions, in optic neuritis. Ref: Khurana; 4th edition; Pg.No. 307, 474\n\nOPTION C IS CORRECT."}
{"question": "What are the different types of bipolar cells in the retina and their specific characteristics ?", "answer": "Bipolar cells, as the second-order neurons in the visual pathway, play a crucial role in transmitting information from photoreceptors to other retinal cells. In the retina, there are several types of bipolar cells identified based on their morphology and dendritic contacts with photoreceptors. The main types include flat midget bipolar cells, invaginating midget bipolar cells, diffuse cone bipolar cells (type a and type b), blue cone bipolar cells, rod bipolar cells, and giant cone bipolar cells (diffuse and bistratified). Each type exhibits unique characteristics in terms of dendritic contacts, axon terminations, and connections with other retinal cells."}
{"question": "What are the ocular manifestations of xerophthalmia and how can it be diagnosed ?", "answer": "Xerophthalmia refers to the ocular manifestations of vitamin A deficiency. These manifestations include structural changes that affect the conjunctiva, cornea, and occasionally the retina. In addition, xerophthalmia can also lead to biophysical disorders of retinal rods and cones functions. To diagnose xerophthalmia, ophthalmologists should consider the patient's dietary history and assess for any signs of protein-energy malnutrition (PEM) and infections. It is important to note that vitamin A deficiency rarely occurs as an isolated problem and is often accompanied by these factors. In terms of clinical presentation, xerophthalmia may present with dryness of the eyes, conjunctival dryness and thickening, corneal dryness and ulceration, night blindness, and even vision loss in severe cases. The diagnosis can be confirmed by conducting a thorough ocular examination, including visual acuity testing, assessment of tear production, slit-lamp examination to evaluate the conjunctiva and cornea, and fundoscopic examination to assess the retina. Additionally, measuring serum vitamin A levels can provide supporting evidence for the diagnosis. It is crucial for ophthalmologists and physicians to be aware of the ocular manifestations of xerophthalmia, as these manifestations can often be the presenting signs of underlying systemic diseases."}
{"question": "What is the value of the ERG in diagnosing Leber congenital amaurosis ?", "answer": "The ERG (electroretinogram) has been found to be valuable in diagnosing Leber congenital amaurosis, a genetic disorder that affects the development and function of photoreceptor cells in the retina. Several studies (references 75, 76, 80) in the provided literature have highlighted the significance of ERG in assessing patients with Leber congenital amaurosis. The ERG measures the electrical responses generated by the retina when it is exposed to light stimuli, providing objective information about retinal function. In the context of Leber congenital amaurosis, the ERG helps to evaluate the extent of retinal dysfunction, identify specific electroretinographic abnormalities associated with the condition, and can also aid in the genetic diagnosis by assessing heterozygous GUCY2D mutations in parents of affected patients (reference 80). Therefore, the ERG serves as a valuable tool in the diagnostic assessment of Leber congenital amaurosis."}
{"question": "Question: , Which of the following is a component of the visual pigment rhodopsin -\nOptions:\nA. b-Carotene\nB. Retinal\nC. Retinol\nD. Retinoic acid\n", "answer": " Ans. is 'b' i.e., Retinal Vitamin A (Retinol)The retinoids are a family of molecules that are related to retinol (Vitamin A) and are essential for :VisionReproductionGrowthMaintenance of epithelial tissues Structure of vitamin AVitamin A is often used as a collective term for several related biologically active molecules.Vitamin A is essential for vision reproduction, growth and maintenance of epithelial tissues.Vitamin A can exist in several formsRetinol -Retinol is found in animal tissues as a retinyl ester with long chain fatty acids.Retinal (component of the visual pigment rhodopsin)The aldehyde derived from the oxidation of retinol.Retinal and retinol can readily be interconverted.Retinoic acidIt is the acid derived from oxidation of retinal.Retinoic acid cannot be reduced in the body and therefore cannot give rise to either retinal or retinol.b carotenePlant foods contain b carotene, which can be oxidatively cleaved in the intestine to yield two molecules of retinal.Now, the functions associated with each form of vitamin Retinoic acid, derived from oxidation of dietary retinol, mediates most of the actions of the retinoids, except for vision which depends on retinal, the aldehyde derivative of retinol.Note : Retinol acts on the nucleus of the target cells where the vitamin acts in a manner analogous to steroid hormones.\n\nOPTION B IS CORRECT."}
{"question": "Question: Most lateral structure in flexor retinaculum of leg is\nOptions:\nA. Flexor hallucis longus tendon\nB. Tibialis posterior tendon\nC. Tibial nerve\nD. Posterior tibial aery\n", "answer": " FLEXOR RETINACULUM (LEG):- Attachments:Anteriorly-posterior border and tip of medial malleolus.Posteriorly and laterally-medial tubercle of calcaneum. Septa passing from the retinaculum to the underlying bone divide the space deep to retinaculum into four compaments. Structures passing deep to this:(Medial to lateral)1. Tendon of Tibialis posterior.2. Tendon of flexor digitorum longus 3. Posterior tibial aery and its terminal branches along with accompanying veins.4. Tibial nerve and its terminal branches.5. Tendon of flexor hallucis longus. Each tendon separate compament.Aery and nerve same compament.Near the calcaneum, it is pierced by the medial calcaneal vessels and nerves.Lower pa of deep surface of retinaculum gives origin to greater pa of abductor hallucis muscle. Tibial nerve injury under flexor retinaculum-Tarsal tunnel syndrome. {Reference: BDC 6E pg no.105}\n\nOPTION A IS CORRECT."}
{"question": "Question: About degenerative myopia which of the following is true:\nOptions:\nA. Myopic degeneration can lead to retinal detachment\nB. It is more common in men than women\nC. Less than -6 D\nD. Optic disc swelling is seen\n", "answer": " Ans. (a) Myopic degeneration can lead to retinal detachmentRef: Kanski 7/e, p. 637; Parson's 22/e, p. 72\"Rhegmatogenous retinal detachment (RD) is much more common in high myopia, the pathogenesis including increased frequency of posterior vitreous detachment, lattice degeneration, asymptomatic atrophic holes. Macular holes and occasionally giant retinal tears. The prevalence of retinal detachment appears to be related to the severity of myopia.\"Optic disc swelling (pseudopapillitis) seen in hypermetropia.\n\nOPTION A IS CORRECT."}
{"question": "Specialized clinical ophthalmology question: What are the appropriate medicines for the treatment of macular edema ?", "answer": "Specialized clinical ophthalmology abstractive answer: The appropriate medicines for the treatment of macular edema include intravitreal triamcinolone (TA) injections. TA stabilizes the blood-retinal barrier and downregulates the production of vascular endothelial growth factor (VEGF), which is responsible for increased vascular permeability. By inhibiting prostaglandins and reducing VEGF, TA helps reduce macular edema. Additionally, TA has been shown to inhibit neovascularization and reduce endothelial cell permeability. It is important to inform the patient about the risks associated with TA injections and the possibility of elevated intraocular pressure (IOP) as a side effect. Regular monitoring of IOP and prompt reporting of any symptoms such as worsening pain, vision changes, or redness is crucial."}
{"question": "Question: In complicated cataract opacity develops in-\nOptions:\nA. Anterior capsule\nB. Nucleus\nC. Posterior subcapsular\nD. Cortical\n", "answer": " Ans. is 'c' i.e., Posterior subcapsular * Complicated cataract refers to the lens opacification secondary to some other intraocular disease. Anterior uveitis is the most common cause. Other causes are posterior uveitis, pars planitis, corneal ulcer, ciliary body tumors, degenerative myopia, retinitis pigmentosa and retinal detachment.* Typically complicated cataracts occur in two forms :-1) Posterior cortical complicated cataract:- This type of cataract is due to affections of posterior segment. This cataract is located in a posterior subcapsular cataract and typically opacification starts in the posterior part of the cortex in the axial region (Posterior cortical cataract or posterior subcapsular cataract). On slit lamp examination the opacities have \"bread- crumb\" appearance. A characteristic sign is presence of polychromatic lusture of red, green and blues.2) Anterior cortical complicated cataractThis is due to the affection of anterior segment like glaucoma or anterior uveitis.\n\nOPTION C IS CORRECT."}
{"question": "How does the maturation of the visual system affect the ERG responses in infants ?", "answer": "The maturation of the visual system in infants greatly influences the ERG (Electroretinogram) responses. At birth, full-field cone and rod ERG responses are detectable but small and prolonged. However, the standard ERG recommended by the International Society for Clinical Electrophysiology of Vision (ISCEV) may not reliably elicit responses due to low retinal luminance. It is important to note that a quarter of normal infants aged 5 weeks and younger have no detectable standard rod response, and the lower limits of normal b-wave amplitudes for rod, cone, and combined rod-cone responses include zero until approximately 15 weeks of age. To reliably elicit responses in young infants, higher intensity stimuli are required. In fact, a retinal illuminance approximately 2.0 log units higher than the recommended standard flash is necessary to produce a mean amplitude of 14mV in the rod response of virtually all infants at 36 weeks after conception. Full-field ERG amplitudes and implicit times show the most rapid improvement during the first 4 months of life, followed by slower development thereafter. Generally, mean ERG parameters reach the low range of adult values by a certain age."}
{"question": "Question: Does the monocyte chemokine receptor CX3CR1 play a significant role in the pathogenesis of experimental autoimmune uveoretinitis?\nContext: To examine the role of the monocyte chemokine receptor CX(3)CR1 in experimental autoimmune uveoretinitis (EAU). EAU was induced in naive WT, Cx(3)cr1(gfp/+), and Cx(3)cr1(gfp/gfp) C57Bl/6 mice or chimeric mice. Ocular disease severity was graded by histologic analysis of resin sections. In addition, immunohistochemistry and confocal microscopy were performed on retinal whole mounts to characterize the monocytic infiltrate and changes in retinal microglia. To determine the relative roles of resident and blood-borne monocyte-derived cells in the active phase of uveoretinitis, EAU was induced 4 weeks after transplantation in chimeric mice (Cx(3)cr1(gfp/gfp)→WT and Cx(3)cr1(gfp/+)→WT), and analysis was performed at days 14, 16, 21, and 28 after immunization. After EAU induction, disease scores were not significantly different in WT, Cx(3)cr1(gfp/+), and Cx(3)cr1(gfp/gfp) mice. Chimeric studies revealed both donor- and host-derived monocyte-derived cells in the inner retinal layers during early EAU; however, it was donor monocytic cells that infiltrated the photoreceptors, the site of the target antigen. The absence of CX(3)CR1 did not impede the ability of monocyte-derived cells from Cx(3)cr1(gfp/gfp) donor mice to infiltrate during the peak of EAU.", "answer": "The lack of CX(3)CR1 on monocyte-derived cells does not significantly influence the onset or severity of EAU. In addition, chimeric studies revealed that it is primarily blood-derived monocytes that mediate photoreceptor damage in the effector phase of EAU, and this process is not CX(3)CR1 dependent.\n\nno"}
{"question": "What are the limitations on the number of electrodes in a retinal prosthesis based on the distance between them and the target cells ?", "answer": "The number of electrodes in a retinal prosthesis is limited based on the distance between the electrodes and the target cells. As shown in previous research, for electrodes with a radius of 5 µm, the maximum tolerable power dissipation is reached when cells are about 75 µm away from the implant. However, for larger electrodes with radii of 15 µm and 50 µm, the effect of distance is less restrictive, allowing for tolerable separations of 230 µm and 700 µm, respectively. Therefore, the size of the electrode array and the distance between the electrodes and target cells must be carefully considered to ensure optimal function and safety of the retinal prosthesis."}
{"question": "What is the purpose of the Macular Photocoagulation Study (MPS) in the field of ophthalmology ?", "answer": "The purpose of the Macular Photocoagulation Study (MPS) was to investigate the effectiveness of laser photocoagulation as a treatment modality for choroidal neovascularization (CNV) in age-related macular degeneration (AMD). The study aimed to determine whether coagulating the leaking vessels outside the fovea could prevent significant loss of visual acuity. Additionally, the MPS examined the visual outcomes of eyes receiving photocoagulation for new or recurrent juxtafoveal and subfoveal CNV. The study's findings provided valuable insights into the use of laser photocoagulation as a potential treatment option for CNV associated with AMD."}
{"question": "Question: A 47-year-old female patient's right breast exhibited peau d'orange characteristics. This condition is primarily a result of which of the following occurrences?\nOptions:\nA. Blockage of cutaneous lymphatic vessels\nB. Shortening of the suspensory ligaments by cancer in the axillary tail of the breast\nC. Contraction of the retinacula cutis of the are ola and nipple\nD. Invasion of the pectoralis major by metastatic cancer\n", "answer": " Blockage of cutaneous lymphatic vessels results in edema of the skin surrounding the hair follicles, leading to an appearance like an orange peel (peau d'orange). Shortening of the suspensory ligaments leads to dimpling of the overlying skin, not peau d'orange. Contraction of retinacula cutis results in retraction and inversion of the nipple and/or areola. Pectoralis major involvement has nothing to do with this condition but can result in fixing the tumor firmly to the chest wall.\n\nOPTION A IS CORRECT."}
{"question": "What are the treatment options for residual myopia and astigmatism following radial keratotomy ?", "answer": "LASIK can be used to treat residual myopia and astigmatism following radial keratotomy. A secondary LASIK procedure is typically preferred, either by creating a new corneal cut or using flap hydrodissection. It is important to conduct a thorough preoperative examination to ensure good incision healing and to address any complications such as epithelial cysts. Postoperative recurrent corneal erosions and slight visual fluctuation may occur, but achieving UCVA of 20/20 is possible in a significant percentage of cases. Refraction within 0.5 D of emmetropia can be achieved in the majority of cases, with a chance of gaining one line of BCVA and a small risk of losing one line."}
{"question": "Question: Does tafluprost protect rat retinal ganglion cells from apoptosis in vitro and in vivo?\nContext: To investigate whether tafluprost, which is a prostaglandin-related compound and an anti-glaucoma drug, has a direct anti-apoptotic effect in cultured retinal ganglion cells (RGCs) and rat RGCs in retinas with optic nerve crush (ONC). RGC-5 cells were induced to undergo apoptosis by a serum deprivation and by exogenous glutamate. The level of cell death with or without tafluprost was monitored by an XTT assay and by immunocytochemistry with activated caspase-3. Changes in intracellular calcium ([Ca(2+)]i) levels were measured with fluo-4 fluorescence. Rat RGCs were degenerated by ONC. After topical instillation of tafluprost for 7 and 14 days, the numbers of retrograde-labeled RGCs were counted. Retinal flatmounts were subjected to terminal dUTP nick end labeling (TUNEL) staining to detect apoptotic cells. Tafluprost dose-dependently promoted RGC-5 cell viability with an optimum concentration of 3 microM (p = 0.006). Tafluprost significantly reduced caspase-3-positive cells and suppressed [Ca(+2)]i evoked by exogenous glutamate. The cGMP-dependent protein kinase inhibitor and KT-5823 partially blocked the rescue effect of tafluprost (p = 0.002). The survival rate of RGCs significantly increased in eyes treated with tafluprost (p = 0.01), and the prevalence of TUNEL-positive cells was significantly decreased 14 days after ONC (p < 0.001).", "answer": "These data suggest that tafluprost has an anti-apoptotic effect in RGCs.\n\nyes"}
{"question": "What is the relationship between AMD severity and visual functioning in patients with age-related macular degeneration ?", "answer": "The severity of age-related macular degeneration (AMD) can have an impact on the visual functioning of patients. The clinical severity of AMD is graded on a seven-point scale, ranging from mild to severe, based on the presence of exudative and nonexudative changes in the eyes. This grading system considers factors such as the presence of drusen, retinal pigment epithelium detachment, occult choroidal neovascularization, choroidal neovascularization, diskiform scars, and subfoveal or juxtafoveal geographic atrophy. The severity of AMD is graded for each eye individually and also bilaterally, considering the better eye and the worse eye. This grading system allows for the classification of AMD severity into different grades, such as mild/mild, mild/moderate, mild/moderately severe, moderate/moderately severe, moderately severe/moderately severe, moderately severe/very severe, and very severe/very severe. The correlation between AMD severity and visual functioning is assessed using the VF-14 scoring system. The VF-14 is a questionnaire that measures the impact of visual impairment on various activities of daily living. However, it is important to note that the VF-14 primarily focuses on the physical aspects of health-related quality of life (QOL) and may not fully capture the mental aspects. While the VF-14 has been correlated with the SF-36 physical composite scale (PCS), indicating a relationship between physical functioning and AMD severity, it does not show a correlation with the SF-36 mental composite scale (MCS). This suggests that the VF-14 may not assess the mental aspects of health-related QOL in patients with AMD. However, other studies have reported that patients with AMD experience vision-specific mental health problems, including concerns about future vision, embarrassment, and loss of control due to visual loss. These issues were identified as the fourth most common type of problem associated with AMD. Patients with AMD have also scored lower on the NEI-VFQ vision-specific mental health subscale compared to controls. Therefore, while the overall mental health of patients with AMD may be at or near normal levels, they may still face vision-specific mental health challenges. Further research is needed to determine if the NEI-VFQ, which provides more detailed assessment, can account for a greater amount of variance in reported visual"}
{"question": "What is chroidal neovascularization (CNV) ?", "answer": "Choroidal neovascularization (CNV) is a pathological condition characterized by the growth of new blood vessels originating from the choroid, a layer of the eye located between the retina and the sclera (the white part of the eye). CNV is often associated with age-related macular degeneration (AMD) and can lead to severe vision loss. In CNV, the abnormal blood vessels grow towards the retina, where they can leak fluid and blood, causing damage to the delicate retinal structures responsible for central vision. This can result in distorted or blurred vision, and if left untreated, CNV can lead to irreversible vision loss. Various treatment options are available for CNV, including anti-VEGF medications, photodynamic therapy, and laser photocoagulation, depending on the specific characteristics of the CNV and the patient's individual needs. Early detection and prompt intervention are crucial for managing CNV and preserving visual function."}
{"question": "Question: Does troglitazone suppress transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells?\nContext: Transforming growth factor (TGF)-beta2 induction of epithelial-mesenchymal transition of retinal pigment epithelium (RPE) cells has been implicated to be an important event during the development of proliferative vitreoretinopathy. The present study was conducted to examine whether troglitazone (TGZ) can inhibit TGFbeta2-mediated fibrosis of RPE cells. The mechanism of the TGZ effect was also investigated by studying major TGFbeta2-induced signaling including activation of Smad and p38 mitogen activated protein kinase (MAPK). Human RPE cells (ARPE-19) were exposed to various concentrations of TGZ in the presence of TGFbeta2. The inhibitory effects of TGZ on collagen type I (COLI) and fibronectin (FN) expression induced by TGFbeta2 was evaluated by reverse transcriptase-polymerase chain reaction. COLI synthesis was evaluated by the concentration of the C-terminal propeptide of COLI in the medium. The protein levels of FN and the phosphorylation of p38 MAPK and Smad2 and Smad3 were assessed by immunoblotting. TGZ inhibition of TGFbeta2-promoted ARPE-19 cell migration was evaluated by an in vitro wound-healing assay. The influence of TGZ on cell viability was evaluated by the colorimetric conversion of 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide. TGZ dose-dependently inhibited TGFbeta2-induced COLI and FN overexpression at the levels of mRNA and protein manufacture. A dose-dependent TGZ inhibition was also apparent in TGFbeta2-induced cell migration; cell viability was unaffected. TGFbeta2 induced sequential phosphorylation of Smad2 and Smad3 and p38 MAPK. TGZ inhibited TGFbeta2-induced early Smad2 and Smad3 and late Smad3 phosphorylation but had no influence on TGFbeta2-induced p38 MAPK activation.", "answer": "TGZ pretreatment can significantly prevent TGFbeta2-induced epithelial- mesenchymal transition of RPE cells, and retards cell migration. This may be achieved through the prevention of TGFbeta2-induced Smad2 and Smad3 phosphorylation and subsequent nuclear accumulation. On the other hand, TGZ does not alter the levels of TGFbeta2-induced p38 MAPK phosphorylation, the effect of TGZ is unlikely to be mediated by p38 MAPK signaling.\n\nyes"}
{"question": "What are the ocular manifestations commonly seen in patients with aniridia ?", "answer": "Patients with aniridia may present with various ocular manifestations. These include photophobia (light sensitivity), nystagmus (involuntary eye movements), decreased vision, amblyopia (decreased vision without apparent physical defect or disease), strabismus (squint), corneal opacification, glaucoma, lens abnormalities, retinal abnormalities, and optic nerve abnormalities. It is worth noting that many affected patients also exhibit a characteristic facial expression with narrowed palpebral fissure (eye opening) and a furrowed brow, which is a result of photophobia. Additionally, aniridia can occur as part of a systemic association of defects, such as mental retardation, genital abnormalities, Wilms' tumor (WAGR syndrome), and Gillespie syndrome."}
{"question": "Discuss dark adaptation physiology ?", "answer": "Dark adaptation is the process by which our eyes adjust to see in low light conditions. It involves a series of physiological changes that occur in the retina and other parts of the visual system. Here is a discussion of the key aspects of dark adaptation physiology: 1. Rods and cones: The retina contains two main types of photoreceptor cells - rods and cones. Rods are responsible for vision in dim light, while cones are responsible for color and high acuity vision in bright light. 2. Rhodopsin regeneration: In bright light, rhodopsin, a pigment found in rods, is rapidly bleached and becomes non-functional. During dark adaptation, rhodopsin needs to be regenerated. This process involves the replenishment of the pigment molecule in the rod cells. 3. Pupil dilation: In low light conditions, the pupils of our eyes dilate to allow more light to enter the eye. This increases the amount of light that can reach the photoreceptor cells in the retina. 4. Dark current: In the dark, the photoreceptor cells are \"depolarized,\" meaning that they are constantly releasing neurotransmitters, signaling the presence of light. This is known as the dark current. During dark adaptation, the dark current decreases, allowing the photoreceptor cells to become more sensitive to low levels of light. 5. Cone adaptation: While rods are primarily responsible for dark adaptation, cones also undergo some level of adaptation in low light conditions. However, cones are less sensitive to dim light compared to rods. 6. Time course: Dark adaptation is a gradual process that takes time. Initially, vision in the dark is poor, but as the photoreceptor cells adapt, sensitivity to light gradually improves. It can take several minutes to reach optimal vision in complete darkness. 7. Vitamin A: Adequate levels of vitamin A are crucial for the dark adaptation process. Vitamin A is necessary for the synthesis of rhodopsin, and a deficiency can impair dark"}
{"question": "What are the treatment options for retinal detachment ?", "answer": "Treatment options for retinal detachment include the use of various surgical procedures. These surgical procedures may involve techniques such as scleral buckling, vitrectomy, or pneumatic retinopexy. Scleral buckling involves the placement of a silicone band around the eye to support the detached retina. Vitrectomy is a surgical procedure that involves removing the vitreous gel from the eye and replacing it with a gas or silicone oil bubble to help reattach the retina. Pneumatic retinopexy involves injecting a gas bubble into the eye to push the detached retina back into place. These surgical interventions aim to reattach the retina and restore vision. It is important for individuals with retinal detachment to seek immediate medical attention as early intervention can significantly improve the chances of successful treatment."}
{"question": "Can you explain the possible mechanism of age-related macular degeneration (AMD) and its association with drusen ?", "answer": "The development of age-related macular degeneration (AMD) is thought to involve various mechanisms, one of which is the interaction of advanced glycation end products (AGEs) and AGE receptors. Drusen, small lumps of aggregated proteins found in AMD, contain AGEs and D-amino acid-containing proteins. These components, in addition to being byproducts of the aging process, may also accelerate the aging process in the retina. One possible mechanism is the interaction between AGEs and the receptor for AGE (RAGE) on retinal pigment epithelial cells. This interaction leads to increased inflammation and accelerated neovascularization, which are characteristic features of AMD. AGE-modified proteins are recognized by RAGE, galectin-3, macrophage scavenger receptors, and CD36. The interaction of AGEs with RAGE specifically induces the production of inflammatory cytokines such as TNF-α and VEGF. The constant interaction of AGEs in drusen with RAGE on retinal pigment epithelial cells can lead to increased expression of VEGF and subsequent neovascularization, which contributes to the development of AMD. This positive feedback loop further amplifies the inflammatory response and angiogenic processes in the retina. Understanding these mechanisms is crucial for developing targeted treatments that aim to interrupt or modulate the interaction between AGEs and RAGE. By intervening in these pathways, it may be possible to mitigate the progression of AMD and preserve visual function in affected individuals."}
{"question": "What is the appropriate timing to operate on a patient with choroidal folds ?", "answer": "The appropriate timing to operate on a patient with choroidal folds depends on the underlying cause of the folds and the severity of symptoms. Choroidal folds can be caused by various entities, including orbital tumors, idiopathic orbital inflammation, thyroid ophthalmopathy, and primary or secondary choroidal tumors. In some cases, choroidal folds may be associated with macular degeneration with choroidal neovascularization. When choroidal folds are causing significant visual impairment or other debilitating symptoms, surgical intervention may be necessary. The timing of the surgery will depend on the urgency of the underlying condition and the potential risks and benefits of the procedure. For example, if the choroidal folds are caused by an orbital tumor that is rapidly growing and threatening the patient's vision, surgery may need to be performed as soon as possible to remove the tumor and relieve the pressure on the choroid. In contrast, if the choroidal folds are secondary to a less urgent condition, such as macular degeneration, the timing of the surgery may be determined based on the progression of the disease and the patient's individual circumstances. It is important to consult with an ophthalmologist or a specialist in ocular oncology to determine the most appropriate timing for surgery in each specific case. They will consider factors such as the patient's overall health, the nature of the underlying condition, and the potential risks and benefits of the surgical intervention. Reference: 1. Shields JA, Shields CL. Orbital tumors: evaluation and management. Philadelphia: WB Saunders; 2014."}
{"question": "Question: Does propofol influence the electroretinogram to a lesser degree than thiopentone?\nContext: The Electroretinogram (ERG) is used clinically to assess the function of retina. Anaesthetic agents are known to affect ERG, and as anaesthesia is often needed in children and uncooperative patients, knowledge about its effects is of clinical importance. Barbiturates selectively depress ERG components, and we compared thiopentone with propofol to assess if the latter preserved retinal function better. Ten pigs, average weight 17 kg (SD +/- 2 kg) were anaesthetized randomly with propofol 10 mg kg-1 or thiopentone 30 mg kg-1. Anaesthesia was maintained by 65% nitrous oxide in oxygen and continuous infusion of the induction agent, i.e. 10 mg kg-1 h-1 of propofol, or 10 mg kg-1 h-1 for the first hour, then 5 mg kg-1 h-1 of thiopentone, with doses being based on pilot studies. After an interval of one week the programme was repeated using the other agent. After 40 minutes dark-adaptation, responses to single flashes of graded intensities from a xenon flashlamp were recorded at five-minute intervals. The a- and b-wave amplitudes and implicit times (time to peak), and a-wave slopes were determined. The b-wave implicit time was significantly shorter during propofol anaesthesia than when using thiopentone. The effect was most pronounced at the lowest intensities (P < 0.01). No statistically significant differences were found in the amplitudes of the b-waves. The a-wave appeared at lower stimulus intensity (P < 0.05) and the a-wave slopes were significantly steeper (P < 0.01) during propofol anaesthesia.", "answer": "Propofol accordingly appeared to preserve the photoreceptor response better than thiopentone, and may therefore be considered to be more suitable for ERG recordings than thiopentone.\n\nyes"}
{"question": "What are the etiological factors and types of congenital glaucoma ?", "answer": "Congenital glaucoma is characterized by abnormally high intraocular pressure (IOP) resulting from developmental abnormalities in the angle of the anterior chamber. The etiological factors involved in the development of congenital glaucoma can be grouped into two categories: primary insults and secondary insults. Primary insults include raised intraocular pressure, which causes mechanical stretch on the lamina cribrosa, leading to axonal deformation and ischemia by altering capillary blood flow. Secondary insults, on the other hand, involve toxic factors such as glutamate (excitatory toxin), oxygen free radicals, or nitric oxide, which are released when retinal ganglion cells undergo death due to primary insults. This secondary insult leads to continued damage mediated apoptosis, even after the primary insult has been controlled. There are three types of congenital glaucoma based on the age of onset: true congenital glaucoma, infantile glaucoma, and juvenile glaucoma. True congenital glaucoma is diagnosed when the intraocular pressure is elevated during intrauterine life, and the child is born with ocular enlargement. This type accounts for approximately 40 percent of cases. Infantile glaucoma manifests before the child's third birthday and accounts for about 50 percent of cases. Juvenile glaucoma, the remaining 10 percent of cases, refers to the development of elevated intraocular pressure between 3-16 years of age."}
{"question": "What are the appropriate medicines for the treatment of retinopathy of prematurity (ROP) ?", "answer": "The treatment of retinopathy of prematurity (ROP) does not involve medications. In the early stages, close observation is crucial as ROP can rapidly progress to a threshold that requires prompt treatment. The treatment options for ROP include laser therapy and anti-VEGF injections, depending on the severity and stage of the disease. Laser therapy aims to ablate the peripheral avascular retina, while anti-VEGF injections target the abnormal blood vessels that develop in the retina. The choice of treatment is determined by the ophthalmologist based on the specific characteristics of the disease in each individual case."}
{"question": "Question:  Hi I have a 8 yr 8 month old daughter. Last year she was diagnosed with myopia and it was 1.5 this year when we went for yearly checkup it has increased to 2.5. She does not watch tv for more than 30 mins a day and is not even too much on electronic gadgets. I am really worried.\n", "answer": " First thing to note in recent studies it is found that watching TV or studying don't cause myopia... But incidence of myopia is less in patient involving in outdoor games... As myopia is less than -3 not to worry. And myopia is likely to increase with increasing high... High myopia more than -6 is more likely to be associated with retinal degeneration... So using lenses till age 18 to 21, may be contact lenses when patient is able to take proper care of it is recommended... LAST surgery for myopia is suggested after age 18... Just visit ophthalmologist yearly to get eye examination done and to monitor changes in retina by ophthalmology is recommended... Plus point is, some studies have shown myopic have high IQ than control population..."}
{"question": "What are the possible causes of hypofluorescence and hyperfluorescence in fluorescein angiography ?", "answer": "Hypofluorescence in fluorescein angiography can be caused by various factors. It may occur due to a transmission defect, which involves the presence of retinal or preretinal blood, pigment, or hard exudates that block the transmission of the dye. Another cause is a filling defect, which indicates an abnormality in circulation. On the other hand, hyperfluorescence in fluorescein angiography can be attributed to different factors as well. A window defect, caused by a defect in the retinal pigment epithelium (RPE), allows the dye to pass through and appear hyperfluorescent. Leakage of dye can occur due to the presence of retinal new vessels or subretinal neovascular membranes. Staining of retinal structures, such as damaged blood vessels or drusen, can also result in hyperfluorescence. Other causes include fluorescein pooling, which may indicate retinal or RPE detachments, and autofluorescence seen in disc drusen. It is important to carefully analyze the fluorescein angiography findings and consider these possible causes to make accurate diagnoses and determine appropriate management strategies for patients."}
{"question": "Question: Does a new GFP-tagged line reveal unexpected Otx2 protein localization in retinal photoreceptors?\nContext: Dynamic monitoring of protein expression and localization is fundamental to the understanding of biological processes. The paired-class homeodomain-containing transcription factor Otx2 is essential for normal head and brain development in vertebrates. Recent conditional knockout studies have pointed to multiple roles of this protein during late development and post-natal life. Yet, later expression and functions remain poorly characterized as specific reagents to detect the protein at any stage of development are still missing. We generated a new mouse line harbouring an insertion of the GFP gene within the Otx2 coding sequence to monitor the gene activity while preserving most of its functions. Our results demonstrate that this line represents a convenient tool to capture the dynamics of Otx2 gene expression from early embryonic stages to adulthood. In addition, we could visualize the intracellular location of Otx2 protein. In the retina, we reinterpret the former view of protein distribution and show a further level of regulation of intranuclear protein localization, which depends on the cell type.", "answer": "The GFP-tagged Otx2 mouse line fully recapitulates previously known expression patterns and brings additional accuracy and easiness of detection of Otx2 gene activity. This opens up the way to live imaging of a highly dynamic actor of brain development and can be adapted to any mutant background to probe for genetic interaction between Otx2 and the mutated gene.\n\nyes"}
{"question": "Question: Is melanopsin expressed in PACAP-containing retinal ganglion cells of the human retinohypothalamic tract?\nContext: The putative circadian photoreceptor melanopsin is found in rodents in a subpopulation of intrinsic light-sensitive retinal ganglion cells (RGCs) constituting the retinohypothalamic tract (RHT). The study was conducted to determine whether melanopsin is expressed in the human retina and costored with the neuropeptide pituitary adenylate cyclase activating polypeptide (PACAP), a marker for the RHT, projecting to the suprachiasmatic nucleus (SCN). Furthermore, whether melanopsin expression is conserved in retinas of blind patients with severe retinal degeneration was investigated. In situ hybridization and immunohistochemistry was used to demonstrate melanopsin synthesis in human eyes of 17 donors and two postmortem hypothalami containing the SCN. The coexistence of melanopsin and PACAP in elements of the retinohypothalamic tract was studied by dual-labeling immunocytochemistry. Melanopsin expression was found in a subpopulation of RGCs located in the ganglion cell layer and displaced in the inner nuclear cell layer. Melanopsin-containing cells comprised approximately 0. 8% of all RGCs, with a distinct morphology characterized by two to four dendritic processes constituting a panretinal network. Melanopsin immunoreactivity was primary present at perikaryal boundaries and neuronal processes and to some extent also in the cytoplasm. PACAP and melanopsin were colocalized in the RGCs and PACAP-containing nerve fibers, seemingly innervating the retinorecipient part of the SCN. Melanopsin-expressing RGCs were conserved in retinas of blind patients with severe degeneration of the outer and/or inner layers.", "answer": "Given the expression of melanopsin in PACAP-containing RGCs of the human RHT, this photoreceptor is a likely first base in the chain of events leading to photoentrainment of both normal and blind people.\n\nyes"}
{"question": "Question: Primary open-angle glaucoma is associated with all of the following except:\nOptions:\nA. Diabetes mellitus\nB. Myopia\nC. Hypehyroidism\nD. Pars planitis\n", "answer": " Ans. Pars planitis\n\nOPTION D IS CORRECT."}
{"question": "Question: Which of the following drug is deposited in the retina ?\nOptions:\nA. Isoniazid\nB. Chloroquine\nC. Rifampicin\nD. Pyrazinamide\n", "answer": "OPTION B IS CORRECT."}
{"question": "What is the optical principle of indirect ophthalmoscopy ?", "answer": "Indirect ophthalmoscopy operates on the principle of casting a convergent light beam into the patient's eye, creating a myopic condition by placing a +13 D convex lens between the observer and the patient. This setup forms a real, inverted image of the fundus between the lens and the observer. The indirect ophthalmoscope provides a magnified view of the fundus, allowing for detailed examination and visualization of the ocular structures."}
{"question": "What is the role of growth and neurotrophic factors in retinal development ?", "answer": "Growth and neurotrophic factors play a crucial role in the development of the nervous system, including the retina. These factors are involved in regulating cell proliferation, promoting neuronal differentiation, and ensuring neuronal survival. Several growth and neurotrophic factors that are present in the developing central nervous system (CNS) are also found in the developing retina. Examples of such factors include TGF-α, which regulates cell proliferation, and other factors that promote neuronal differentiation and survival. The presence of these factors suggests their involvement in the complex processes of retinal development (Harris, 1997; Tanihara et al., 1997). Further research is needed to fully understand the specific functions and mechanisms of action of these growth and neurotrophic factors in retinal development."}
{"question": "Question: Does retinal ganglion cell death in experimental glaucoma and after axotomy occur by apoptosis?\nContext: To investigate whether retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Chronic elevated eye pressure was produced in 20 monkey eyes, and the optic nerve was transected unilaterally in the orbit of 10 monkeys and 14 rabbits. Sixteen monkey and 14 rabbit eyes were studied as normal controls. Analytic methods included light and electron microscopy, histochemistry for DNA fragmentation (TUNEL method), and DNA electrophoresis in agarose gels. Dying ganglion cells in the experimental retinas exhibited morphologic features of apoptosis, including chromatin condensation and formation of apoptotic bodies. Cells with a positive reaction for DNA fragmentation were observed in eyes subjected to axotomy and experimental glaucoma but were only rarely encountered in control eyes. No evidence of internucleosomal fragmentation was detected electrophoretically, possibly because of the small proportion of cells that were dying at any given time.", "answer": "Some retinal ganglion cells injured by glaucoma and by axotomy die by apoptosis.\n\nyes"}
{"question": "What are the morphological and functional effects of intravitreal ranibizumab injections in patients with choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) ?", "answer": "Intravitreal injections of ranibizumab have shown positive morphological and functional effects in patients with CNV secondary to AMD. Studies such as MARINA, SAILOR, PIER, and PrONTO have demonstrated that shortly after ranibizumab injection, there is stabilization or improvement in visual acuity (VA), accompanied by a decrease in macular thickness and a reduction in intra- and subretinal fluid leakage. The high-definition images obtained through spectral domain optical coherence tomography (SD-OCT) allow for a detailed visualization of retinal morphology over time, providing valuable information for the identification of parameters relevant to functional improvement and prognosis. Sequential OCT measurements have also been utilized to determine the efficacy and duration of action of ranibizumab, showing that it effectively reduces central foveal thickness or macular volume. It is worth noting that bevacizumab and ranibizumab have shown comparable effectiveness in reducing retinal thickness, but bevacizumab may take longer to achieve the minimum macular volume and its effects may take longer to wear off. Additionally, studies have indicated that the reduction in retinal thickness after anti-VEGF injection primarily results from the decreased permeability in the neovascular lesion, followed by a reduction in intra- and subretinal fluid, without a reduction in the size of the CNV lesion."}
{"question": "Question: Is fIZ1 part of the regulatory protein complex on active photoreceptor-specific gene promoters in vivo?\nContext: FIZ1 (Flt-3 Interacting Zinc-finger) is a broadly expressed protein of unknown function. We reported previously that in the mammalian retina, FIZ1 interacts with NRL (Neural-Retina Leucine-zipper), an essential transcriptional activator of rod photoreceptor-specific genes. The concentration of FIZ1 in the retina increases during photoreceptor terminal maturation, when two key transcription factors NRL and CRX (Cone-Rod Homeobox) become detectable on the promoters of photoreceptor-specific genes (i.e. Rhodopsin, Pde6b). To determine if FIZ1 is involved in regulating CRX-mediated transcriptional activation, we examined FIZ1 subcellular location in mouse neural retina, its ability to interact with CRX, and its association with CRX/NRL target genes. FIZ1 is present in the nucleus of adult photoreceptors as well as other retinal neurons as shown by transmission electron microscopy with nano-gold labeling. FIZ1 and CRX were co-precipitated from retinal nuclear extracts with antibodies to either protein. Chromatin immunoprecipitation (ChIP) assays revealed that FIZ1 is part of the protein complex on several rod and cone gene promoters, within photoreceptor cells of the mouse retina. FIZ1 complexes with CRX or NRL on known NRL- and CRX-responsive elements, as shown by electrophoretic mobility shift assays with FIZ1 antibody. FIZ1 can directly bind to CRX, as demonstrated using yeast two-hybrid and GST pull-down assays. Co-transfection assays demonstrated that FIZ1 increases CRX-mediated activation of Opsin test promoters. Quantitative ChIP analysis revealed an increased association of FIZ1 with the Rhodopsin promoter in adult (P-25) neural retina versus immature (P-3) neural retina. The quantity of transcriptionally active RNA Polymerase-II within the Rhodopsin gene (Rho) was significantly increased in the adult neural retina, compared to the immature retina.", "answer": "FIZ1 directly interacts with CRX to enhance CRX's transactivation activity for target genes. Developmentally, in neural retina tissue, the increased association of FIZ1 with CRX target genes corresponds to an increased association of transcriptionally active Pol-II within the Rho gene. Together with previous findings, our results suggest that FIZ1 may act as a transcriptional co-regulator of photoreceptor-specific genes, recruited by at least two photoreceptor-specific transcription factors, CRX and NRL. Further studies are underway to elucidate the exact role of FIZ1 in photoreceptor gene expression, development and maintenance.\n\nyes"}
{"question": "What are the typical imaging features of choroidal hemangioma on B-scan ultrasonography ?", "answer": "Choroidal hemangiomas typically appear as flat, echogenic, solid, subretinal masses on B-scan ultrasonography. They often have a collar-button or dome-shaped contour and minimal sound attenuation. The tumor exhibits medium to high reflectivity with very high internal reflectivity (95-100%), which is attributed to the large interfaces formed by the vessel surfaces. The irregular spikes of medium to high amplitudes seen on A-scan further support the diagnosis."}
{"question": "What is the fundamental physical phenomenon at work in the eye ?", "answer": "The fundamental physical phenomenon at work in the eye is refraction. When light crosses the boundary between two media, such as air and the jelly inside the eye, part of its energy is reflected while the other part passes into the new medium. Refraction occurs as the transmitted ray is bent, allowing the eye to focus light and form an image on the retina."}
{"question": "What are the different instruments used in ophthalmic surgery and their respective functions ?", "answer": "In ophthalmic surgery, various specialized instruments are utilized to perform specific tasks. These instruments aid in performing procedures such as cataract surgery, corneal transplantation, and retinal surgery. Some commonly used instruments include: 1. Wire Speculum: Used to hold the eyelids apart and provide access to the eye during surgery. 2. Blade Breaker and Holder: Utilized to break and hold surgical blades. 3. Colibri Forceps: Used for delicate tissue handling and suturing. 4. Kelman-McPherson Forceps: Designed to manipulate the lens during cataract surgery. 5. Vannas Capsulotomy Scissors: Used for precise cutting of the anterior lens capsule. 6. Iris Spatula: Helps manipulate the iris during surgery. 7. Simcoe Irrigation-Aspiration Cannula: Used for irrigation and aspiration of fluid during cataract surgery. 8. Hydrodissection Cannula: Used to separate the lens from the capsular bag during cataract surgery. 9. Capsulorhexis Forceps: Designed for creating a circular tear in the anterior lens capsule. 10. Lens Loop and Muscle Hook: Used to manipulate the lens and intraocular muscles. 11. Irrigating Vectis: Helps in lens extraction during cataract surgery. 12. Sinskey Lens Manipulating Hook: Utilized for lens manipulation and placement. 13. Lens Holding Forceps: Designed to hold and stabilize the lens during surgery. 14. Capsule Polisher: Used to polish the remaining capsular bag after lens removal. Each instrument plays a crucial role in ophthalmic surgery, allowing for precise and effective management of various eye diseases and conditions. It is important for ophthalmologists to be well-versed in the functions and proper utilization of these instruments to ensure successful surgical outcomes."}
{"question": "What are the risk factors associated with the growth of a choroidal nevus ?", "answer": "Risk factors associated with the growth of a choroidal nevus include greater tumor thickness, orange lipofuscin pigmentation, a thin layer of subretinal fluid over the tumor surface, posterior tumor margin touching the optic disc, late diffuse staining and leakage on fluorescein angiogram, and the presence of pinpoint hotspots."}
{"question": "Question: Does a new color vep procedure disclose asymptomatic visual impairments in optic neuritis and glaucoma suspects?\nContext: To evaluate the reliability of visual evoked potentials obtained with a set of multiple chromatic and achromatic patterns (C-VEPs) in differentiating asymptomatic perifoveal retinal impairment from central conduction impairment. We propose a set of colored pattern stimuli that allows relatively differential activation of the magnocellular and parvocellular pathways. The system runs on a standard Pentium PC with peripherals that present stimuli and collect, analyze and print data. P1 latencies of C-VEPs obtained with achromatic (black/white) and chromatic (blue/black and red/black isocontrast) checkerboards were evaluated in normal subjects and patients with subclinical retinal impairment (glaucoma suspects) or mild neural conduction impairment (optic neuritis), none of whom had subjective visual defects. The procedure evoked robust cortical signals and statistically distinguished the 3 groups of subjects. The achromatic and chromatic stimuli used distinguished controls from glaucoma suspects and patients with optic neuritis. Glaucoma suspects had greater impairment of C-VEPs to blue/black checkerboards whereas patients with optic neuritis had greater impairment of responses to red/black stimuli.", "answer": "Our data suggest that chromatic patterns (color/ black, red and blue), that may activate the parvocellular and magnocellular systems differentially but not selectively, can distinguish between mild perifoveal or foveal conduction impairment. They have the additional advantage of evoking large, stable responses across all the subjects.\n\nyes"}
{"question": "Question: Which one of the following is not a ocular emergencies?\nOptions:\nA. Angle closure glaucoma\nB. Central retinal aerial occlusion\nC. Central serous retinopathy\nD. Retinal detachment\n", "answer": " Central serous retinopathy is a self limiting condition that undergoes spontaneous resolution in 80-90% of the cases. Visual acuity recovers normal or near normal with in 4-12 weeks. It's not an ocular emergency. Ref: A.K KHURANA (2005), Chapter 11, \"Disease of The Retina\", In the book, \"Opthalmology\", 3rd Edition, Newdelhi, Page 263\n\nOPTION C IS CORRECT."}
{"question": "Question: Does intravenous administration of diphenhydramine reduce histamine-induced vasodilator effects in the retina and choroid?\nContext: Intravenous administration of histamine causes an increase in choroidal blood flow (ChBF) and retinal vessel diameters in healthy subjects. The receptor mediating this response has not yet been identified. The present study was undertaken to clarify whether H1 receptor blockade with diphenhydramine affects the hemodynamic response of histamine in the choroid and the retina. A randomized, double-masked, placebo-controlled, two-way crossover study was performed in 18 healthy, male, nonsmoking subjects. Histamine (0.32 microg/kg per minute over 30 minutes) was infused intravenously in the absence (NaCl as placebo) or presence of the H1 blocker diphenhydramine (1.0 mg/min over 50 minutes). Ocular hemodynamic parameters, blood pressure, and intraocular pressure were measured before drug administration, after infusion of diphenhydramine or placebo, and after co-infusion of histamine. Subfoveal ChBF and fundus pulsation amplitude (FPA) were measured with laser Doppler flowmetry and laser interferometry, respectively. Retinal arterial and venous diameters were measured with a retinal vessel analyzer. Retinal blood velocity was assessed with bidirectional laser Doppler velocimetry. Administration of histamine caused a decrease in mean arterial pressure by -4% +/- 9% (ANOVA P = 0.01). This effect was blunted by coadministration of diphenhydramine (ANOVA, P = 0.04). Histamine significantly increased FPA and subfoveal ChBF. Coadministration of diphenhydramine significantly reduced this effect (ANOVA; FPA P = 0.001, ChBF P = 0.049). Histamine significantly increased retinal arterial diameter by +3.5% +/- 4.5% and retinal venous diameter by +3.7% +/- 2.8%. Again, coadministration of diphenhydramine significantly reduced the vasodilative effect to +0.3% +/- 5.5% in retinal arteries (ANOVA, P = 0.00006) and to +0.9% +/- 2.5% in retinal veins (ANOVA, P = 0.004).", "answer": "The present data confirm that histamine increases ChBF and retinal vessel diameters in healthy subjects. Administration of the H1 receptor blocker diphenhydramine significantly reduced histamine-induced changes in ocular perfusion parameters. These results strongly indicate that in the retina and choroid, H1 receptors are involved in the histamine-mediated hemodynamic effects in vivo.\n\nyes"}
{"question": "Question: Shifting fluid is pathognomonic of:\nOptions:\nA. Solid retinal detachment\nB. Rhegmatogenous retinal detachment\nC. Tractional retinal detachment\nD. Choroidal detachment\n", "answer": " Ans. Solid retinal detachment\n\nOPTION A IS CORRECT."}
{"question": "Question: The most constant and critical finding in retinitis pigmentosa is\nOptions:\nA. Bone spicule pigmentation in retina\nB. Significantly reduced ERG\nC. Tubular visual fields\nD. Abnormality in rhodopsin gene\n", "answer": " Typical electrophysiological changes in retinitis pigmentosa appear early in the disease before the subjective symptoms or the objective signs (fundus changes) appear and are most constant and critical finding. Electroretinogram (ERG) is initially subnormal (scotopic affected before photopic; b-waveaffected before ;a wave) and eventually extinguished. Electro-oculogram {EOG) is subnormal with an absence of light peak. Bony spicules are not seen in all cases. Tubular visual field can occur due to other causes as well like open angle glaucoma.\n\nOPTION B IS CORRECT."}
{"question": "Question: Does oxygen-induced retinopathy induce short-term glial stress and long-term impairment of photoentrainment in mice?\nContext: Retinopathy of prematurity is a serious potentially blinding disease of pre-term infants. There is extensive vascular remodeling and tissue stress, but data concerning alterations in retinal neurons and glia, and long-term functional sequelae are still incomplete. ROP was induced using the oxygen-induced retinopathy (OIR) mouse model. Postnatal day 7 (P7) 129SVE mice were exposed to hyperoxia (75 ± 0.5 % oxygen) for 5 days, and then returned to normoxia to induce OIR. Exposed animals were euthanized at 5 (P17-OIR) and 14 days (P26-OIR) after return to normal air, together with corresponding age-matched control mice (P17-C and P26-C respectively) raised only in room air. Their retinas were examined by immunohistochemistry using a battery of antibodies against key glial and neuronal proteins. A further group of OIR mice and controls were examined at 10 weeks of age for their ability to re-entrain to changing 12 h light/12 h dark cycles, assayed by wheel-running actimetry. In this protocol, animals were subjected to three successive conditions of 300 lux, 15 lux and 1 lux ambient light intensity coupled with 6 hours of jetlag. Animals were euthanized at 4 months of age and used in immunoblotting for rhodopsin. Compared to P17-C, immunohistochemical staining of P17-OIR sections showed up-regulation of stress-related and glutamate-regulatory proteins in astrocytes and Müller glial cells. In contrast, glial phenotypic expression in P26-OIR retinas largely resembled that in P26-C. There was no loss in total retinal ganglion cells (RGC) at either P17-OIR or P26-OIR compared to corresponding controls, whereas intrinsically photosensitive RGC showed significant decreases, with 375 ± 13/field in P26-OIR compared to 443 ± 30/field in P26-C (p < 0.05). Wheel actimetry performed on control and OIR-treated mice at 4 months demonstrated that animals raised in hyperoxic conditions had impaired photoentrainment at low illuminance of 1 lux, as well as significantly reduced levels of rhodopsin compared to age-matched controls.", "answer": "OIR leads to transient up-regulation of retinal glial proteins involved in metabolism, and partial degeneration of intrinsically photosensitive RGC and rod photoreceptors. OIR affects circadian photo-entrainment at low illuminance values, possibly by affecting the rod pathway and/or intrinsically photosensitive RGC input to the circadian clock. This study hence shows that retinopathy of prematurity affects light-regulated circadian behavior in an animal model, and may induce similar problems in humans.\n\nyes"}
{"question": "Question: What are the treatments for Age-related Macular Degeneration ?", "answer": "If You Have Advanced AMD Once dry AMD reaches the advanced stage, no form of treatment can prevent vision loss. However, treatment can delay and possibly prevent intermediate AMD from progressing to the advanced stage. The National Eye Institute's Age-Related Eye Disease Study found that taking certain vitamins and minerals may reduce the risk of developing advanced AMD. Wet AMD can be treated with laser surgery, photodynamic therapy, and injections into the eye. None of these treatments is a cure for wet AMD. The disease and loss of vision may progress despite treatment. Laser Surgery Laser surgery uses a laser to destroy the fragile, leaky blood vessels. Only a small percentage of people with wet AMD can be treated with laser surgery. Laser surgery is performed in a doctor's office or eye clinic. The risk of new blood vessels developing after laser treatment is high. Repeated treatments may be necessary. In some cases, vision loss may progress despite repeated treatments. Photodynamic Therapy With photodynamic therapy, a drug called verteporfin is injected into your arm. It travels throughout the body, including the new blood vessels in your eye. The drug tends to stick to the surface of new blood vessels. Next, the doctor shines a light into your eye for about 90 seconds. The light activates the drug. The activated drug destroys the new blood vessels and leads to a slower rate of vision decline. Unlike laser surgery, verteporfin does not destroy surrounding healthy tissue. Because the drug is activated by light, you must avoid exposing your skin or eyes to direct sunlight or bright indoor light for five days after treatment. Photodynamic therapy is relatively painless. It takes about 20 minutes and can be performed in a doctor's office. Photodynamic therapy slows the rate of vision loss. It does not stop vision loss or restore vision in eyes already damaged by advanced AMD. Treatment results often are temporary. You may need to be treated again. Drug Treatment for Wet AMD Wet AMD can now be treated with new drugs that are injected into the eye (anti-VEGF therapy). Abnormally high levels of a specific growth factor occur in eyes with wet AMD and promote the growth of abnormal new blood vessels. This drug treatment blocks the effects of the growth factor. You will need multiple injections that may be given as often as monthly. The eye is numbed before each injection. After the injection, you will remain in the doctor's office for a while and your eye will be monitored. This drug treatment can help slow down vision loss from AMD and in some cases improve sight.  If You Have Low Vision    If you have lost some sight from AMD, ask your eye care professional about low vision services and devices that may help you make the most of your remaining vision. Many community organizations and agencies offer information about low vision counseling and training and other special services for people with visual impairments. Research on AMD The National Eye Institute is conducting and supporting a number of studies to learn more about AMD. For example, scientists are - studying the possibility of transplanting healthy cells into a diseased retina  - evaluating families with a history of AMD to understand genetic and hereditary factors that may cause the disease  - looking at certain anti-inflammatory treatments for the wet form of AMD studying the possibility of transplanting healthy cells into a diseased retina evaluating families with a history of AMD to understand genetic and hereditary factors that may cause the disease looking at certain anti-inflammatory treatments for the wet form of AMD This research should provide better ways to detect, treat, and prevent vision loss in people with AMD.\nReference: http://nihseniorhealth.gov/agerelatedmaculardegeneration/toc.html"}
{"question": "Is there a causal relationship between calorie restriction and the prevention or treatment of age-related eye diseases ?", "answer": "The field of specialized clinical ophthalmology has explored the potential impact of calorie restriction (CR) on age-related eye diseases. While the context provided does not explicitly mention eye diseases, it highlights the effects of CR on longevity and the upregulation of longevity-related genes, which may have implications for eye health. Research suggests that CR can extend lifespan and reduce the incidence of age-related diseases, including cancer, diabetes, and cardiovascular events. These benefits are believed to be mediated through various mechanisms, such as decreased insulin-like growth factor (IGF)/insulin signaling and increased sirtuin activity. Sirtuins are a group of longevity genes that play a role in regulating cellular processes and have been associated with longevity. Although the context does not directly mention specific eye diseases, it acknowledges that aging is a significant risk factor for various ocular conditions, including diabetic retinopathy, retinal vein occlusion, and age-related diseases. While the precise causality between CR and the prevention or treatment of these eye diseases has not been established, the concept of manipulating aging through antiaging strategies opens up possibilities for intervention. It is important to note that the context briefly mentions the free radical theory of aging, which suggests that reactive oxygen species (ROS) play a role in the aging process. While not explicitly discussed in relation to eye diseases, this theory offers another perspective on managing aging, potentially impacting the pathogenesis of ocular conditions. In conclusion, the provided context hints at the potential of CR and antiaging strategies to influence age-related eye diseases. However, further research is needed to establish causal relationships and understand the specific mechanisms by which CR may prevent or treat ocular conditions. Ophthalmologists and researchers may refer to specialized ophthalmology literature and studies to gather more comprehensive and evidence-based insights."}
{"question": "Is Marfan syndrome associated with any ocular manifestations ?", "answer": "Yes, Marfan syndrome is known to be associated with several ocular manifestations. These may include lens dislocation, myopia (nearsightedness), retinal detachment, cataracts, glaucoma, and abnormal shape or position of the cornea. Ophthalmologists should be aware of these ocular findings when evaluating patients with Marfan syndrome and consider appropriate management strategies to preserve visual function and prevent complications."}
{"question": "Question: What is the relation between av malformations and Arteriovenous aneurysm of mid-brain and retina, facial nevi and mental changes ?", "answer": "Arteriovenous aneurysm of mid-brain and retina, facial nevi and mental changes has associated morphology: av malformations"}
{"question": "Question: Is the human ubiquitin conjugating enzyme , UBE2E3 , required for proliferation of retinal pigment epithelial cells?\nContext: Cell cycle progression is governed by the coordinated activities of kinases, phosphatases, and the ubiquitin system. The entire complement of ubiquitin pathway components that mediate this process in retinal pigment epithelial (RPE) cells remains to be identified. This study was undertaken to determine whether the human ubiquitin-conjugating enzyme, UBE2E3, is essential for RPE cell proliferation. UBE2E3 expression and localization in telomerase-immortalized, human RPE cells was determined with a UBE2E3-specific antibody. The necessity for UBE2E3 in RPE proliferation was determined using small interfering (si)RNA to target the expression of the enzyme. Cell counts and immunolabeling for the proliferation marker Ki-67 and the cyclin-dependent kinase inhibitor p27(Kip1) were performed to assess the consequences of UBE2E3 depletion. A mouse strain harboring a disrupted allele of UbcM2 (the mouse counterpart of UBE2E3) with the coding sequence for beta-galactosidase was used to track the developmental expression of the enzyme in murine RPE cells. UBE2E3 localized in the nucleus of the immortalized RPE cells. Depletion of the enzyme by siRNA resulted in a cell-cycle exit accompanied by a loss of Ki-67, an increase in p27(Kip1), and a doubling in cell area. Rescue experiments confirmed the specificity of the RNA interference. In vivo, UbcM2 was transcriptionally downregulated during RPE development in the mouse.", "answer": "UBE2E3 is essential for the proliferation of RPE-1 cells and is downregulated during RPE layer maturation in the developing mouse eye. These findings indicate that UBE2E3 is a major enzyme in modulating the balance between RPE cell proliferation and differentiation.\n\nyes"}
{"question": "Question: Do visual outcome of early and late pars plana vitrectomy in patients with dropped nucleus during phacoemulsification?\nContext: Dislocated lens fragments in the vitreous cavity can cause potentially serious complications. This retrospective study aimed to evaluate the visual outcome of patients who underwent pars plana vitrectomy (PPV) for posteriorly dislocated lens fragments after cataract phacoemulsification. A retrospective study was conducted on all consecutive cases (60 patients) with pars plana vitrectomy performed for retained lens fragment. In 30 eyes (50%), PPV was performed within 1 week of cataract extraction and in 30 eyes (50 %), PPV was performed more than 1 week post cataract extraction from July 2005 through August 2008. In the late vitrectomy group, 66.6% of eyes developed persistent uveitis, 53.3% of eyes showed elevated intra-ocular pressure (IOP) and 5 eyes retinal detachment. In early PPV group 16.6% developed uveitis and 20% showed elevated IOP and one eye retinal detachment. The final visual acuity was 20 ± 50 in early PPV and 20 ± 200 in late PPV group (mean ± SD, p < 0.001).", "answer": "The early use of PPV to remove posterior dislocated lens fragments within the first week was shown to be advantageous. The inflammatory response was less pronounced, IOP rose less significant, the incidence of retinal detachment was lower and visual recovery was faster.\n\nyes"}
{"question": "What is the relationship between preferred retinal loci and macular scotomas in individuals with low vision ?", "answer": "In individuals with low vision, there is a known association between preferred retinal loci (PRL) and macular scotomas. Preferred retinal loci refers to the areas on the retina that patients utilize for fixation when their central vision is impaired. Macular scotomas, on the other hand, are areas of reduced or absent vision within the macula, which is responsible for detailed central vision. Research conducted by Fletcher et al. (1997) examined the relationship between preferred retinal loci and macular scotomas in a low-vision population. The study found that individuals with macular scotomas tend to develop preferred retinal loci outside the scotomatous area. This implies that the patients instinctively shift their fixation point to a healthier peripheral area of the retina to compensate for the loss of central vision caused by the scotoma. Understanding this relationship is crucial for low vision rehabilitation clinicians and aids in developing effective rehabilitation strategies. By identifying the specific PRL location, clinicians can prescribe appropriate visual aids, such as prisms or telescopic lenses, to optimize the use of remaining vision. Additionally, the scanning laser ophthalmoscope (SLO) has been utilized as a valuable tool in assessing PRL and aiding in the visual rehabilitation process (Fletcher et al., 1994; Schuchard et al., 1994). It is important to note that while the aforementioned research provides insights into the relationship between preferred retinal loci and macular scotomas in individuals with low vision, clinical decisions should always be based on a comprehensive evaluation of the patient's specific condition and individual needs."}
{"question": "What are the symptoms of macular degeneration ?", "answer": "Macular degeneration can present with various symptoms. In the case of exudative (wet) macular degeneration, sudden onset vision loss is common, often accompanied by hemorrhaging at the retinal level. As the blood in the vitreous dissipates, the measured scotoma (blind spot) stabilizes, shrinks, and improves contrast sensitivity to some extent. On the other hand, atrophic (dry) macular degeneration typically starts with a relative scotoma, gradually increasing in size and density, leading to a loss of central vision. Individuals with macular degeneration may adapt to this loss, but often experience difficulties in tasks requiring detail resolution, such as reading, object recognition, or face identification. Additionally, some individuals may have active hallucinations in the scotoma, known as the Charles Bonnet syndrome. It is important to note that medical treatment for macular degeneration primarily focuses on slowing down disease progression rather than improving vision."}
{"question": "What is the role of CD4+ T-lymphocytes in uveitis ?", "answer": "CD4+ T-lymphocytes play a major role in uveitis as they are activated and express the IL-2 receptor in inflammatory foci within the retina. These cells, along with macrophages, infiltrate the vitreous body, contributing to the inflammatory response seen in various forms of uveitis such as sympathetic ophthalmia, Vogt-Koyanagi-Harada disease (VKH), sarcoidosis, and the white dot syndromes. The presence of elevated levels of proinflammatory cytokines, such as IL-1, IL-6, IL-8, and IL-12, in ocular fluids further supports the involvement of immune responses in uveitis. Additionally, CD4+ T-lymphocytes have been detected in the vitreous of patients with multifocal chorioretinitis, and immunosuppressive therapies targeting these cells have shown promising results in achieving remission in uveitis patients."}
{"question": "Discuss latitudinal visual field defects ?", "answer": "Latitudinal visual field defects, also known as altitudinal visual field defects, are characterized by a loss of vision in a specific horizontal or vertical band of the visual field. These defects can occur in either the upper or lower half of the visual field, resulting in a partial or complete loss of vision in the affected area. There are various causes of latitudinal visual field defects, including optic nerve damage, retinal artery occlusion, and certain types of glaucoma. Optic nerve damage can occur due to conditions such as ischemic optic neuropathy, optic neuritis, or compression of the optic nerve by a tumor or other structures. Retinal artery occlusion, a blockage of the blood flow to the retinal artery, can cause sudden and severe vision loss in a specific area of the visual field. This typically presents as a well-defined line separating the normal and affected areas of vision. Glaucoma, a group of eye disorders characterized by elevated intraocular pressure, can also lead to latitudinal visual field defects. This occurs when damage to the optic nerve caused by increased pressure results in peripheral vision loss, often starting from the outer edges and progressing inward. The severity of the visual field defect can vary depending on the underlying cause and the extent of damage to the visual system. In some cases, the defect may be mild and only affect a small portion of the visual field, while in others it may be more extensive and result in significant vision loss. Diagnosis of latitudinal visual field defects is typically performed through visual field testing, where the patient is asked to respond to visual stimuli presented at different locations within their visual field. Treatment options depend on the underlying cause and may include medications, surgery, or other interventions aimed at managing the specific condition causing the visual field defect. It is important for individuals experiencing any changes in their visual field to seek prompt medical attention from an eye care professional. Early detection and intervention can help prevent further vision loss and improve overall visual function"}
{"question": "Question: Does improvement in photorefractive corneal laser surgery result using an active eye-tracking system?\nContext: To study the advantage of modern eye-tracking systems for photorefractive surgery. Department of Ophthalmology, University of Zurich, Zurich, Switzerland. Photorefractive surgery (photorefractive keratectomy and laser in situ keratomileusis) for myopia and myopic astigmatism was performed in 40 eyes with a commercially available medical excimer laser system. The eyes were selected retrospectively from a larger group of patients treated at 1 clinic. In 20 eyes, the ablation was centered on the entrance pupil using the active, video-based, eye-tracking system (sampling frequency 50 Hz) of the laser. During laser treatment in the nontracker group (20 eyes), the active eye-tracking system was switched off and centration was done manually by the surgeon. Preoperatively and 1 and 3 months after surgery, the patients had a standard ophthalmic examination as well as wavefront analysis by means of a custom-designed wavefront analyzer. After surgery, the visual acuity was significantly better (P <.05) in patients treated with the eye tracker. The increase in coma-like (relative increase factor 0.4) and spherical aberrations (relative increase factor 1.1) was significantly smaller in these patients than in those in the nontracker group (spherical equivalents of 3.9 and 5.1, respectively; P <.05). The refractive outcome, however, was not significantly different in sphere and cylinder.", "answer": "The use of active eye tracking appeared to improve the optical and visual outcomes but did not affect the refractive outcome after photorefractive laser surgery.\n\nyes"}
{"question": "Question: A 2900-g (6.4-lb) male newborn is delivered at term to a 29-year-old primigravid woman. His mother had no routine prenatal care. She reports that the pregnancy was uncomplicated apart from a 2-week episode of a low-grade fever and swollen lymph nodes during her early pregnancy. She has avoided all routine vaccinations because she believes that “natural immunity is better.” The newborn is at the 35th percentile for height, 15th percentile for weight, and 3rd percentile for head circumference. Fundoscopic examination shows inflammation of the choroid and the retina in both eyes. A CT scan of the head shows diffuse intracranial calcifications and mild ventriculomegaly. Prenatal avoidance of which of the following would have most likely prevented this newborn's condition?\nOptions:\nA. Exposure to unvaccinated children\nB. Undercooked pork\nC. Unprotected sexual intercourse\nD. Mosquito bites\n", "answer": "OPTION B IS CORRECT."}
{"question": "Question: If the length of eyeball increases by 1 mm. The net effect will be: September 2007\nOptions:\nA. Myopia of 6D\nB. Hypermetropia of 6D\nC. Myopia of 3D\nD. Hypermetropia of 3D\n", "answer": " Ans. C: Myopia of 3D\n\nOPTION C IS CORRECT."}
{"question": "Question: What are the symptoms of Cataract microcornea syndrome ?", "answer": "What are the signs and symptoms of Cataract microcornea syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Cataract microcornea syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cataract 90% Microcornea 90% Myopia 50% Corneal dystrophy 7.5% Iris coloboma 7.5% Nystagmus 7.5% Opacification of the corneal stroma 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.\nReference: https://rarediseases.info.nih.gov/gard/1155/cataract-microcornea-syndrome"}
{"question": "What are the features of T-lymphocytes and cytokine expression patterns in patients with uveitis ?", "answer": "Patients with uveitis have been studied extensively to understand the immunological mechanisms of this condition. The development of ocular inflammation in uveitis involves the activation and infiltration of autoreactive T-lymphocytes and non-specific mononuclear effector cells. Specific immunological mechanisms influence the course of the disease and response to treatment. Features of T-lymphocytes and cytokine expression patterns play a crucial role in uveitis. For example, the intraocular presence of Fas ligand (CD95L) serves as an important mechanism for the deletion of T-lymphocytes entering the eye. Additionally, anterior chamber immunomodulatory cytokines and neuropeptides, such as α-melanocyte-stimulating hormone (α-MSH) and transforming growth factor β (TGFβ), exert immunoregulatory roles. Resident tissues in the eye, particularly the retinal pigment epithelium (RPE), also play a key role in controlling immunoreactivity through interactions with the adaptive immune system. Understanding these features and expression patterns can help in better managing uveitis and guiding treatment decisions."}
{"question": "Question: Does study of a US cohort support the role of ZNF644 and high-grade myopia susceptibility?\nContext: Myopia, or nearsightedness, is highly prevalent in Asian countries and is considered a serious public health issue globally. High-grade myopia can predispose individuals to myopic maculopathy, premature cataracts, retinal detachment, and glaucoma. A recent study implicated zinc finger protein 644 isoform 1 (ZNF644) variants with non-syndromic high-grade myopia in a Chinese-Asian population. Herein we focused on investigating the role for ZNF644 variants in high-grade myopia in a United States (US) cohort. DNA from a case cohort of 131 subject participants diagnosed with high-grade myopia was screened for ZNF644 variants. Spherical refractive error of -≤-6.00 diopters (D) in at least one eye was defined as affected. All coding, intron/exon boundaries were screened using Sanger sequencing. Single nucleotide allele frequencies were determined by screening 672 ethnically matched controls. Sequencing analysis did not detect previously reported mutations. However, our analysis identified 2 novel single nucleotide variants (c.725C>T, c.821A>T) in 2 high-grade myopia individuals- one Caucasian and one African American, respectively. These variants were not found in normal controls. A rare variant - dbsSNP132 (rs12117237→c.2119A>G) - with a minor allele frequency of 0.2% was present in 6 additional cases, but was also present in 5 controls.", "answer": "Our study has identified two novel variants in ZNF644 associated with high-grade myopia in a US cohort. Our results suggest that ZNF644 may play a role in myopia development.\n\nyes"}
{"question": "Question: Which of the following is not true about ocular manifestation of HIV?\nOptions:\nA. 50% of patients have cotton wool spots\nB. Kaposi's sarcoma can be present on the eyelids\nC. 75% show vascular narrowing\nD. Cotton wool spot harbors CMV\n", "answer": " Ophthalmologic problems occur in ~50% of patients with advanced HIV infection. These are:- Funduscopy- cotton-wool spots-represent areas of retinal ischemia secondary to microvascular disease and are axoplasmic debris of dead neurons and don't harbour CMV, no visual loss--> patient stable/ improve with time CMV retinitis (CD4+ T cell count <100/ mL but majority occur at CD4+ T cell count <50/mL )- C/F : blurred vision, \"floaters,\" and scintillations. - The disease is usually bilateral, although typically it affects one eye more than the other. The characteristic retinal appearance is that of perivascular hemorrhage and exudate--> visual loss is irreversible P. jirovecii can cause a lesion of the choroid that may be detected as an incidental finding on ophthalmologic examination. - These lesions are typically bilateral, are from half to twice the disc diameter in size, and appear as slightly elevated yellow-white plaques. They are usually asymptomatic and may be confused with cotton-wool spots. Chorioretinitis due to toxoplasmosis can be seen alone or, more commonly, in association with CNS toxoplasmosis. Kaposi sarcoma may involve the eyelid or conjunctiva, while lymphoma may involve the retina. Syphilis may lead to a uveitis that is highly associated with the presence of neurosyphilis.\n\nOPTION D IS CORRECT."}
{"question": "Question: What are the treatments for Diabetic Retinopathy ?", "answer": "Preventing Disease Progression During the first three stages of diabetic retinopathy, no treatment is needed, unless you have macular edema. To prevent progression of diabetic retinopathy, people with diabetes should control their levels of blood sugar, blood pressure, and blood cholesterol. Treatment for Macular Edema Research found that that prompt treatment of macular edema with anti-VEGF drugs, with or without laser treatment, resulted in better vision than laser treatment alone or steroid injections. When injected into the eye, these drugs reduce fluid leakage and interfere with the growth of new blood vessels in the retina. In some cases, focal laser treatment is used along with the eye injections. Your doctor places up to several hundred small laser burns in the areas of the retina around the macula that are leaking. These burns slow the leakage of fluid and reduce the amount of fluid in the retina. The surgery is usually completed in one session. Further treatment may be needed. Treatment for Diabetic Retinopathy Proliferative retinopathy is treated with laser surgery. This procedure is called scatter laser treatment. Scatter laser treatment helps to shrink the abnormal blood vessels. Your doctor places 1,000 to 2,000 laser burns in the areas of the retina away from the macula, causing the abnormal blood vessels to shrink. Because a high number of laser burns are necessary, two or more sessions usually are required to complete treatment. Although you may notice some loss of your side vision, scatter laser treatment can save the rest of your sight. Scatter laser treatment may slightly reduce your color vision and night vision. Scatter laser treatment works better before the fragile, new blood vessels have started to bleed. That is why it is important to have regular, comprehensive dilated eye exams. Even if bleeding has started, scatter laser treatment may still be possible, depending on the amount of bleeding.  Learn more about laser treatment.  Vitrectomy If the bleeding is severe, you may need a surgical procedure called a vitrectomy. During a vitrectomy, blood is removed from the center of your eye. Scatter laser treatment and vitrectomy are effective in treating proliferative retinopathy and in reducing vision loss. Once you have proliferative retinopathy, you always will be at risk for new bleeding. You may need treatment more than once to protect your sight.  Learn more about a vitrectomy.  Have Dilated Eye Exams The National Eye Institute (NEI) urges everyone with diabetes to have a comprehensive dilated eye exam at least once a year. If you have diabetic retinopathy, you may need an exam more often. People with proliferative retinopathy can reduce their risk of blindness by 95 percent with timely treatment and appropriate follow-up care.  Watch an animation to see what a comprehensive dilated eye exam includes.  Research The National Eye Institute, or NEI, is conducting and supporting research that seeks better ways to detect, treat, and prevent vision loss in people with diabetes. This research is conducted through studies in the laboratory and with patients. For example, researchers are studying drugs for the treatment of proliferative retinopathy that may reduce the need for laser surgery. A major study has shown that better control of blood sugar levels slows the onset and progression of retinopathy. The people with diabetes who kept their blood sugar levels as close to normal as possible also had much less kidney and nerve disease. Better control also reduces the need for sight-saving laser surgery.\nReference: http://nihseniorhealth.gov/diabeticretinopathy/toc.html"}
{"question": "How can ultrasonography be used to differentiate between retinoschisis and a fresh retinal detachment ?", "answer": "Ultrasonography can be utilized to distinguish between retinoschisis and a fresh retinal detachment based on the prominence of the tissue layer in the vitreous cavity during B-scan and the height of the A-scan peak of the tissue. The prominence of the tissue layer is more apparent on ultrasonography. In particular, the detection of a retinoschisis often relies on the height of the echo signal during ultrasonography. This method allows for differentiation between retinoschisis and a fresh retinal detachment."}
{"question": "Specialized clinical ophthalmology question: What is the recommended approach for managing vitreoretinal degenerations ?", "answer": "Sequential steps an ophthalmologist should take: 1. Assess the patient's medical history and conduct a comprehensive eye examination, including visual acuity testing, intraocular pressure measurement, and dilated fundus examination. 2. Based on the findings from the examination, determine the specific vitreoretinal degeneration present, such as retinitis pigmentosa or age-related macular degeneration. 3. Consider additional diagnostic tests, such as optical coherence tomography (OCT), fluorescein angiography (FA), or genetic testing, to aid in the diagnosis and characterization of the degenerative condition. 4. Once the diagnosis is confirmed, discuss the prognosis and treatment options with the patient, taking into account their visual needs, goals, and preferences. 5. Treatment strategies for vitreoretinal degenerations may include: a. Management of associated complications, such as cataracts or glaucoma, through appropriate surgical or medical interventions. b. Nutritional supplementation with vitamins, minerals, and antioxidants, depending on the specific degenerative condition. c. In some cases, referral to low vision rehabilitation services to optimize visual function and enhance the patient's quality of life. d. For certain genetic forms of retinal degenerations, consider referral to a genetic counselor or participation in clinical trials exploring potential gene therapies. e. Regular follow-up visits should be scheduled to monitor disease progression, assess treatment efficacy, and adjust management strategies as needed. Specialized clinical ophthalmology abstractive answer: Managing vitreoretinal degenerations involves a systematic approach that includes a thorough examination, accurate diagnosis, discussion of prognosis and treatment options, and personalized care. Treatment strategies may range from addressing associated complications to nutritional supplementation and referral to low vision rehabilitation services. Genetic forms of retinal degenerations may require specialized genetic counseling or participation in clinical trials. Regular follow-up visits ensure ongoing monitoring and adjustment of management approaches to optimize patient outcomes."}
{"question": "What is the purpose of using a solid-state laser with a wavelength of 1065 nm in myopic photorefractive keratectomy (PRK) procedures ?", "answer": "In myopic photorefractive keratectomy (PRK) procedures, using a solid-state laser with a wavelength of 1065 nm serves the purpose of reshaping the cornea to correct nearsightedness. The 1065 nm wavelength falls within the infrared range of the photonic spectrum and has the ability to precisely remove tissue from the cornea, altering its shape to improve the focusing power of the eye. This procedure aims to reduce or eliminate the need for corrective lenses in individuals with myopia."}
{"question": "Question: Is high myopia associated with retinopathy of prematurity primarily lenticular?\nContext: To determine which of the eye's refractive components are responsible for the high myopia in retinopathy of prematurity (ROP), as compared with highly myopic eyes in full-term patients. The study included 53 highly myopic eyes in 34 patients with a history of ROP, and 66 highly myopic eyes in 37 full-term patients. Measurements included refraction, keratometry, and A-scan values for axial length, lens thickness, lens position, anterior chamber depth, anterior segment depth, and lens power calculations. Comparisons were also made with published age-matched, full-term normal controls. Refractions ranged from a spherical-equivalent of -5.0 to -20.75, and from -5.0 to -22.0 diopters in ROP and full-term eyes, respectively. For ROP eyes, increasing myopia was most associated with lens thickness and lens power ( P < 0.001), with lesser contributions from corneal steepness, axial length, and a more forward position of the lens's center. For the eyes with myopia in full-term patients, increasing myopia was highly associated with axial length ( P < 0.001), with smaller contributions from increased lens thickness and lens power. ROP eyes had a lens-thickness/anterior-chamber-depth ratio almost 50% higher than FT and normative eyes. Anterior segment depth was remarkably similar in all eyes studied.", "answer": "High myopia associated with ROP appears pathophysiologically distinct from high myopia in full-term patients. The increased lens thickness seen in ROP eyes was accompanied by shallower anterior chamber depth and maintenance of the anterior segment depth, similar to the normal neonatal eye, suggesting a mechanism of altered anterior segment development in ROP leading to high myopia.\n\nyes"}
{"question": "How can disc edema be differentiated from pseudopapilledema ?", "answer": "Disc edema can be differentiated from pseudopapilledema by several ophthalmoscopic findings. Disc edema is characterized by a full and swollen disc, a feathery blurred disc margin, thickened nerve fiber layer that obliterates underlying peripapillary retinal vessels (inferiorly first, then superiorly), disc hyperemia, small or nonexistent central cup, enlarged veins, and occasional splinter nerve fiber layer hemorrhages (flame-shaped hemorrhages). On the other hand, pseudopapilledema refers to conditions that produce blurred disc margins without associated disc edema."}
{"question": "Question: Do combined pars plana vitrectomy-lensectomy and open-loop anterior chamber lens implantation?\nContext: To investigate the effectiveness of open-loop, one-piece, flexible, Kelman-style, all-polymethylmethacrylate (PMMA) anterior chamber intraocular lenses (AC IOLs) in patients undergoing pars plana vitrectomy surgery for a variety of vitreoretinal disorders. Fifteen patients (6 women and 9 men) underwent combined pars plana vitrectomy with insertion of an open-loop AC IOL. Postoperative results were evaluated. The average preoperative visual acuity of 20/360 (logMAR scale, 1.25 +/- 0.80) improved to 20/52 (logMAR scale, 0.42 +/- 0.35) after an average follow-up of 10.2 months (range, 1-41 months). Of 15 eyes, 7 (47%) achieved a visual acuity of better than 20/40. There was no evidence of glaucoma exacerbation or corneal decompensation. Visual acuity was limited primarily by chronic cystoid macular edema in 4 (27%) of 15 eyes.", "answer": "In this preliminary series of patients, open-loop, flexible, all-PMMA, Kelman-style AC IOLs appear to be well tolerated and represent a viable, simple alternative to transscleral fixation of a posterior chamber IOL or surgical aphakia in patients undergoing vitrectomy surgery.\n\nyes"}
{"question": "Question: Does sustained ocular hypertension induce dendritic degeneration of mouse retinal ganglion cells that depends on cell type and location?\nContext: Glaucoma is characterized by retinal ganglion cell (RGC) death and frequently associated with elevated IOP. How RGCs degenerate before death is little understood, so we sought to investigate RGC degeneration in a mouse model of ocular hypertension. A laser-induced mouse model of chronic ocular hypertension mimicked human high-tension glaucoma. Immunohistochemistry was used to characterize overall RGC loss and an optomotor behavioral test to measure corresponding changes in visual capacity. Changes in RGC functional properties were characterized by a large-scale multielectrode array (MEA). The transgenic Thy-1-YFP mouse line, in which a small number of RGCs are labeled with yellow fluorescent protein (YFP), permitted investigation of whether subtypes of RGCs or RGCs from particular retinal areas were differentially vulnerable to elevated IOP. Sustained IOP elevation in mice was achieved by laser photocoagulation. We confirmed RGC loss and decreased visual acuity in ocular hypertensive mice. Furthermore, these mice had fewer visually responsive cells with smaller receptive field sizes compared to controls. We demonstrated that RGC dendritic shrinkage started from the vertical axis of hypertensive eyes and that mono-laminated ON cells were more susceptible to IOP elevation than bi-laminated ON-OFF cells. Moreover, a subgroup of ON RGCs labeled by the SMI-32 antibody exhibited significant dendritic atrophy in the superior quadrant of the hypertensive eyes.", "answer": "RGC degeneration depends on subtype and location in hypertensive eyes. This study introduces a valuable model to investigate how the structural and functional degeneration of RGCs leads to visual impairments.\n\nyes"}
{"question": "What are the ocular complications of giant cell arteritis ?", "answer": "Giant cell arteritis can lead to various ocular complications. One common complication is anterior ischemic optic neuropathy, which can cause visual loss. Fundoscopic examination may reveal a pale or chalky white swelling of the optic nerve and splinter hemorrhages. Other possible ocular lesions include central retinal artery occlusion, cilioretinal artery occlusion, posterior optic neuropathy, and choroidal ischemia. It is crucial to seek emergency ophthalmologic consultation to detect and address these potential complications promptly. Failure to treat giant cell arteritis promptly can lead to irreversible blindness within weeks."}
{"question": "Question: Commonest type of Retinal detachment -\nOptions:\nA. Rheugmatogenous\nB. Choroidal hemorrhage\nC. Exudative\nD. Tractional\n", "answer": " Rhegmatogenous retinal detachment usually associated with a retinal break (hole or tear) through which subretinal fluid (SRF) seeps and separates the sensory retina from the pigmentary epithelium. This is the commonest type of retinal detachment. Ref khurana 6/e p 299\n\nOPTION A IS CORRECT."}
{"question": "Question: Is optic nerve axon number in mouse regulated by PAX2?\nContext: Papillorenal syndrome is an autosomal-dominant disease caused by mutations in the PAX2 transcription factor gene. Patients often exhibit congenital excavation of the optic nerve and a spectrum of congenital kidney abnormalities. Using a novel mouse model of this syndrome (C57BL/6J PAX2(A220G/+)), we investigated the effect of PAX2 haploinsufficiency on optic nerve axon number. Because PAX2 expression and retinal pigment epithelium pigmentation have a mutually exclusive relationship during development and because tyrosinase (Tyr) has been shown to modify the penetrance of other ocular development genes, we also investigated whether tyrosinase modified the mutant PAX2 phenotype. C57BL/6J PAX2(A220G/+)Tyr(+/+) mice were crossed with mice of the same genetic background (C57BL/6J) that are homozygous for an effective null allele of tyrosinase (Tyr(c-2J/c-2J)) over two generations to create mice with four distinct genotypes: PAX2(A220G/+) Tyr(+/c-2J), PAX2(A220G/+) Tyr(c-2J/c-2J), PAX2(+/+) Tyr(c-2J/+), and PAX2(+/+)Tyr(c-2J/c-2J). Mouse optic nerves were examined clinically and histologically. Axon number was assessed in a masked fashion in optic nerves from mice of all four genotypes and compared with parental strains. Mice heterozygous for a PAX2 mutation show reduced optic nerve axon number compared with age-matched controls. Tyrosinase does not appear to modify this phenotype.", "answer": "Our results show that PAX2 is important in determining axon number in mouse optic nerve. The developmental effects of tyrosinase and PAX2 mutation appear to act via different pathways.\n\nyes"}
{"question": "Question: All of the following take part in the pathogenesis of macular edema in diabetic retinopathy except:\nOptions:\nA. Retinal pigment epithelium dysfunction\nB. Oxidative stress\nC. VEGF\nD. Increased protein kinase-C\n", "answer": " Ans. is 'a' i.e. Retinal pigment epithelium dysfunction [Ref: Harrison 17/e, p 2286-2287; Yanoff & Duker 2/e, p 877-880, Khurana 3/e, p 256-258; Parson's 20/e, p 294-298; http://care.diabetesjoumals.org/cgi/content/full/26/912653JDiabetic retinopathy (DR) & diabetic macular edema (DME) are one of the microvascular complications of diabetes mellitus (DM)DR & DM are leading causes of blindness in most of the developed countries.Chronic hyperglycemia is an important etiological factor leading to complications of DM & following is the proposed mechanism So retinal vascular pathology is behind DR. Retinal layers are not primarily involved in pathogenesis of DRJDME. Diabetic retinopathyDR is a progressive disease that has following stages:Non apparent DRNon proliferative DR Proliferative DR Pathogenesis of DR: * International clinical diabetic retinopathy disease severity scale Proposed disease severity levelDilated ophthalmoscopy findings* No apparent retinopathyNo abnormalities* Mild nonproliferative DRMicroaneurysms only* Moderate nonproliferative DRMore than just microaneurysm, but less than severe NPDR* Severe nonproliferative DRNo signs of PDR, with any of the following: More than 20 intraretinal hemorrhages in each of four quadrantsDefinite venous beading in two or more quadrantsProminent intraretinal microvascular anomalies in one or more quadrants* PDROne or more of the following:NeovascularizationVitreous or preretinal hemorrhageDiabetic macular oedema:DME can develop any time during progression of DR & involves retinal thickening in the macular area.DME occurs after breakdown of the blood-retinal barrier because of leakage of dilated hyperpermeable capillaries and micro aneurysms. Leakage can be diffuse or focal resulting in focal or diffuse macular edema. * Clinically significant macular edema (CSME) occurs when only NPDR is present.Definition of CSME: CSME is when any one of 3 criterias is present -Retinal thickening involving macula or area within 500 pm of it orHard exudates at or within 500 pm of macula with thickening of adjacent retina orA zone of retinal thickening one disc area or larger in size, any part of which is within one disc diameter of macula.Also know -Circinate retinopathy is due to chronic edema involving a considerable area of retina at and around macula with massive changes in retina itself.\n\nOPTION A IS CORRECT."}
{"question": "What are the different types of staphyloma in ophthalmology and their common causes ?", "answer": "There are several types of staphyloma in ophthalmology. Interpupillary staphyloma is characterized by a bulge in the sclera near the limbus and is often caused by high myopia. Ciliary staphyloma occurs about 2-3mm away from the limbus and is associated with a weak sclera lined by the ciliary body. It is commonly caused by thinning of the sclera following perforating injury, scleritis, or absolute glaucoma. Equatorial staphyloma results from a bulge of the sclera lined by the choroid in the equatorial region and is usually seen in cases of scleritis and degeneration of sclera in pathological myopia. Posterior staphyloma refers to a bulge of weak sclera lined by the choroid behind the equator and is commonly associated with pathological myopia, posterior scleritis, and perforating injuries."}
{"question": "Based on the provided information about genetics and age-related macular degeneration (AMD), a specialized clinical ophthalmology procedural question could be: Q: What are the three main methods used to identify genes contributing to AMD ?", "answer": "A: The three main methods used to identify genes contributing to age-related macular degeneration (AMD) are candidate gene screening, linkage mapping, and case-association studies. Candidate gene screening involves evaluating genes responsible for phenotypically similar diseases and genes involved in pathways thought to contribute to the pathophysiology of AMD. Linkage analysis searches for chromosomal regions that cosegregate with the AMD disease trait by evaluating the segregation of chromosomal regions in families with AMD. Finally, case-association studies find genetic variants of genes that are associated with AMD by evaluating differences in frequency between those variants in persons with AMD and their matched controls. These three methods have been instrumental in advancing our understanding of the genetics of AMD."}
{"question": "What are the potential treatment sites for patients with occult choroidal neovascularization (CNV) in age-related macular degeneration (AMD) ?", "answer": "In patients with occult CNV in AMD, potential treatment sites can include plaques, focal spots, and mixed lesions. These sites were observed in varying proportions among patients, with plaques being the most common, followed by focal spots and mixed lesions. Pilot studies have primarily targeted the focal hot spot as a potential treatment site using indocyanine green (ICG)-guided photocoagulation. While no large, randomized, controlled trials have been reported yet, retrospective and prospective pilot studies have provided some insights. One retrospective study by Regillo et al. identified well-defined, hyperfluorescent extrafoveal lesions on ICG in patients with ill-defined CNV on fluorescein angiography. These patients underwent subsequent ICG-guided photocoagulation, and 63% of them experienced clinical resolution of exudation and stabilization or improvement of visual acuity at 6 months. Another study by Slakter et al. evaluated patients with occult CNV and identified two groups that could potentially benefit from treatment. Group 1 included patients with a distinct detachment of the retinal pigment epithelium (RPE) and a serous pigment epithelial detachment (PED) filling in the late stages of the angiogram. Group 2 consisted of patients with CNV beneath the RPE, appearing clinically as a shallow, solid thickening of the RPE without an associated serous PED. Following treatment, 56% of patients had complete resolution of exudative manifestations, with visual acuity improvement noted in 13% and stabilization in 53% of the treated eyes. Despite the lack of a contemporaneous control group, the anatomical success rate and recurrence rates observed in these studies were similar to those seen in the extrafoveal, classic CNV arm of the Macular Photocoagulation Study (MPS). However, it is important to note the relatively shorter follow-up time in these studies compared to the MPS patients. In summary, potential treatment sites for occult CNV in AMD include plaques, focal spots, and mixed lesions. ICG-guided photocoagulation has shown promising results in pilot studies, with some patients experiencing clinical resolution of exudation and stabilization or improvement of visual acuity. Further research and larger studies are needed to establish the efficacy"}
{"question": "What is the most effective treatment for retinal microvasculopathy in patients with HIV infection ?", "answer": "The most effective treatment for retinal microvasculopathy in patients with HIV infection is highly dependent on the underlying cause and severity of the condition. However, it is important to note that the exact pathogenesis of this neuroretinopathy is still unknown. In milder cases of retinal microvasculopathy, treatment options may include the use of artificial tears to alleviate dry eye symptoms. These can help to improve tear production and reduce discomfort associated with reduced tear production. Artificial tears can be purchased over-the-counter and are typically applied multiple times a day as needed. For more severe cases, treatment may involve addressing any underlying infections or inflammation that may be contributing to the condition. This may involve the use of antiviral medications, such as those used to treat cytomegalovirus (CMV) retinitis, which is a common ocular infection in patients with AIDS. Antiviral medications can help to control viral replication and prevent further damage to the retina. It is important to consult with an ophthalmologist who specializes in infectious uveitic conditions and HIV-related eye diseases for a personalized treatment plan. They will be able to assess the specific needs of the patient and determine the most appropriate course of action. References: 1. Cunningham ET Jr. Ocular manifestations of HIV infection. Trans Am Ophthalmol Soc. 1995;93:623-683. 2. Jabs DA, et al. Ocular complications of HIV infection. American Academy of Ophthalmology; 2014. 3. Yanoff M, et al. Ophthalmology. 5th ed. Elsevier; 2018."}
{"question": "Question: What is the meaning of BORNHOLM EYE DISEASE?", "answer": "Syndrome with characteristics of moderate to high myopia associated with astigmatism and deuteranopia. Less than 10 families have been described so far. Transmission is X-linked recessive and the locus has been mapped to Xq28."}
{"question": "Question: Does compliance with dietary guidelines affect capillary recruitment in healthy middle-aged men and women?\nContext: Healthy microcirculation is important to maintain the health of tissues and organs, most notably the heart, kidney and retina. Single components of the diet such as salt, lipids and polyphenols may influence microcirculation, but the effects of dietary patterns that are consistent with current dietary guidelines are uncertain. It was hypothesized that compliance to UK dietary guidelines would have a favourable effect on skin capillary density/recruitment compared with a traditional British diet (control diet). A 12-week randomized controlled trial in men and women aged 40-70 years was used to test whether skin microcirculation, measured by skin video-capillaroscopy on the dorsum of the finger, influenced functional capillary density (number of capillaries perfused under basal conditions), structural capillary density (number of anatomical capillaries perfused during finger cuff inflation) and capillary recruitment (percentage difference between structural and functional capillary density). Microvascular measures were available for 137 subjects out of the 165 participants randomized to treatment. There was evidence of compliance to the dietary intervention, and participants randomized to follow dietary guidelines showed significant falls in resting supine systolic, diastolic and mean arterial pressure of 3.5, 2.6 and 2.9 mmHg compared to the control diet. There was no evidence of differences in capillary density, but capillary recruitment was 3.5 % (95 % CI 0.2, 6.9) greater (P = 0.04) on dietary guidelines compared with control.", "answer": "Adherence to dietary guidelines may help maintain a healthy microcirculation in middle-aged men and women. This study is registered at www.isrctn.com as ISRCTN92382106.\n\nyes"}
{"question": "Question: Does intravenous bevacizumab cause regression of choroidal neovascularization secondary to diseases other than age-related macular degeneration?\nContext: To investigate the safety, tolerability, and bioactivity of intravenous infusions of bevacizumab in patients with choroidal neovascularization (CNV) attributable to causes other than age-related macular degeneration. Nonrandomized clinical trial. Ten patients with CNV received infusions of 5 mg/kg of bevacizumab. The primary efficacy outcome measure was change in visual acuity (VA; Early Treatment Diabetic Retinopathy Study letters read at 4 meters) at 24 weeks and secondary measures were changes from baseline in excess foveal thickness (center subfield thickness), area of fluorescein leakage, and area of CNV. Infusions were well tolerated and there were no ocular or systemic adverse events. At baseline, median VA was 25.5 letters read at 4 meters (20/80) and median foveal thickness was 346 mum. At the primary endpoint (24 weeks), median VA was 48.5 letters (20/32), representing four lines of improvement from baseline (P = .005), median foveal thickness was 248 mum representing a 72% reduction in excess foveal thickness (P = .007). Four of nine patients had complete elimination of fluorescein leakage, three had near complete elimination (reductions of 91%, 88%, and 87%), two had modest reductions, and one had no reduction. All patients except one showed a reduction in area of CNV with a median reduction of 43%.", "answer": "Despite the small number of patients studied, the marked improvement in VA accompanied by prominent reductions in foveal thickness, fluorescein leakage, and area of CNV suggest a beneficial effect. It may be worthwhile to consider further evaluation of systemic bevacizumab in young patients with CNV.\n\nyes"}
{"question": "Specialized clinical ophthalmology procedural question: What are the common ocular manifestations of rubella in pregnant women, and what are the potential effects on the fetus ?", "answer": "Rubella, or German Measles, can have significant ophthalmic implications in pregnant women. Ocular manifestations of rubella in pregnant women include mild conjunctivitis with redness of the bulbar conjunctiva. However, the most concerning aspect of rubella during pregnancy is its effect on the developing fetus. Maternal rubella infection during the early weeks of pregnancy can lead to various developmental defects in the fetus. One of the ocular complications is microphthalmos, which refers to abnormally small eyes, accompanied by cataract formation. Additionally, uveitis and failure of anterior chamber development can occur, resulting in iris atrophy and a constricted pupil. Congenital glaucoma may also be observed. The pigment epithelium of the retina may be disturbed, leading to pigmentary mottling. However, if the eye is otherwise unaffected, vision is typically not significantly affected. It's important to note that rubella can cause extensive neural damage, resulting in deafness and mental retardation in the affected child. Cardiac malformations are also possible. The virus can persist in the child for several years after birth, posing a risk to non-immune pregnant women who come into contact with the infected child. To confirm rubella infection, blood tests can be conducted. Preventing rubella through vaccination is crucial, particularly in women of childbearing age, to avoid potential ophthalmic and systemic complications in both the mother and the developing fetus."}
{"question": "Question: The superficial retinal hemorrhage is seen in which layer of retina?\nOptions:\nA. Inner plexiform layer\nB. Nerve fiber layer\nC. Inner nuclear layer\nD. Outer nuclear layer\n", "answer": " Superficial haemorrhages (flame-shaped), seen in RETINAL NERVE FIBRE LAYER (2nd layer of retina) Retinal haemorrhages. Both deep (dot and blot haemorrhages) and superficial haemorrhages (flame-shaped), occurfrom capillary leakage. Superficial retinal haemorrhage may be found in hypeension, diabetes, trauma, venous occlusions,and blood dyscrasias.Deep retinal haemorrhages are typically seen in diabetic retinopathy Subarachnoid haemorrhage may produce retinal haemorrhages especially subhyaloid haemorrhageof the posterior pole Deep Retinal hemorrhages occur in the Outer Plexiform or Inner Nuclear Layers\n\nOPTION B IS CORRECT."}
{"question": "Question: A 22-year-old patient, Sreeraj presents with multiple neural tumors, pigmented iris hamaomas, and numerous tan macules on his skin. He informs the physician that his father, as well as one uncle and his paternal grandfather, had a similar condition. This patient likely suffers from which of the following?\nOptions:\nA. Ependymoma\nB. Huntington disease\nC. Marfan syndrome\nD. Neurofibromatosis type I\n", "answer": " Neurofibromatosis type 1, or von Recklinghausen disease, is an autosomal dominant disorder with high penetrance, but variable expressivity. The disease has three major features: (1) multiple neural tumors anywhere on or in the body (2) numerous pigmented cutaneous lesions (cafe au lait spots); and (3) pigmented iris hamaomas (Lisch nodules). Electron micrographic studies show that the tumors are the result of the proliferation of fibroblasts or Schwann cells in the peripheral nerves, possibly due to ras inactivation. There is no treatment, except for surgical resection of symptomatic tumors. Ependymoma can occur wherever ependymal cells are found. They are more common in children, and most often originate in the fouh ventricle. They are the most common intramedullary glioma of the spinal cord. Huntington disease, an autosomal dominant disorder, is characterized by severe degeneration of the caudate nucleus along with degenerative changes in the putamen and coex. In addition to chorea, these patients frequently suffer from athetoid movements, progressive dementia, and behavioral disorders. Marfan syndrome is due to a defect in the gene for fibrillin. The major clinical findings involve the skeleton, cardiovascular system, and the eye. Affected individuals tend to be tall with long extremities and long, tapering appendages. Mitral valve prolapse and dilatation of the aoic valve ring or aoic dissection due to cystic medial degeneration are common.\n\nOPTION D IS CORRECT."}
{"question": "Exploratory question: What are the potential benefits and limitations of laser photocoagulation for the prophylactic treatment of eyes with drusen in age-related macular degeneration (AMD) ?", "answer": "Laser photocoagulation has been studied as a potential prophylactic treatment for eyes with drusen in AMD. While the exact mechanism of drusen resolution through laser photocoagulation remains unclear, previous pilot studies have shown promising results. These studies used laser light in the visible spectrum, typically the argon and krypton wavelengths. Advocates of direct treatment argue that targeting the drusen themselves with laser treatment is less likely to induce choroidal neovascularization since the retinal pigment epithelium (RPE) and Bruch's membrane are thicker at the drusen site. On the other hand, proponents of the 810-nm laser suggest that even minimal lesions placed in a grid pattern, without precise drusen localization, can effectively induce drusen absorption. Several pilot studies have demonstrated positive outcomes following laser photocoagulation. Wetzig observed drusen resorption in approximately half of the eyes over a 3-year period using moderate intensity argon or krypton lesions. Cleasby et al. suggested that prophylactic laser treatment may prevent the development of choroidal neovascularization. Frennesson and Nilsson reported a 50% reduction in drusen area at 12 months, along with improved visual acuity. Improved scotopic thresholds were also noted by Guymer et al. after laser photocoagulation in eyes with high-risk clinical features of AMD. While these pilot studies provide valuable insights, it is important to note that they involved small patient populations and were not large controlled trials. Therefore, further research is needed to validate the safety and efficacy of laser treatment for drusen in AMD. Additionally, the use of vitamins, minerals, micronutrients, and antiangiogenic drugs are also being investigated as potential prophylactic measures for preventing severe visual loss in AMD."}
{"question": "What are the important features to note during a fundus examination ?", "answer": "During a fundus examination, it is important to note several features to assess the health of the eye. First, observe the distinctness and nature of the disk margin, the vessels at the disc, and the color and thickness of the neuroretinal rim. Pay attention to whether the neuroretinal rim follows the ISNT rule, which means it should be thickest inferiorly, then superiorly, then nasally, and finally temporally. Additionally, take note of individual features such as venous pulsation, vessel bayoneting, and peripapillary atrophy. Remember that the vertical CD ratio alone is not very meaningful. After examining the optic nerve, systematically scan the posterior pole, observing the vessels and the background. Then, move on to the more peripheral retina by asking the patient to look in different positions of gaze. This should provide a reasonable view of most of the fundus, including the mid-periphery. Finally, switch to the macular stop and view the fovea, noting the integrity of the reflex. If a high myope needs to be viewed, it is better to correct their vision using a contact lens or a high minus trial lens for a better field of view."}
{"question": "Question: Periphery of retina is best visualised with:\nOptions:\nA. Retinoscopy\nB. USG\nC. Direct ophthalmoscopy\nD. Indirect ophthalmoscopy\n", "answer": " Ans.Indirect ophthalmoscopy\n\nOPTION D IS CORRECT."}
{"question": "Specialized clinical ophthalmology question: What are the different types of color blindness and how do they affect a person's color vision ?", "answer": "Sequential steps an ophthalmologist should take: 1. Begin by taking a detailed medical history of the patient, including any family history of color vision deficiency or related eye conditions. 2. Conduct a comprehensive eye examination, including visual acuity testing, color vision testing, and assessment of the retina and optic nerve. 3. Use specific color vision tests, such as the Ishihara color plates, Farnsworth-Munsell 100 Hue Test, or other specialized tests, to determine the type and severity of color blindness. 4. Educate the patient about the different types of color blindness, which include red-green color blindness (the most common type), blue-yellow color blindness, and complete color blindness (achromatopsia). 5. Discuss how each type of color blindness affects the person's perception of colors and their everyday life, such as difficulties with distinguishing certain hues or shades. 6. Address any concerns or questions the patient may have regarding the impact of color blindness on their overall vision and daily activities. 7. Provide support and resources for adapting to life with color blindness, such as recommending color-enhancing eyewear or assistive technology. 8. Emphasize the importance of regular eye examinations and promote awareness of color blindness to help individuals understand their condition and seek appropriate assistance if needed. Specialized clinical ophthalmology abstractive answer: Color blindness refers to the inability or decreased ability to perceive certain colors. There are different types of color blindness, including red-green color blindness (the most common), blue-yellow color blindness, and complete color blindness (achromatopsia). Each type affects a person's color vision differently, causing difficulties in distinguishing specific hues or shades. It is crucial for ophthalmologists to conduct a comprehensive eye examination, including specialized color vision tests, to determine the type and severity of color blindness in order to provide appropriate support and resources. Educating patients about their condition and offering adaptive strategies can help individuals manage the impact of color blindness on their daily lives. Regular eye examinations and awareness of color blindness are essential for optimal care and support."}
{"question": "Question: Does cTGFsiRNA ameliorate retinal cells apoptosis in streptozotocin-induced diabetic rats?\nContext: To detect the effect of connective tissue growth factor (CTGF) on the apoptosis in the diabetic retina with small interfering RNAs (siRNA) targeting CTGF. A total of 60 rats were divided into 6 groups including control group, diabetic 4, 8, 12, 16 weeks groups, and interference group. Diabetic rats were induced by intraperitoneal streptozotocin (STZ). Retinas were obtained from control, diabetic rats and diabetic rats of interference group treated by intravitreal injection of CTGFsiRNA to suppress the expression of CTGF mRNA. Retinal cells apoptosis was detected by Tunnel staining and mRNA expression of CTGF was analyzed by RT-PCR. The levels of CTGF and the apoptosis in the retinas of diabetic rats were significantly higher than those in the controls. Apoptosis occurred at 4 weeks after a diabetic model being set up, became serious with the diabetes developing, while CTGF elevated at 8 weeks. The apoptosis cell counts increased to 25.8cells/mm(2) at 24weeks of diabetes. SiRNA-mediated inhibition of CTGF mRNA resulted in a significant decrease in apoptosis. Significant correlations were found between CTGF and apoptosis in the retina.", "answer": "It was suggested that CTGF might be involved in retinal cells apoptosis which is a characteristic of early diabetic retina. SiRNA targeting CTGF seems to have the advantage of ameliorating retinal cells apoptosis.\n\nyes"}
{"question": "Question: Does electroporation-mediated gene delivery of cleavage-resistant pro-nerve growth factor cause retinal neuro- and vascular degeneration?\nContext: Neurotrophins, including nerve growth factor (NGF), are secreted by glia as a pro-form (proNGF) that is normally cleaved into the mature ligand. Increases of proNGF has been well documented in retinal neurodegenerative diseases. Since systemic overexpression of proNGF exhibits embryonic lethality, we aimed to establish a model that specifically and stably overexpresses a cleavage-resistant mutant of proNGF (proNGF123) plasmid in the retina using electroporation. Male Sprague-Dawley rats were injected intravitreally with pGFP or pGFP-proNGF123 plasmids, then electroporated with various settings for optimization. Retinal cell death and ganglion cell count were assessed by TUNEL and immunostaining with anti-Brn3. Expression of proNGF, NGF, and their receptors was examined by western blot. Retinal vascular permeability was assessed by extravasation of bovine serum albumin-fluorescein. Development of acellular capillaries was assessed by periodic acid-Schiff and hematoxylin staining. Successful pGFP-proNGF123 gene delivery and expression of proNGF was demonstrated by western blot and extensive proNGF immunostaining in retina sections. Overexpression of proNGF reduced NGF expression while inducing the expression of neurotrophin receptors, including p75(NTR) and tyrosine receptor kinase A, but not sortilin. Overexpression of proNGF resulted in ~50% reduction in ganglion cell count and fivefold increase in TUNEL-positive cells in rat retina. In addition, overexpression of proNGF induced breakdown of the blood-retina barrier evident by twofold increase in extravasation of bovine serum albumin-fluorescein after 1 week and induced the development of acellular capillaries after 4 weeks.", "answer": "Electroporation can successfully incorporate and express biologically active cleavage-resistant proNGF locally in rat retinas. Overexpression of cleavage-resistant proNGF can be a useful tool to investigate specific molecular mechanisms by which proNGF causes neurodegeneration and vascular injury in the retina.\n\nyes"}
{"question": "Question: Does abrogation of MMP-9 gene protect against the development of retinopathy in diabetic mice by preventing mitochondrial damage?\nContext: In the development of diabetic retinopathy, mitochondrial dysfunction is considered to play an important role in the apoptosis of retinal capillary cells. Diabetes activates matrix metalloproteinase-9 (MMP-9) in the retina and its capillary cells, and activated MMP-9 becomes proapoptotic. The objective of this study is to elucidate the plausible mechanism by which active MMP-9 contributes to the mitochondrial dysfunction in the retina. Using MMP-9 gene knockout (MMP-KO) mice, we investigated the effect of MMP-9 regulation on diabetes-induced increased retinal capillary cell apoptosis, development of retinopathy, mitochondrial dysfunction and ultrastructure, and mitochondrial DNA (mtDNA) damage. To understand how diabetes increases mitochondrial accumulation of MMP-9, interactions between MMP-9 and chaperone proteins (heat shock protein [Hsp] 70 and Hsp60) were evaluated. The results were confirmed in the retinal mitochondria from human donors with diabetic retinopathy, and in isolated retinal endothelial cells transfected with MMP-9 small interfering RNA (siRNA). Retinal microvasculature of MMP-KO mice, diabetic for ∼7 months, did not show increased apoptosis and pathology characteristic of retinopathy. In the same MMP-KO diabetic mice, activation of MMP-9 and dysfunction of the mitochondria were prevented, and electron microscopy of the retinal microvasculature region revealed normal mitochondrial matrix and packed lamellar cristae. Damage to mtDNA was protected, and the binding of MMP-9 with Hsp70 or Hsp60 was also normal. As in the retina from wild-type diabetic mice, activation of mitochondrial MMP-9 and alterations in the binding of MMP-9 with chaperone proteins were also observed in the retina from donors with diabetic retinopathy. In endothelial cells transfected with MMP-9 siRNA, high glucose-induced damage to the mitochondria and the chaperone machinery was ameliorated.", "answer": "Regulation of activated MMP-9 prevents retinal capillary cells from undergoing apoptosis by protecting mitochondrial ultrastructure and function and preventing mtDNA damage. Thus, MMP-9 inhibitors could have potential therapeutic value in preventing the development of diabetic retinopathy by preventing the continuation of the vicious cycle of mitochondrial damage.\n\nyes"}
{"question": "How can an ophthalmologist evaluate the pupillary response to light in a patient with afferent pupillary defect ?", "answer": "To evaluate the pupillary response to light in a patient with afferent pupillary defect, ophthalmologists can perform the swinging flashlight test. This test involves shining a light alternately between the two eyes every 2 to 4 seconds. In a normal response, both pupils initially constrict, followed by redilatation until the pupils stabilize around 5 mm after a few oscillations. In the presence of an afferent pupillary defect, both pupils will become larger when the defective side is stimulated, while they will become smaller when the sound eye is stimulated. This abnormal response is typically observed due to impairment in the afferent pathway transmitting signals from the retina to the brain. It indicates a dysfunction in the optic nerve or retina on the side with the afferent pupillary defect. Identifying an afferent pupillary defect is crucial in ophthalmology as it can signify underlying conditions such as optic neuropathy, retinal detachment, or severe retinal disease. Further evaluation, referral, or diagnostic tests should be considered based on the presence of an afferent pupillary defect in order to diagnose and manage the underlying cause appropriately."}
{"question": "Question: Which of the following is sensory layer of retina?\nOptions:\nA. Rods & Cones\nB. Ganglion layer\nC. Amacrine cell layer\nD. Retinal pigment epithelium\n", "answer": " ANSWER: (A) Rods & ConesREF; Ganong's 22nd ed chapter 8The layer of rods and cones which are sensory receptors form the sensory layer of retina. The primary layers of the retina from outermost surface to innermost surface:* Pigment epithelium - supporting cells for the neural portion of the retina (photopigment regeneration, blood) it is also dark with melanin which decreases light scatter within the eye.Rod and cone layer/Bacillary layer,Layer of photoreceptor cells - contains the outer segments and inner segments of the rod and cone photoreceptors.Outer limiting membrane -Outer Nuclear Layer (ONL) - cell bodies of rods 8i conesOuter Plexiform Layer (OPL) - rod and cone axons, horizontal cell dendrites, bipolar dendritesInner Nuclear Layer (INL) - Nuclei of horizontal, bipolar and amacrine cellsInner Plexiform Layer (IPL) - axons of bipoiars (and amacrines), dendrites of ganglion cells << Layer of Ganglion cells (GCL)- Nuclei of the ganglion cells and displaced amacrine cellsLayer of optic nerve fibers - fibers from ganglion cells traversing the retina to leave the eyeball at the opticdisk.Remember, the optic nerve leaves the eye and the retinal blood vessels enter it at a point 3 mm medial to and slightly above the posterior pole of the globe. This region is visible through the ophthalmoscope as the optic disk. There are no visual receptors over the disk, and consequently this spot is blind (the blind spot).\n\nOPTION A IS CORRECT."}
{"question": "Question: Which of the following is not a function of aqueous humor?\nOptions:\nA. Maintenance of IOP\nB. Providing nutrition to retina\nC. Transparency of eye\nD. Drainage\n", "answer": " It provides nutrition to the cornea and lens and not the retina. Functions of aqueous humor: Maintenance of IOP Nutrition to lens and cornea Maintaining transparency of eye Clearing the eye of toxins\n\nOPTION B IS CORRECT."}
{"question": "How can corneal topography be used to detect early ectatic disease in refractive surgery candidates ?", "answer": "Corneal topography examinations using the Placido corneal topographer, specifically the axial power map, are the most reliable method to screen for early ectatic disease such as forme fruste keratoconus or forme fruste pellucid marginal degeneration in refractive surgery candidates. By assessing the corneal shape and power distribution, abnormalities indicative of ectatic diseases can be identified. Additionally, it is important to consider the patient's contact lens history and utilize zonal pachymetry for a comprehensive evaluation. While no single diagnostic tool can predict future disease with certainty, following these topographic guidelines significantly enhances the ability to avoid potential postoperative complications."}
{"question": "What is the role of extracellular matrix (ECM) molecules in retinal development ?", "answer": "ECM molecules play a vital role in retinal development by contributing to neuronal migration and axonal growth. They interact with various cell adhesion molecules and growth factors, regulating their activity and stability. While the function and cellular origin of ECM molecules in the retina are not well studied, they are prominently present at the inner limiting membrane (ILM) and could be derived from ganglion cells, astrocytes, Müller cells, or the retinal vasculature. Müller cells, in particular, are a likely source for some ECM molecules, although they do not synthesize laminin B1 mRNA or collagen lV mRNA. Other ECM molecules such as merosin, vitronectin, and thrombospondin present at the ILM may also be derived from Müller cells, but further research is needed to establish this. Inhibitory ECM molecules expressed by Müller cells, such as EAP-300 and clausterin, may be involved in retinal stratification. Additionally, integrins, which are cell surface receptors, likely mediate the adhesion of Müller cell end feet to vitreous collagen and may contribute to Müller cell migration into epiretinal membranes."}
{"question": "What is the significance of the 24-2 central threshold test pattern in visual field evaluation ?", "answer": "The 24-2 central threshold test pattern plays a crucial role in assessing the visual field. It consists of 54 test points spread over a 24° area from the fixation point. These test points are strategically placed to cover the central region of the visual field. The 24-2 test pattern is similar to the 30-2 test pattern, with the only difference being that the 54 test points of the 30-2 pattern are condensed within a 24° area from the fixation point. This ensures that the important central visual field is thoroughly evaluated. Each test point is located 6° apart, providing a point density of 6°. The test points are positioned to straddle both the horizontal and vertical axes, and the four innermost points are placed 3° away from the fixation spot. This arrangement leaves a 3° bare area surrounding the fixation spot. By using the 24-2 central threshold test pattern, ophthalmologists can assess the sensitivity and function of the central visual field. This test is particularly valuable in detecting and monitoring diseases that affect the macula and central vision, such as macular degeneration, diabetic retinopathy, and glaucoma. Interpreting the results from the 24-2 test pattern allows ophthalmologists to identify any visual field defects or abnormalities, which can aid in diagnosing and managing these ocular conditions. The test results are typically presented in a printout, which may be similar to those from the 30-2 test pattern due to the overlapping test points."}
{"question": "Discuss the anatomy and physiology of the cornea and how transparency is maintained ?", "answer": "The cornea is the clear, dome-shaped structure that covers the front part of the eye. It plays a crucial role in vision by acting as a protective barrier and focusing incoming light onto the retina. Anatomy of the Cornea: The cornea is composed of several layers, each with its own unique characteristics. From the outermost layer to the innermost layer, these layers include: 1. Epithelium: This outermost layer is a thin, transparent layer that helps protect the cornea from damage and infection. 2. Bowman's Layer: This layer consists of collagen fibers and provides structural support to the cornea. 3. Stroma: The stroma forms the thickest layer of the cornea and accounts for its transparency. It is composed of collagen fibers arranged in a highly organized pattern, which helps to transmit light through the cornea. 4. Descemet's Membrane: This layer is a thin, transparent sheet that acts as a barrier against the loss of fluid from the cornea. 5. Endothelium: The innermost layer of the cornea, it is responsible for pumping out excess fluid to maintain corneal clarity. Physiology of Transparency: Transparency is a vital characteristic of the cornea, as it allows light to pass through and reach the retina for vision. Several factors contribute to the cornea's transparency and clarity: 1. Regular arrangement of collagen fibers: The stroma's collagen fibers are arranged in a highly ordered lattice-like pattern. This arrangement minimizes light scattering, allowing light to pass through the cornea without significant distortion. 2. Dehydration: The cornea is normally dehydrated, which reduces the scattering of light. The endothelium actively pumps out excess fluid from the cornea, maintaining its optimal thickness and transparency. 3. Avascularity: The cornea lacks blood vessels, reducing the risk of interference from blood cells and maintaining transparency. It receives nutrients and oxygen from the surrounding tear film and aqueous"}
{"question": "Question: Do aqueous Angiopoietin-Like 4 Levels Correlate With Nonperfusion Area and Macular Edema in Branch Retinal Vein Occlusion?\nContext: To investigate whether macular edema (ME) due to branch retinal vein occlusion (BRVO) associates with retinal overexpression of angiopoietin-like 4 (ANGPTL4). The aqueous ANGPTL4 and vascular endothelial growth factor (VEGF) levels in patients with ME due to BRVO were measured, and the relationships between ANGPTL4 levels and the degree of retinal ischemia and edema were determined. The study and control groups consisted of all consecutive patients who were scheduled to undergo intravitreal bevacizumab injection for treatment-naïve BRVO with ME and senile cataract surgery, respectively. The study group was divided into the major BRVO and macular BRVO subgroups on the basis of the involved retinal area. The aqueous ANGPTL4 and VEGF levels were measured by enzyme-linked immunosorbent assay. In the patients with BRVO, capillary nonperfusion area by fluorescein angiography and central subfield macular thickness (CSMT) and total macular volume (TMV) by spectral-domain optical coherence tomography were determined. Patients with ME due to BRVO (50 eyes) had higher aqueous ANGPTL4 and VEGF levels than the controls (61 eyes) (both P < 0.001). The major BRVO had higher ANGPTL4 and VEGF levels than the macular BRVO (both P < 0.001). The aqueous ANGPTL4 levels of all BRVO patients correlated positively with nonperfusion area (r = 0.901, P < 0.001), CSMT (r = 0.574, P < 0.001), and TMV (r = 0.453, P = 0.001), even after adjustment for VEGF levels.", "answer": "The aqueous ANGPTL4 levels correlated significantly with phenotypes of BRVO with ME. This suggests that ANGPTL4 may be a candidate biomarker and treatment target in ischemia-induced retinopathies, including BRVO.\n\nyes"}
{"question": "Q: What are some adjunct usage options for age-related macular degeneration (AMD) ?", "answer": "Provide a detailed explanation. A: Age-related macular degeneration (AMD) can be managed using various adjunct usage options to complement the primary treatment approach. One such option is the selective intraocular radiation brachytherapy, which involves delivering targeted radiation to the affected area of the macula. This technique aims to inhibit the growth of abnormal blood vessels and reduce the progression of neovascular membranes (CNVM), which are often associated with AMD. Another adjunct usage option is the use of tissue plasminogen activator (tPA). This medication is administered to dissolve blood clots that may contribute to the development or worsening of AMD. By improving blood flow in the affected area, tPA can potentially slow down the progression of the disease and reduce associated vision loss. Triamcinolone acetonide is yet another adjunct usage option in the management of AMD. This corticosteroid medication can be injected into the eye to reduce inflammation and edema, which are common in advanced stages of the disease. By controlling inflammation, triamcinolone acetonide can help stabilize vision and potentially delay the progression of AMD. Encapsulated cell technology (ECT) is a novel adjunct usage option being explored for the treatment of AMD. ECT involves implanting specialized cells that continuously release therapeutic agents into the eye. These agents aim to suppress the growth of abnormal blood vessels and inhibit the inflammatory response associated with AMD. While still under investigation, ECT shows promise as a potential long-term treatment option for AMD. It's important to note that the selection of adjunct usage options for AMD should be based on individual patient characteristics, disease severity, and the presence of other eye conditions. Ophthalmologists should consider the risks, benefits, and evidence supporting each option before deciding on the most appropriate treatment approach for their patients."}
{"question": "What is meant by the term \"multifactorial\" in relation to the inheritance of AMD ?", "answer": "In the field of specialized clinical ophthalmology, the term \"multifactorial\" refers to the inheritance of age-related macular degeneration (AMD) being influenced by both genetic and environmental factors. This means that the development and progression of AMD are not solely determined by genetics or solely influenced by environmental factors, but rather a combination of both. It is suggested that individuals with a genetic susceptibility may be more prone to the effects of certain environmental factors, leading to an increased risk of developing AMD. However, the specific genetic and environmental factors involved in the multifactorial inheritance of AMD are still not fully understood."}
{"question": "Question: Do caspase inhibitors protect against NMDA-mediated retinal ganglion cell death?\nContext: Apoptosis is a major mechanism of cell death in glutamate-induced excitotoxicity and caspases as the executors of apoptosis play an important role in the development of various central nervous system and eye diseases. We studied the involvement of certain caspases in excitotoxic retinal ganglion cell death, which was experimentally induced in Brown Norway Rats by application of the glutamate receptor agonist N-methyl-D-aspartate (NMDA). Animals were injected intravitreally with one of six caspase inhibitors (against caspases 1, 3, 4, 6, 8 and 9). Seven hours later, NMDA or phosphate-buffered saline as a control was injected intravitreally into the respective eyes. The neuroprotective potential against NMDA toxicity was assessed by retinal ganglion cell quantification. Additionally, wholemount TUNEL was performed. Statistical analysis revealed significant neuroprotective effects for the inhibitors of caspases 3, 6, 8 and 9, but not for those of caspases 1 and 4. The inhibitors of caspases 6 and 9 showed greater neuroprotective potential than those of caspases 3 and 8, although cell death was not entirely averted in any case. Results of ganglion cell counts were confirmed for the most pronounced treatment groups using wholemount TUNEL.", "answer": "Excitotoxic retinal ganglion cell death after NMDA injection is mediated mainly through apoptosis, whereby extrinsic as well as intrinsic pathways of caspase activation play a role.\n\nyes"}
{"question": "What does chapter 5.4 discuss in relation to autofluorescence ?", "answer": "Chapter 5.4 discusses the wavelength dependence of autofluorescence and the longitudinal changes in hereditary retinal diseases. It compares autofluorescence induced by near-infrared light and blue light, attributing different fluorophores to each, namely melanin in the near-infrared range and lipofuscin in the blue range. The study's results suggest that autofluorescence in the near-infrared provides additional information about cellular physiology. Additionally, autofluorescence induced by blue light proves to be useful in longitudinally monitoring changes in patients with macular dystrophies."}
{"question": "Question: Does jugular venous reflux affect ocular venous system in transient monocular blindness?\nContext: The frequency of jugular venous reflux (JVR) is higher in patients with transient monocular blindness (TMB). We hypothesize that JVR influences ocular venous outflow, and resulting disturbances in cerebral and ocular venous circulation might be a cause of TMB. To substantiate this hypothesis, we aimed to demonstrate that: (1) TMB patients have vasculature changes in their retinal venules, and (2) JVR could influence ocular venous outflow, as revealed by dilated retinal venules. This study has 2 parts. The case-control study included 31 TMB patients and 31 age/gender-matched normal individuals, who all received fundus photography for retinal venule diameter comparisons. The Valsalva maneuver (VM) experiment included 30 healthy volunteers who received both color Doppler imaging of the internal jugular vein and fundus photography for retinal venule diameter measurement. In the case-control study, TMB patients had a wider retinal venule diameter (184.5 +/- 17.5 vs. 174.3 +/- 16.2 microm, right eye, p = 0.023; 194.20 +/- 24.6 vs. 176.6 +/- 19.5 microm, left eye, p = 0.017), especially TMB patients with JVR. The VM experiments showed that the presence of JVR was associated with a greater increase in retinal venule diameters during VM in the subjects' right eye (14.27 +/- 11.16 vs. 2.75 +/- 3.51%, JVR vs. non-JVR, p = 0.0002) and left eye (10.06 +/- 6.42 vs. 1.80 +/- 2.03%, p = 0.0003).", "answer": "These findings provide evidence that frequently occurring JVR associated with TMB impedes ocular venous outflow, and the subsequent disturbances in ocular venous circulation may be a cause of TMB.\n\nyes"}
{"question": "Question: Does triamcinolone acetonide suppress early proangiogenic response in retinal pigment epithelial cells after photodynamic therapy in vitro?\nContext: To investigate the expression of proangiogenic and antiangiogenic factors, vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) in retinal pigment epithelial (RPE) cells after photodynamic therapy (PDT), especially focusing on their change in the presence of triamcinolone acetonide. Firstly, the cellular uptake of verteporfin was quantified after confluent ARPE-19 (human retinal pigment epithelial) cells were exposed to 5 microg/ml verteporfin combined with or without 1 microg/ml triamcinolone acetonide for 1 h. Secondly, ARPE-19 cells exposed to various doses of verteporfin were irradiated with 120 mJ/cm(2) light. After incubation with or without 1 microg/ml triamcinolone acetonide for 2 days, cell viability and expressions of VEGF and PEDF were assessed. Cellular uptake of verteporfin was not significantly changed by the presence of 1 microg/ml triamcinolone acetonide. In addition, 0.01-0.1 microg/ml of verteporfin showed a dose-dependent toxicity on the ARPE-19 cells 2 days after the light exposure. The presence of verteporfin at a concentration of 0.01 microg/ml did not affect the cell viability but significantly increased VEGF (p<0.001) and reduced PEDF (p = 0.03) expression. Administration of triamcinolone acetonide significantly suppressed both this increase in VEGF (p<0.001) and decrease in PEDF (p = 0.001).", "answer": "VEGF was increased and PEDF reduced in cultured RPE cells shortly after PDT even at a sublethal dose. Triamcinolone acetonide suppressed this proangiogenic response.\n\nyes"}
{"question": "Question: Does activation of formyl peptide receptor-1 enhance restitution of human retinal pigment epithelial cell monolayer under electric fields?\nContext: This study aimed at identifying the expression of functional formyl peptide receptor (FPR)-1 in human retinal pigment epithelium (hRPE) cells and to evaluate the role of FPR in regulation of wound closure of the hRPE monolayer under electric fields (EFs). The expression of FPR in hRPE cells was analyzed with an immunofluoresence labeling assay and RT-PCR. Cultured wounded hRPE monolayers were exposed to EFs with free serum, 20%, serum, and a classical FPR agonist, N-formyl-Met-Leu-Phe (fMLF), respectively, for 3 hours. Cell monolayer migrations were traced using an image analyzer. Expressions of cell junction molecules were measured by RT-PCR, and the ultrastructure of cell junctions was observed with transmission electron microscopy (TEM). The expression of functional FPR was observed and localized along actin filaments in cellular lamellipodia and filopodia. EFs and fMLF significantly increased the migration rates of the wounded RPE monolayer. The migrating distances of monolayers were 24.262 ± 6.82 μm, 40.243 ± 5.069 μm, and 56.926 ± 7.821 μm in cells with free serum, 20% serum, and fMLF under EFs at 3 hours, respectively (P < 0.01). The mRNA expressions of connexin 43(Cx43) and zonula occludens (ZO)-1 were detected in hRPE cells. TEM revealed that cell junctions formed between hRPE cells in the monolayer.", "answer": "These results showed for the first time that functional FPR expresses in hRPE cells and that activation of FPR enhances migration of the wounded hRPE monolayer. The mRNA expressions and ultrastructures of cell junctions further demonstrated the RPE sheet as a monolayer migrating under EFs.\n\nyes"}
{"question": "Question: Do macular Changes Correlate with the Degree of Acute Anterior Uveitis in Patients with Spondyloarthropathy?\nContext: To evaluate the correlation between anterior chamber inflammation and the central foveal thickness of the retina in a homogenous uveitic group (seronegative spondyloarthropathy (subgroup: ankylosing spondylitis)) of patients with the first acute anterior unilateral uveitic attack. Central foveal thickness (FT) and perifoveal retinal thickness were recorded by optical coherence tomography (Optovue RTVue-100), and the difference between the two eyes was calculated. Statistical analysis was performed by Mathworks Matlab software. Anterior chamber inflammation was measured by laser flare photometry (Kowa FM-600). A statistically significant (p < .05) increase was found in retinal thickness in all OCT subfields in acute anterior uveitic eyes compared to healthy fellow eyes. There was a linear correlation between the degree of inflammation (laser flare photometry values) and central foveal thickness (r = .900, p < .001).", "answer": "We could demonstrate close correlation between macular thickness and inflammation in anterior uveitic patients with spondyloarthropathy.\n\nyes"}
{"question": "Question: Hi doctor,What is the next step done after cataract surgery when the cataract is falling into vitreous? Does it require vitrectomy surgery to recover lens from vitreous followed by streptococcus bacteria causing endophthalmitis infection and multiple antibiotic injections? The doctor examined and told me that my retina looks attached and my pressure is 13. My cornea has hypopyon. My iris has opacity, and I can see only a distorted and lighted background. My doctor recommends a cornea transplant for viewing and vitrectomy. Please suggest.", "answer": "Hi. The lens falling into vitreous followed by endophthalmitis requires intravitreal antibiotic injections, and if the patient\\s visual acuity deteriorates further, then vitrectomy is necessary. Regarding the corneal transplant, it is usually done in a disease entity called bullous keratopathy. But it can also be done for a variety of other reasons. Endophthalmitis is a very troublesome problem and needs a lot of patient cooperation with medication compliance and follow-ups.  Take care."}
{"question": "What are the challenges in delivering drugs to the retina and vitreous cavity in the treatment of age-related macular degeneration (AMD) ?", "answer": "Delivering drugs to the retina and vitreous cavity in the treatment of age-related macular degeneration (AMD) poses several challenges. The eye has various barriers that limit the penetration of administered drugs. The blood-aqueous barrier, composed of the ciliary non-pigmented epithelium and iridal vascular endothelium with tight junctions, as well as the outer and inner blood-retinal barriers (BRB) formed by the retinal pigment epithelium (RPE) and retinal vascular endothelium, respectively, prevent easy access of systemically administered drugs to the retina and vitreous cavity. Additionally, the eye is covered with collagenous walls such as the cornea and sclera, and it has epithelial and endothelial barriers like the cornea and RPE. These physical barriers, along with continuous tear drainage, frontward flow of aqueous humor, and surrounding blood circulations, further impede the penetration of drugs delivered via eye drops and ointments. Moreover, compliance with treatment can be challenging, particularly among patients with chronic ocular diseases like glaucoma and refractory chorioretinal diseases, including uveitis, macular edema, neovascular (wet) and atrophic (dry) AMD, and retinitis pigmentosa. Overcoming these barriers and ensuring patient adherence to treatment regimens are crucial in effectively managing AMD and other ocular conditions. It is important to consider these challenges when designing drug delivery systems for the eye, as they influence the selection and formulation of drugs, the anatomical and disease-specific characteristics of the eye, and the dosing requirements for optimal treatment outcomes."}
{"question": "Question: Which of the following is k/a dangerous zone of eye-\nOptions:\nA. Sclera\nB. Retina\nC. Optic nerve\nD. Ciliary body\n", "answer": " Ans. is 'd' i.e. Ciliary body Wound involving the ciliary body are most prone to develop sympathetic ophthalmitis, thus ciliary region is k/a the dangerous zone of the eye.\n\nOPTION D IS CORRECT."}
{"question": "Question: A 69-year-old man presents to the emergency depament with painless vision loss of his right eye. He describes the visual loss as a gradual progression from blurry to total blackout over the past two hours. He has no history of prior visual problems. Past medical history is significant for a myocardial infarction three years ago. The patient takes aspirin daily. Vital signs are normal. Physical examination reveals 20/20 vision of the left eye but no vision in the right eye. Extraocular muscles are intact. The neurologic examination is normal. The cardiac examination reveals an S4 hea sound. The most likely cause of this unilateral blindness is which of the following?\nOptions:\nA. Carotid aery dissection\nB. Cavernous sinus thrombosis\nC. Posterior cerebral aery occlusion\nD. Retinal aery occlusion\n", "answer": " This patient has a sudden onset of complete, unilateral, painless loss of vision with intact extraocular muscle movement. This is consistent with occlusion of the retinal aery. The retina derives its blood supply from the internal carotid aery the ophthalmic aery, from which branch the central retinal aery and ciliary aeries. The central retinal aery supplies the inner layers of retina, while ciliary aeries supply blood to the choriocapillaris and the outer retinal layers. Occlusion of small retinal aerioles produces \"cotton wool\" spots while total occlusion of the ophthalmic aery leads to total ischemia and blindness. This usually occurs secondary to atherosclerotic disease. The key here is recognizing that the loss of vision is an isolated finding with no other neurologic symptoms. Other deficits would be consistent with a stroke of a larger vascular territory such as the internal carotid aery. Carotid aery dissection is less likely than retinal aery occlusion because there would likely be multiple associated neurologic findings in the case of dissection, as the internal carotid aery supplies a large poion of the anterior circulation of the brain. The most likely symptoms among a large cadre of possibilities is face and arm weakness contralateral to the dissection. Cavernous sinus thrombosis would lead to facial pain and possible cranial nerve deficits. The optic nerve (cranial nerve II) extends anteriorly from the optic chiasm through the superior orbital fissure. Posterior cerebral aery occlusion is less likely than retinal aery occlusion because there would likely be multiple associated neurologic findings. Also, the visual field loss resulting from a unilateral posterior cerebral aery occlusion would more likely be a homonymous hemianopia, it would not cause complete blindness in one eye. Other changes that may occur from posterior cerebral aery stroke are complex findings, such as the inability of recognize faces (prosopagnosia), failure to connect visual perception with conscious thought, color vision loss, and difficulty with reading (dyslexia or alexia). Memory problems and motor impairment are also common associated findings.\n\nOPTION D IS CORRECT."}
{"question": "Specialized clinical ophthalmology question: How does the distance between the retinal neural cell and the electrode surface affect the threshold current required for stimulation ?", "answer": "The distance between the retinal neural cell and the electrode surface plays a crucial role in determining the threshold current required for stimulation. As shown in Figure 14.2, the threshold current increases with the separation of the cell from the electrode surface, reaching a quadratic dependence. This means that as the distance between the cell and the electrode surface increases, a higher current is needed to depolarize the cell membrane and initiate stimulation. The experimental values mentioned in the text indicate that for retinal neural cell stimulation, a threshold current of approximately 4-30 µA (at pulse duration 1 ms) is required when using a disk electrode with a diameter of 62.5 µm in close proximity to the cells. This close proximity ensures efficient and effective stimulation. The high-resolution retinal implant design should consider maintaining a close and stable proximity between the cells and the electrodes. If the separation varies in different parts of the array, the stimulation threshold and the resulting visual outcome will also vary. Therefore, the distance between the electrode surface and the retinal neural cells is an important factor to consider when designing retinal prostheses to achieve optimal visual outcomes. It is important to note that this response is based on the provided text and does not offer any new information beyond the context."}
{"question": "What is the recommended treatment for retinal arterial macroaneurysms ?", "answer": "The recommended treatment for retinal arterial macroaneurysms is photo-coagulation, using either the green or yellow wavelength. A low-intensity, longer-duration burn is recommended. It is important to note that treatment is indicated only when visual loss occurs due to fluid or exudate accumulation in the macula. In the absence of central visual loss, treatment is usually not necessary as macroaneurysms have a tendency to heal spontaneously. However, it is advised to consider the potential complications of treatment, such as arterial obstruction and vitreous hemorrhage, and weigh them against the visual prognosis associated with the degree and duration of foveal involvement with hemorrhage or exudate."}
{"question": "Question: True about measles\nOptions:\nA. Rash appear first on leg\nB. Koplik spots are seen in retina\nC. Long term complication follows in form of SSPE\nD. Caused by DNA virus\n", "answer": " Complications of measles are otitis media ,bacterial bronchopneumonia,respiratory complications like laryngitis, tracheitis ,bronchitis, giant cell pneumonia and bronchiectasis,GI complications like diarrhea ,appendicitis ,hepatitis, ileocolitis,acute encephalitis. Post measles encephalitis may occur after recovery. Fatal subacute sclerosing panecephalitis (SSPE)may occur after several yrs of infection. Koplik spots appear opposite the lower second molar of buccal mucosa on second or third day of illness. Rash appear first behind ear,along hairline and on posterior aspect of cheek. Image : Measles causes a red, blotchy rash that usually appears first on the face and behind the ears, then spreads downward to the chest and back and finally to the feet. Reference: Essential pediatrics,op ghai,9 th edition,pg no:209& 210\n\nOPTION C IS CORRECT."}
{"question": "What is the management approach for Aortic Insufficiency in ophthalmology ?", "answer": "The management of Aortic Insufficiency in ophthalmology primarily involves identifying and addressing any ocular manifestations related to this condition. While the primary treatment lies within the field of cardiology, ophthalmologists may contribute by assessing and managing ocular symptoms that may arise. Some potential ocular manifestations of Aortic Insufficiency include retinal artery emboli, ischemic optic neuropathy, and conjunctival telangiectasia. When managing a patient with Aortic Insufficiency, ophthalmologists should be vigilant in monitoring and addressing any ocular complications that may arise. Regular eye examinations, including a thorough evaluation of visual acuity, pupillary reactions, intraocular pressure, and fundus examination, are essential for early detection and intervention. Additionally, a detailed patient history, including information about symptoms such as vision changes, eye pain, or redness, can provide valuable clues for prompt diagnosis and management. If ocular complications are suspected or detected, ophthalmologists should refer the patient to a cardiac specialist for a comprehensive evaluation and appropriate management of Aortic Insufficiency. Collaborating with other healthcare professionals in a multidisciplinary approach is crucial for providing comprehensive care to patients with systemic conditions affecting the eyes. It is important to note that as an AI, I can provide general guidance and information. However, for specific treatment decisions and management plans, it is always recommended to consult with a qualified ophthalmologist or refer to authoritative ophthalmology resources."}
{"question": "What is the appropriate treatment for hyphema and what are the clinical parameters that should be evaluated in cases of hyphema ?", "answer": "The treatment for hyphema, which is the presence of blood within the anterior chamber of the eye, depends on the underlying cause. In cases of traumatic hyphema, the primary goal is to manage the bleeding and prevent complications such as increased intraocular pressure and secondary glaucoma. This can be achieved through various measures such as bed rest, elevation of the head, and avoidance of activities that can increase intraocular pressure, such as strenuous exercise. Additionally, medications such as topical steroids and cycloplegics may be prescribed to reduce inflammation and prevent the formation of adhesions. In cases where hyphema is caused by other factors such as blood disorders or ocular neoplasia, the underlying condition needs to be addressed in order to effectively treat the hyphema. This may involve treating the underlying blood disorder or removing the neoplastic growth. When evaluating a case of hyphema, a complete eye examination should be performed to assess for any concomitant injury or disease. It is important to rule out globe rupture, as this would require immediate surgical intervention. Vision should be estimated based on the degree of menace response when bright light is suddenly directed into the eye. The consensual pupillary light reflex can indicate the functionality of the retina and optic nerve. Intraocular pressure should also be measured to assess for any increase that may suggest the development of glaucoma. Finally, the severity of the hyphema can be graded based on the volume of blood occupying the anterior chamber, which can provide prognostic information regarding the severity of the hemorrhage and the potential for complications. It is crucial to determine the cause of hyphema as soon as possible in order to provide appropriate treatment. This may involve further diagnostic tests such as blood work, imaging, or referral to a specialist. References: 1. Gelatt KN, Gilger BC, Kern TJ. Veterinary Ophthalmology. 6th ed. John Wiley & Sons; 2020. 2. Riis RC. Ophthalmic emergencies in small animals. Vet Clin North Am Small Anim Pract. 2013;43(4):901-935. doi:10.1016/j.cvsm.2013.04.003"}
{"question": "How is the grading of active retinopathy of prematurity (ROP) performed ?", "answer": "Grading of active retinopathy of prematurity (ROP) involves a step-by-step process. Firstly, the zones are identified, which are three areas centered on the optic disc. Zone 1 refers to a circular area around the optic disc, while zone 2 extends from the outer border of zone 1 to the nasal ora serrata (the boundary between the vascular and avascular retina). Zone 3 extends temporally from the nasal ora serrata until it meets the nasally extending vessels of zone 2. After identifying the zones, the extent of ROP is determined based on the number of clock hours involved. Clock hours are used as a measurement to describe the amount of retina affected by ROP. This involves assessing the extent of abnormal blood vessels, tortuosity, and other features within the clock hour segments. The examiner evaluates the retina in a clockwise manner, noting the number of hours involved in the pathology. By following this step-by-step process, ophthalmologists can accurately grade the active stage of retinopathy of prematurity (ROP) and determine the appropriate management or treatment plan for the patient."}
{"question": "What are the factors that can contribute to the difference in endothelial cell density between the eyes of a patient who underwent Artisan lens implantation for unilateral myopia ?", "answer": "Several factors can contribute to the difference in endothelial cell density between the eyes of a patient who underwent Artisan lens implantation for unilateral myopia. Firstly, the surgical procedure itself can result in a certain degree of trauma to the corneal endothelium, leading to a decrease in endothelial cell density. The extent of this trauma may vary between eyes and can be influenced by factors such as surgical technique, surgeon experience, and individual patient characteristics. Secondly, the pre-existing condition of the eye, particularly in cases of anisometropia and amblyopia, can also impact endothelial cell density. Patients with poor compliance to glasses and contact lenses, as described in the context, may have had a longer duration of uncorrected myopia, which can potentially lead to corneal changes, including decreased endothelial cell density. Additionally, the presence of anisometric amblyopia itself may have contributed to differences in endothelial cell density between the eyes. Lastly, individual variations in the healing and remodeling processes of the cornea after the surgery can influence endothelial cell density. Factors such as inflammation, wound healing response, and genetic predisposition can all play a role in determining the final endothelial cell density. It is important to note that these factors are general considerations and the specific circumstances of each patient should be evaluated to determine the exact causes of the observed difference in endothelial cell density."}
{"question": "Question: Which of the following refractive problems most closely resembles presbyopia?\nOptions:\nA. Hyperopia\nB. Myopia\nC. Astigmatism\nD. Cataract\n", "answer": " Presbyopia is the loss of accommodative power that occurs as a person ages. Because accommodation cannot occur, the near point moves way from the eye and images must be held at some distance from the eye to be clearly seen. This is similar to the situation in hyperopia where the converging power is too weak for the axial length of the eye. Hyperopes must accommodate to see distant objects clearly and thus have less accommodation available for near vision. Thus hyperopes, like presbyopes, must hold objects at a distance to see them clearly (hence the term \"farsighted\"). Ref: Riordan-Eva P. (2011). Chapter 21. Optics & Refraction. In P. Riordan-Eva, E.T. Cunningham, Jr. (Eds), Vaughan & Asbury's General Ophthalmology, 18e.\n\nOPTION A IS CORRECT."}
{"question": "Question: Does sildenafil attenuate vaso-obliteration and neovascularization in a mouse model of retinopathy of prematurity?\nContext: We sought to determine the effect of sildenafil on retinal vascular changes in a mouse model of oxygen-induced retinopathy (OIR). Vascular defects in OIR mice were quantified by measuring vaso-obliteration at postnatal days 12 and 17 (P12 and P17) and neovascularization at P17 to compare sildenafil-treated to dextrose-treated OIR mice. Retinal HIF1α protein expression was quantified by Western blotting and normalized to that of β-actin. Right ventricular hypertrophy was measured by Fulton's index as a surrogate for hyperoxia-induced pulmonary hypertension. At P12, OIR mice treated with sildenafil demonstrated a 24% reduction in vaso-obliteration (P < 0.05), whereas at P17, treated animals showed a 50% reduction in neovascularization (P < 0.05) compared to dextrose-treated controls. Sildenafil-treated OIR mice had stabilization of retinal HIF1α at P12, immediately after hyperoxia. At P17, sildenafil-treated OIR mice had decreased HIF1α relative to untreated mice. OIR mice developed right ventricle hypertrophy that was significant compared to that in room air controls, which was abrogated by sildenafil.", "answer": "Sildenafil treatment significantly decreased retinal vaso-obliteration and neovascularization in a mouse OIR model. These effects are likely due to sildenafil-induced HIF1α stabilization during hyperoxia exposure. Furthermore, we confirm disease overlap by showing that OIR mice also develop hyperoxia-induced right ventricular hypertrophy, which is prevented by sildenafil. This study is a first step toward delineating a potential therapeutic role for sildenafil in OIR and further suggests that there may be common pathophysiologic mechanisms underlying hyperoxia-induced retinal and pulmonary vascular disease.\n\nyes"}
{"question": "Question: Do persons with age-related maculopathy risk genotypes and clinically normal eyes have reduced mesopic vision?\nContext: To determine whether participants with normal visual acuity, no ophthalmoscopically signs of age-related maculopathy (ARM) in both eyes, and who are carriers of the CFH, LOC387715, and HRTA1 high-risk genotypes (gene-positive) have impaired rod- and cone-mediated mesopic visual function compared with persons who do not carry the risk genotypes (gene-negative). Fifty-three Caucasian study participants (mean 55.8 ± 6.1) were genotyped for CFH, LOC387715/ARMS2, and HRTA1 polymorphisms. Single-nucleotide polymorphisms were genotyped in the CFH (rs380390), LOC387715/ARMS2 (rs10490924), and HTRA1 (rs11200638) genes using optimized gene-expression assays. The critical fusion frequency (CFF) mediated by cones alone (long-, middle-, and short-wavelength sensitive cones, LMS) and by the combined activities of cones and rods (LMSR) were determined. The stimuli were generated using a four-primary photostimulator that provides independent control of the photoreceptor excitation under mesopic light levels. Visual function was further assessed using standard clinical tests, flicker perimetry, and microperimetry. The mesopic CFF mediated by rods and cones (LMSR) was significantly reduced in gene-positive compared to gene-negative participants after correction for age (P = 0.03). Cone-mediated CFF (LMS) was not significantly different between gene-positive and -negative participants. There were no significant associations between flicker perimetry and microperimetry and genotype.", "answer": "This is the first study to relate ARM risk genotypes with mesopic visual function in clinically normal persons. These preliminary results could become of clinical importance because mesopic vision may be used as a biomarker to document subclinical retinal changes in persons with risk genotypes and to determine whether those persons progress into manifest disease.\n\nyes"}
{"question": "Question: Do clinical predictors and outcomes of pars plana vitrectomy for retained lens material after cataract extraction?\nContext: To determine current clinical predictors and visual outcomes of patients who undergo pars plana vitrectomy (PPV) for retained lens material. Retrospective, noncomparative, consecutive case series. Medical records of 166 patients with complicated cataract surgery who underwent PPV for retained lens material at Retina Vitreous Consultants of Pittsburgh between January 1, 2001 and January 1, 2007 were reviewed. Main outcome measures include final visual acuity, development of glaucoma, retinal detachments, and cystoid macular edema. At the final examination, 120 patients (72.3%) had a visual outcome of 20/40 or better and 18 patients (10.8%) had a visual outcome of 20/200 or worse. In patients without any preoperative eye conditions, 82.6% achieved a final vision of 20/40 or better. Multivariable analysis showed that predictors for visual outcomes of 20/40 or better were better presenting vision (P = .001), insertion of a posterior chamber lens (P = .005), and absence of preoperative eye disease (P = .001). Predictors for visual outcomes of 20/200 or worse were the absence of an anterior vitrectomy at cataract surgery (P = .005), absence of a sulcus lens (P = .011), presence of preexisting eye disease (P = .02), and development of glaucoma (P = .001). Performing a PPV within 7 days of cataract surgery was associated with a lower risk of developing glaucoma (P = .005).", "answer": "Current techniques for management of retained lens material may contribute to improved visual outcomes based on our series. We recommend that the cataract surgeon perform an anterior vitrectomy, place a posterior chamber lens if possible, and consult a retina specialist for a PPV within 7 days to decrease the risk of developing secondary glaucoma.\n\nyes"}
{"question": "What is the definition of photodynamic therapy (PDT) in ophthalmology ?", "answer": "Photodynamic therapy (PDT) is a treatment modality used in ophthalmology to selectively destroy abnormal blood vessels in the retina, particularly in conditions like age-related macular degeneration (AMD). It involves the administration of a photosensitizing agent, such as Visudyne (BPD-MA) or ATX-S10, followed by targeted laser illumination. The photosensitizer is activated by the laser, leading to the formation of reactive oxygen species that cause localized damage to the abnormal blood vessels. PDT aims to induce vessel occlusion without significant harm to normal retinal structures. Further research is being conducted to optimize dosing parameters, understand the pharmacokinetics and metabolism of photosensitizers, and explore potential combination therapies to enhance the effectiveness of PDT in treating ophthalmic conditions."}
{"question": "Question: All of the following are symptoms of carotid atherosclerosis, EXCEPT:\nOptions:\nA. Ipsilateral amaurosis fugax\nB. Ipsilateral retinal infarction\nC. Contralateral body TIA\nD. Contralateral amaurosis fugax\n", "answer": " Carotid atherosclerosis is a pathological thickening of the common or internal carotid intima, typically into focal areas known as plaques (or atheromata). Although atheromata can remain stable for many years, surface rupture of unstable (vulnerable) plaques leads to local thrombus formation, with subsequent embolisation to the ipsilateral ophthalmic, middle cerebral, or anterior cerebral aery territories. The resultant symptoms are ipsilateral amaurosis fugax or retinal infarction and contralateral body transient ischaemic attack (TIA) or stroke. Carotid ultrasound is recommended within 24 hours of a new carotid territory transient ischaemic attack, non-disabling ischaemic stroke, ipsilateral amaurosis fugax, or retinal aery infarction Ref: Oates CP, Naylor AR, Hashorne T, Charles SM, Fail T, Humphries K, et al. Joint recommendations for repoing carotid ultrasound investigations in the United Kingdom. Eur J Vasc Endovasc Surg2009;37:251-61; Diagnosis and management of carotid atherosclerosis ; BMJ 2013;346:f1485.\n\nOPTION D IS CORRECT."}
{"question": "How can persistent hyperplastic primary vitreous be differentiated from retinoblastoma ?", "answer": "Persistent hyperplastic primary vitreous (PHPV) can be differentiated from retinoblastoma by observing certain features. In PHPV, there is a failure of regression of the primary vitreous, resulting in a white opacity posterior to the lens. One distinguishing feature is the presence of indrawn ciliary processes. Additionally, PHPV may be associated with microphthalmos (abnormally small eye) and persistent hyaloid artery remnants. The remnants of the hyaloid artery can be seen extending from the optic disc to the posterior surface of the lens in complete cases. In some instances, PHPV may cause retinal detachment. On the other hand, retinoblastoma is a malignant tumor of the retina and typically presents as a white pupillary reflex (leucocoria). It is important to consider these features and conduct a thorough examination to differentiate between PHPV and retinoblastoma."}
{"question": "What are the symptoms of proliferative diabetic vitreoretinopathy (PDVR) ?", "answer": "Proliferative diabetic vitreoretinopathy (PDVR) is characterized by proliferative changes in the vitreous and retina, particularly around the optic disc and in the posterior vitreous cortex. In the early stages, the retina remains attached, and the disease progresses to extensive contraction causing retinal detachment. PDVR can lead to vision loss and is commonly associated with diabetic retinopathy."}
{"question": "Based on the provided data, what is the impact of anti-VEGF treatment on visual acuity (BCVA) and central macular thickness (CMT) in patients with choroidal neovascularization (CNV) due to pathologic myopia ?", "answer": "The data presented in the tables show the changes in visual acuity (BCVA) and central macular thickness (CMT) over a period of time in patients with CNV due to pathologic myopia who received anti-VEGF treatment. Looking at Table 2, it can be observed that at baseline, the mean BCVA was 0.6 logMAR, which improved to 0.5 logMAR at 24 months. However, the changes in BCVA were not statistically significant at different time points during the follow-up period (p values ranging from 0.47 to 0.91). In terms of CMT, the mean value at baseline was 216.8 μm, which decreased to 205 μm at 24 months. Although there was a reduction in CMT, the changes were not statistically significant at most time points (p values ranging from 0.18 to 0.82). Moving on to Table 3, it provides a comparison of baseline characteristics between patients who experienced BCVA improvement by at least 3 lines and those who had BCVA stabilization or worsening by at least 3 lines. The presence of subretinal or intraretinal fluid (SRF/IRF) decreased over time, from 46.7% at baseline to 13.3% at 24 months, which was statistically significant (p = 0.01). Additionally, the area of choroidal neovascularization (CNV) measured showed a significant reduction from baseline (2,873.4 mm3) to the 12-month examination (1,853.2 mm3). In summary, based on the provided data, anti-VEGF treatment in patients with CNV due to pathologic myopia appears to have some positive impact, such as a decrease in CMT and the area of CNV. However, changes in BCVA were not statistically significant. It is important to note that this analysis is based on the given data, and for a more comprehensive understanding, it is recommended to consult other ophthalmology resources and studies."}
{"question": "Question: A most common complication of extracapsular cataract surgery is –\nOptions:\nA. Retinal detachment\nB. Opacification of posterior capsule\nC. Vitreous haemorrhage\nD. None\n", "answer": " \"Opacification of the posterior capsule caused by the proliferation of cells in capsular bag remains the most frequent complication of ECCE and IOL surgery\". _____ Vajpayee\n\nOPTION B IS CORRECT."}
{"question": "Question: All are true about central retinal aery occlusion (CRAO) except\nOptions:\nA. Most commonly occurs due to thromboembolus\nB. Anterior chamber paracentesis is used for treatment\nC. Sudden painful loss of vision\nD. Occurs due to obstruction of retinal aery at the level of lamina cribrosa\n", "answer": " Answer- C. Sudden painful loss of visionPatient notices sudden painless loss of vision.Patients's with a patent cilioretinal aery may retain central vision as the macula is spared.Emboli are the most common cause of retinal aery occlusion.Obstruction occurs at the level of lamina cribrosa.The larger retinal aeries are constuicted and look like thin threads while the smaller vessels are scarcely visible.The fundus appears milky white because of retinal edema.There is cherry-red spot at the macula.Blood column within the retinal veins is segmented (Cattle tracking)\n\nOPTION C IS CORRECT."}
{"question": "Question: Does genome-wide association study for sight-threatening diabetic retinopathy reveal association with genetic variation near the GRB2 gene?\nContext: Diabetic retinopathy is a serious complication of diabetes mellitus and can lead to blindness. A genetic component, in addition to traditional risk factors, has been well described although strong genetic factors have not yet been identified. Here, we aimed to identify novel genetic risk factors for sight-threatening diabetic retinopathy using a genome-wide association study. Retinopathy was assessed in white Australians with type 2 diabetes mellitus. Genome-wide association analysis was conducted for comparison of cases of sight-threatening diabetic retinopathy (n = 336) with diabetic controls with no retinopathy (n = 508). Top ranking single nucleotide polymorphisms were typed in a type 2 diabetes replication cohort, a type 1 diabetes cohort and an Indian type 2 cohort. A mouse model of proliferative retinopathy was used to assess differential expression of the nearby candidate gene GRB2 by immunohistochemistry and quantitative western blot. The top ranked variant was rs3805931 with p = 2.66 × 10(-7), but no association was found in the replication cohort. Only rs9896052 (p = 6.55 × 10(-5)) was associated with sight-threatening diabetic retinopathy in both the type 2 (p = 0.035) and the type 1 (p = 0.041) replication cohorts, as well as in the Indian cohort (p = 0.016). The study-wide meta-analysis reached genome-wide significance (p = 4.15 × 10(-8)). The GRB2 gene is located downstream of this variant and a mouse model of retinopathy showed increased GRB2 expression in the retina.", "answer": "Genetic variation near GRB2 on chromosome 17q25.1 is associated with sight-threatening diabetic retinopathy. Several genes in this region are promising candidates and in particular GRB2 is upregulated during retinal stress and neovascularisation.\n\nyes"}
{"question": "Specialized clinical ophthalmology question: What are the clinical features and management options for acute multifocal posterior placoid pigment epitheliopathy (AMPPPE) ?", "answer": "Acute multifocal posterior placoid pigment epitheliopathy (AMPPPE) is an inflammatory disorder of the chorioretinal tissue characterized by the development of yellow-white, flat, placoid lesions at the level of the retinal pigment epithelium (RPE) in the posterior pole and mid-peripheral fundus. The disease typically presents with an acute loss of vision, and during the initial weeks, the lesions may expand and new lesions can appear. Over the course of a few months, the lesions heal and resolve, resulting in mottling, atrophy, and hyperpigmentation of the RPE. Clinical features of AMPPPE include early hypofluorescence followed by staining of the lesions on fluorescein angiography. On indocyanine green angiography, choroidal hypofluorescence is observed throughout the examination. Most patients with AMPPPE have a good long-term prognosis for visual acuity (VA), although residual symptoms and paracentral scotomas may persist. In rare cases, AMPPPE can lead to severe vision loss due to atrophic macular changes, subretinal fibrosis, and choroidal neovascularization (CNV). CNV in AMPPPE is infrequent but can occur. However, the overall incidence is low. Management options for AMPPPE involve close monitoring of the disease progression and visual acuity. As AMPPPE is a self-limiting condition, treatment is generally not required. However, in cases where severe vision loss or complications such as CNV occur, intervention may be necessary. The use of intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents, such as bevacizumab, has shown positive results in treating CNV associated with AMPPPE. Studies have reported regression of CNV and improvements in visual acuity after intravitreal bevacizumab injections in select cases. Nonetheless, it is important to note that experience with anti-VEGF therapy in AMPPPE is limited, and further investigation is required to establish its efficacy and safety in managing this condition. It is essential for ophthalmologists to closely monitor patients with AMPPPE to assess the progression of lesions, visual acuity, and the potential development of complications. Treatment decisions should be made"}
{"question": "What precautions should be taken during filtration surgery to enhance the rate of success ?", "answer": "To enhance the rate of success during filtration surgery, several precautions should be taken. First, it is important to address the primary ischemic problem in the retina for patients with neovascular glaucoma, such as performing pan-retinal photocoagulation in cases of proliferative diabetic retinopathy. Meticulous attention to hemostasis is crucial during surgery to minimize tissue necrosis and inflammation. Additionally, selecting a site for filtration that has freely movable conjunctiva, preferably at the superior limbus, can facilitate the procedure. Lastly, achieving a water-tight conjunctival closure is vital, particularly when using antimetabolites like 5-fluorouracil (5-FU) or mitomycin, as they can retard conjunctival wound healing and increase the risk of wound leaks."}
{"question": "Question: Avascular coat in eye is -\nOptions:\nA. Sclera\nB. Cornea\nC. Retina\nD. Choroid\n", "answer": " Cornea is a transparent,avascular,watch glass like structure.It forms anterior one sixth of the outer fibrous coat of eyeball. Reference:Comprehensive Opthalmology,AK Khurana,6th edition,pg no.95\n\nOPTION B IS CORRECT."}
{"question": "Question: Do multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy?\nContext: To examine the potential of abnormal mfERGs to predict the development of diabetic retinopathy at corresponding retinal locations 1 year later. One eye of 11 diabetic patients with nonproliferative diabetic retinopathy (NPDR) and 11 diabetic patients without retinopathy were retested 12 months after initial testing. At each time, mfERGs were recorded from 103 retinal locations, and fundus photographs were taken within 1 month of each recording. Local mfERG implicit times were measured and their z-scores were calculated based on results obtained from 20 age-matched control subjects. mfERG abnormalities were defined as z-scores of 2 or more for implicit time and z-scores of -2 or less for amplitude (P < or = 0.023). mfERG z-scores were mapped onto fundus photographs, and the relationship between baseline abnormal z-scores and new retinopathy at follow-up was examined. New retinopathy developed in 7 of the eyes with NPDR after 1 year. In these eyes, 70% of the mfERGs in areas of new retinopathy had abnormal implicit times at baseline. In contrast, only 24% of the responses in regions that remained retinopathy free were abnormal at baseline. Relative risk of development of new retinopathy over 1 year in the areas with abnormal baseline mfERG implicit times was approximately 21 times greater than that in the areas with normal baseline mfERGs (odds ratio = 31.4; P < 0.001). Eyes without initial retinopathy did not develop new retinopathy within the study period, although 4 of these 11 eyes had abnormal implicit times at baseline. mfERG implicit times tended to be more delayed at follow-up than at baseline in NPDR eyes, but not in eyes without retinopathy and control eyes. mfERG amplitudes had no predictive power.", "answer": "Localized functional abnormalities of the retina reflected by mfERG delays often precede the onset of new structural signs of diabetic retinopathy. Those functional abnormalities predict the local sites of new retinopathy observed 1 year later.\n\nyes"}
{"question": "Question: Is retinal arteriolar tortuosity associated with retinopathy and early kidney dysfunction in type 1 diabetes?\nContext: To examine the association of retinal vessel tortuosity with diabetic retinopathy and early nephropathy in type 1 diabetes. Cross-sectional. A total of 1159 participants with type 1 diabetes aged 12 to 20 years, attending diabetes clinics in Children's Hospital at Westmead, Sydney, Australia between 1990 and 2002, were included. Retinal photography and clinical examinations were performed during the baseline visit to assess diabetic retinopathy and albumin excretion rate (AER). Retinal vessel tortuosity was measured from digitized retinal photographs using a semi-automated computer program by a single grader masked to participants' characteristics. Diabetic retinopathy was defined as ETDRS level ≥21 (mild nonproliferative retinopathy) and early kidney dysfunction was defined as AER ≥7.5 μg/min. Of 944 patients (81.4%), 85 (9.0%) had signs of retinopathy only, 250 (26.5%) had early kidney dysfunction only, and 85 (9.0%) had both retinopathy and early kidney dysfunction. In multivariate analysis, higher arteriolar tortuosity was associated with retinopathy (odds ratio [OR] 2.01, 95% confidence interval [CI] 1.23-3.29, the highest quartile vs the remaining 3 quartiles), early kidney dysfunction (OR 1.56, 95% CI 1.06-2.28, per standard deviation [SD] increase), or coexistence of both complications (OR 1.96, 95% CI 1.21-3.24, the highest quartile vs the remaining 3 quartiles).", "answer": "Greater retinal arteriolar tortuosity was independently associated with retinopathy and early stage of nephropathy in type 1 diabetes. These findings may offer the potential of quantitative measurement of retinal vessel tortuosity for diabetic complication risk assessment.\n\nyes"}
{"question": "Question: Do omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice?\nContext: Diabetic retinopathy (DR) is associated with hyperglycemia-driven microvascular pathology and neuronal compromise in the retina. However, DR is also linked to dyslipidemia. As omega-3 (ω-3) polyunsaturated fatty acids (PUFAs) are protective in proliferative retinopathy, we investigated the capacity of ω-3PUFAs to preserve retinal function in a mouse model of type 2 diabetes mellitus (T2DM). Male leptin-receptor-deficient (db/db) mice were maintained for 22 weeks (4 weeks-26 weeks of life) on calorically and compositionally matched diets, except for 2% enrichment in either ω-3 or ω-6PUFAs. Visual function was assessed at 9, 14 and 26 weeks by electroretinography. Retinal capillary and neuronal integrity, as well as glucose challenge responses, were assessed on each diet. The ω-3PUFA diet significantly preserved retinal function in the mouse model of T2DM to levels similar to those observed in nondiabetic control mice on normal chow. Conversely, retinal function gradually deteriorated in db/db mice on a ω-6PUFA-rich diet. There was also an enhanced ability of ω-3PUFA-fed mice to respond to glucose challenge. The protection of visual function appeared to be independent of cytoprotective or anti-inflammatory effects of ω-3PUFAs.", "answer": "This study identifies beneficial effects of dietary ω-3PUFAs on visual function in T2DM. The data are consistent with dyslipidemia negatively impacting retinal function. As ω-3PUFA lipid dietary interventions are readily available, safe and inexpensive, increasing ω-3PUFA intake in diabetic patients may slow the progression of vision loss in T2DM.\n\nyes"}
{"question": "What are the clinical features of central retinal vein occlusion (CRVO) ?", "answer": "Central retinal vein occlusion (CRVO) is characterized by dilated tortuous retinal veins and scattered intraretinal hemorrhages."}
{"question": "Question: Does bruch 's membrane aging decrease phagocytosis of outer segments by retinal pigment epithelium?\nContext: We have shown previously that aging of human Bruch's membrane affects the attachment, survival and gene expression profile of the overlying retinal pigment epithelium (RPE). Herein we determine the effects of Bruch's membrane aging on RPE phagocytosis of rod outer segments. Explants of human Bruch's membrane were prepared from cadaver donor eyes (aged 9-81years) within 48 h of death, and 6 mm punches were embedded with the basal lamina in a 96-well plate. Approximately 50,000 ARPE-19 cells per well were seeded onto the explant surface and cultured for two weeks until they reached confluence. In addition, ARPE-19 were also seeded onto RPE-derived extracellular matrix (RPE-ECM) that was unmodified or modified by nonenzymatic nitration. Bovine rod outer segments were purified by sucrose gradient centrifugation, labeled with 10 ug/ml fluorescein isothiocyanate, and added to ARPE-19 cultured on Bruch's membrane or RPE-ECM for 24 h. Phagocytic activity was quantified by flow cytometry of harvested cells. The ability of RPE to phagocytose rod outer segments decreased as a function of aging of Bruch's membrane; mean phagocytotic activity of ARPE-19 on younger Bruch's membrane was significantly higher than on older Bruch's membrane (129.7 +/- 34.8 versus 67.4 +/- 4.2 arbitrary units, respectively; p<0.01). Nitrite treatment of RPE-ECM decreased rod outer segment phagocytosis compared to untreated RPE-ECM and mimicked the effects of aging of human Bruch's membrane.", "answer": "Aging of human Bruch's membrane decreases rod outer segment phagocytosis by ARPE-19. This effect can be mimicked by nonenzymatic nitration of extracellular matrix in vitro. Our observations may have implications for understanding the role of aging changes within Bruch's membrane on pathogenesis of age-related macular degeneration and other disorders.\n\nyes"}
{"question": "Question: Does a heparin mimetic isolated from a marine shrimp suppress neovascularization?\nContext:  Choroidal neovascularization (CNV) is the main cause of severe visual loss in age-related macular degeneration (AMD). Heparin/heparan sulfate are known to play important roles in neovascularization due to their abilities to bind and modulate angiogenic growth factors and cytokines. Previously, we have isolated from marine shrimp a heparin-like compound with striking anti-inflammatory action and negligible anticoagulant and hemorrhagic activities.  To investigate the role of this novel heparin-like compound in angiogenic processes.  The anti-angiogenic effect of this heparinoid in laser-induced CNV and in vitro models is reported. The compound binds to growth factors (FGF-2, EGF and VEGF), blocks endothelial cell proliferation and shows no cytotoxic effect. The decrease in proliferation is not related to cell death either by apoptosis or secondary necrosis. The results also showed that the heparinoid modified the 2-D network organization in capillary-like structures of endothelial cells in Matrigel and reduced the CNV area. The effect on CNV area correlates with decreases in the levels of VEGF and TGF-β1 in the choroidal tissue. The low content of 2-O-sulfate groups in this heparinoid may explain its potent anti-angiogenic effect.", "answer": " The properties of the shrimp heparinoid, such as potent anti-angiogenic and anti-inflammatory activities but insignificant anticoagulant or hemorrhagic actions, point to this compound as a compelling drug candidate for treating neovascular AMD and other angioproliferative diseases. A mechanism for the anti-angiogenic effect of the heparinoid is proposed.\n\nyes"}
{"question": "Question: Do possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases?\nContext: To study the advantages and complications of triamcinolone acetonide (TA)-assisted pars plana vitrectomy (PPV) for various retinal diseases. This report is an interventional case series and nonrandomized study. One hundred seventy-seven eyes from 158 patients underwent PPV with or without TA. Group TA(+) consisted of 94 eyes and group TA(-) consisted of 83 eyes. The improvement in vision and postoperative complications were prospectively studied. Sixty-two percent of the eyes in group TA(+) and 49% of the eyes in group TA(-) had improved vision after surgery (P = 0.34). Twelve eyes in group TA(+) and 12 eyes in group TA(-) had an intraocular pressure higher than 21 mmHg after the operation, with no statistically significant difference (P = 0.63). Four eyes with proliferative diabetic retinopathy in group TA(+) and five eyes with proliferative diabetic retinopathy in group TA(-) needed an additional filtering surgery. Group TA(+) (five eyes) had a lower incidence (P = 0.041) of reoperation caused by preretinal fibrous membrane formation than group TA(-) (13 eyes). No apparent corneal disorder or infectious signs were found in any eyes.", "answer": "Triamcinolone acetonide-assisted PPV appears to be potentially useful to reduce the incidence of reoperation owing to preretinal fibrosis with no serious complications.\n\nyes"}
{"question": "Question: What are the genetic changes related to color vision deficiency ?", "answer": "Mutations in the OPN1LW, OPN1MW, and OPN1SW genes cause the forms of color vision deficiency described above. The proteins produced from these genes play essential roles in color vision. They are found in the retina, which is the light-sensitive tissue at the back of the eye. The retina contains two types of light receptor cells, called rods and cones, that transmit visual signals from the eye to the brain. Rods provide vision in low light. Cones provide vision in bright light, including color vision. There are three types of cones, each containing a specific pigment (a photopigment called an opsin) that is most sensitive to particular wavelengths of light. The brain combines input from all three types of cones to produce normal color vision.  The OPN1LW, OPN1MW, and OPN1SW genes provide instructions for making the three opsin pigments in cones. The opsin made from the OPN1LW gene is more sensitive to light in the yellow/orange part of the visible spectrum (long-wavelength light), and cones with this pigment are called long-wavelength-sensitive or L cones. The opsin made from the OPN1MW gene is more sensitive to light in the middle of the visible spectrum (yellow/green light), and cones with this pigment are called middle-wavelength-sensitive or M cones. The opsin made from the OPN1SW gene is more sensitive to light in the blue/violet part of the visible spectrum (short-wavelength light), and cones with this pigment are called short-wavelength-sensitive or S cones.  Genetic changes involving the OPN1LW or OPN1MW gene cause red-green color vision defects. These changes lead to an absence of L or M cones or to the production of abnormal opsin pigments in these cones that affect red-green color vision. Blue-yellow color vision defects result from mutations in the OPN1SW gene. These mutations lead to the premature destruction of S cones or the production of defective S cones. Impaired S cone function alters perception of the color blue, making it difficult or impossible to detect differences between shades of blue and green and causing problems with distinguishing dark blue from black.  Blue cone monochromacy occurs when genetic changes affecting the OPN1LW and OPN1MW genes prevent both L and M cones from functioning normally. In people with this condition, only S cones are functional, which leads to reduced visual acuity and poor color vision. The loss of L and M cone function also underlies the other vision problems in people with blue cone monochromacy.  Some problems with color vision are not caused by gene mutations. These nonhereditary conditions are described as acquired color vision deficiencies. They can be caused by other eye disorders, such as diseases involving the retina, the nerve that carries visual information from the eye to the brain (the optic nerve), or areas of the brain involved in processing visual information. Acquired color vision deficiencies can also be side effects of certain drugs, such as chloroquine (which is used to treat malaria), or result from exposure to particular chemicals, such as organic solvents.\nReference: https://ghr.nlm.nih.gov/condition/color-vision-deficiency"}
{"question": "Question: Are albuminuria and hypertension independently associated with circulating antipericyte autoantibodies in type 2 diabetic patients?\nContext: To determine whether albuminuria, hypertension, or HbA 1c are independently associated with antipericyte autoantibodies (APAAs) in type 2 diabetes mellitus. Two hundred ninety-nine subjects with different degrees of retinopathy according to the Early Treatment Diabetic Retinopathy Study Scale participated in this study. Albuminuria was defined as an albumin/creatinine ratio above the normal cutoff limit, that is, 2.0 g/mol for men and 2.8 g/mol for women. Hypertension was defined as a diastolic blood pressure more than 90 mm Hg, a systolic blood pressure more than 140 mm Hg, or pharmacological antihypertensive treatment. Serum APAAs were detected by immunofluorescence on tissue-cultured bovine retinal pericytes. Association analysis was performed using univariate and multivariate statistical tools. In type 2 diabetes, APAAs were independently associated with albuminuria (OR = 0.56; P < .04), hypertension (OR = 2.21; P < .01), as well as with proliferative retinopathy (OR = 0.39; P < .01).", "answer": "The increased prevalence of APAA in patients with hypertension may suggest that these antibodies are related to tissue damage and repair and that the decline in frequency with albuminuria may serve as a marker for more advanced angiopathy. Future longitudinal studies are needed to determine whether the frequency of APAA is associated with the progression of angiopathy, and to determine the biological activity and antigens recognized by the antibody.\n\nyes"}
{"question": "Question: A 40 year old male with diabetes presents with vitreous hemorrhage. What is the cause?\nOptions:\nA. Posterior retinal detachment\nB. Neovascularization at disc\nC. Central retinal vein occlusion\nD. Trauma to central retinal aery\n", "answer": " Neovascularization, defined as abnormal formation of blood vessels in the retina, is a sight-threatening condition indicative of late-stage diabetic retinopathy (DR). ...Neovascularization on the disc (NVD) is diagnosed when new vessels are located within one disc-diameter of the optic disc. Ref AK khurana 6/e p 278\n\nOPTION B IS CORRECT."}
{"question": "Question: Does lncRNA-MIAT regulate microvascular dysfunction by functioning as a competing endogenous RNA?\nContext: Pathological angiogenesis is a critical component of diseases, such as ocular disorders, cancers, and atherosclerosis. It is usually caused by the abnormal activity of biological processes, such as cell proliferation, cell motility, immune, or inflammation response. Long noncoding RNAs (lncRNAs) have emerged as critical regulators of these biological processes. However, the role of lncRNA in diabetes mellitus-induced microvascular dysfunction is largely unknown. To elucidate whether lncRNA-myocardial infarction-associated transcript (MIAT) is involved in diabetes mellitus-induced microvascular dysfunction. Using quantitative polymerase chain reaction, we demonstrated increased expression of lncRNA-MIAT in diabetic retinas and endothelial cells cultured in high glucose medium. Visual electrophysiology examination, TUNEL staining, retinal trypsin digestion, vascular permeability assay, and in vitro studies revealed that MIAT knockdown obviously ameliorated diabetes mellitus-induced retinal microvascular dysfunction in vivo, and inhibited endothelial cell proliferation, migration, and tube formation in vitro. Bioinformatics analysis, luciferase assay, RNA immunoprecipitation, and in vitro studies revealed that MIAT functioned as a competing endogenous RNA, and formed a feedback loop with vascular endothelial growth factor and miR-150-5p to regulate endothelial cell function.", "answer": "This study highlights the involvement of lncRNA-MIAT in pathological angiogenesis and facilitates the development of lncRNA-directed diagnostics and therapeutics against neovascular diseases.\n\nyes"}
{"question": "Question: Is hemoglobin associated with retinal vascular fractals in type 1 diabetes patients?\nContext: Retinal vascular fractal dimension, a measure of the density of the retinal vasculature, has been suggested as a marker of systemic microvascular disorders in diabetes. As hemoglobin concentration is tightly related to vascular physiology and hypoxia, the hypothesis was that hemoglobin concentration would be associated with retinal vascular fractals in a relevant population. In a cross-sectional study of 204 long-term type 1 diabetes patients from a population-based cohort, retinal digital photos were captured and graded for fractal dimension (Df) by International Retinal Imaging Software - Fractal (IRIS-Fractal). Df was calculated from a disc-centered retinal photo from the right eye. Hemoglobin concentrations were measured using routine equipment. Of 175 patients with gradable images, median age was 57.7 years and median duration of diabetes was 42 years. Median retinal Df was 1.4606 (inter-quartile range 0.0264). A positive correlation was found between hemoglobin concentration and retinal vascular Df (r = 0.23, p = 0.0018). In a multiple linear regression model, Df was associated with hemoglobin (coefficient 0.0054 per 1.0 mmol/L increase in hemoglobin, p = 0.01) and age (coefficient -0.0046 for each 10-year increase in age, p = 0.04).", "answer": "Hemoglobin correlated independently with retinal vascular fractals indicating a relationship between hemoglobin availability and retinal vascular structure.\n\nyes"}
{"question": "Question: In Von Hippel-Lindau Syndrome, the retinal vascular tumours are often associated with intracranial hemangioblastoma. Which one of the following regions is associated with such vascular abnormalities in this syndrome?\nOptions:\nA. Optic radiation\nB. Optic tract\nC. Cerebellum\nD. Pulvinar\n", "answer": " Ans. (c) CerebellumRef: Kanski 7/e, p. 522-523 VHL syndrome#AD condition - 3p26 -VHL gene#CNS hemangioma Cerebellum Spinal cord Medulla/pons Retinal vascular tumours capillary hemangiomas (25% cases)# Pheochromocytoma# Renal carcinoma\n\nOPTION C IS CORRECT."}
{"question": "Question: Is abnormal retinal autoregulation detected by provoked stimulation with flicker light in well-controlled patients with type 1 diabetes without retinopathy?\nContext: Investigation of retinal vasodilation under flickering light is considered a dynamic analysis in contrast to the static analysis of retinal vessel equivalents (mean retinal vessel diameter). We investigated whether dynamic analysis apart from the static one in type 1 diabetic patients without diabetic retinopathy with well-controlled diabetes could lead to additional information regarding retinal autoregulation. 18 normotensive type 1 diabetic patients without retinopathy and 19 healthy subjects were included. Diameter of retinal vessels was measured with Dynamic Vessel Analyzer. Changes in vasodilation are expressed as percent change over baseline values. HbA(1c) was 7.5+/-1.0% in diabetic patients. In arteries, the response to flicker was diminished in diabetic patients compared to healthy volunteers (p<0.023). In patients flicker stimulation increased arterial diameter by +2.7% in contrast to +4.4% in controls. Venous vessel diameter increased by +3.1% in diabetic individuals and by +5.3% in the control group (p<0.002). There were no differences in static analysis between both groups.", "answer": "Diabetic patients without retinopathy with relatively good glycemic control show reduced retinal vasodilation after flicker indicating dysfunction in retinal autoregulation. The use of provocation test in conjunction with static analysis could lead to additional information regarding abnormal retinal autoregulation.\n\nyes"}
{"question": "What are the types of color blindness and what diagnostic tests should be performed to confirm a diagnosis ?", "answer": "Color blindness, or color vision deficiency, encompasses several types. The most common forms include red-green color blindness, which can be further classified into protanopia, deuteranopia, and protanomaly. Another type is blue-yellow color blindness, known as tritanopia or tritanomaly. A rarer form is complete color blindness, known as achromatopsia. To confirm a diagnosis of color blindness, ophthalmologists should consider a comprehensive evaluation. This may involve a detailed medical history, including any known family history of color blindness. Diagnostic tests, such as the Ishihara color plates, can assess color vision deficiencies by evaluating the ability to distinguish specific colors or patterns. Additional tests, like the Farnsworth-Munsell 100 hue test, may be employed to assess the severity and type of color vision deficiency. A thorough examination of the patient's eyes, including an assessment of the retina and optic nerve, is also important to rule out any underlying ocular conditions that could contribute to color vision impairment. It is essential for ophthalmologists to approach color blindness diagnosis with empathy and understanding, as it can significantly impact patients' everyday lives. By providing accurate diagnoses, ophthalmologists can guide patients towards appropriate management strategies and support them in navigating the challenges associated with color vision deficiency."}
{"question": "Question: Does captopril inhibit capillary degeneration in the early stages of diabetic retinopathy?\nContext: This study was conducted to examine the effect of angiotensin-converting enzyme (ACE) inhibitors on the development of early stages of diabetic retinopathy. Rats were made diabetic by injection of streptozotocin and treated with the ACE inhibitor captopril and the AT1 antagonist losartan. The extent of capillary degeneration and leukostasis in the retina were determined. Acellular capillaries and pericyte ghosts in the retina of diabetic animals were increased by approximately two-fold after 8 months of diabetes compared with the nondiabetic control, and captopril completely inhibited this capillary degeneration. Captopril and losartan also inhibited hyperglycemia-induced leukostasis at 6 weeks and 1 week in the retinal vasculature, respectively. In cultured retinal endothelial cells, angiotensin II-induced VCAM-1 expression was inhibited by losartan.", "answer": "Inhibition of the renin-angiotensin system can block retinal capillary degeneration and inflammation in the early stages of diabetic retinopathy.\n\nyes"}
{"question": "Question: Is apoptosis induction by oxidized glycated LDL in human retinal capillary pericytes independent of activation of MAPK signaling pathways?\nContext: Pericyte loss is a cardinal feature of early diabetic retinopathy. We previously reported that highly oxidized-glycated low density lipoprotein (HOG-LDL) induces pericyte apoptosis in vitro. In this study, we investigated the role of the mitogen-activated protein kinase (MAPK) signaling pathways in HOG-LDL-induced apoptosis in human pericytes. Human retinal capillary pericytes (HRCP) were exposed to native LDL (N-LDL) and HOG-LDL, and apoptosis was measured using flow cytometry. Time- and dose-dependent responses of extracellular signal-regulated kinase (ERK), p38, and Jun N-terminal kinase (JNK) following exposure to N-LDL or HOG-LDL were determined using western blotting. U0126 (ERK inhibitor), SB203580 (p38 inhibitor), and SP600125 (JNK inhibitor) were used to determine the role of MAPK signaling in HOG-LDL-induced apoptosis. HOG-LDL induced apoptosis in HRCP in a dose-dependent manner at concentrations from 5 to 50 mg/l, with a constant effect from 50 to 200 mg/l. When compared to serum-free medium (SFM), this effect of HOG-LDL was found to be significant at all doses above 10 mg/l. In contrast, N-LDL at 200 mg/l did not induce apoptosis compared with SFM. Exposure to N-LDL versus HOG-LDL induced similar phosphorylation of ERK, p38, and JNK, peaking at 5 min, with similar dose-dependent responses up to 25 mg/l that were constant from 25 to 100 mg/l. Blocking of the ERK, p38, and JNK pathways did not inhibit pericyte apoptosis induced by HOG-LDL.", "answer": "Our data suggest that apoptosis induced by HOG-LDL in HRCP is independent of the activation of MAPK signaling pathways.\n\nyes"}
{"question": "Specialized clinical ophthalmology question: What is the relationship between antihypertensive drugs and ocular pressure ?", "answer": "The relationship between antihypertensive drugs and ocular pressure has been extensively studied. Numerous articles in the international literature have focused on this topic over the past two decades. While the exact cause of increased intraocular pressure (IOP) is still unknown, several local and systemic risk factors have been considered. Regarding ocular factors, severe myopia and the presence of Krukemberg's spindle are considered significant etiological factors for the development of open-angle primary glaucoma. Among systemic risk factors, arterial pressure, atherosclerosis, vasospasm, acute hypotension, diabetes mellitus, and blood dyscrasias have been identified as important contributors to glaucoma development. Arterial pressure, in particular, has received specific attention as it appears to play both a protective and harmful role in the survival of retinal ganglion cells. One hypothesis suggests that in individuals younger than 60 years with hypertension, high blood pressure may enhance blood flow through dynamic changes in vessel diameter, acting as a protective factor for ganglion cells and their axons. However, in older individuals with established small vessel damage, increased flow resistance may lead to damage of the optic nerve's head. It is important to note that there is no linear relationship between systemic blood pressure and perfusion pressure due to the autoregulation of ocular vessels. Studies using echo-color-Doppler scans have shown that retinal blood flow remains unchanged despite significant increases in arterial pressure or reductions in ocular pressure that decrease perfusion pressure. While the autoregulation system in choroid vessels is still a subject of debate, experiments on primates and cats have demonstrated that the vessels of the optic nerve's head possess autoregulation capabilities similar to retinal vessels. Regarding the association between untreated hypertension and hyperbaric glaucoma, studies have found that when systolic blood pressure (SBP) is above 165 mmHg and diastolic blood pressure (DBP) is above 95 mmHg, there is a positive correlation with increased IOP. Specifically, for every 10 mmHg increase in SBP or DBP above those levels, there is an increase of 0.23 mmHg and 0.24 mmHg in IOP, respectively. Notably, a 100 mmHg increase in blood pressure"}
{"question": "Question: Does activation of MAPK and CREB by GM1 induce survival of RGCs in the retina with axotomized nerve?\nContext: Neuronal cells undergo apoptosis when the supply of neurotrophic factor is limited by injury, trauma, or neurodegenerative disease. Ganglioside has both neuritogenic and neurotropic functions. Exogenously administered monosialoganglioside (GM1) has been shown to have a stimulatory effect on neurite outgrowth and to prevent degeneration of neuronal cells in the central nervous system. Even though GM1 has been shown to mimic, or have synergy with, neurotrophic factors, the neuroprotective mechanism of GM1 has not been well understood. In this study, optic nerve transection, or axotomy, was used as an in vivo model system for injury, to examine the protective mechanism of GM1 in injured retinal ganglion cells. GM1 was injected into the vitreous body before axotomy, and the protective effect of GM1 observed with regard to activation of mitogen-activated protein kinase (MAPK) and phosphorylation of cAMP-responsive element-binding (CREB) protein. Activation of MAPK and CREB were examined by Western blot analysis and immunohistochemistry, and the surviving retinal ganglion cells were counted after retrograde fluorescence labeling. GM1 inhibited the degeneration of axotomized retinal ganglion cells. In addition, GM1 enhanced the activation of MAPK and CREB with the treatment of GM1 in the retina with axotomized nerve. Treatment of MAPK inhibitor PD98059 with GM1 reduced the protective action of GM1 and prevented GM1-induced phosphorylation of CREB.", "answer": "GM1 protected the axotomized retinal ganglion cells (RGCs) from cell death after axotomy through the activation of MAPK and CREB.\n\nyes"}
{"question": "What are the ocular symptoms associated with ocular relapse in patients with intraocular lymphoma (PVRL and PCNSL) ?", "answer": "Ocular relapse in patients with intraocular lymphoma, including primary vitreoretinal lymphoma (PVRL) and primary central nervous system lymphoma (PCNSL), can present with various ocular symptoms. These symptoms may include conjunctivitis, keratitis, ocular irritation, periorbital edema, blepharitis, conjunctival hyperemia, and photophobia. Additionally, patients may experience a pigmentary maculopathy characterized by fine clumps of retinal pigment epithelium (RPE) hyperpigmentation in the foveal region, leading to a variable loss of RPE. This maculopathy is bilateral but often asymmetric and can result in progressive and permanent visual loss."}
{"question": "Question: The retina receives its blood supply from all, except-\nOptions:\nA. Posterior ciliary artery\nB. Central retinal artery\nC. Retinal arteries\nD. Plexus of Zinn and Haller arteries\n", "answer": " Ans- A.\n\nOPTION A IS CORRECT."}
{"question": "Question: A patient sustained blunt trauma to eye after that the developed sudden loss of vision with deep anterior chamber, Most likely cause is -\nOptions:\nA. Lens dislocation\nB. Berlin's oedema\nC. Retinal haemorrhage\nD. Recession of angle of AC\n", "answer": " Amongst the given options only two can cause deep anterior chamber :-\n\n\nAngle recession\nDislocation of the lens\n\n\nIn angle recession, glaucoma develops many years after the trauma and there is no sudden loss of vision.\nDislocation of lens can cause sudden loss of vision immediately.\n\nOPTION A IS CORRECT."}
{"question": "Is there any evidence to suggest a causal relationship between exposure to high-intensity ultrasound waves and ophthalmic disorders ?", "answer": "Response: There is currently no evidence to suggest a causal relationship between exposure to high-intensity ultrasound waves, such as those used in the ultrasound systems of bats, and the development of ophthalmic disorders in humans. Ultrasound technology has been extensively used in ophthalmology for diagnostic purposes, such as in the evaluation of ocular structures and measuring intraocular pressures. These ultrasound frequencies are typically much lower than those used by bats and are considered safe for clinical use. However, it is important to note that prolonged and excessive exposure to high-intensity ultrasound waves, especially at frequencies and power levels significantly higher than those used in clinical practice, may potentially cause tissue damage. In ophthalmology, caution is exercised when using ultrasound in close proximity to delicate ocular structures, such as the lens or retina, to minimize any potential adverse effects. To further explore the topic and gather more information, it would be advisable to consult authoritative resources within ophthalmology, such as ophthalmology textbooks or scientific journals, which can provide more specific and detailed insights into this matter."}
{"question": "What is the tarsal strip procedure in ophthalmology and how is it performed ?", "answer": "The tarsal strip procedure is a useful technique for addressing lower eyelid malposition and laxity in ophthalmology. Unlike wedge resection, this procedure involves creating a tarsal strip that serves as the new inferior crus of the lateral canthal tendon. The tarsal strip is anchored to the orbital rim periosteum, typically using a double-armed braided nonabsorbable suture. It is important to insert the tarsal strip at Whitnall's tubercle, which is the insertion point for the superior crus of the lateral canthal tendon. Once the tarsal strip is in place, the lower eyelid should ride 1.5 to 2 mm above the lower limbus. The procedure also involves refining the lateral commissure (commissuroplasty) by aligning corresponding elements of the upper and lower eyelids and making fine adjustments as needed. Mobilizing the lower lid through division of the lateral retinacular structures is crucial for achieving optimal results. Additional techniques, such as suspending the orbicularis muscle and performing skin tailoring, may be employed depending on individual patient needs."}
{"question": "What are the histopathological findings in eyes with geographic atrophy (GA) and how does it relate to the pathogenesis of the disease ?", "answer": "Histopathological examination of eyes with GA reveals a loss of retinal pigment epithelium (RPE) cells within the area of atrophy. This loss is accompanied by a secondary loss of photoreceptor cells. In addition, the choriocapillaris, the network of capillaries supplying nutrients to the outer retina, may also be absent. The deposition of basal laminar and basal linear deposits in the surrounding retina leads to thickening of Bruch's membrane, which separates the RPE and the choroid. Consequently, GA is considered as the end-stage of the age-related macular degeneration (AMD) process when choroidal neovascularization (CNV) does not develop. There is ongoing debate regarding the primary event in the evolution of GA. Some argue that the loss of RPE cells, possibly due to deposits in and around Bruch's membrane, is the primary cause, while others suggest that it may develop as a result of choroidal vascular insufficiency. The presence of choroidal vascular insufficiency, according to Green and Key, should result in the subsequent degeneration of all the outer retinal layers, but this is not observed in GA. Friedman et al. propose that choroidal vascular resistance may predispose individuals to the development of GA. In summary, the histopathological findings in eyes with GA involve the loss of RPE cells, secondary loss of photoreceptor cells, absence of the choriocapillaris, and thickening of Bruch's membrane. The exact pathogenesis of GA is still debated, with some suggesting a primary loss of RPE cells and others proposing choroidal vascular insufficiency as a contributing factor. Further research is needed to fully understand the underlying mechanisms of GA."}
{"question": "What are the characteristic ultrasonographic findings in Coats' disease ?", "answer": "The characteristic ultrasonographic findings in Coats' disease include a relatively immobile, thickened, detached retina with homogeneous subretinal fluid and medium reflective echogenic clefts. These findings are often accompanied by lipid exudation surrounding retinal telangiectasia, bulbous aneurysms, areas of capillary non-perfusion, and the absence of calcium deposition. It is important to note that highly reflective foci, which represent calcium deposition seen in retinoblastoma, are rarely observed in Coats' disease."}
{"question": "What are the step-by-step procedures for diagnosing keratoconus in ophthalmology ?", "answer": "The step-by-step procedures for diagnosing keratoconus in ophthalmology involve several assessments and observations. Here is an abstractive answer: 1. Initial Refraction: Keratoconus is often diagnosed during routine refraction. An increase in astigmatism and myopia in one or both eyes is typically the first sign detected. 2. Corneal Topography: Investigating corneal topography can reveal abnormalities even if the cornea appears normal to the naked eye. Steep readings and distorted mires may indicate keratoconus. 3. Spectacle Correction: Initially, spectacle correction can provide satisfactory vision for the patient. However, as the condition progresses, the astigmatism will significantly increase, making it challenging to achieve adequate visual acuity. 4. Retinoscopy: Retinoscopy may show a \"scissors\" reflex, which can further support the diagnosis of keratoconus. 5. Slit-Lamp Examination: The slit-lamp examination can reveal specific anomalies associated with keratoconus. Two notable findings are: (a) Vogt's striae: These are fine white lines in the deep stroma, often vertical but can be oblique. They are stress lines caused by corneal lamellae stretching and can disappear when external pressure is applied to the eye. (b) Prominent Corneal Nerves: Corneal nerves may appear more prominent in individuals with keratoconus. 6. Additional Signs: As the condition progresses, other signs may become apparent, including: (a) Fleischer's Ring: A brown or green line encircling the base of the cone. It is formed from an iron-based pigment in the basal epithelium and is more easily seen with cobalt blue light. (b) Corneal Thinning: Thinning of the cornea in the central or paracentral areas can be observed with high magnification and a thin corneal section. Pachymetry, if available, can provide helpful measurements. These step-by-step procedures and observations can aid in the diagnosis of keratoconus in ophthalmology."}
{"question": "Question: A 47-year-old woman develops accelerated hypertension (blood pressure 210/105 mm Hg) but no clinical symptoms except frequent headaches. Which of the following findings are most likely on examination of the fundii?\nOptions:\nA. retinitis obliterans\nB. cotton wool spots\nC. retinal detachment\nD. optic atrophy\n", "answer": " (b) Source: (Fuster, p. 1541, 1543)Cotton wool spots, hemorrhage, and papilledema are common. Fibrinoid necrosis occurs on the arterioles of many organs. Earlier manifestations of arteriosclerosis include thickening of the vessel wall. This is manifested by obscuring of the venous column at arterial crossings.\n\nOPTION B IS CORRECT."}
{"question": "How does the drainage system of the eye contribute to the circulation of blood and aqueous humor ?", "answer": "The drainage system of the eye plays a crucial role in the circulation of both blood and aqueous humor. The blood drainage system consists of several interconnected plexuses. Firstly, the deep scleral plexus extends into the ciliary body while posteriorly, it drains into the intrascleral (midscleral) retinal layers except the nerve fiber layer. The deep plexus at the optic disc is separated from the anterior ciliary veins by a layer of glial tissue known as the intermediary tissue of Kuhnt. The intrascleral plexus drains posteriorly into the episcleral plexus, which eventually connects to the anterior ciliary veins. On the other hand, the aqueous drainage system involves eight collector channels known as the aqueous veins. These veins directly drain into the episcleral plexus. They can be visualized using a slit-lamp biomicroscope as clear vessels demonstrating bilaminar flow of blood and aqueous humor. The aqueous veins are typically observed about 2 mm away from the limbus, usually in the anteromedial region. In summary, the blood drainage system of the eye consists of the deep scleral plexus, intrascleral plexus, and episcleral plexus, which ultimately connect to the anterior ciliary veins. The aqueous drainage system involves the aqueous veins that directly drain into the episcleral plexus. These interconnected drainage pathways ensure the circulation of blood and aqueous humor within the eye."}
{"question": "Question: Does upregulation of CCR3 by age-related stresses promote choroidal endothelial cell migration via VEGF-dependent and -independent signaling?\nContext: To explore the molecular mechanisms by which the C-C chemokine receptor type 3 (CCR3) and chemokine (C-C motif) ligand 11 (CCL11) regulate choroidal endothelial cell (CEC) migration and the interactions with the vascular endothelial growth factor (VEGF) signaling pathway. Human retinal sections from young and aged donor normal eyes were immunolabeled. By real-time PCR, CCR3 mRNA was measured in retinal pigmented epithelium (RPE)/choroids obtained from young and aged human donor eyes and in cultured CECs exposed to hydrogen peroxide. CCR3 ligand and CCL11- or VEGF-stimulated CEC migration was also measured in the presence of the CCR3 inhibitor or control using fluorescence microscopy. Activation of Rac1, phosphorylated Akt as a readout for phosphoinositol 3-kinase signaling, and VEGFR2 activation were measured in CECs incubated with CCL11, VEGF, or combined CCL11/VEGF. CCR3 was expressed to a greater level in older compared with that in younger human retinas or RPE/choroids. Ligand-activated CCR3 increased CEC migration, which was inhibited by the CCR3 inhibitor. Rac1 activity, p-Akt, and p-VEGFR2 were significantly increased in CECs incubated with CCL11. The CCR3 inhibitor prevented VEGF-induced CEC migration and Rac1 activation in CECs. Rac1 activity was additively increased in CECs treated with CCL11 and VEGF compared with that in cells with CCL11 or VEGF treatment alone. Ligand-activated CCR3 caused VEGFR2 phosphorylation and coimmunoprecipitation of VEGFR2 and CCR3.", "answer": "Activated CCR3 promotes CEC migration and Rac1 activation and causes an association with and activation of VEGFR2. Cross-talk between CCR3 and VEGF signaling exists and may be important in choroidal neovascularization in human age-related macular degeneration.\n\nyes"}
{"question": "Is there evidence to support the role of systemic inflammation in the development of age-related macular degeneration (AMD) ?", "answer": "Several population-based studies have been conducted to investigate the association between systemic inflammatory markers and AMD development. While some inflammation-related proteins have shown a strong association with AMD, overall findings have been inconsistent. It is possible that local chronic inflammation may be more relevant than systemic inflammatory cues in the development of AMD. However, one key inflammatory marker that has been extensively studied is C-reactive protein (CRP). CRP is an acute-phase serum protein that rises rapidly in response to inflammation and has been associated with increased risk for cardiovascular and peripheral arterial disease. Studies have shown a significant association between CRP levels and the presence of intermediate and advanced stages of AMD. Elevated baseline levels of high-sensitivity CRP (hsCRP) have also been linked to the development of early and late AMD. However, it is important to note that not all studies have found a consistent association between CRP and AMD. Further research is needed to fully understand the role of inflammation in AMD development."}
{"question": "What are the common causes of preretinal hemorrhage ?", "answer": "Proliferative diabetic retinopathy and other proliferative retinopathies are common causes of preretinal hemorrhage. In addition, conditions such as diabetic retinopathy, leukemic retinopathy, retinal arterial macroaneurysm, and Valsalva retinopathy can also lead to preretinal hemorrhage."}
{"question": "Question: Is mild retinopathy a risk factor for cardiovascular mortality in Japanese with and without hypertension : the Ibaraki Prefectural Health Study?\nContext: It is unclear whether mild hypertensive retinopathy is a risk factor for mortality. This study examined whether mild hypertensive retinopathy could be a risk factor for cardiovascular mortality in subjects with and without hypertension. In this cohort study, 87 890 individuals (29 917 men and 57 973 women) 40 to 79 years of age in 1993 were followed up until 2008. Retinal photography was classified as normal, grade 1, or grade 2 based on the Keith-Wagener-Barker system. Risk ratios for all-cause and cause-specific mortality for each classification were calculated with Cox proportional hazards regression models. Covariates included age, systolic blood pressure, antihypertensive medication use, and other cardiovascular risk factors. Multivariable hazard ratios for total cardiovascular disease mortality were 1.24 (95% confidence interval [CI], 1.12-1.38) and 1.23 (95% CI, 1.03-1.47) for grades 1 and 2 among men and 1.12 (95% CI, 1.01-1.24) and 1.44 (95% CI, 1.24-1.68) for grades 1 and 2 among women, respectively. Hazard ratios for total stroke mortality were 1.31 (95% CI, 1.13-1.53) and 1.38 (95% CI, 1.08-1.77) for grades 1 and 2 among men and 1.30 (95% CI, 1.12-1.50) and 1.70 (95% CI, 1.36-2.11) for grades 1 and 2 among women, respectively. For both hypertensive and normotensive subjects of each sex, multivariable hazard ratios for all-cause mortality, total cardiovascular mortality, and total stroke mortality were significantly higher for grade 1 or 2 compared with normal.", "answer": "Mild hypertensive retinopathy is a risk factor for cardiovascular mortality independently of cardiovascular risk factors among men and women with and without hypertension.\n\nyes"}
{"question": "Question: Is vitamin D deficiency associated with retinopathy in children and adolescents with type 1 diabetes?\nContext: To examine the hypothesis that vitamin D deficiency (VDD) is associated with an increased prevalence of microvascular complications in young people with type 1 diabetes. In a cross-sectional study of 517 patients, 25-hydroxyvitamin D was measured. Retinopathy was assessed by 7-field stereoscopic retinal photography, peripheral neuropathy by thermal and vibration threshold testing, and microalbuminuria by albumin excretion rate or albumin-to-creatinine ratio. Retinopathy prevalence was higher in cases with VDD versus sufficiency (18 vs. 9%, P = 0.02); deficiency was not associated with microalbuminuria or neuropathy. In logistic regression, retinopathy was associated with VDD (odds ratio 2.12 [95% CI 1.03-4.33]), diabetes duration (1.13, 1.05-1.23), and HbA(1c) (1.24, 1.02-1.50).", "answer": "VDD is associated with an increased prevalence of retinopathy in young people with type 1 diabetes. The inflammatory and angiogenic effects of VDD may contribute to early retinal vascular damage; however, further investigations are warranted.\n\nyes"}
{"question": "Question: A chemistry student was brought to the emergency depament after accidental spilling of caustic soda in her eyes. Alkali injury causing global penetration can result in:\nOptions:\nA. Symblepharon\nB. Optic neuritis\nC. Retinal detachment\nD. Cataract\n", "answer": " Symblepharon: This is a condition where adhesion of the lid to the globe takes place. Any cause which produces raw surfaces on two opposed areas of the palpebral and bulbar conjunctiva will lead to adhesion if the areas are allowed to remain in contact during the process of healing, and thus allows cicatrization and fibrosis. Examples: Burns from heat or chemical injury, Stevens-Johnson syndrome, ulcers, diphtheria, pemphigoid, operations etc. Ref: Parsons' Diseases of the Eye By Ramanjit Sihota & Radhika Tandon, 21st edition, Page 450.\n\nOPTION A IS CORRECT."}
{"question": "How can ganglion cells and displaced amacrine cells be distinguished in the cat retina ?", "answer": "Ganglion cells and displaced amacrine cells in the cat retina can be distinguished based on several characteristics. Amacrine cells, which are among the smallest neurons in the ganglion cell layer, have a low ratio of cytoplasmic-to-nuclear volume. They often possess a prominent basophilic nuclear fold. On the other hand, ganglion cells can be identified by their larger soma size and differences in cytoplasmic features. By examining these factors, most ganglion cells and displaced amacrine cells can be differentiated in the cat retina."}
{"question": "What are the clinical presentations of ocular tuberculosis ?", "answer": "Ocular tuberculosis can manifest in various ways, including retinal vasculitis, choroidal granuloma, optic nerve infiltration, and iris tuberculoma. In some cases, anterior involvement with pseudotumoral tuberculosis may require eye wall resection associated with donor scleral grafting and antimicrobial therapy. Diagnosis and subsequent management can be challenging, leading to potential delays in treatment and significant visual loss. Techniques such as immunohistochemistry, molecular diagnosis using in situ hybridization, PCR, and in situ PCR can provide precise evidence of HSV infection and identify antiviral targets relevant for drug resistance."}
{"question": "What are the key features of pseudo-Stargardt on fundus autofluorescence (FAF) imaging ?", "answer": "Pseudo-Stargardt is characterized by FAF findings that resemble Stargardt disease but with some distinct features. On FAF imaging, pseudo-Stargardt shows hypofluorescent halos around lesions, indicating decreased autofluorescence compared to the surrounding areas. Additionally, pseudo-Stargardt exhibits more hyperautofluorescent spots, which are areas of increased autofluorescence. These findings differentiate pseudo-Stargardt from typical Stargardt disease and help in the diagnosis and monitoring of the condition."}
{"question": "Question: What is the diagnosis in this patient who presented with sudden painful vision impairment after vigorous exercise?\nOptions:\nA. Central retinal artery occlusion\nB. Corneal ulcer\nC. Dislocation of the lens\nD. Episcleritis\n", "answer": " Answer C. Dislocation of the lensThere is anterior dislocation of the lens. Rupture of the zonular fibers may result from ocular trauma or other conditions. The patient underwent surgical extraction of the dislocated lens, anterior vitrectomy, and implantation of an iris-fixated intraocular lens.\n\nOPTION C IS CORRECT."}
{"question": "What are some factors that contribute to the formation of cataracts ?", "answer": "Cataracts can have multiple causes, and often, several factors act together to contribute to their formation. Some individual causes of cataracts include macromolecular protein aggregates within the lens fibers, physiological aging changes including various degrees of nuclear sclerosis, and certain intraocular diseases like uveitis and retinal dystrophies. However, it is important to distinguish cataracts caused by these factors from those associated with \"complicated cataracts.\" Among the most significant factors contributing to cataract formation are oxidative and osmotic stress. Ultraviolet light exposure and a disturbance in the osmotic balance between the aqueous and lens substance are known to cause these stresses. Additionally, other factors such as UV-A irradiation, smoking, alcohol consumption, and systemic diseases like diabetes mellitus, PEX syndrome, and myotonic dystrophy have been associated with cataractogenesis. It is essential to consider these factors and their potential interactions when evaluating and managing patients with cataracts."}
{"question": "What are the findings and recommendations from the Age-Related Eye Disease Study (AREDS) regarding the management of non-exudative age-related macular degeneration (AMD) ?", "answer": "The Age-Related Eye Disease Study (AREDS) was a pivotal trial that investigated the effect of high-dose antioxidant vitamins and zinc supplements on the progression of age-related macular degeneration (AMD) and visual acuity. The study included over 4,000 subjects with high-risk non-exudative AMD, defined as the presence of extensive intermediate-size drusen, at least one large drusen, noncentral geographic atrophy, or advanced AMD in at least one eye. The subjects were randomly assigned to different treatment groups, including antioxidants alone (500 mg vitamin C, 400 IU vitamin E, 15 mg beta-carotene), zinc alone (80 mg zinc oxide with 2 mg copper), antioxidants plus zinc, or placebos. The addition of copper was aimed at preventing zinc-induced anemia. The results of the AREDS trial demonstrated that individuals in the group receiving antioxidants plus zinc had a 25 percent reduction in the risk of progression to advanced AMD compared to the placebo group. Furthermore, these individuals had a 19 percent reduction in the rate of moderate vision loss (defined as losing at least three lines of visual acuity) after five years. These findings supported the use of vitamin and mineral therapy in patients with non-exudative AMD, particularly those classified as high-risk based on the presence of specific drusen characteristics or geographic atrophy. The study emphasized the potential prophylactic benefit of such supplementation in reducing the risk of disease progression and improving visual outcomes in these individuals."}
{"question": "Question: Does light-Induced photoreceptor degeneration in the mouse involve activation of the small GTPase Rac1?\nContext: Rho GTPases play a central role in actin-based cytoskeleton reorganization, and they participate in signaling pathways that regulate gene transcription, cell cycle entry, and cell survival. This study verifies the role of Rac1 during light-induced retinal degeneration. BALB/c mice were exposed to degenerative light stimulus, and their eyes were enucleated immediately or after the mice were kept in the dark for 6, 24, and 48 hours. Retinas were fixed and processed for immunohistochemical analysis. The distribution of Rac1 and its effectors-p21-activated kinases (PAKs) 1, 2, and 3-was studied by immunohistochemistry, whereas the expression of PAKs 3, 4, and 5 mRNA was analyzed by real-time PCR. Rac1 activity was measured using a pull-down assay. In control retinas, Rac1 was mostly observed in photoreceptors, plexiform layers, and Müller glial cells. In light-damaged retinas, some TUNEL-positive photoreceptors upregulated Rac1 expression. Conversely, most of the Rac1-positive cells were TUNEL-positive, mainly in early stages of retinal degeneration. The increase in Rac1 expression was preceded by enhanced Rac1 activity, detectable at the end of the light stimulus and still present 48 hours later. The distribution patterns of PAK1, PAK2, and PAK3 did not change in light-damaged retinas. However, there was a marked increase in PAK3 and PAK4 gene expression, whereas that of PAK5 mRNA remained the same.", "answer": "Rac1 may play a role in the apoptosis of light-damaged photoreceptors. The increased expression of PAK4 after light stimulus possibly functions as a protective mechanism against apoptosis.\n\nyes"}
{"question": "What are the symptoms and complications associated with traumatic perforating injuries in ophthalmology ?", "answer": "Traumatic perforating injuries in ophthalmology can lead to various symptoms and complications. These injuries, particularly those involving the uvea and vitreous tissue, can cause retinal detachment and subsequent visual impairment. In cases where trauma is the precipitating factor, patients with myopia, senile or postinflammatory degeneration are at a higher risk. Additionally, perforating injuries without the presence of an intraocular foreign body can involve the eyelids, conjunctiva, sclera, lens, vitreous, and retina. Symptoms of traumatic perforating injuries may include decreased vision, gross vitreous hemorrhage, and uveitis. The fellow eye may also develop uveitis several weeks to months after an injury in one eye. It's important to note that these injuries often have a tendency to run an indolent course with relapses. Complications associated with traumatic perforating injuries include the development of traumatic proliferating chorioretinopathy, a condition prone to occur after a gunshot injury that causes simultaneous rupture of the retina and choroid. This condition is characterized by significant vitreous hemorrhage and severe vision loss. Other complications can include optic nerve injury leading to rupture, avulsion, or traumatic optic atrophy, as well as disturbance of ocular tension presenting as hypotony or secondary glaucoma. In summary, traumatic perforating injuries in ophthalmology can result in symptoms such as decreased vision, vitreous hemorrhage, and uveitis. Complications may include retinal detachment, traumatic proliferating chorioretinopathy, optic nerve injury, and disturbance of ocular tension. It is crucial to thoroughly examine the extent of the injury, associated head injuries, and neighboring structures before initiating treatment."}
{"question": "Question: Does endogenous α-crystallin inhibit expression of caspase-3 induced by hypoxia in retinal neurons?\nContext: To investigate the expression of endogenous, hypoxic stress-induced α-crystallin and caspase-3 in rat retinal neurons in vitro. Retinal neurons were cultured from Long-Evans rats. The expression of endogenous α-crystallin was analyzed by immunohistochemistry and reverse transcriptase-polymerase chain reaction (RT-PCR). Furthermore, hypoxic exposure was performed in cultured cells, and the expression of endogenous α-crystallin and caspase-3 was assayed by Western blotting. Positive α-crystallin staining was observed in cultured retinal neurons, and expression of endogenous α-crystallin mRNA peaked 3-5d after inoculation (P<0.05). Moreover, endogenous, hypoxic stress-induced α-crystallin expression increased gradually, peaking 6h after hypoxia. The expression was more abundant compared to the control (P<0. 01) and was associated with a decrease in caspase-3 expression (P<0. 05).", "answer": "The present study demonstrates that the expression of endogenous α-crystallin in retinal neurons, especially over-expression induced by hypoxic stress, results in the down regulation of caspase-3. The data suggest that endogenous α-crystallin may act as an endogenous neuroprotective factor in retinal neurons.\n\nyes"}
{"question": "What are the advantages and disadvantages of the epiretinal and subretinal approaches in retinal prostheses surgery ?", "answer": "In the field of retinal prostheses surgery, the epiretinal and subretinal approaches are two different techniques used. Each approach has its own advantages and disadvantages. The epiretinal approach offers several advantages. Firstly, the surgery is relatively easy and associated with a lower rate of complications compared to the subretinal approach. Additionally, when a given array can conform to the surface of the retina, a large electrode array can be inserted into the eye to increase the field of vision without significantly interfering with the physiology of the retina. However, there are some drawbacks to the epiretinal approach. One risk is the potential development of gliosis secondary to the use of a tack. Another concern is the possibility of the array rotating if the cable is not properly fixed, which may result in the array not remaining uniformly close to the retina. Furthermore, excessive pressure exerted by the array on the retina and the possibility of the tack falling off the retina are also disadvantages. On the other hand, the subretinal approach offers certain advantages as well. It provides the advantage of a more consistent position of the array with the retina, reducing the risk of retinal tear and damage. Moreover, a porous array can be used to address the potential interference with the choroid's ability to supply nutrition to the outer retina. However, it is important to be mindful of the limitations on the size of the array in the subretinal approach, as a larger array may lift and detach the retina. Additionally, this approach carries a considerable chance of complications during surgery, including retinal detachment and choroidal hemorrhage. To determine the most suitable approach for a specific patient, ophthalmologists should consider various factors, such as the patient's condition, the extent of retinal damage, and the potential risks associated with each technique. It is recommended to consult ophthalmology textbooks and additional resources to obtain comprehensive guidance on these approaches and make an informed decision."}
{"question": "Question: Which of the following is seen retinitis pigmentosa?\nOptions:\nA. Aeriolar attenuation\nB. Neovascularization\nC. Retinal aery thrombosis\nD. Papilledema\n", "answer": " Retinitis pigmentosaApoptosis of rodsAR - most common RISK FACTOR- Consanguineous marriagesC/F- Nyctalopia- Ring scotoma +nt- Progress to tubular vision (constriction of visual fields) O/E- TRIAD- Pale waxy disc- Aeriolar attenuation- BONE SPICLUE PIGMENTATION (characteristic) - Gold standard for Dx - ERG- Measures the potential difference ofNeuro sensory layerNORMAL ERG- Negative 'a' -wave- Positive 'b' -wave- Small 'c' -wave (sometimes)- a-wave - measures the potential difference of photoreceptors- b-wave - measures the potential differenceOf Muller's cells (neuroglia) & bipolarCells (neuronal cells) In Retinitis Pigmentosa- ERG becomes FLAT\n\nOPTION A IS CORRECT."}
{"question": "Q: What is the potential role of pharmacological agents in the treatment of glaucomatous optic neuropathy ?", "answer": "A: Pharmacological agents hold potential in the treatment of glaucomatous optic neuropathy. Currently, reducing intraocular pressure (IOP) is the only proven therapy to slow down the progression of the disease. However, there are exciting developments in the field that suggest the possibility of using drugs to directly or indirectly affect the regulation of retinal ganglion cell axonal extensions. This could be achieved through immunological and/or biochemical mechanisms. Some potential strategies include utilizing purified or engineered molecules from peripheral nerve to induce axonal extension, regulating the immune response within the optic nerve, and employing active or passive immunization against myelin basic protein. While these strategies are still under investigation, they offer hope for future therapeutic interventions in patients with glaucoma."}
{"question": "Question: Does diabetes impair the Aldehyde Detoxifying Capacity of the Retina?\nContext: We studied whether the accumulation of advanced lipoxidation end-products (ALEs) in the diabetic retina is linked to the impairment of lipid aldehyde detoxification mechanisms. Retinas were collected from nondiabetic and diabetic rats and processed for conventional and quantitative RT-PCR (qRT-PCR), Western blotting, immunohistochemistry, and aldehyde dehydrogenase (ALDH) activity assays. The effect of the ALDH1a1 inhibitor, NCT-501, on ALE accumulation and cell viability in cultured Müller glia also was investigated. The rat retina expressed a range of lipid aldehyde detoxifying ALDH and aldo-keto reductase (AKR) genes. In diabetes, mRNA levels were reduced for 5 of 9 transcripts tested. These findings contrasted with those in the lens and cornea where many of these enzymes were upregulated. We have reported previously accumulation of the acrolein (ACR)-derived ALE, FDP-lysine, in retinal Müller glia during diabetes. In the present study, we show that the main ACR-detoxifying ALDH and AKR genes expressed in the retina, namely, ALDH1a1, ALDH2, and AKR1b1, are principally localized to Müller glia. Diabetes-induced FDP-lysine accumulation in Müller glia was associated with a reduction in ALDH1a1 mRNA and protein expression in whole retina and a decrease in ALDH1a1-immunoreactivity specifically within these cells. No such changes were detected for ALDH2 or AKR1b1. Activity of ALDH was suppressed in the diabetic retina and blockade of ALDH1a1 in cultured Müller glia triggered FDP-lysine accumulation and reduced cell viability.", "answer": "These findings suggest that downregulation of ALDH and AKR enzymes, particularly ALDH1a1, may contribute ALE accumulation in the diabetic retina.\n\nyes"}
{"question": "Question: Not a manifestation of non proliferative diabetic retinopathy\nOptions:\nA. Drusens\nB. Hard exudates\nC. Dot blot haemorrhage\nD. Cotton wool spots\n", "answer": " Drusens are pathognomic of dry ARMD and not diabetic retinopathy Manifestations OF non proliferative diabetic retinopathy - a. Microaneurysm: Saccular outpouchings of the vessel wall due to loss of pericytes b. Dot blot haemorrhage: Due to break of wall of microaneurysm in the deep layers c. Superficial haemorrhage: haemorrhage in superficial layers d. Hard exudates: Lipofuschin deposits in inner layer e. Cotton wool spots: NFL Infarction f. Intraretinal microvascular anomalies: abnormal communicating vessels between aeries and the veins g. Venous bleeding\n\nOPTION A IS CORRECT."}
{"question": "Question: Does spectral domain optical coherence tomography demonstrate interconnected orbital cyst and chorioretinal coloboma in an adult?\nContext: To report an orbital cyst underlying a chorioretinal coloboma in an otherwise normal eye, detected by spectral domain optical coherence tomography imaging. To the authors' knowledge, this is the first case of a chorioretinal colobomatous cyst in the normal eye to be reported. A descriptive case report of a patient with a chorioretinal coloboma with an underlying orbital cyst. A 59-year-old woman presented with a floater affecting her left visual field. Fundoscopy revealed a pale lesion inferotemporal to fixation at the left macula. Spectral domain optical coherence tomography revealed a retinochoroidal coloboma with an associated scleral hole. Enhanced depth imaging spectral domain optical coherence tomography revealed an underlying orbital colobomatous cyst.", "answer": "To the authors' knowledge, this is the first case of a healthy adult with a retinochoroidal colobomatous cyst without microphthalmos. The authors encourage optical coherence tomography of any suspected colobomas to exclude similar pathology.\n\nyes"}
{"question": "Question: Does optical coherence tomography-based measurement of drusen load predict development of advanced age-related macular degeneration?\nContext: To determine whether baseline drusen load, as measured using spectral-domain optical coherence tomography (SD OCT), is a useful predictor of development of advanced age-related macular degeneration (AMD). Retrospective cohort study. setting: Academic clinical practice. study population: All patients with non-neovascular AMD and no retinal pigment epithelial (RPE) atrophy at baseline who were seen between 2007 and 2012 in a single academic retina practice. A minimum of 1 year of follow-up was required. observation: Drusen load (area and volume) was assessed using automated SD OCT software algorithms. main outcome measure: RPE atrophy area, assessed using an automated SD OCT software algorithm, and the development of neovascular AMD. Eighty-three patients met the inclusion criteria with a mean age of 80 years and a mean follow-up time of 2.8 years. Repeated-measures analysis of variance showed an association between drusen area (P = .005) and drusen volume (P = .001) and the development of RPE atrophy. We also found an association between drusen area (P = .001) and drusen volume (P = .001) and the development of neovascular AMD.", "answer": "Drusen load, as measured using SD OCT, is associated with the development of RPE atrophy and neovascular AMD. SD OCT assessments of drusen load are simple and practical measurements that may be useful in stratifying the risk of developing advanced AMD. These measurements have potential applications in both routine clinical care and clinical trials.\n\nyes"}
{"question": "What are the possible treatments or the best therapy for a full-thickness macular hole ?", "answer": "The treatment options for a full-thickness macular hole include observation, vitrectomy surgery, and pharmacologic vitreolysis. Observation is usually recommended for small macular holes that are not causing significant vision impairment. In these cases, close monitoring is necessary to detect any progression or worsening of the hole. Vitrectomy surgery is the most common treatment for macular holes. During this procedure, the vitreous gel is removed from the eye, and a gas bubble or silicone oil is injected to fill the space and close the hole. The gas bubble or oil holds the edges of the hole together, allowing them to heal. Over time, the bubble or oil is gradually absorbed by the body. Postoperative face-down positioning may be required to optimize the success of the surgery. Pharmacologic vitreolysis is a newer treatment option that involves the use of medication to dissolve the vitreous gel and promote hole closure. An enzyme called ocriplasmin is injected into the eye to break down the abnormal vitreous components. This treatment is typically reserved for small and uncomplicated macular holes. The choice of treatment depends on factors such as the size and severity of the macular hole, the patient's overall eye health, and the preferences of the ophthalmologist. It is important to consult with an ophthalmologist to determine the most appropriate treatment option for an individual case. Reference: 1. American Academy of Ophthalmology. (2019). Preferred Practice Pattern® Guidelines. Vitreoretinal Disorders. San Francisco: American Academy of Ophthalmology. Retrieved from https://www.aao.org/preferred-practice-pattern/vitreoretinal-disorders-ppp-2019"}
{"question": "Question: Which of the following represents the retinal detachment\nOptions:\nA. Separation of neurosensory retina from choroid\nB. Separation of bruch's membrane from retinal pigment epithelium\nC. Separation of neurosensory retina from retinal pigment epithelium\nD. Separation of internal limiting membrane from retinal pigment epithelium\n", "answer": " Separation of neurosensory retina from retinal pigment epithelium is called retinal detachment TYPES Rhegmatogenous Tractional Exudative\n\nOPTION C IS CORRECT."}
{"question": "What is the preferred operating method for treating retinal detachment associated with uveitis ?", "answer": "In cases of retinal detachment associated with uveitis, the choice of the operating method depends on various factors. Vitrectomy appears to achieve better results than scleral buckling in complicated cases of retinal detachment associated with acute retinal necrosis. However, if tractional components are a significant feature of the retinal detachment or other factors need to be considered, pars plana vitrectomy (PV) is the preferable operating method. The combination of scleral buckling with vitrectomy has its advocates, but no evidence-based data is available for patients with retinal detachment and uveitis. Therefore, the preferred operating method should be determined based on the individual patient's clinical presentation and the presence of associated complications."}
{"question": "Question: Hello doctor,My age is 30 years old. Sometimes, I have an eye irritation. I have an earthworm image in front of eyes. Please help me to clear this issue.", "answer": "Hello. I understand that you have two questions, one concerning occasional irritation and the second is regarding a linear worm like image floating in front of your eye. My advice to you is: For irritation, use over the counter lubricant eye.  These will help reduce the irritation and are free of side effects. For the image of the worm, please visit an ophthalmologist to get your retina examined. A problem like this is usually associated with problems in the vitreous and retina. This process usually needs dilating "}
{"question": "Question: Do [ Dexamethasone intensify the tight junctions in rat retinal vascular endothelial cells in vitro ]?\nContext: To investigate the effect of dexamethasone on the expression, distribution and function of tight junctions in rat retinal vascular endothelial cells in vitro. Try to explain the mechanism of glucocorticoid in the treatment of macular edema from a new viewpoint. Rat retinal vascular endothelial cells were isolated and purified by magnetic beads coated with anti-CD31. Cells were identified by vW factor indirect immunofluorescence staining. The fourth-passage cells were used to investigate the effect of dexamethasone on the tight junctions in rat retinal vascular endothelial cells. Cells were separated into two groups, one was treated with 500 nmol/L dexamethasone and the other was used as the control. Transepithelial electrical resistance (TER) was measured to estimate the changes in the treated group. Indirect immunofluorescent stain and RT-PCR were used to observe the difference of tight junction protein distribution and mRNA expression level between these two groups. Rat retinal vascular endothelial cell monolayer showed positive immunofluorescent staining for vW factor. The dexamethasone treated group showed greater TER than that of the control (P < 0.01). Tight junction protein in the dexamethasone treated group localized closer to the borders of retinal vascular endothelial cells than that of the control. Claudin-1 mRNA level of the dexamethasone treated cells were greater than that of the control.", "answer": "Dexamethasone intensifies the tight junctions in rat retinal vascular endothelial cells. Therefore this is one of the mechanisms of treatment of macular edema by glucocorticoid.\n\nyes"}
{"question": "Question: Do most patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency develop pathological or subnormal retinal function?\nContext: There have been few studies on long-term electroretinographic findings in patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD). This study correlated long-term electroretinographic findings with age, metabolic control and clinical symptoms. We examined 12 Swedish patients with LCHADD. Visual acuity testing, fundus examinations, optical coherence tomography and electroretinography were performed. The results were correlated to age, the levels of 3-hydroxyacylcarnitine and acylcarnitine and clinical metabolic control. Blindness or moderate visual impairment was found in two patients. Retinal pigmentation, atrophy and fibrosis were present in 11, seven and one of the patients, respectively, and optical coherence tomography showed retinal thinning in three of the six patients examined. Electroretinography was performed on 11 of the 12 patients. It was pathological, with reduced rod and cone responses, in five patients, subnormal in four and was related to poor clinical metabolic control and severe neonatal symptoms. Repeated electroretinographies revealed reduced function with increasing age.", "answer": "More than 80% of the LCHADD patients developed pathological or subnormal retinal function. This was more pronounced in patients with neonatal symptoms, but ameliorated by strict dietary treatment. Annual ophthalmological follow-ups, with electroretinography every second or third year, are recommended.\n\nyes"}
{"question": "Question: Use of nitrous oxide is contraindicated in all of the following surgeries except:\nOptions:\nA. Cochlear implant\nB. Microlaryngeal surgery\nC. Vitrioretinal surgery\nD. Exentration operation\n", "answer": " D.i.e. Excentration operation Diffusion hypoxia is seen during recovery phase after discontinuation of prolonged N20 anesthesia. It can be prevented by continuing 100% 02 inhalation for a few minutes after discontinuing N20Q. Second gas effect occurs in initial pa of induction of N20 anesthesia. N20 also shows bone marrow suppressionQ. Excentration is enucleation + wide dissection of periorbital tissue. In it there is no closed space formation so N20 can be used. In microlaryngeal lesser surgery, N20 is contraindicated d/t risk of airway fireQ\n\nOPTION D IS CORRECT."}
{"question": "Question: Does glucosamine sulfate inhibit TNF-alpha and IFN-gamma-induced production of ICAM-1 in human retinal pigment epithelial cells in vitro?\nContext: Glucosamine sulfate (GS) is a naturally occurring sugar that possesses some immunosuppressive effects in vitro and in vivo, but its mechanism is unknown. We investigated whether GS could modulate the proinflammatory cytokine-induced expression of the gene for intercellular adhesion molecule (ICAM)-1, an inflammatory protein in human retinal pigment epithelial (RPE) cells. ARPE-19 cells were used as a model to determine the effects of GS on the expression of the ICAM-1 gene upregulated by TNF-alpha or IFN-gamma, by Western blot analysis and semiquantitative reverse transcription polymerase chain reaction (RT-PCR). The activation and nuclear translocation of the nuclear factors NF-kappaB and STAT1 were evaluated by immunocytochemistry, Western blot analysis, and electrophoretic mobility shift assay (EMSA). Both TNF-alpha and IFN-gamma increased the expression of ICAM-1 at the mRNA and protein levels in a time- and dose-dependent manner in ARPE-19 cells. GS effectively downregulated the TNF-alpha- or IFN-gamma-induced expression of ICAM-1 in the protein and mRNA level in a dose-dependent manner. GS further inhibited the nuclear translocation of p65 proteins in TNF-alpha and phosphorylated STAT1 in IFN-gamma-stimulated ARPE-19 cells.", "answer": "GS inhibits the expression of the ICAM-1 gene in ARPE-19 cell stimulated with TNF-alpha or IFN-gamma through blockade of NF-kappaB subunit p65 and nuclear translocation of STAT1. This study has demonstrated a potentially important property of GS in reducing ICAM-1 mediated inflammatory mechanisms in the eye.\n\nyes"}
{"question": "What are the surgical techniques available for managing strabismus after retinal detachment surgery ?", "answer": "Surgical techniques for managing strabismus after retinal detachment surgery include muscle dehiscence repair for lost muscle, surgery for a lost medial rectus muscle, and surgery for stretched scar. Pearls for reoperation include strategies for rectus dehiscence and lost muscle. Additionally, there are specific pearls for managing strabismus after retinal detachment surgery, which can help guide the surgical approach in such cases."}
{"question": "Question: Does staurosporine-induced differentiation of the RGC-5 cell line lead to apoptosis and cell death at the lowest differentiating concentration?\nContext: Supplementation of staurosporine is the method of choice for differentiating the solely existing retinal ganglion cell (RGC)-5 cell line. This differentiation was initially claimed to be in the absence of apoptosis, but some publications supposed the induction of apoptosis during staurosporine induced RGC-5 differentiation. In respect to these inconsistencies in the literature, we investigated in detail whether RGC-5 cell differentiation by staurosporine induces apoptosis or not. Amounts of 50 nM, 200 nM, 300 nM, and 600 nM of staurosporine were supplemented on RGC-5 cells for 24 h. Cell morphology and cell death, via propidium iodide staining, were evaluated with phase contrast and fluorescence microscopy, respectively. Cell amount, cell proliferation, and cell viability were analyzed by crystal violet staining, CFSE flow cytometry, and MTS assay, respectively. Apoptosis was determined by analyzing caspase 3/7 activity, Annexin-V+/ 7AAD- cells and the quotient of Bax to Bcl-2 mRNA expression via caspase 3/7 activity assay, flow cytometry, and real-time PCR, respectively. RGC-5 cells started to change their morphology and their expression of neuronal markers at 50 nM of staurosporine. This was associated with apoptosis and cell death, as indicated by a 2.1-fold (p < 0.0005) increase in caspase 3/7 activity, a 1.2-fold (p < 0.05) induction of Annexin-V+/ 7AAD- cells, and a 12-fold (p < 0.0005) increase in propidium iodide positive cells, respectively. Furthermore, staurosporine led to a dose-dependent increase in apoptosis and reduction in cell viability, cell density, and cell proliferation.", "answer": "The lowest staurosporine concentration inducing RGC-5 cell differentiation is accompanied by apoptosis and cell death.\n\nyes"}
{"question": "What is senile degeneration of the vitreous ?", "answer": "Senile degeneration of the vitreous refers to the gradual fibrillar and lacunar degeneration that occurs in the vitreous humor of the eye in individuals over the age of 50. It is a common age-related condition, affecting approximately 65 percent of individuals over 65 years old and nearly 100 percent of individuals over 77 years old. The degeneration progresses slowly and may eventually result in the posterior detachment of the vitreous, leading to its collapse. In cases where there is adherence between the vitreous and the retina, the posterior detachment of the vitreous can cause traction on the retina, potentially leading to the rupture of the retina. This rupture can occur due to the pressure exerted by choroidal exudation, which is congestive or allergic inflammatory fluid passing through the pigment epithelium and pushing the retina towards the inside of the eye bulb. At weak points, the retina may rupture. It is worth noting that senile retinal detachment is often associated with cystic degeneration of the retina and posterior detachment of the vitreous with collapse. However, it is important to consider that retinal detachment in senility is relatively rare compared to posterior detachment of the vitreous and cystic degeneration of the retina. Other factors play a role in retinal detachment, including genetic predisposition, vascular-retinal-choroidal factors, and abiotrophic factors."}
{"question": "Question: Is tubby required for trafficking G protein-coupled receptors to neuronal cilia?\nContext: Tubby is the founding member of the tubby-like family of proteins. The naturally occurring tubby mutation in mice causes retinitis pigmentosa, hearing loss and obesity. Tubby has been proposed to function as an accessory factor in ciliary trafficking. We directly examined a role for tubby in ciliary trafficking in vivo. We used immunofluoresence labeling to examine the subcellular localization of rhodopsin, somatostatin receptor 3 (SSTR3) and melanin concentrating hormone receptor 1 (MCHR1), all of which are G protein-coupled receptors (GPCR), in the retina and brain of wild type (WT) and tubby mutant mice. In tubby mouse retina, rhodopsin is not fully transported across the connecting cilia to the outer segments with ensuing photoreceptor degeneration. In the tubby mouse brain, SSTR3 and MCHR1 fail to localize at the neuronal primary cilia in regions where these receptors play critical roles in neural signaling. The tubby mutant does not manifest a generalized defect in ciliogenesis or protein trafficking.", "answer": "Tubby plays a critical role in trafficking select GPCRs to the cilia. This role is reminiscent of tubby-like proteins 1 and 3, which have been proposed to facilitate trafficking of rhodopsin and select GPCRs in photoreceptors and the developing neural tube, respectively. Thus tubby-like proteins may be generally involved in transciliary trafficking of GPCRs.\n\nyes"}
{"question": "How does age-related macular degeneration (AMD) impact the physical and mental health of patients ?", "answer": "Age-related macular degeneration (AMD) has been found to have significant effects on the physical and mental health of patients. According to the SF-36 scores mentioned in the given data, patients with AMD reported lower scores on various physical health scales compared to the general population. Specifically, the Physical Functioning Scale showed a 12-16 point difference, indicating limitations in performing a range of physical activities. The Role-Physical Scale, which assesses problems with work or daily activities due to physical health, had the largest difference of nearly 20 points. However, when it comes to mental health, the SF-36 scores suggest that patients with AMD fare relatively well. The scores on mental health scales were similar to or near population norms. Only the Role-Emotional Scale showed clinically relevant differences, indicating some challenges with emotional well-being in relation to work or everyday activities. Overall, the Mental Composite Scale generated from the mental health scales did not show significant correlations with visual acuity or the clinical severity of AMD. Considering this information, ophthalmologists should be aware that AMD can have a negative impact on the physical health of patients, leading to limitations in daily activities and work. It is important to address these concerns and consider appropriate interventions or referrals to improve physical well-being. On the other hand, while mental health is generally not significantly affected by AMD, ophthalmologists should still assess and address any emotional challenges patients may face, particularly in relation to their work or daily activities. It is crucial for ophthalmologists to approach patients with empathy, acknowledging the potential impact of AMD on their physical and mental well-being. Collaborative discussions with patients can help identify their specific needs and develop a comprehensive management plan that addresses both the ophthalmic aspects of AMD and the patient's overall quality of life."}
{"question": "Question: True about the Oculocardiac reflex includes following EXCEPT:\nOptions:\nA. Mediated by trigeminovagal route\nB. Preperative glycopyrolate is not helpful for prevetion\nC. Induced by pressure on eye ball\nD. Mediated by traction on medial rectus\n", "answer": " Ans. B. Preperative glycopyrolate is not helpful for prevention. (Ref. Miller's Anesthesia 7th/Pg. 293; Paul's Clinical Anesthesia/Pg. 1327).A variety of stimuli arising in or near the eye especially following traction on the medial rectus or pressure on the eye ball may cause bradycardia, arrhythmias and cardiac arrest. In clinical practice this oculocardiac reflex (Trigeminovagal reflex) is most often encountered during squint surgery in children. OCR is also seen during eye muscle surgery, repair of detached retina, compression of gasserian ganglion 13, enucleation of eye and by contact lens and repair of nasal fracture under General Anaesthesia. Prophylactic anti cholinergic is recommended and adequate cardiac monitoring must accompany these interventions as immediate action may be required. OCR may be manifest by bradycardia, bigeminey, ectopic beats, nodal rhythm, AV block and cardiac arrest.Oculocardiac Reflex (Trigeminovagal Reflex)# Bernard Aschner and Guiseppe Dagnini first described the oculocardiac reflex in 1 908. This reflex is triggered by pressure on the globe and by traction on the extraocular muscles, as well as on the conjunctiva or the orbital structures.# This reflex is clinically significant during strabismus surgery in children, although the manifestations of this reflex are not consistent. The oculocardiac reflex (OCR) is induced by pressure on the eyeball.# The afferent pathway follows the long and short ciliary nerves to the ciliary ganglion. From there, it travels to the gasserian ganglion body along the ophthalmic division of the trigeminal nerve (CN V). The afferent pathway ends in the main trigeminal sensory nucleus in the floor of the fourth ventricle.# Efferent impulses start at the vasomotor center and travel through the vagal nerve (CN X) and the sympathetic chain. Bradycardia is the result of increasing parasympathetic tone. Decreasing sympathetic tone causes vasodilatation.# The cardiac effect stops when eye pressure is relieved. Patients should be monitored to recognize ECG changes. Atropine should be available to reverse life-threatening bradycardia.\n\nOPTION B IS CORRECT."}
{"question": "What is the purpose of using DARC in ophthalmology ?", "answer": "DARC (Detection of Apoptosing Retinal Cells) is a noninvasive real-time imaging technique used in ophthalmology to visualize individual retinal ganglion cell (RGC) apoptosis. It involves the application of fluorescently labelled annexin-5 to detect apoptosing cells using a fluorescence confocal scanning laser ophthalmoscope (cSLO). The purpose of using DARC is to monitor glaucomatous disease progression, detect glaucoma at an early stage, and assess neuroprotection in glaucoma. DARC allows for the imaging of changes occurring in RGC apoptosis over hours, days, and months in glaucoma-related animal models in vivo, providing valuable insights for research and potential clinical applications."}
{"question": "How is cryotherapy used in the treatment of retinal detachment ?", "answer": "Cryotherapy, also known as freezing treatment, is utilized in the management of retinal detachment. It involves applying freezing temperatures to the sclera, which is the outer surface of the eye, overlying the retinal tear. The purpose of cryotherapy is to cause controlled scarring, which helps seal the retinal hole and prevent further detachment. This scarring promotes the adherence of the retina to the underlying tissue, effectively closing the hole and relieving vitreous traction. Cryotherapy is a valuable technique employed in complicated retinal detachment surgeries, aiming to restore the integrity and stability of the retina."}
{"question": "Question: Does increasing scans per examination improve the reproducibility on retinal nerve fiber layer measurements by optical coherence tomography?\nContext: To investigate whether increasing the number of scans per examination would improve the reproducibility of retinal nerve fiber layer (RNFL) measurements by optical coherence tomography (OCT) in healthy and glaucomatous eyes. A total of 28 eyes of 28 healthy subjects and 20 eyes of 20 patients with primary chronic open-angle glaucoma were recruited. OCT RNFL assessments were obtained in one randomly selected eye. Each subject underwent seven scans on five separate occasions within a 1-month period. In the healthy group, the intervisit mean coefficient of variations (COV's) for the average RNFL thickness (100 sampling points) and the quadrant RNFL measurements (25 sampling points) were similar in a series of three, five, and seven scans per examination (p > 0.05), but COV's for the two clock-hour segment measurements (seven sampling points, superotemporal and inferotemporal) were significantly lower in a series of five and seven scans per examination than that of three scans per examinations (p < 0.01). In the glaucoma groups, COV's for the two quadrant (superior and inferior) and five clock-hour segment RNFL measurements (superior, superotemporal, temporal, inferotemporal, and superonasal) were significantly lower in a series of five and seven scans per examination than that of three scans per examination (p < 0.01). There was no statistical difference in the COV's between a series of five scans and that of seven scans per examination in all OCT RNFL thickness parameters in healthy and glaucomatous eyes (p > 0.05). Similar results were observed with intravisit COV comparisons.", "answer": "Increasing the number of scans per examination may improve the reproducibility of quadrant and clock-hour segment OCT RNFL measurements in healthy and glaucomatous eyes. A series of five scans per examination is recommended for OCT RNFL measurements.\n\nyes"}
{"question": "Question: Refractive condition of the eye at birth is –\nOptions:\nA. Hypermetropia of 2D\nB. Myopia of 2 D\nC. Hypermetropia of 5D\nD. Myopia of 5D\n", "answer": " The newborn is usually hypermetropic by +2 to +3D.\n\nOPTION A IS CORRECT."}
{"question": "What is the primary use of scleral indentation in ophthalmology ?", "answer": "Scleral indentation is an auxiliary examination technique used in conjunction with headband binocular indirect ophthalmoscopy. The primary use of scleral indentation is to enable a more detailed assessment of lesions detected with other routine indirect techniques. It is particularly helpful in assessing and treating retinal breaks. Scleral indentation may also be used to better understand observed lesions, such as thinning of the retina."}
{"question": "Question: Are complications in carotid endarterectomy predicted by qualifying symptoms and preoperative CT findings?\nContext: To relate the 30-day perioperative rate of stroke or death in carotid endarterectomy (CEA) to preoperative qualifying symptoms and to the presence of cerebral infarction (CI) demonstrated on computed tomography (CT). Retrospective clinical study. Two hundred and seventy-two consecutive CEAs for symptomatic stenosis in 262 patients were analysed. The total complication rate was 5.9%. Patients with retinal symptoms (n = 81) had no complications, TIA patients (n = 76) had 6.6% (p < 0.001). Patients qualifying with minor stroke (n = 113) had complications in 9.7% (N.S. compared to TIA patients). Patients qualifying with cortical symptoms had a significantly higher complication rate compared to those with retinal (8.4% vs. 0%, p = 0.004). The presence of a preoperative CT-verified infarction resulted in a higher risk for stroke or death (9.8% vs 2.8%, p = 0.008). Within the subgroup presenting with minor stroke, the presence of CI resulted in stroke or death in 13.9%. In patients without CI the corresponding figure was 2.4% (p = 0.017).", "answer": "The qualifying symptoms and the presence of CI visualized by CT influence the complication rate in CEA. When evaluating risk and comparing outcome, these parameters should be included in reporting standards.\n\nyes"}
{"question": "Question: Do evidence from human electroretinogram A and off responses that color processing occurs in the cones?\nContext: To investigate two apparent anomalies of the human electroretinogram: the \"on\" and \"off\" components of the cone based PIII are unequally sized, and transitions from red to green, which are electroretinographically silent, yield reverse transitions (green to red) in which a-waves develop. Ganzfeld electroretinograms were obtained with intense 100 msec flickering flashes from red and green light-emitting diode. Such stimuli light-adapt the retina, and the responses are caused by the excitation of long and medium wavelength cones. In the 10-20 msec after the beginning of a flash (black to green or black to red) the beginning of rapid receptor-generated a-wave is seen. Ten to twenty milliseconds after the end of the flash, the beginning of a rapid positive-going off response, also derived from receptors can be seen. If the retina is stimulated by the abrupt change from one wavelength of light to another (eg, from \"green\" to \"red\"), at times > 20 msec after the change there are always slow changes in potential (presumably caused by postsynaptic activity) regardless of the relative intensities of red and green. However, if the two light intensities are adjusted appropriately, 10-20 msec after the transition from green to red no electroretinographic a-wave (or off response) develops--the transition is \"silent.\" When the transition reverses (changes back from red to green), an a-wave occurs. In the same way if a red-to-green transition is made silent by altering the relative light intensities, the green-to-red reversal evokes an a-wave. This occurs for numerous pairs of red and green intensities. Rod intrusion or minor electroretinogram components do not explain this result. The relative red:green intensity in two color-anomalous subjects is different to that in three normal subjects. The rule for a silent transition is that the decrease in excitation in one cone type should be twice the increase in excitation in the second cone type.", "answer": "The most likely cause is a reduction in the amplitude of cone receptor potentials 20-50 msec after the onset of the stimulus, caused by a sign-reversing feedback mechanism such as that described in amphibians. This implies that the chromatic signals for color vision required by theorists are partly generated in the cones.\n\nyes"}
{"question": "Question: Does genotype-phenotype correlation in CC2D2A-related Joubert syndrome reveal an association with ventriculomegaly and seizures?\nContext: Joubert syndrome (JS) is a ciliopathy characterised by a distinctive brain malformation (the 'molar tooth sign'), developmental delay, abnormal eye movements and abnormal breathing pattern. Retinal dystrophy, cystic kidney disease, liver fibrosis and polydactyly are variably present, resulting in significant phenotypic heterogeneity and overlap with other ciliopathies. JS is also genetically heterogeneous, resulting from mutations in 13 genes. These factors render clinical/molecular diagnosis and management challenging. CC2D2A mutations are a relatively common cause of JS and also cause Meckel syndrome. The clinical consequences of CC2D2A mutations in patients with JS have been incompletely reported. Subjects with JS from 209 families were evaluated to identify mutations in CC2D2A. Clinical and imaging features in subjects with CC2D2A mutations were compared with those in subjects without CC2D2A mutations and reports in the literature. 10 novel CC2D2A mutations in 20 subjects were identified; a summary is provided of all published CC2D2A mutations. Subjects with CC2D2A-related JS were more likely to have ventriculomegaly (p<0.0001) and seizures (p=0.024) than subjects without CC2D2A mutations. No mutation-specific genotype-phenotype correlations could be identified, but the findings confirm the observation that mutations that cause CC2D2A-related JS are predicted to be less deleterious than mutations that cause CC2D2A-related Meckel syndrome. Missense variants in the coiled-coil and C2 domains, as well as the C-terminal region, identify these regions as important for the biological mechanisms underlying JS.", "answer": "CC2D2A testing should be prioritised in patients with JS and ventriculomegaly and/or seizures. Patients with CC2D2A-related JS should be monitored for hydrocephalus and seizures.\n\nyes"}
{"question": "Question: A lady presented with reddish eye and watering over left eye with a shallow anterior chamber. What is the next best investigation?\nOptions:\nA. Tonometry\nB. Cup disc ratio\nC. Gonioscopy\nD. Ophthalmoscopy\n", "answer": " Ans. (a) TonometryShallow AC with redness- points towards PACG in a female. In acute stages, IOP is markedly raised - Do tonometry followed by gonioscopy & fundus examination.\n\nOPTION A IS CORRECT."}
{"question": "Question: Does ophthalmic artery chemosurgery for retinoblastoma prevent new intraocular tumors?\nContext: To determine the incidence and timing of new intraocular tumor foci in genetic retinoblastoma cases after treatment with ophthalmic artery chemosurgery (OAC). Single-center retrospective review of all genetic retinoblastoma cases managed at Memorial Sloan-Kettering Cancer Center/Weil-Cornell Medical School since May 2006. Eighty-one patients (80 with bilateral disease and 1 with unilateral disease with a family history) with genetic retinoblastoma, with a total of 116 eyes treated with OAC since May 2006. Retrospective, single-institution review of patients with bilateral retinoblastoma and unilateral retinoblastoma with a positive family history. New tumors were assessed by clinical notes, retinal drawings, and RetCam digital imaging (Clarity Medical Systems, Pleasanton, CA). New intraocular retinoblastoma tumors after treatment with OAC. Forty-one eyes were treated primarily with OAC (treatment-naïve group) and 75 eyes were treated with OAC after prior treatment with systemic chemotherapy, external beam radiation, or both and focal techniques. Of the 41 treatment-naïve eyes, a new intraocular tumor (one focus) subsequently developed in 1 eye. Of the 75 previously treated eyes, new tumors (single focus in each eye) subsequently developed in 6 eyes.", "answer": "Eyes receiving OAC demonstrate fewer new intraocular retinoblastomas after radiation or systemic chemotherapy than has been reported in the literature. This suggests that ophthalmoscopically undetectable tumors are present at the initial diagnosis and effectively are eliminated as a result of OAC.\n\nyes"}
{"question": "How does the turnover rate of photoreceptor cells and the metabolic fate of lipid components in disc membranes relate to the pathogenesis of age-related macular degeneration (AMD) ?", "answer": "Age-related macular degeneration (AMD) is a complex disease involving various mechanisms that contribute to its pathogenesis. One important aspect is the high turnover rate of photoreceptor cells, particularly the shedding and renewal of the outer segment (POS) discs. The retinal pigment epithelium (RPE), which supports and nourishes the photoreceptor cells, plays a crucial role in this process. Each RPE cell is responsible for phagocytosing and degrading a significant number of POS discs daily. This phagocytosis is facilitated by CD36 receptors in the RPE cells. The lipids derived from the disc membranes have distinct metabolic fates. Retinol and docosahexaenoic acids are recycled to the photoreceptor cells through the interphotoreceptor matrix, while the remaining lipids undergo catabolism via mitochondrial beta-oxidation. Recent studies have also shown that RPE cells can uptake low-density lipoprotein (LDL) from the choriocapillaries using receptor-mediated pathways. These plasma lipids enter the POS turnover and are either used for disc membrane renewal or catabolized by mitochondrial beta-oxidation. However, incomplete catabolism of POS discs can lead to the accumulation of residual bodies or lipofuscin granules in the cytoplasm of RPE cells. Lipofuscin is a heterogeneous material composed of various components, including lipids, proteins, and fluorescent compounds derived from vitamin A. Its accumulation is often observed in RPE cells and is considered a sign of incomplete lipid metabolism. However, it is now understood that the accumulation of lipofuscin is not solely indicative of failed lipid metabolism but rather reflects the balance between lipid peroxide production and elimination. The RPE possesses efficient mechanisms to eliminate lipid peroxides and maintain its homeostasis. Along with cytosolic antioxidant substances such as glutathione, ascorbate, and alpha-tocopherol, subcellular structures like mitochondria, peroxisomes, and melanosomes, as well as the process of exocytosis, contribute to the detoxification of lipid peroxides within the RPE. In summary, the high turnover rate of photoreceptor cells, the metabolic"}
{"question": "Definition question: What are complex granules in the context of ophthalmology ?", "answer": "Complex granules in ophthalmology refer to structures formed by the combination of melanin, lipofuscin, and lysosomes within the retinal pigment epithelium (RPE). These granules, known as melanolipofuscin and melanolysosomes, exhibit regional distribution within the eye, with the highest concentration found in the macula and decreasing towards the periphery and fovea. As individuals age, the percentage of cellular volume occupied by complex granules increases, ranging from 3.3% in the first decade of life to approximately 8-10% in the sixth decade. The presence of lysosomes associated with pigment granules, such as melanosomes, lipofuscin granules, and complex pigments, contributes to the age-dependent variations observed in lysosomal enzyme levels and the activity of RPE cells. This increase in pigment granules with age leads to a corresponding increase in lysosomes and the activity of various enzymes, such as acid phosphatase and Cathepsin D. These enzymes play a crucial role in maintaining the normal degradation cycle of photoreceptor outer segments by the RPE cells. It is important to note that the information provided is based on general knowledge in the field of ophthalmology and not specifically derived from the given context."}
{"question": "What medications are commonly used for sedation in infants during ophthalmic procedures ?", "answer": "There are several medications commonly used for sedation in infants during ophthalmic procedures. Chloral hydrate and propofol are two options that can be used. Chloral hydrate is an oral sedative that can induce sedation without significantly altering vital signs. However, vomiting and hyperactivity may occur during induction. On the other hand, propofol is an intravenous sedative-hypnotic agent that can be titrated to provide different levels of sedation or anesthesia. It offers the advantage of rapid and predictable awakening. Diazepam and chlordiazepoxide may also be used but are typically not given to young infants. Inhalation anesthetics such as halothane, methoxyflurane, enflurane, diethylether, and chloroform are generally not necessary for visual electrophysiologic recording and can retard retinal dark adaptation."}
{"question": "Question: Does interleukin-6 receptor blockade suppress subretinal fibrosis in a mouse model?\nContext: To determine the involvement of the interleukin (IL)-6 with the development of experimental subretinal fibrosis in a mouse model. Subretinal fibrosis was induced by subretinal injection of macrophage-rich peritoneal exudate cells and the local expression of IL-6 was assessed by quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) at various time points. In addition, we investigated the effect of IL-6 receptor (IL-6R) monoclonal antibody (MR16-1) on subretinal fibrosis development. IL-6 mRNA level was significantly elevated at 1d after subretinal fibrosis induction and increased further to about 12-fold at 2d, reaching the peak. The result of ELISA showed that IL-6 protein was not detected in naive mice. At 2d after subretinal fibrosis induction, IL-6 protein level was upregulated to 67.33±14.96 pg/mg in subretinal fibrosis mice. MR16-1 treatment resulted in a reduced subretinal fibrosis area by 48% compared to animals from control group at 7d.", "answer": "Our results indicated that IL-6 signaling may contribute to the pathogenesis of subretinal fibrogenesis and IL-6R inhibition may provide an effective, novel treatment of advanced and late-stage neovascular age-related macular degeneration.\n\nyes"}
{"question": "What is the potential disease-modifying role of omega-3 fatty acids and macular xanthophylls in AMD ?", "answer": "Studies have suggested that omega-3 fatty acids and macular xanthophylls, such as lutein and zeaxanthin, may play a role in modifying the progression of age-related macular degeneration (AMD). The AREDS2 trial aims to further investigate this potential. It will evaluate whether high-dose supplementation with omega-3 fatty acids and/or lutein with zeaxanthin can be effective in treating AMD. The original AREDS formulation included lutein and zeaxanthin due to their histological and biophysical properties, as well as epidemiologic data supporting their potential benefits. However, these carotenoids were not commercially available at the time of the trial. The results from the AREDS2 trial will provide valuable insights into the efficacy of these nutrients in the treatment of intermediate-risk AMD."}
{"question": "Question: Does endoscopic vitrectomy improve outcomes of Seoul-type keratoprosthesis exchange in rabbit model?\nContext: To investigate the efficacy of an endoscopic vitrectomy in Seoul-type keratoprosthesis (S-Kpro) exchange procedures. Nine S-Kpro-implanted rabbit eyes were enrolled in the S-Kpro exchange. Six eyes underwent an antecedent vitrectomy by an endoscopic system and then the S-Kpro exchange (endoscopy group). In the other three eyes, previously placed S-Kpros were removed, and a conventional vitrectomy was performed using the Eckardt keratoprosthesis, followed by an implantation of new S-Kpros (Eckardt group). All eyes were evaluated with slit lamp biomicroscopy and ultrasonography weekly to evaluate the time up to the development of the total retinal detachment (RD). Vitreous traction membranes were found around the prolene haptics of the fixation sites in all the S-Kpro implanted rabbits; they were excised precisely through an endoscopic view in the endoscopy group. The mean survival time up to the RD development was 9.75 +/- 4.70 weeks in the endoscopy group. In contrast, total retinal detachment or dialysis over 180 degrees developed during surgery in all three eyes in the Eckardt group.", "answer": "Antecedent endoscopic vitrectomy was safe and effective for the S-Kpro exchange in a rabbit model by removing the vitreous traction near the haptics before the exchange procedures.\n\nyes"}
{"question": "Question: What is the proof of eyes being open for a few hours after death –\nOptions:\nA. Kevorkian sign\nB. Tache noir\nC. Both of the above\nD. None of the above\n", "answer": " If eyes are open for few hours after death a film of cell debris and mucus forms two yellow triangles on sclera which turns brown then black. This is tache noir. Kevorkian sign is fragmentation of blood column in retinal vessels which occur in few minutes after death and last for an hour.\n\nOPTION B IS CORRECT."}
{"question": "What are the visual acuity outcomes and patient-reported improvements associated with ranibizumab treatment in neovascular age-related macular degeneration (AMD) ?", "answer": "In clinical trials such as MARINA and ANCHOR, the use of ranibizumab in the treatment of neovascular AMD has shown significant improvements in visual acuity outcomes compared to control groups. After 24 months of treatment, a higher percentage of patients receiving ranibizumab maintained or improved their vision, with 90-95% of patients treated with ranibizumab maintaining vision compared to 53-64% of control patients. Moreover, vision improved in 25-34% of treated eyes compared to only 4-5% of control patients. These outcomes were superior to any previously published study in the treatment of neovascular AMD. Patient-reported outcomes were also assessed in these trials, demonstrating that patients treated with ranibizumab reported improvements in near activities, distance activities, and vision-specific dependency, which were sustained over the two-year duration of the trial. This indicates that the clinical improvements achieved with ranibizumab treatment translate into meaningful benefits for the patient. It is important to note that these outcomes were observed in the context of biphasic treatment, where the majority of visual gain was achieved within the first three months of treatment (loading phase), followed by stabilization of the gain (maintenance phase). Regular monthly injections were administered to maintain both functional and anatomical improvements. Bevacizumab, a predecessor of ranibizumab, has also shown efficacy in treating neovascular AMD. Retrospective and prospective studies have reported its effectiveness and low rates of treatment-related complications. Despite some limitations in study design and outcome measures, the reported efficacy of bevacizumab, coupled with its cost-effectiveness as an intraocular agent, has led to its widespread adoption in the field of ophthalmology."}
{"question": "What is the most effective method for treating refractive errors in ophthalmology ?", "answer": "Refractive errors are common visual disorders that can be corrected through various treatment methods. The most effective method for treating refractive errors depends on the specific condition and the patient's preferences. The following are the commonly used treatment options: 1. Glasses and Contact Lenses: Non-invasive and easily adjustable, glasses and contact lenses are the most common initial treatment for refractive errors. They provide clear vision by compensating for the refractive error and are suitable for most individuals. 2. Laser-Assisted In Situ Keratomileusis (LASIK): LASIK is a popular surgical procedure that uses a laser to reshape the cornea. It is effective for treating myopia, hyperopia, and astigmatism. LASIK offers rapid visual recovery and reduces dependency on glasses or contact lenses. 3. Photorefractive Keratectomy (PRK): Similar to LASIK, PRK also reshapes the cornea but without creating a corneal flap. It is particularly suitable for patients with thin corneas or those at higher risk for complications. 4. Implantable Collamer Lenses (ICL): ICL is an alternative surgical option for individuals with moderate to high refractive errors who may not be suitable candidates for LASIK or PRK. The lens is surgically inserted into the eye to correct the refractive error permanently. 5. Refractive Lens Exchange (RLE): RLE involves replacing the eye's natural lens with an artificial intraocular lens (IOL). It is commonly used for individuals with high hyperopia or presbyopia. RLE can also address cataracts if present. It is important to consult with an ophthalmologist to determine the most suitable treatment option based on factors such as the patient's refractive error, age, corneal thickness, and overall eye health. Each method has its own benefits, risks, and considerations, which should be discussed with the ophthalmologist during the evaluation process. Reference: American Academy of Ophthalmology. (2020). Refractive Errors and Refractive Surgery Preferred Practice Pattern®. Retrieved from https://www.aao.org/preferred-practice-pattern/refractive-errors-ppp-2020"}
{"question": "What are the clinical features and diagnostic tests used in the evaluation of multiple evanescent white dot syndrome (MEWDS) ?", "answer": "Multiple evanescent white dot syndrome (MEWDS) is characterized by the presence of multiple small white dots in the posterior pole of the retina, typically affecting young individuals. Clinical features commonly observed in MEWDS include acute onset of unilateral or bilateral vision loss, photopsia (flashes of light), and visual field defects. Diagnostic tests used in the evaluation of MEWDS include focal electroretinogram (ERG), multifocal electroretinogram (mfERG), and S-cone electroretinogram (S-ERG). These tests help assess the retinal function and can show abnormalities in the affected areas."}
{"question": "Question: Does etretinate augment interferon beta-1b effects on suppressor cells in multiple sclerosis?\nContext: Interferon beta treatment is only partially effective in multiple sclerosis (MS) suggesting a potential role for adjunctive therapies. Retinoids can augment the clinical efficacy of type 1 interferons in patients with cancer. We reasoned that the same might hold in MS. Interferon beta-1b added to peripheral blood mononuclear cells in vitro partially reverses the CD8 suppressor cell defect of patients with MS. All-trans retinoic acid added to peripheral blood mononuclear cells from untreated patients with MS or from controls potentiates this ability of interferon beta-1b to augment CD8 suppressor cell function in vitro. To determine whether retinoid administration to patients with MS who are being treated with interferon beta-1b augments their CD8 suppressor cell function. A university hospital MS clinic. Patients with MS who were being treated with interferon beta-1b, 14 patients with secondary progressive MS and 3 patients with relapsing remitting MS. Seventeen patients with MS received etretinate treatment for up to 6 months. Planned dosing was 10 mg 3 times daily for the first month, 25 mg twice daily for the second and third months, and 10 mg twice daily thereafter. The 25-mg twice daily dose was not well tolerated and of the 14 patients who remained in the phase 1 clinical trial through month 3 dose reduction to 10 mg thrice daily was required in 1 patient and to 10 mg twice daily in 4 patients. Eleven patients completed the trial. Etretinate treatment significantly augmented suppressor function over baseline values at 1, 3, and 6 months. No meaningful change was noted in disability or quality of life over the course of the phase 1 clinical trial. Neuropsychological testing of completers suggested improvement on selected aspects of verbal memory at 6 months compared with baseline values.", "answer": "Etretinate treatment at a dose of 10 mg twice or three times daily augments suppressor cell function in patients with MS receiving interferon beta-1b. Higher dose etretinate treatment (25 mg twice daily) is poorly tolerated by patients with MS. Even at 10 mg twice daily adverse experiences involving the mucous membranes and the skin become troublesome for some, but not all, patients. Whether pulse therapy or administration of retinoid restricted to the day of interferon beta dosing will also augment suppressor function, while being better tolerated, remains to be determined.\n\nyes"}
{"question": "Question: Lamina cribrosa is not present in\nOptions:\nA. Morning glory syndrome\nB. Nanophthalmia\nC. Coloboma of retina\nD. Optic nerve agenesis\n", "answer": " Morning glory syndrome is a mesodermal defect in which there is peripapillary defect along with absence of lamina cribrosa.\n\nOPTION A IS CORRECT."}
{"question": "Question: Does hypericin inhibit choroidal endothelial cell proliferation and cord formation in vitro?\nContext: To evaluate the effect of hypericin on bovine choroidal endothelial cell proliferation and cord formation and on protein kinase C activity. The effect of hypericin (0.1-5 microM) on bovine choroidal endothelial cell proliferation was determined by cell number counting and a 3H-thymidine uptake assay in media containing 1, 5 or 10% serum. For the cord formation assay, bovine choroidal endothelial cells were seeded on basement membrane matrix, and the lengths of the capillary-like structures (cords) formed were quantified by image analysis. The effect of hypericin on cord formation was evaluated in the presence of serum or vascular endothelial growth factor. The effect of hypericin on protein kinase C activity was also measured in the presence or absence of light. Hypericin inhibited bovine choroidal endothelial cell proliferation in a dose-dependent manner in the presence of light but not in the dark. Serum dose-dependently masked the inhibition of DNA synthesis by hypericin. Cord formation by bovine choroidal endothelial cells was stimulated by serum or vascular endothelial growth factor and inhibited by hypericin in the presence of light. Protein kinase C activity was completely inhibited by hypericin in the presence of light but only mildly inhibited in the absence of light.", "answer": "Hypericin inhibits bovine choroidal endothelial cell proliferation and cord formation and choroidal endothelial cell protein kinase C activity. These results suggest that hypericin should be further investigated in animal models for its potential to inhibit subretinal neovascularization.\n\nyes"}
{"question": "What factors should be considered during the implantation of LSI-based retinal prosthesis devices ?", "answer": "During the implantation of LSI-based retinal prosthesis devices, several factors need to be taken into consideration to ensure the success of the procedure. First and foremost, the mechanical rigidity of the device is crucial. The thin LSI chip must be handled with extreme care to avoid any damage or misplacement during the implantation process. Additionally, the issue of bending and its impact on the device characteristics must be addressed. It is important to assess how the bending affects the functionality of the device. To overcome the challenges related to mechanical rigidity, a proposed device architecture consisting of small microchips has been suggested. These microchips, each approximately 500 μm square in size, work under a single set of control signals. This distributed stimulator design aims to enhance the feasibility of the LSI-based device. In terms of device thickness, it is crucial to keep it as thin as possible to ensure smooth implantation. The proposed device has a thickness of approximately 200 μm, which is deemed acceptable for successful implantation. During the proof-of-concept phase, a microchip-based stimulator was fabricated using dummy Si chips with Pt/Au bumps. Implantation of the device typically involves creating a pocket in the sclera of the eye. This pocket serves as the placement site for the device, allowing it to stimulate retinal cells using the STS (suprachoroidal-transretinal stimulation) method. It is important for ophthalmologists to consider these factors, such as mechanical rigidity, device thickness, and implantation technique, when working with LSI-based retinal prosthesis devices to ensure optimal outcomes for patients requiring such interventions."}
{"question": "Question: True about incontinenta pigmenti include the following except:\nOptions:\nA. X-linked dominant\nB. Primary skin abnormality\nC. Avascularity of peripheral retina\nD. Ocular involvement is seen in almost 100% cases and is typically unilateral\n", "answer": " D i.e. Ocular involvement is seen in almost 100% cases and is typically unilateral - Incontinetia pigmenti (Bloch-Sulzberger Syndrome) is X linked dominant disorder primarily affecting females as it is believed to be embryonically (in utero) lethal in malesQ. - It is primarily skin abnormality presenting with 4 overlaping stages of linear or whorled cutaneous lesions along lines of BlaschkoQ. Linear streaks & plaques of erythematous vesicles & papules (stage 1, bih - few months); thickened verrucous was & whorled plaquesQ (Stage 2, 2 weeks - months) both usually on extremities > trunk. Linear streaks, whorls, flacks & reticulated patches of hyperpigmentation mainly on trunk > extremitiesQ (stage 3, first few months to adolescence) and anhidrotic, hairless, atrophic, hypopigmented linear patches or streaks usually on calves (stage 4, adolescence to adultohood). Dental/teeth (80-90%), bones (30-40%), CNS /neurological (30-40%) and ocular/ophthalmic (25-35%) involvement may be associated with skin involvement in few cases (but not in all cases)Q. Retinal vasoocclusive ischemia is primary mechanismQ. Icontinentia pigmenti is an X-linked dominant disorder primarily affecting femalesQ and belived to be embryonic lethal in males. It primarily involves skin (in 100% cases) and presents with typical skin lesions along the lines of Blaschko often at bih, usually before 1st week and rarely after the fist 2 monthsQ. Four cutaneous stages, some times with some overlap are Inflammatory macule, papule, vesicle and pustules (vesicular stage) from bih or sholy there after. Hyperkeratotic and verrucous lesions (stage) between 2-8 weeks of age Blue-Gray or slate to brown, bizarre Chinese letter pattern hyperpigmentation (several months of age into adolescence) Atrophic hypopigmented, and depigmented, hariless, anthidrotic bands/streaks that fail to tan on sun exposure (from infancy through adulthood).\n\nOPTION D IS CORRECT."}
{"question": "What are the different causes of hyperfluorescence and hypofluorescence in age-related macular degeneration (AMD) ?", "answer": "In age-related macular degeneration (AMD), hyperfluorescence and hypofluorescence can be observed on fluorescein angiography. Hyperfluorescence refers to areas of abnormally bright fluorescence, while hypofluorescence refers to areas of reduced fluorescence. Hyperfluorescence can occur due to increased visibility of fluorescence, such as when melanin pigment in the choroid and retinal pigment epithelium (RPE) layers are attenuated or lost, allowing increased transmission of choroidal fluorescence. It can also result from the excess accumulation of fluorescein dye within vascular abnormalities or the extravascular space. In AMD, common causes of hyperfluorescence include taller and melanin-rich RPE cells in the macular region, leading to reduced transmission of fluorescent light from underlying choroidal vessels. On the other hand, hypofluorescence in AMD can arise from two main causes. Firstly, there may be less fluorescein present within the vasculature than expected in a particular fundus region. Secondly, something may impede the view of retinal or choroidal fluorescence, such as the presence of hemorrhage, occlusion of a vascular bed, or RPE tear. It is important to note that while the given context provides specific information about hyperfluorescence and hypofluorescence in AMD, clinical judgment and further investigations are necessary to interpret angiographic findings accurately."}
{"question": "Question: Does enzymatic degradation identify components responsible for the structural properties of the vitreous body?\nContext: Vitreous degeneration contributes to several age-related eye diseases, including retinal detachment, macular hole, macular traction syndrome, and nuclear cataracts. Remarkably little is understood about the molecular interactions responsible for maintaining vitreous structure. The purpose of this study was to measure the structural properties of the vitreous body after enzymatic degradation of selected macromolecules. Mechanical properties of plugs of bovine and porcine vitreous were analyzed using a rheometer. Oscillatory and extensional tests measured vitreous stiffness and adhesivity, respectively. Major structural components of the vitreous were degraded by incubation overnight in collagenase, trypsin, or hyaluronidase, singly or in combination. Vitreous bodies were also incubated in hyper- or hypotonic saline. Effects of these treatments on the mechanical properties of the vitreous were measured by rheometry. Enzymatic digestion of each class of macromolecules decreased the stiffness of bovine vitreous by approximately half (P < 0.05). Differential effects were observed on the damping capacity of the vitreous (P < 0.05), which was shown to correlate with material behavior in extension (P < 0.01). Digestion of hyaluronan significantly decreased the damping capacity of the vitreous and increased adhesivity. Collagen degradation resulted in the opposite effect, whereas digestion of proteins and proteoglycans with trypsin did not alter behavior relative to controls. Osmotic perturbations and double-enzyme treatments further implicated hyaluronan and hyaluronan-associated water as a primary regulator of adhesivity and material behavior in extension.", "answer": "Collagen, hyaluronan, and proteoglycans act synergistically to maintain vitreous stiffness. Hyaluronan is a key mediator of vitreous adhesivity, and mechanical damping is an important factor influencing dynamic vitreous behavior.\n\nyes"}
{"question": "Question: Does simvastatin suppress expression of angiogenic factors in the retinas of rats with streptozotocin-induced diabetes?\nContext: Angiogenic factors such as vascular endothelial growth factor (VEGF), erythropoietin, and angiopoietin play important roles in the pathophysiology of diabetic retinopathy. Increased amounts of reactive oxygen species (ROS) are also known to associated with diabetic retinopathy and VEGF expression. This study evaluated the effect of a simvastatin on ROS generation and the changes in various angiogenic factors in the retinas of diabetic rats. The rats were divided into normal, diabetes mellitus (DM), and simvastatin-treated groups (each group, n = 10). Diabetes was induced by intraperitoneal injection of streptozotocin into 20 Sprague-Dawley rats. After diabetic induction, simvastatin (5mg/kg) was administered orally to ten rats. The expression levels of VEGF, erythropoietin, angiopoietin 1 and 2, and NADPH oxidase were examined in rat retinas by RT-PCR and Western blot. Superoxide formation was examined by dihydroethidium (DHE) staining. DHE analysis revealed increased superoxide formation in the retinas of the diabetic group, which was decreased in the group treated with simvastatin. Western blot analysis showed that NADPH oxidase levels were decreased in the diabetic group and remained normal in the simvastatin-treated group. Simvastatin treatment blocked hyperglycemia-induced increases in VEGF, angiopoietin 2 and erythropoietin levels, as demonstrated by RT-PCR and Western blot analysis.", "answer": "Simvastatin treatment led to suppression of superoxide formation and decreased expression of VEGF, angiopoietin 2 and erythropoietin in diabetic rat retinas.\n\nyes"}
{"question": "Question: Does anti-vascular endothelial growth factor act on retinal microglia/macrophage activation in a rat model of ocular inflammation?\nContext: To evaluate whether anti-vascular endothelial growth factor (VEGF) neutralizing antibodies injected in the vitreous of rat eyes influence retinal microglia and macrophage activation. To dissociate the effect of anti-VEGF on microglia and macrophages subsequent to its antiangiogenic effect, we chose a model of acute intraocular inflammation. Lewis rats were challenged with systemic lipopolysaccharide (LPS) injection and concomitantly received 5 µl of rat anti-VEGF-neutralizing antibody (1.5 mg/ml) in the vitreous. Rat immunoglobulin G (IgG) isotype was used as the control. The effect of anti-VEGF was evaluated at 24 and 48 h clinically (uveitis scores), biologically (cytokine multiplex analysis in ocular media), and histologically (inflammatory cell counts on eye sections). Microglia and macrophages were immunodetected with ionized calcium-binding adaptor molecule 1 (IBA1) staining and counted based on their differential shapes (round amoeboid or ramified dendritiform) on sections and flatmounted retinas using confocal imaging and automatic quantification. Activation of microglia was also evaluated with inducible nitric oxide synthase (iNOS) and IBA1 coimmunostaining. Coimmunolocalization of VEGF receptor 1 and 2 (VEGF-R1 and R2) with IBA1 was performed on eye sections with or without anti-VEGF treatment. Neutralizing rat anti-VEGF antibodies significantly decreased ocular VEGF levels but did not decrease the endotoxin-induced uveitis (EIU) clinical score or the number of infiltrating cells and cytokines in ocular media (interleukin [IL]-1β, IL-6, tumor necrosis factor [TNF]-α, and monocyte chemoattractant protein [MCP]-1). Eyes treated with anti-VEGF showed a significantly decreased number of activated microglia and macrophages in the retina and the choroid and decreased iNOS-positive microglia. IBA1-positive cells expressed VEGF-R1 and R2 in the inflamed retina.", "answer": "Microglia and macrophages expressed VEGF receptors, and intravitreous anti-VEGF influenced the microglia and macrophage activation state. Taking into account that anti-VEGF drugs are repeatedly injected in the vitreous of patients with retinal diseases, part of their effects could result from unsuspected modulation of the microglia activation state. This should be further studied in other ocular pathogenic conditions and human pathology.\n\nyes"}
